CINXE.COM

Frontiers | Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure via Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism

<!doctype html> <html data-n-head-ssr lang="en" data-n-head="%7B%22lang%22:%7B%22ssr%22:%22en%22%7D%7D"> <head > <link data-n-head="ssr" rel="icon" type="image/png" sizes="16x16" href="https://brand.frontiersin.org/m/ed3f9ce840a03d7/favicon_16-tenantFavicon-Frontiers.png"> <link data-n-head="ssr" rel="icon" type="image/png" sizes="32x32" href="https://brand.frontiersin.org/m/ed3f9ce840a03d7/favicon_32-tenantFavicon-Frontiers.png"> <link data-n-head="ssr" rel="apple-touch-icon" type="image/png" sizes="180x180" href="https://brand.frontiersin.org/m/ed3f9ce840a03d7/favicon_180-tenantFavicon-Frontiers.png"> <title>Frontiers | Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure via Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism</title><meta data-n-head="ssr" charset="utf-8"><meta data-n-head="ssr" name="viewport" content="width=device-width, initial-scale=1"><meta data-n-head="ssr" data-hid="charset" charset="utf-8"><meta data-n-head="ssr" data-hid="mobile-web-app-capable" name="mobile-web-app-capable" content="yes"><meta data-n-head="ssr" data-hid="apple-mobile-web-app-title" name="apple-mobile-web-app-title" content="Frontiers | Articles"><meta data-n-head="ssr" data-hid="theme-color" name="theme-color" content="#0C4DED"><meta data-n-head="ssr" data-hid="description" property="description" name="description" content="Diabetic osteoporosis (DOP) belongs to secondary osteoporosis caused by diabetes; it has the characteristics of high morbidity and high disability. In the pr..."><meta data-n-head="ssr" data-hid="og:title" property="og:title" name="title" content="Frontiers | Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure via Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism"><meta data-n-head="ssr" data-hid="og:description" property="og:description" name="description" content="Diabetic osteoporosis (DOP) belongs to secondary osteoporosis caused by diabetes; it has the characteristics of high morbidity and high disability. In the pr..."><meta data-n-head="ssr" data-hid="keywords" name="keywords" content="chondroitin sulfate,diabetes,Osteoporosis,Bone microstructure,bone metabolism"><meta data-n-head="ssr" data-hid="og:site_name" property="og:site_name" name="site_name" content="Frontiers"><meta data-n-head="ssr" data-hid="og:image" property="og:image" name="image" content="https://images-provider.frontiersin.org/api/ipx/w=1200&amp;f=png/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g001.jpg"><meta data-n-head="ssr" data-hid="og:type" property="og:type" name="type" content="article"><meta data-n-head="ssr" data-hid="og:url" property="og:url" name="url" content="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.759843/full"><meta data-n-head="ssr" data-hid="twitter:card" name="twitter:card" content="summary_large_image"><meta data-n-head="ssr" data-hid="citation_volume" name="citation_volume" content="12"><meta data-n-head="ssr" data-hid="citation_journal_title" name="citation_journal_title" content="Frontiers in Endocrinology"><meta data-n-head="ssr" data-hid="citation_publisher" name="citation_publisher" content="Frontiers"><meta data-n-head="ssr" data-hid="citation_journal_abbrev" name="citation_journal_abbrev" content="Front. Endocrinol."><meta data-n-head="ssr" data-hid="citation_issn" name="citation_issn" content="1664-2392"><meta data-n-head="ssr" data-hid="citation_doi" name="citation_doi" content="10.3389/fendo.2021.759843"><meta data-n-head="ssr" data-hid="citation_firstpage" name="citation_firstpage" content="759843"><meta data-n-head="ssr" data-hid="citation_language" name="citation_language" content="English"><meta data-n-head="ssr" data-hid="citation_title" name="citation_title" content="Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure via Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism"><meta data-n-head="ssr" data-hid="citation_keywords" name="citation_keywords" content="chondroitin sulfate; diabetes; Osteoporosis; Bone microstructure; bone metabolism"><meta data-n-head="ssr" data-hid="citation_abstract" name="citation_abstract" content="&lt;p&gt;Diabetic osteoporosis (DOP) belongs to secondary osteoporosis caused by diabetes; it has the characteristics of high morbidity and high disability. In the present study, we constructed a type 1 diabetic rat model and administered chondroitin sulfate (200 mg/kg) for 10 weeks to observe the preventive effect of chondroitin sulfate on the bone loss of diabetic rats. The results showed that chondroitin sulfate can reduce blood glucose and relieve symptoms of diabetic rats; in addition, it can significantly increase the bone mineral density, improve bone microstructure, and reduce bone marrow adipocyte number in diabetic rats; after 10 weeks of chondroitin sulfate administration, the SOD activity level was upregulated, as well as CAT levels, indicating that chondroitin sulfate can alleviate oxidative stress in diabetic rats. Chondroitin sulfate was also found to reduce the level of serum inflammatory cytokines (TNF-α, IL-1, IL-6, and MCP-1) and alleviate the inflammation in diabetic rats; bone metabolism marker detection results showed that chondroitin sulfate can reduce bone turnover in diabetic rats (decreased RANKL, CTX-1, ALP, and TRACP 5b levels were observed after 10 weeks of chondroitin sulfate administration). At the same time, the bone OPG and RUNX 2 expression levels were higher after chondroitin sulfate treatment, the bone RANKL expression was lowered, and the OPG/RANKL ratio was upregulated. All of the above indicated that chondroitin sulfate could prevent STZ-induced DOP and repair bone microstructure; the main mechanism was through anti-oxidation, anti-inflammatory, and regulating bone metabolism. Chondroitin sulfate could be used to develop anti-DOP functional foods and diet interventions for diabetes.&lt;/p&gt;"><meta data-n-head="ssr" data-hid="citation_pdf_url" name="citation_pdf_url" content="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.759843/pdf"><meta data-n-head="ssr" data-hid="citation_online_date" name="citation_online_date" content="2021/09/29"><meta data-n-head="ssr" data-hid="citation_publication_date" name="citation_publication_date" content="2021/10/27"><meta data-n-head="ssr" data-hid="citation_author_0" name="citation_author" content="Qi, Shan Shan"><meta data-n-head="ssr" data-hid="citation_author_institution_0" name="citation_author_institution" content="College of Food Science and Engineering, Northwest Agriculture and Forestry (A&amp;F) University, China"><meta data-n-head="ssr" data-hid="citation_author_1" name="citation_author" content="Shao, Meng Li"><meta data-n-head="ssr" data-hid="citation_author_institution_1" name="citation_author_institution" content="College of Biological Science and Engineering, Shaanxi University of Technology, China"><meta data-n-head="ssr" data-hid="citation_author_2" name="citation_author" content="Sun, Ze"><meta data-n-head="ssr" data-hid="citation_author_institution_2" name="citation_author_institution" content="College of Biological Science and Engineering, Shaanxi University of Technology, China"><meta data-n-head="ssr" data-hid="citation_author_3" name="citation_author" content="Chen, Si Min"><meta data-n-head="ssr" data-hid="citation_author_institution_3" name="citation_author_institution" content="College of Biological Science and Engineering, Shaanxi University of Technology, China"><meta data-n-head="ssr" data-hid="citation_author_4" name="citation_author" content="Hu, Ying Jun"><meta data-n-head="ssr" data-hid="citation_author_institution_4" name="citation_author_institution" content="College of Biological Science and Engineering, Shaanxi University of Technology, China"><meta data-n-head="ssr" data-hid="citation_author_5" name="citation_author" content="Li, Xin Sheng"><meta data-n-head="ssr" data-hid="citation_author_institution_5" name="citation_author_institution" content="College of Biological Science and Engineering, Shaanxi University of Technology, China"><meta data-n-head="ssr" data-hid="citation_author_6" name="citation_author" content="Chen, De Jing"><meta data-n-head="ssr" data-hid="citation_author_institution_6" name="citation_author_institution" content="College of Biological Science and Engineering, Shaanxi University of Technology, China"><meta data-n-head="ssr" data-hid="citation_author_7" name="citation_author" content="Zheng, Hong Xing"><meta data-n-head="ssr" data-hid="citation_author_institution_7" name="citation_author_institution" content="College of Biological Science and Engineering, Shaanxi University of Technology, China"><meta data-n-head="ssr" data-hid="citation_author_8" name="citation_author" content="Yue, Tian Li"><meta data-n-head="ssr" data-hid="citation_author_institution_8" name="citation_author_institution" content="College of Food Science and Engineering, Northwest Agriculture and Forestry (A&amp;F) University, China"><meta data-n-head="ssr" data-hid="dc.identifier" name="dc.identifier" content="doi:10.3389/fendo.2021.759843"><link data-n-head="ssr" rel="manifest" href="/article-pages/_nuxt/manifest.c499fc0a.json" data-hid="manifest"><link data-n-head="ssr" rel="canonical" href="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.759843/full"><script data-n-head="ssr" data-hid="newrelic-browser-script" type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"agent":"","beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"598a124f17","applicationID":"588603994","agentToken":null,"applicationTime":2.806207,"transactionName":"MQcDMkECCkNSW0YMWghNIgldDQFTRxd1IGFJTQ==","queueTime":0,"ttGuid":"cc761c4f97941629"}; (window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"594400880",accountID:"230385",trustKey:"230385",xpid:"VgUHUl5WGwYIXFdSBAgOUg==",licenseKey:"598a124f17",applicationID:"588603994"};;/*! For license information please see nr-loader-spa-1.281.0.min.js.LICENSE.txt */ (()=>{var e,t,r={8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{if(null===e[a]){r[a]=null;continue}Array.isArray(e[a])&&Array.isArray(t[a])?r[a]=Array.from(new Set([...e[a],...t[a]])):"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},2555:(e,t,r)=>{"use strict";r.d(t,{Vp:()=>c,fn:()=>s,x1:()=>u});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){try{const t=c(e);return!!t.licenseKey&&!!t.errorBeacon&&!!t.applicationID}catch(e){return!1}}function c(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function u(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.a)(t,o);const r=(0,n.nY)(e);r&&(r.info=a[e])}},9417:(e,t,r)=>{"use strict";r.d(t,{D0:()=>p,gD:()=>m,xN:()=>g});var n=r(3333),i=r(993);const o=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var a=r(2614),s=r(944),c=r(384),u=r(8122);const d="[data-nr-mask]",l=()=>{const e={feature_flags:[],experimental:{marks:!1,measures:!1,resources:!1},mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,autoStart:!0},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},get feature_flags(){return e.feature_flags},set feature_flags(t){e.feature_flags=t},generic_events:{enabled:!0,autoStart:!0},harvest:{interval:30},jserrors:{enabled:!0,autoStart:!0},logging:{enabled:!0,autoStart:!0,level:i.p_.INFO},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,autoStart:!0},performance:{get capture_marks(){return e.feature_flags.includes(n.$v.MARKS)||e.experimental.marks},set capture_marks(t){e.experimental.marks=t},get capture_measures(){return e.feature_flags.includes(n.$v.MEASURES)||e.experimental.measures},set capture_measures(t){e.experimental.measures=t},capture_detail:!0,resources:{get enabled(){return e.feature_flags.includes(n.$v.RESOURCES)||e.experimental.resources},set enabled(t){e.experimental.resources=t},asset_types:[],first_party_domains:[],ignore_newrelic:!0}},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:a.wk,inactiveMs:a.BB},session_replay:{autoStart:!0,enabled:!1,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){o(t)?e.mask_selector="".concat(t,",").concat(d):""===t||null===t?e.mask_selector=d:(0,s.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){o(t)?e.block_selector+=",".concat(t):""!==t&&(0,s.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,s.R)(7,t)}},session_trace:{enabled:!0,autoStart:!0},soft_navigations:{enabled:!0,autoStart:!0},spa:{enabled:!0,autoStart:!0},ssl:void 0,user_actions:{enabled:!0,elementAttributes:["id","className","tagName","type"]}}},f={},h="All configuration objects require an agent identifier!";function p(e){if(!e)throw new Error(h);if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function g(e,t){if(!e)throw new Error(h);f[e]=(0,u.a)(t,l());const r=(0,c.nY)(e);r&&(r.init=f[e])}function m(e,t){if(!e)throw new Error(h);var r=p(e);if(r){for(var n=t.split("."),i=0;i<n.length-1;i++)if("object"!=typeof(r=r[n[i]]))return;r=r[n[n.length-1]]}return r}},5603:(e,t,r)=>{"use strict";r.d(t,{a:()=>c,o:()=>s});var n=r(384),i=r(8122);const o={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},a={};function s(e){if(!e)throw new Error("All loader-config objects require an agent identifier!");if(!a[e])throw new Error("LoaderConfig for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All loader-config objects require an agent identifier!");a[e]=(0,i.a)(t,o);const r=(0,n.nY)(e);r&&(r.loader_config=a[e])}},3371:(e,t,r)=>{"use strict";r.d(t,{V:()=>f,f:()=>l});var n=r(8122),i=r(384),o=r(6154),a=r(9324);let s=0;const c={buildEnv:a.F3,distMethod:a.Xs,version:a.xv,originTime:o.WN},u={customTransaction:void 0,disabled:!1,isolatedBacklog:!1,loaderType:void 0,maxBytes:3e4,onerror:void 0,ptid:void 0,releaseIds:{},appMetadata:{},session:void 0,denyList:void 0,timeKeeper:void 0,obfuscator:void 0,harvester:void 0},d={};function l(e){if(!e)throw new Error("All runtime objects require an agent identifier!");if(!d[e])throw new Error("Runtime for ".concat(e," was never set"));return d[e]}function f(e,t){if(!e)throw new Error("All runtime objects require an agent identifier!");d[e]={...(0,n.a)(t,u),...c},Object.hasOwnProperty.call(d[e],"harvestCount")||Object.defineProperty(d[e],"harvestCount",{get:()=>++s});const r=(0,i.nY)(e);r&&(r.runtime=d[e])}},9324:(e,t,r)=>{"use strict";r.d(t,{F3:()=>i,Xs:()=>o,Yq:()=>a,xv:()=>n});const n="1.281.0",i="PROD",o="CDN",a="^2.0.0-alpha.17"},6154:(e,t,r)=>{"use strict";r.d(t,{A4:()=>s,OF:()=>d,RI:()=>i,WN:()=>h,bv:()=>o,gm:()=>a,lR:()=>f,m:()=>u,mw:()=>c,sb:()=>l});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),a=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),s="complete"===a?.document?.readyState,c=Boolean("hidden"===a?.document?.visibilityState),u=""+a?.location,d=/iPad|iPhone|iPod/.test(a.navigator?.userAgent),l=d&&"undefined"==typeof SharedWorker,f=(()=>{const e=a.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),h=Date.now()-(0,n.t)()},7295:(e,t,r)=>{"use strict";r.d(t,{Xv:()=>a,gX:()=>i,iW:()=>o});var n=[];function i(e){if(!e||o(e))return!1;if(0===n.length)return!0;for(var t=0;t<n.length;t++){var r=n[t];if("*"===r.hostname)return!1;if(s(r.hostname,e.hostname)&&c(r.pathname,e.pathname))return!1}return!0}function o(e){return void 0===e.hostname}function a(e){if(n=[],e&&e.length)for(var t=0;t<e.length;t++){let r=e[t];if(!r)continue;0===r.indexOf("http://")?r=r.substring(7):0===r.indexOf("https://")&&(r=r.substring(8));const i=r.indexOf("/");let o,a;i>0?(o=r.substring(0,i),a=r.substring(i)):(o=r,a="");let[s]=o.split(":");n.push({hostname:s,pathname:a})}}function s(e,t){return!(e.length>t.length)&&t.indexOf(e)===t.length-e.length}function c(e,t){return 0===e.indexOf("/")&&(e=e.substring(1)),0===t.indexOf("/")&&(t=t.substring(1)),""===e||e===t}},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>c,Ze:()=>l,x3:()=>u});var n=r(7836),i=r(3606),o=r(860),a=r(2646);const s={};function c(e,t){const r={staged:!1,priority:o.P3[t]||0};d(e),s[e].get(t)||s[e].set(t,r)}function u(e,t){e&&s[e]&&(s[e].get(t)&&s[e].delete(t),h(e,t,!1),s[e].size&&f(e))}function d(e){if(!e)throw new Error("agentIdentifier required");s[e]||(s[e]=new Map)}function l(e="",t="feature",r=!1){if(d(e),!e||!s[e].get(t)||r)return h(e,t);s[e].get(t).staged=!0,f(e)}function f(e){const t=Array.from(s[e]);t.every((([e,t])=>t.staged))&&(t.sort(((e,t)=>e[1].priority-t[1].priority)),t.forEach((([t])=>{s[e].delete(t),h(e,t)})))}function h(e,t,r=!0){const o=e?n.ee.get(e):n.ee,s=i.i.handlers;if(!o.aborted&&o.backlog&&s){if(r){const e=o.backlog[t],r=s[t];if(r){for(let t=0;e&&t<e.length;++t)p(e[t],r);Object.entries(r).forEach((([e,t])=>{Object.values(t||{}).forEach((t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])}))}))}}o.isolatedBacklog||delete s[t],o.backlog[t]=null,o.emit("drain-"+t,[])}}function p(e,t){var r=e[1];Object.values(t[r]||{}).forEach((t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}}))}},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>c,ee:()=>u});var n=r(384),i=r(8990),o=r(3371),a=r(2646),s=r(5607);const c="nr@context:".concat(s.W),u=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&(0,o.f)(r).isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(u.aborted&&!i)return;t&&o&&t.emit(e,r,n);for(var a=h(n),c=g(e),d=c.length,l=0;l<d;l++)c[l].apply(a,r);var p=v()[s[e]];p&&p.push([f,e,r,a]);return a},get:m,listeners:g,context:h,buffer:function(e,t){const r=v();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach((([e,n])=>{s[n]=t,t in r||(r[t]=[])}))},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach((e=>{delete f.backlog[e]}))},isBuffering:function(e){return!!v()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function h(e){return e&&e instanceof a.y?e:e?(0,i.I)(e,c,(()=>new a.y(c))):new a.y(c)}function p(e,t){n[e]=g(e).concat(t)}function g(e){return n[e]||[]}function m(t){return d[t]=d[t]||e(f,t)}function v(){return f.backlog}}(void 0,"globalEE"),d=(0,n.Zm)();d.ee||(d.ee=u)},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.d,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>s,ZF:()=>c,bz:()=>a,el:()=>u});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map((e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const a=[];for(var s=0;s<e;s++)a.push(o(r,i++).toString(16));return a.join("")}function c(){return s(16)}function u(){return s(32)}},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>a,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>s,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,a=18e5,s={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},7485:(e,t,r)=>{"use strict";r.d(t,{D:()=>i});var n=r(6154);function i(e){if(0===(e||"").indexOf("data:"))return{protocol:"data"};try{const t=new URL(e,location.href),r={port:t.port,hostname:t.hostname,pathname:t.pathname,search:t.search,protocol:t.protocol.slice(0,t.protocol.indexOf(":")),sameOrigin:t.protocol===n.gm?.location?.protocol&&t.host===n.gm?.location?.host};return r.port&&""!==r.port||("http:"===t.protocol&&(r.port="80"),"https:"===t.protocol&&(r.port="443")),r.pathname&&""!==r.pathname?r.pathname.startsWith("/")||(r.pathname="/".concat(r.pathname)):r.pathname="/",r}catch(e){return{}}}},944:(e,t,r)=>{"use strict";function n(e,t){"function"==typeof console.debug&&console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t)}r.d(t,{R:()=>n})},5284:(e,t,r)=>{"use strict";r.d(t,{t:()=>c,B:()=>s});var n=r(7836),i=r(6154);const o="newrelic";const a=new Set,s={};function c(e,t){const r=n.ee.get(t);s[t]??={},e&&"object"==typeof e&&(a.has(t)||(r.emit("rumresp",[e]),s[t]=e,a.add(t),function(e={}){try{i.gm.dispatchEvent(new CustomEvent(o,{detail:e}))}catch(e){}}({loaded:!0})))}},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout((()=>{i=clearTimeout(i)}),t)),n||(clearTimeout(i),i=setTimeout((()=>{e.apply(this,r)}),t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},3304:(e,t,r)=>{"use strict";r.d(t,{A:()=>o});var n=r(7836);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())??""}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}return""}}},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,sB:()=>a});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function a(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}},384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>o,US:()=>d,Zm:()=>a,bQ:()=>c,dV:()=>s,nY:()=>u,pV:()=>l});var n=r(6154),i=r(1863);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function s(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket}),e}function c(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function u(e){let t=a();return t.initializedAgents?.[e]}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",(function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)}),r,i)}},8139:(e,t,r)=>{"use strict";r.d(t,{u:()=>f});var n=r(7836),i=r(3434),o=r(8990),a=r(6154);const s={},c=a.gm.XMLHttpRequest,u="addEventListener",d="removeEventListener",l="nr@wrapped:".concat(n.P);function f(e){var t=function(e){return(e||n.ee).get("events")}(e);if(s[t.debugId]++)return t;s[t.debugId]=1;var r=(0,i.YM)(t,!0);function f(e){r.inPlace(e,[u,d],"-",p)}function p(e,t){return e[1]}return"getPrototypeOf"in Object&&(a.RI&&h(document,f),c&&h(c.prototype,f),h(a.gm,f)),t.on(u+"-start",(function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var i=(0,o.I)(n,l,(function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n}));this.wrapped=e[1]=i}})),t.on(d+"-start",(function(e){e[1]=this.wrapped||e[1]})),t}function h(e,t,...r){let n=e;for(;"object"==typeof n&&!Object.prototype.hasOwnProperty.call(n,u);)n=Object.getPrototypeOf(n);n&&t(n,...r)}},3434:(e,t,r)=>{"use strict";r.d(t,{Jt:()=>o,YM:()=>c});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W);var a=Object.prototype.hasOwnProperty,s=!1;function c(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const a="-"===n.charAt(0);for(let s=0;s<t.length;s++){const c=t[s],u=e[c];d(u)||(e[c]=r(u,a?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,s,c){return d(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach((function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})})),t}catch(e){u([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,d,l;try{a=this,o=[...arguments],d="function"==typeof n?n(o,a):n||{}}catch(t){u([t,"",[o,a,s],d],e)}i(r+"start",[o,a,s],d,c);try{return l=t.apply(a,o)}catch(e){throw i(r+"err",[o,a,e],d,c),e}finally{i(r+"end",[o,a,l],d,c)}}}function i(r,n,i,o){if(!s||t){var a=s;s=!0;try{e.emit(r,n,i,t,o)}catch(t){u([t,r,n,i],e)}s=a}}}function u(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function d(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},9300:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.ajax},3333:(e,t,r)=>{"use strict";r.d(t,{$v:()=>u,TZ:()=>n,Zp:()=>i,kd:()=>c,mq:()=>s,nf:()=>a,qN:()=>o});const n=r(860).K7.genericEvents,i=["auxclick","click","copy","keydown","paste","scrollend"],o=["focus","blur"],a=4,s=1e3,c=["PageAction","UserAction","BrowserPerformance"],u={MARKS:"experimental.marks",MEASURES:"experimental.measures",RESOURCES:"experimental.resources"}},6774:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.jserrors},993:(e,t,r)=>{"use strict";r.d(t,{ET:()=>o,TZ:()=>a,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o="log",a=n.K7.logging},3785:(e,t,r)=>{"use strict";r.d(t,{R:()=>c,b:()=>u});var n=r(9908),i=r(1863),o=r(860),a=r(3969),s=r(993);function c(e,t,r={},c=s.p_.INFO){(0,n.p)(a.xV,["API/logging/".concat(c.toLowerCase(),"/called")],void 0,o.K7.metrics,e),(0,n.p)(s.ET,[(0,i.t)(),t,r,c],void 0,o.K7.logging,e)}function u(e){return"string"==typeof e&&Object.values(s.p_).some((t=>t===e.toUpperCase().trim()))}},3969:(e,t,r)=>{"use strict";r.d(t,{TZ:()=>n,XG:()=>s,rs:()=>i,xV:()=>a,z_:()=>o});const n=r(860).K7.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},6344:(e,t,r)=>{"use strict";r.d(t,{BB:()=>d,G4:()=>o,Qb:()=>l,TZ:()=>i,Ug:()=>a,_s:()=>s,bc:()=>u,yP:()=>c});var n=r(2614);const i=r(860).K7.sessionReplay,o={RECORD:"recordReplay",PAUSE:"pauseReplay",REPLAY_RUNNING:"replayRunning",ERROR_DURING_REPLAY:"errorDuringReplay"},a=.12,s={DomContentLoaded:0,Load:1,FullSnapshot:2,IncrementalSnapshot:3,Meta:4,Custom:5},c={[n.g.ERROR]:15e3,[n.g.FULL]:3e5,[n.g.OFF]:0},u={RESET:{message:"Session was reset",sm:"Reset"},IMPORT:{message:"Recorder failed to import",sm:"Import"},TOO_MANY:{message:"429: Too Many Requests",sm:"Too-Many"},TOO_BIG:{message:"Payload was too large",sm:"Too-Big"},CROSS_TAB:{message:"Session Entity was set to OFF on another tab",sm:"Cross-Tab"},ENTITLEMENTS:{message:"Session Replay is not allowed and will not be started",sm:"Entitlement"}},d=5e3,l={API:"api"}},5270:(e,t,r)=>{"use strict";r.d(t,{Aw:()=>c,CT:()=>u,SR:()=>s});var n=r(384),i=r(9417),o=r(7767),a=r(6154);function s(e){return!!(0,n.dV)().o.MO&&(0,o.V)(e)&&!0===(0,i.gD)(e,"session_trace.enabled")}function c(e){return!0===(0,i.gD)(e,"session_replay.preload")&&s(e)}function u(e,t){const r=t.correctAbsoluteTimestamp(e);return{originalTimestamp:e,correctedTimestamp:r,timestampDiff:e-r,originTime:a.WN,correctedOriginTime:t.correctedOriginTime,originTimeDiff:Math.floor(a.WN-t.correctedOriginTime)}}},3738:(e,t,r)=>{"use strict";r.d(t,{He:()=>i,Kp:()=>s,Lc:()=>u,Rz:()=>d,TZ:()=>n,bD:()=>o,d3:()=>a,jx:()=>l,uP:()=>c});const n=r(860).K7.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState",l=1e3},3962:(e,t,r)=>{"use strict";r.d(t,{AM:()=>o,O2:()=>c,Qu:()=>u,TZ:()=>s,ih:()=>d,pP:()=>a,tC:()=>i});var n=r(860);const i=["click","keydown","submit","popstate"],o="api",a="initialPageLoad",s=n.K7.softNav,c={INITIAL_PAGE_LOAD:"",ROUTE_CHANGE:1,UNSPECIFIED:2},u={INTERACTION:1,AJAX:2,CUSTOM_END:3,CUSTOM_TRACER:4},d={IP:"in progress",FIN:"finished",CAN:"cancelled"}},7378:(e,t,r)=>{"use strict";r.d(t,{$p:()=>x,BR:()=>b,Kp:()=>R,L3:()=>y,Lc:()=>c,NC:()=>o,SG:()=>d,TZ:()=>i,U6:()=>p,UT:()=>m,d3:()=>w,dT:()=>f,e5:()=>T,gx:()=>v,l9:()=>l,oW:()=>h,op:()=>g,rw:()=>u,tH:()=>A,uP:()=>s,wW:()=>E,xq:()=>a});var n=r(384);const i=r(860).K7.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",l="remaining",f="interaction",h="spaNode",p="jsonpNode",g="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=(0,n.dV)().o.ST,w="-start",R="-end",x="-body",E="cb"+R,T="jsTime",A="fetch"},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},7767:(e,t,r)=>{"use strict";r.d(t,{V:()=>o});var n=r(9417),i=r(6154);const o=e=>i.RI&&!0===(0,n.gD)(e,"privacy.cookies_enabled")},425:(e,t,r)=>{"use strict";r.d(t,{j:()=>j});var n=r(860),i=r(2555),o=r(3371),a=r(9908),s=r(7836),c=r(1687),u=r(5289),d=r(6154),l=r(944),f=r(3969),h=r(384),p=r(6344);const g=["setErrorHandler","finished","addToTrace","addRelease","recordCustomEvent","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId","setApplicationVersion","start",p.G4.RECORD,p.G4.PAUSE,"log","wrapLogger"],m=["setErrorHandler","finished","addToTrace","addRelease"];var v=r(1863),b=r(2614),y=r(993),w=r(3785),R=r(2646),x=r(3434);const E=new Map;function T(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||s.ee).get("logger")}(e),o=(0,x.YM)(i),a=new R.y(s.P);a.level=n.level,a.customAttributes=n.customAttributes;const c=t[r]?.[x.Jt]||t[r];return E.set(c,a),o.inPlace(t,[r],"wrap-logger-",(()=>E.get(c))),i}function A(){const e=(0,h.pV)();g.forEach((t=>{e[t]=(...r)=>function(t,...r){let n=[];return Object.values(e.initializedAgents).forEach((e=>{e&&e.api?e.exposed&&e.api[t]&&n.push(e.api[t](...r)):(0,l.R)(38,t)})),n.length>1?n:n[0]}(t,...r)}))}const S={};var N=r(9417),_=r(5603),O=r(5284);const I=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};let P=!1;function j(e,t={},g,R){let{init:x,info:E,loader_config:j,runtime:C={},exposed:k=!0}=t;C.loaderType=g;const L=(0,h.pV)();E||(x=L.init,E=L.info,j=L.loader_config),(0,N.xN)(e.agentIdentifier,x||{}),(0,_.a)(e.agentIdentifier,j||{}),E.jsAttributes??={},d.bv&&(E.jsAttributes.isWorker=!0),(0,i.x1)(e.agentIdentifier,E);const H=(0,N.D0)(e.agentIdentifier),M=[E.beacon,E.errorBeacon];P||(H.proxy.assets&&(I(H.proxy.assets),M.push(H.proxy.assets)),H.proxy.beacon&&M.push(H.proxy.beacon),A(),(0,h.US)("activatedFeatures",O.B),e.runSoftNavOverSpa&&=!0===H.soft_navigations.enabled&&H.feature_flags.includes("soft_nav")),C.denyList=[...H.ajax.deny_list||[],...H.ajax.block_internal?M:[]],C.ptid=e.agentIdentifier,(0,o.V)(e.agentIdentifier,C),e.ee=s.ee.get(e.agentIdentifier),void 0===e.api&&(e.api=function(e,t,h=!1){t||(0,c.Ak)(e,"api");const g={};var R=s.ee.get(e),x=R.get("tracer");S[e]=b.g.OFF,R.on(p.G4.REPLAY_RUNNING,(t=>{S[e]=t}));var E="api-",A=E+"ixn-";function N(t,r,n,o){const a=(0,i.Vp)(e);return null===r?delete a.jsAttributes[t]:(0,i.x1)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),I(E,n,!0,o||null===r?"session":void 0)(t,r)}function _(){}g.log=function(e,{customAttributes:t={},level:r=y.p_.INFO}={}){(0,a.p)(f.xV,["API/log/called"],void 0,n.K7.metrics,R),(0,w.R)(R,e,t,r)},g.wrapLogger=(e,t,{customAttributes:r={},level:i=y.p_.INFO}={})=>{(0,a.p)(f.xV,["API/wrapLogger/called"],void 0,n.K7.metrics,R),T(R,e,t,{customAttributes:r,level:i})},m.forEach((e=>{g[e]=I(E,e,!0,"api")})),g.addPageAction=I(E,"addPageAction",!0,n.K7.genericEvents),g.recordCustomEvent=I(E,"recordCustomEvent",!0,n.K7.genericEvents),g.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,o.f)(e).customTransaction=(r||"http://custom.transaction")+t,I(E,"setPageViewName",!0)()},g.setCustomAttribute=function(e,t,r=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof t)||null===t)return N(e,t,"setCustomAttribute",r);(0,l.R)(40,typeof t)}else(0,l.R)(39,typeof e)},g.setUserId=function(e){if("string"==typeof e||null===e)return N("enduser.id",e,"setUserId",!0);(0,l.R)(41,typeof e)},g.setApplicationVersion=function(e){if("string"==typeof e||null===e)return N("application.version",e,"setApplicationVersion",!1);(0,l.R)(42,typeof e)},g.start=()=>{try{(0,a.p)(f.xV,["API/start/called"],void 0,n.K7.metrics,R),R.emit("manual-start-all")}catch(e){(0,l.R)(23,e)}},g[p.G4.RECORD]=function(){(0,a.p)(f.xV,["API/recordReplay/called"],void 0,n.K7.metrics,R),(0,a.p)(p.G4.RECORD,[],void 0,n.K7.sessionReplay,R)},g[p.G4.PAUSE]=function(){(0,a.p)(f.xV,["API/pauseReplay/called"],void 0,n.K7.metrics,R),(0,a.p)(p.G4.PAUSE,[],void 0,n.K7.sessionReplay,R)},g.interaction=function(e){return(new _).get("object"==typeof e?e:{})};const O=_.prototype={createTracer:function(e,t){var r={},i=this,o="function"==typeof t;return(0,a.p)(f.xV,["API/createTracer/called"],void 0,n.K7.metrics,R),h||(0,a.p)(A+"tracer",[(0,v.t)(),e,r],i,n.K7.spa,R),function(){if(x.emit((o?"":"no-")+"fn-start",[(0,v.t)(),i,o],r),o)try{return t.apply(this,arguments)}catch(e){const t="string"==typeof e?new Error(e):e;throw x.emit("fn-err",[arguments,this,t],r),t}finally{x.emit("fn-end",[(0,v.t)()],r)}}}};function I(e,t,r,i){return function(){return(0,a.p)(f.xV,["API/"+t+"/called"],void 0,n.K7.metrics,R),i&&(0,a.p)(e+t,[r?(0,v.t)():performance.now(),...arguments],r?null:this,i,R),r?void 0:this}}function P(){r.e(478).then(r.bind(r,8778)).then((({setAPI:t})=>{t(e),(0,c.Ze)(e,"api")})).catch((e=>{(0,l.R)(27,e),R.abort()}))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{O[e]=I(A,e,void 0,h?n.K7.softNav:n.K7.spa)})),g.setCurrentRouteName=h?I(A,"routeName",void 0,n.K7.softNav):I(E,"routeName",!0,n.K7.spa),g.noticeError=function(t,r){"string"==typeof t&&(t=new Error(t)),(0,a.p)(f.xV,["API/noticeError/called"],void 0,n.K7.metrics,R),(0,a.p)("err",[t,(0,v.t)(),!1,r,!!S[e]],void 0,n.K7.jserrors,R)},d.RI?(0,u.GG)((()=>P()),!0):P(),g}(e.agentIdentifier,R,e.runSoftNavOverSpa)),void 0===e.exposed&&(e.exposed=k),P=!0}},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>u,K7:()=>s,P3:()=>c,XX:()=>i,qY:()=>n,v4:()=>a});const n="events",i="jserrors",o="browser/blobs",a="rum",s={ajax:"ajax",genericEvents:"generic_events",jserrors:i,logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},c={[s.pageViewEvent]:1,[s.pageViewTiming]:2,[s.metrics]:3,[s.jserrors]:4,[s.spa]:5,[s.ajax]:6,[s.sessionTrace]:7,[s.softNav]:8,[s.sessionReplay]:9,[s.logging]:10,[s.genericEvents]:11},u={[s.pageViewEvent]:a,[s.pageViewTiming]:n,[s.ajax]:n,[s.spa]:n,[s.softNav]:n,[s.metrics]:i,[s.jserrors]:i,[s.sessionTrace]:o,[s.sessionReplay]:o,[s.logging]:"browser/logs",[s.genericEvents]:"ins"}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>({212:"nr-spa-compressor",249:"nr-spa-recorder",478:"nr-spa"}[e]+"-1.281.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.281.0.PROD:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){s=l;break}}if(!s){c=!0;var f={478:"sha512-jmvAlmjCn64ans8tLueqHRlBI/iWekylsDWb94A77CG0ukSriVDvgD3dThx+XjUSBBBMYhFn8B1a18fViyBPEQ==",249:"sha512-ICY/ZrcytM/86t5KFy+9OAWVYmNNJy10EBtxoSUGjQWuZx53p/eLo+L8HfrGjvHuRHRnutqLTGSnvNttffJkaA==",212:"sha512-pQSn+X/RfBOvx/49HvlghaiXMLhhDQXTi13n1N2XMpDquWJgs9U0pbqE3RbAnYC9nsdaTu/RVGvneEPv1fpCxA=="};(s=document.createElement("script")).charset="utf-8",s.timeout=120,i.nc&&s.setAttribute("nonce",i.nc),s.setAttribute("data-webpack",t+o),s.src=r,0!==s.src.indexOf(window.location.origin+"/")&&(s.crossOrigin="anonymous"),f[a]&&(s.integrity=f[a])}e[r]=[n];var h=(t,n)=>{s.onerror=s.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},p=setTimeout(h.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=h.bind(null,s.onerror),s.onload=h.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={38:0,788:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u<a.length;u++)o=a[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.281.0.PROD"]=self["webpackChunk:NRBA-1.281.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(944),t=i(6344),r=i(9566);class n{agentIdentifier;constructor(){this.agentIdentifier=(0,r.LA)(16)}#e(t,...r){if("function"==typeof this.api?.[t])return this.api[t](...r);(0,e.R)(35,t)}addPageAction(e,t){return this.#e("addPageAction",e,t)}recordCustomEvent(e,t){return this.#e("recordCustomEvent",e,t)}setPageViewName(e,t){return this.#e("setPageViewName",e,t)}setCustomAttribute(e,t,r){return this.#e("setCustomAttribute",e,t,r)}noticeError(e,t){return this.#e("noticeError",e,t)}setUserId(e){return this.#e("setUserId",e)}setApplicationVersion(e){return this.#e("setApplicationVersion",e)}setErrorHandler(e){return this.#e("setErrorHandler",e)}addRelease(e,t){return this.#e("addRelease",e,t)}log(e,t){return this.#e("log",e,t)}}class o extends n{#e(t,...r){if("function"==typeof this.api?.[t])return this.api[t](...r);(0,e.R)(35,t)}start(){return this.#e("start")}finished(e){return this.#e("finished",e)}recordReplay(){return this.#e(t.G4.RECORD)}pauseReplay(){return this.#e(t.G4.PAUSE)}addToTrace(e){return this.#e("addToTrace",e)}setCurrentRouteName(e){return this.#e("setCurrentRouteName",e)}interaction(){return this.#e("interaction")}wrapLogger(e,t,r){return this.#e("wrapLogger",e,t,r)}}var a=i(860),s=i(9417);const c=Object.values(a.K7);function u(e){const t={};return c.forEach((r=>{t[r]=function(e,t){return!0===(0,s.gD)(t,"".concat(e,".enabled"))}(r,e)})),t}var d=i(425);var l=i(1687),f=i(4234),h=i(5289),p=i(6154),g=i(5270),m=i(7767),v=i(6389);class b extends f.W{constructor(e,t,r=!0){super(e.agentIdentifier,t),this.auto=r,this.abortHandler=void 0,this.featAggregate=void 0,this.onAggregateImported=void 0,!1===e.init[this.featureName].autoStart&&(this.auto=!1),this.auto?(0,l.Ak)(e.agentIdentifier,t):this.ee.on("manual-start-all",(0,v.J)((()=>{(0,l.Ak)(e.agentIdentifier,this.featureName),this.auto=!0,this.importAggregator(e)})))}importAggregator(t,r={}){if(this.featAggregate||!this.auto)return;let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let o;try{if((0,m.V)(this.agentIdentifier)){const{setupAgentSession:e}=await i.e(478).then(i.bind(i,6526));o=e(t)}}catch(t){(0,e.R)(20,t),this.ee.emit("internal-error",[t]),this.featureName===a.K7.sessionReplay&&this.abortHandler?.()}try{if(!this.#t(this.featureName,o))return(0,l.Ze)(this.agentIdentifier,this.featureName),void n(!1);const{lazyFeatureLoader:e}=await i.e(478).then(i.bind(i,6103)),{Aggregate:a}=await e(this.featureName,"aggregate");this.featAggregate=new a(t,r),t.runtime.harvester.initializedAggregates.push(this.featAggregate),n(!0)}catch(t){(0,e.R)(34,t),this.abortHandler?.(),(0,l.Ze)(this.agentIdentifier,this.featureName,!0),n(!1),this.ee&&this.ee.abort()}};p.RI?(0,h.GG)((()=>o()),!0):o()}#t(e,t){switch(e){case a.K7.sessionReplay:return(0,g.SR)(this.agentIdentifier)&&!!t;case a.K7.sessionTrace:return!!t;default:return!0}}}var y=i(6630);class w extends b{static featureName=y.T;constructor(e,t=!0){super(e,y.T,t),this.importAggregator(e)}}var R=i(384);var x=i(9908),E=i(2843),T=i(3878),A=i(782),S=i(1863);class N extends b{static featureName=A.T;constructor(e,t=!0){super(e,A.T,t),p.RI&&((0,E.u)((()=>(0,x.p)("docHidden",[(0,S.t)()],void 0,A.T,this.ee)),!0),(0,T.sp)("pagehide",(()=>(0,x.p)("winPagehide",[(0,S.t)()],void 0,A.T,this.ee))),this.importAggregator(e))}}var _=i(3969);class O extends b{static featureName=_.TZ;constructor(e,t=!0){super(e,_.TZ,t),this.importAggregator(e)}}var I=i(6774),P=i(3304);class j{constructor(e,t,r,n,i){this.name="UncaughtError",this.message="string"==typeof e?e:(0,P.A)(e),this.sourceURL=t,this.line=r,this.column=n,this.__newrelic=i}}function C(e){return H(e)?e:new j(void 0!==e?.message?e.message:e,e?.filename||e?.sourceURL,e?.lineno||e?.line,e?.colno||e?.col,e?.__newrelic)}function k(e){const t="Unhandled Promise Rejection";if(!e?.reason)return;if(H(e.reason))try{return e.reason.message=t+": "+e.reason.message,C(e.reason)}catch(t){return C(e.reason)}const r=C(e.reason);return r.message=t+": "+r?.message,r}function L(e){if(e.error instanceof SyntaxError&&!/:\d+$/.test(e.error.stack?.trim())){const t=new j(e.message,e.filename,e.lineno,e.colno,e.error.__newrelic);return t.name=SyntaxError.name,t}return H(e.error)?e.error:C(e)}function H(e){return e instanceof Error&&!!e.stack}class M extends b{static featureName=I.T;#r=!1;constructor(e,r=!0){super(e,I.T,r);try{this.removeOnAbort=new AbortController}catch(e){}this.ee.on("internal-error",((e,t)=>{this.abortHandler&&(0,x.p)("ierr",[C(e),(0,S.t)(),!0,{},this.#r,t],void 0,this.featureName,this.ee)})),this.ee.on(t.G4.REPLAY_RUNNING,(e=>{this.#r=e})),p.gm.addEventListener("unhandledrejection",(e=>{this.abortHandler&&(0,x.p)("err",[k(e),(0,S.t)(),!1,{unhandledPromiseRejection:1},this.#r],void 0,this.featureName,this.ee)}),(0,T.jT)(!1,this.removeOnAbort?.signal)),p.gm.addEventListener("error",(e=>{this.abortHandler&&(0,x.p)("err",[L(e),(0,S.t)(),!1,{},this.#r],void 0,this.featureName,this.ee)}),(0,T.jT)(!1,this.removeOnAbort?.signal)),this.abortHandler=this.#n,this.importAggregator(e)}#n(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var D=i(8990);let K=1;const U="nr@id";function V(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===p.gm?0:(0,D.I)(e,U,(function(){return K++}))}function G(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,P.A)(e).length}catch(e){return}}}var F=i(8139),B=i(7836),W=i(3434);const z={},q=["open","send"];function Z(t){var r=t||B.ee;const n=function(e){return(e||B.ee).get("xhr")}(r);if(void 0===p.gm.XMLHttpRequest)return n;if(z[n.debugId]++)return n;z[n.debugId]=1,(0,F.u)(r);var i=(0,W.YM)(n),o=p.gm.XMLHttpRequest,a=p.gm.MutationObserver,s=p.gm.Promise,c=p.gm.setInterval,u="readystatechange",d=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],l=[],f=p.gm.XMLHttpRequest=function(t){const r=new o(t),a=n.context(r);try{n.emit("new-xhr",[r],a),r.addEventListener(u,(s=a,function(){var e=this;e.readyState>3&&!s.resolved&&(s.resolved=!0,n.emit("xhr-resolved",[],e)),i.inPlace(e,d,"fn-",y)}),(0,T.jT)(!1))}catch(t){(0,e.R)(15,t);try{n.emit("internal-error",[t])}catch(e){}}var s;return r};function h(e,t){i.inPlace(t,["onreadystatechange"],"fn-",y)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,f),f.prototype=o.prototype,i.inPlace(f.prototype,q,"-xhr-",y),n.on("send-xhr-start",(function(e,t){h(e,t),function(e){l.push(e),a&&(g?g.then(b):c?c(b):(m=-m,v.data=m))}(t)})),n.on("open-xhr-start",h),a){var g=s&&s.resolve();if(!c&&!s){var m=1,v=document.createTextNode(m);new a(b).observe(v,{characterData:!0})}}else r.on("fn-end",(function(e){e[0]&&e[0].type===u||b()}));function b(){for(var e=0;e<l.length;e++)h(0,l[e]);l.length&&(l=[])}function y(e,t){return t}return n}var Y="fetch-",X=Y+"body-",J=["arrayBuffer","blob","json","text","formData"],Q=p.gm.Request,ee=p.gm.Response,te="prototype";const re={};function ne(e){const t=function(e){return(e||B.ee).get("fetch")}(e);if(!(Q&&ee&&p.gm.fetch))return t;if(re[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[B.P]&&o[B.P].dt&&(e=o[B.P].dt);var a=i.apply(this,r);return t.emit(n+"start",[r,e],a),a.then((function(e){return t.emit(n+"end",[null,e],a),e}),(function(e){throw t.emit(n+"end",[e],a),e}))})}return re[t.debugId]=1,J.forEach((e=>{r(Q[te],e,X),r(ee[te],e,X)})),r(p.gm,"fetch",Y),t.on(Y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(Y+"done",[null,r],n)}else t.emit(Y+"done",[e],n)})),t}var ie=i(7485),oe=i(5603);class ae{constructor(e){this.agentIdentifier=e}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var t=(0,oe.o)(this.agentIdentifier);if(!t)return null;var n=(t.accountID||"").toString()||null,i=(t.agentID||"").toString()||null,o=(t.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,r.ZF)(),s=(0,r.el)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof p.gm?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,P.A)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var t=!1,r={};if((0,s.gD)(this.agentIdentifier,"distributed_tracing")&&(r=(0,s.D0)(this.agentIdentifier).distributed_tracing),e.sameOrigin)t=!0;else if(r.allowed_origins instanceof Array)for(var n=0;n<r.allowed_origins.length;n++){var i=(0,ie.D)(r.allowed_origins[n]);if(e.hostname===i.hostname&&e.protocol===i.protocol&&e.port===i.port){t=!0;break}}return t}isDtEnabled(){var e=(0,s.gD)(this.agentIdentifier,"distributed_tracing");return!!e&&!!e.enabled}excludeNewrelicHeader(){var e=(0,s.gD)(this.agentIdentifier,"distributed_tracing");return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=(0,s.gD)(this.agentIdentifier,"distributed_tracing");return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=(0,s.gD)(this.agentIdentifier,"distributed_tracing");return!!e&&!!e.cors_use_tracecontext_headers}}var se=i(9300),ce=i(7295),ue=["load","error","abort","timeout"],de=ue.length,le=(0,R.dV)().o.REQ,fe=(0,R.dV)().o.XHR;class he extends b{static featureName=se.T;constructor(e,t=!0){super(e,se.T,t),this.dt=new ae(e.agentIdentifier),this.handler=(e,t,r,n)=>(0,x.p)(e,t,r,n,this.ee);try{const e={xmlhttprequest:"xhr",fetch:"fetch",beacon:"beacon"};p.gm?.performance?.getEntriesByType("resource").forEach((t=>{if(t.initiatorType in e&&0!==t.responseStatus){const r={status:t.responseStatus},n={rxSize:t.transferSize,duration:Math.floor(t.duration),cbTime:0};pe(r,t.name),this.handler("xhr",[r,n,t.startTime,t.responseEnd,e[t.initiatorType]],void 0,a.K7.ajax)}}))}catch(e){}ne(this.ee),Z(this.ee),function(e,t,r,n){function i(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=R,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){E(t,e)}),(0,T.jT)(!1)),p.lR||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,T.jT)(!1))}function o(e){this.params={method:e[0]},pe(this,e[1]),this.metrics={}}function s(t,r){e.loader_config.xpid&&this.sameOrigin&&r.setRequestHeader("X-NewRelic-ID",e.loader_config.xpid);var i=n.generateTracePayload(this.parsedOrigin);if(i){var o=!1;i.newrelicHeader&&(r.setRequestHeader("newrelic",i.newrelicHeader),o=!0),i.traceContextParentHeader&&(r.setRequestHeader("traceparent",i.traceContextParentHeader),i.traceContextStateHeader&&r.setRequestHeader("tracestate",i.traceContextStateHeader),o=!0),o&&(this.dt=i)}}function c(e,r){var n=this.metrics,i=e[0],o=this;if(n&&i){var a=G(i);a&&(n.txSize=a)}this.startTime=(0,S.t)(),this.body=i,this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof r.onload)&&"function"==typeof o.end)&&o.end(r)}catch(e){try{t.emit("internal-error",[e])}catch(e){}}};for(var s=0;s<de;s++)r.addEventListener(ue[s],this.listener,(0,T.jT)(!1))}function u(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function d(e,t){var r=""+V(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function l(e,t){var r=""+V(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function f(){this.endTime=(0,S.t)()}function h(e,r){r instanceof fe&&"load"===e[0]&&t.emit("xhr-load-added",[e[1],e[2]],r)}function g(e,r){r instanceof fe&&"load"===e[0]&&t.emit("xhr-load-removed",[e[1],e[2]],r)}function m(e,t,r){t instanceof fe&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,S.t)()))}function v(e,r){this.xhrCbStart&&t.emit("xhr-cb-time",[(0,S.t)()-this.xhrCbStart,this.onload,r],r)}function b(e){var t,r=e[1]||{};if("string"==typeof e[0]?0===(t=e[0]).length&&p.RI&&(t=""+p.gm.location.href):e[0]&&e[0].url?t=e[0].url:p.gm?.URL&&e[0]&&e[0]instanceof URL?t=e[0].href:"function"==typeof e[0].toString&&(t=e[0].toString()),"string"==typeof t&&0!==t.length){t&&(this.parsedOrigin=(0,ie.D)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var i=n.generateTracePayload(this.parsedOrigin);if(i&&(i.newrelicHeader||i.traceContextParentHeader))if(e[0]&&e[0].headers)s(e[0].headers,i)&&(this.dt=i);else{var o={};for(var a in r)o[a]=r[a];o.headers=new Headers(r.headers||{}),s(o.headers,i)&&(this.dt=i),e.length>1?e[1]=o:e.push(o)}}function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function y(e,t){this.params={},this.metrics={},this.startTime=(0,S.t)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof le?r=i.url:p.gm?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),pe(this,r);var o=(""+(i&&i instanceof le&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.body=n.body,this.txSize=G(n.body)||0}function w(e,t){if(this.endTime=(0,S.t)(),this.params||(this.params={}),(0,ce.iW)(this.params))return;let n;this.params.status=t?t.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);const i={txSize:this.txSize,rxSize:n,duration:(0,S.t)()-this.startTime};r("xhr",[this.params,i,this.startTime,this.endTime,"fetch"],this,a.K7.ajax)}function R(e){const t=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(let t=0;t<de;t++)e.removeEventListener(ue[t],this.listener,!1);t.aborted||(0,ce.iW)(t)||(n.duration=(0,S.t)()-this.startTime,this.loadCaptureCalled||4!==e.readyState?null==t.status&&(t.status=0):E(this,e),n.cbTime=this.cbTime,r("xhr",[t,n,this.startTime,this.endTime,"xhr"],this,a.K7.ajax))}}function E(e,r){e.params.status=r.status;var n=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?G(e.response):"text"===r||""===r||void 0===r?G(e.responseText):void 0}(r,e.lastSize);if(n&&(e.metrics.rxSize=n),e.sameOrigin){var i=r.getResponseHeader("X-NewRelic-App-Data");i&&((0,x.p)(_.rs,["Ajax/CrossApplicationTracing/Header/Seen"],void 0,a.K7.metrics,t),e.params.cat=i.split(", ").pop())}e.loadCaptureCalled=!0}t.on("new-xhr",i),t.on("open-xhr-start",o),t.on("open-xhr-end",s),t.on("send-xhr-start",c),t.on("xhr-cb-time",u),t.on("xhr-load-added",d),t.on("xhr-load-removed",l),t.on("xhr-resolved",f),t.on("addEventListener-end",h),t.on("removeEventListener-end",g),t.on("fn-end",v),t.on("fetch-before-start",b),t.on("fetch-start",y),t.on("fn-start",m),t.on("fetch-done",w)}(e,this.ee,this.handler,this.dt),this.importAggregator(e)}}function pe(e,t){var r=(0,ie.D)(t),n=e.params||e;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}const ge={},me=["pushState","replaceState"];function ve(e){const t=function(e){return(e||B.ee).get("history")}(e);return!p.RI||ge[t.debugId]++||(ge[t.debugId]=1,(0,W.YM)(t).inPlace(window.history,me,"-")),t}var be=i(3738);const{He:ye,bD:we,d3:Re,Kp:xe,TZ:Ee,Lc:Te,uP:Ae,Rz:Se}=be;class Ne extends b{static featureName=Ee;constructor(e,t=!0){super(e,Ee,t);if(!(0,m.V)(this.agentIdentifier))return void this.deregisterDrain();const r=this.ee;let n;ve(r),this.eventsEE=(0,F.u)(r),this.eventsEE.on(Ae,(function(e,t){this.bstStart=(0,S.t)()})),this.eventsEE.on(Te,(function(e,t){(0,x.p)("bst",[e[0],t,this.bstStart,(0,S.t)()],void 0,a.K7.sessionTrace,r)})),r.on(Se+Re,(function(e){this.time=(0,S.t)(),this.startPath=location.pathname+location.hash})),r.on(Se+xe,(function(e){(0,x.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,a.K7.sessionTrace,r)}));try{n=new PerformanceObserver((e=>{const t=e.getEntries();(0,x.p)(ye,[t],void 0,a.K7.sessionTrace,r)})),n.observe({type:we,buffered:!0})}catch(e){}this.importAggregator(e,{resourceObserver:n})}}var _e=i(2614);class Oe extends b{static featureName=t.TZ;#i;#o;constructor(e,r=!0){let n;super(e,t.TZ,r),this.replayRunning=!1,this.#o=e;try{n=JSON.parse(localStorage.getItem("".concat(_e.H3,"_").concat(_e.uh)))}catch(e){}(0,g.SR)(e.agentIdentifier)&&this.ee.on(t.G4.RECORD,(()=>this.#a())),this.#s(n)?(this.#i=n?.sessionReplayMode,this.#c()):this.importAggregator(e),this.ee.on("err",(e=>{this.replayRunning&&(this.errorNoticed=!0,(0,x.p)(t.G4.ERROR_DURING_REPLAY,[e],void 0,this.featureName,this.ee))})),this.ee.on(t.G4.REPLAY_RUNNING,(e=>{this.replayRunning=e}))}#s(e){return e&&(e.sessionReplayMode===_e.g.FULL||e.sessionReplayMode===_e.g.ERROR)||(0,g.Aw)(this.agentIdentifier)}#u=!1;async#c(e){if(!this.#u){this.#u=!0;try{const{Recorder:t}=await Promise.all([i.e(478),i.e(249)]).then(i.bind(i,8589));this.recorder??=new t({mode:this.#i,agentIdentifier:this.agentIdentifier,trigger:e,ee:this.ee,agentRef:this.#o}),this.recorder.startRecording(),this.abortHandler=this.recorder.stopRecording}catch(e){}this.importAggregator(this.#o,{recorder:this.recorder,errorNoticed:this.errorNoticed})}}#a(){this.featAggregate?this.featAggregate.mode!==_e.g.FULL&&this.featAggregate.initializeRecording(_e.g.FULL,!0):(this.#i=_e.g.FULL,this.#c(t.Qb.API),this.recorder&&this.recorder.parent.mode!==_e.g.FULL&&(this.recorder.parent.mode=_e.g.FULL,this.recorder.stopRecording(),this.recorder.startRecording(),this.abortHandler=this.recorder.stopRecording))}}var Ie=i(3962);class Pe extends b{static featureName=Ie.TZ;constructor(e,t=!0){if(super(e,Ie.TZ,t),!p.RI||!(0,R.dV)().o.MO)return;const r=ve(this.ee);Ie.tC.forEach((e=>{(0,T.sp)(e,(e=>{a(e)}),!0)}));const n=()=>(0,x.p)("newURL",[(0,S.t)(),""+window.location],void 0,this.featureName,this.ee);r.on("pushState-end",n),r.on("replaceState-end",n);try{this.removeOnAbort=new AbortController}catch(e){}(0,T.sp)("popstate",(e=>(0,x.p)("newURL",[e.timeStamp,""+window.location],void 0,this.featureName,this.ee)),!0,this.removeOnAbort?.signal);let i=!1;const o=new((0,R.dV)().o.MO)(((e,t)=>{i||(i=!0,requestAnimationFrame((()=>{(0,x.p)("newDom",[(0,S.t)()],void 0,this.featureName,this.ee),i=!1})))})),a=(0,v.s)((e=>{(0,x.p)("newUIEvent",[e],void 0,this.featureName,this.ee),o.observe(document.body,{attributes:!0,childList:!0,subtree:!0,characterData:!0})}),100,{leading:!0});this.abortHandler=function(){this.removeOnAbort?.abort(),o.disconnect(),this.abortHandler=void 0},this.importAggregator(e,{domObserver:o})}}var je=i(7378);const Ce={},ke=["appendChild","insertBefore","replaceChild"];function Le(e){const t=function(e){return(e||B.ee).get("jsonp")}(e);if(!p.RI||Ce[t.debugId])return t;Ce[t.debugId]=!0;var r=(0,W.YM)(t),n=/[?&](?:callback|cb)=([^&#]+)/,i=/(.*)\.([^.]+)/,o=/^(\w+)(\.|$)(.*)$/;function a(e,t){if(!e)return t;const r=e.match(o),n=r[1];return a(r[3],t[n])}return r.inPlace(Node.prototype,ke,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var o=(s=e.src,c=s.match(n),c?c[1]:null);var s,c;if(!o)return;var u=function(e){var t=e.match(i);if(t&&t.length>=3)return{key:t[2],parent:a(t[1],window)};return{key:e,parent:window}}(o);if("function"!=typeof u.parent[u.key])return;var d={};function l(){t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,T.jT)(!1)),e.removeEventListener("error",f,(0,T.jT)(!1))}function f(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,T.jT)(!1)),e.removeEventListener("error",f,(0,T.jT)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",l,(0,T.jT)(!1)),e.addEventListener("error",f,(0,T.jT)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}const He={};function Me(e){const t=function(e){return(e||B.ee).get("promise")}(e);if(He[t.debugId])return t;He[t.debugId]=!0;var r=t.context,n=(0,W.YM)(t),i=p.gm.Promise;return i&&function(){function e(r){var o=t.context(),a=n(r,"executor-",o,null,!1);const s=Reflect.construct(i,[a],e);return t.context(s).getCtx=function(){return o},s}p.gm.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return i.toString()},Object.setPrototypeOf(e,i),["all","race"].forEach((function(r){const n=i[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=i[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=i.prototype;const o=i.prototype.then;i.prototype.then=function(...e){var i=this,a=r(i);a.promise=i,e[0]=n(e[0],"cb-",a,null,!1),e[1]=n(e[1],"cb-",a,null,!1);const s=o.apply(this,e);return a.nextPromise=s,t.emit("propagate",[i,!0],s,!1,!1),s},i.prototype.then[W.Jt]=o,t.on("executor-start",(function(e){e[0]=n(e[0],"resolve-",this,null,!1),e[1]=n(e[1],"resolve-",this,null,!1)})),t.on("executor-err",(function(e,t,r){e[1](r)})),t.on("cb-end",(function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)})),t.on("propagate",(function(e,r,n){this.getCtx&&!r||(this.getCtx=function(){if(e instanceof Promise)var r=t.context(e);return r&&r.getCtx?r.getCtx():this})}))}(),t}const De={},Ke="setTimeout",Ue="setInterval",Ve="clearTimeout",Ge="-start",Fe=[Ke,"setImmediate",Ue,Ve,"clearImmediate"];function Be(e){const t=function(e){return(e||B.ee).get("timer")}(e);if(De[t.debugId]++)return t;De[t.debugId]=1;var r=(0,W.YM)(t);return r.inPlace(p.gm,Fe.slice(0,2),Ke+"-"),r.inPlace(p.gm,Fe.slice(2,3),Ue+"-"),r.inPlace(p.gm,Fe.slice(3),Ve+"-"),t.on(Ue+Ge,(function(e,t,n){e[0]=r(e[0],"fn-",null,n)})),t.on(Ke+Ge,(function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)})),t}const We={};function ze(e){const t=function(e){return(e||B.ee).get("mutation")}(e);if(!p.RI||We[t.debugId])return t;We[t.debugId]=!0;var r=(0,W.YM)(t),n=p.gm.MutationObserver;return n&&(window.MutationObserver=function(e){return this instanceof n?new n(r(e,"fn-")):n.apply(this,arguments)},MutationObserver.prototype=n.prototype),t}const{TZ:qe,d3:Ze,Kp:Ye,$p:Xe,wW:$e,e5:Je,tH:Qe,uP:et,rw:tt,Lc:rt}=je;class nt extends b{static featureName=qe;constructor(e,t=!0){if(super(e,qe,t),!p.RI)return;try{this.removeOnAbort=new AbortController}catch(e){}let r,n=0;const i=this.ee.get("tracer"),o=Le(this.ee),a=Me(this.ee),s=Be(this.ee),c=Z(this.ee),u=this.ee.get("events"),d=ne(this.ee),l=ve(this.ee),f=ze(this.ee);function h(e,t){l.emit("newURL",[""+window.location,t])}function g(){n++,r=window.location.hash,this[et]=(0,S.t)()}function m(){n--,window.location.hash!==r&&h(0,!0);var e=(0,S.t)();this[Je]=~~this[Je]+e-this[et],this[rt]=e}function v(e,t){e.on(t,(function(){this[t]=(0,S.t)()}))}this.ee.on(et,g),a.on(tt,g),o.on(tt,g),this.ee.on(rt,m),a.on($e,m),o.on($e,m),this.ee.on("fn-err",((...t)=>{t[2]?.__newrelic?.[e.agentIdentifier]||(0,x.p)("function-err",[...t],void 0,this.featureName,this.ee)})),this.ee.buffer([et,rt,"xhr-resolved"],this.featureName),u.buffer([et],this.featureName),s.buffer(["setTimeout"+Ye,"clearTimeout"+Ze,et],this.featureName),c.buffer([et,"new-xhr","send-xhr"+Ze],this.featureName),d.buffer([Qe+Ze,Qe+"-done",Qe+Xe+Ze,Qe+Xe+Ye],this.featureName),l.buffer(["newURL"],this.featureName),f.buffer([et],this.featureName),a.buffer(["propagate",tt,$e,"executor-err","resolve"+Ze],this.featureName),i.buffer([et,"no-"+et],this.featureName),o.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),v(d,Qe+Ze),v(d,Qe+"-done"),v(o,"new-jsonp"),v(o,"jsonp-end"),v(o,"cb-start"),l.on("pushState-end",h),l.on("replaceState-end",h),window.addEventListener("hashchange",h,(0,T.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",h,(0,T.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){h(0,n>1)}),(0,T.jT)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#n,this.importAggregator(e)}#n(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var it=i(3333);class ot extends b{static featureName=it.TZ;constructor(e,t=!0){super(e,it.TZ,t);const r=[e.init.page_action.enabled,e.init.performance.capture_marks,e.init.performance.capture_measures,e.init.user_actions.enabled,e.init.performance.resources.enabled];if(p.RI&&(e.init.user_actions.enabled&&(it.Zp.forEach((e=>(0,T.sp)(e,(e=>(0,x.p)("ua",[e],void 0,this.featureName,this.ee)),!0))),it.qN.forEach((e=>{const t=(0,v.s)((e=>{(0,x.p)("ua",[e],void 0,this.featureName,this.ee)}),500,{leading:!0});(0,T.sp)(e,t)}))),e.init.performance.resources.enabled&&p.gm.PerformanceObserver?.supportedEntryTypes.includes("resource"))){new PerformanceObserver((e=>{e.getEntries().forEach((e=>{(0,x.p)("browserPerformance.resource",[e],void 0,this.featureName,this.ee)}))})).observe({type:"resource",buffered:!0})}r.some((e=>e))?this.importAggregator(e):this.deregisterDrain()}}var at=i(993),st=i(3785);class ct extends b{static featureName=at.TZ;constructor(e,t=!0){super(e,at.TZ,t);const r=this.ee;this.ee.on("wrap-logger-end",(function([e]){const{level:t,customAttributes:n}=this;(0,st.R)(r,e,n,t)})),this.importAggregator(e)}}new class extends o{constructor(t){super(),p.gm?(this.features={},(0,R.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(t.features||[]),this.desiredFeatures.add(w),this.runSoftNavOverSpa=[...this.desiredFeatures].some((e=>e.featureName===a.K7.softNav)),(0,d.j)(this,t,t.loaderType||"agent"),this.run()):(0,e.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}run(){try{const t=u(this.agentIdentifier),r=[...this.desiredFeatures];r.sort(((e,t)=>a.P3[e.featureName]-a.P3[t.featureName])),r.forEach((r=>{if(!t[r.featureName]&&r.featureName!==a.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&r.featureName===a.K7.spa)return;if(!this.runSoftNavOverSpa&&r.featureName===a.K7.softNav)return;const n=function(e){switch(e){case a.K7.ajax:return[a.K7.jserrors];case a.K7.sessionTrace:return[a.K7.ajax,a.K7.pageViewEvent];case a.K7.sessionReplay:return[a.K7.sessionTrace];case a.K7.pageViewTiming:return[a.K7.pageViewEvent];default:return[]}}(r.featureName).filter((e=>!(e in this.features)));n.length>0&&(0,e.R)(36,{targetFeature:r.featureName,missingDependencies:n}),this.features[r.featureName]=new r(this)}))}catch(t){(0,e.R)(22,t);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,R.Zm)();delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return r.ee.get(this.agentIdentifier).abort(),!1}}}({features:[he,w,N,Ne,Oe,O,M,ot,ct,Pe,nt],loaderType:"spa"})})()})();</script><link rel="preload" href="/article-pages/_nuxt/75f1046.js" as="script"><link rel="preload" href="/article-pages/_nuxt/2abb6c5.js" as="script"><link rel="preload" href="/article-pages/_nuxt/css/66101cf.css" as="style"><link rel="preload" href="/article-pages/_nuxt/701e3a3.js" as="script"><link rel="preload" href="/article-pages/_nuxt/css/dac93f2.css" as="style"><link rel="preload" href="/article-pages/_nuxt/c9b2266.js" as="script"><link rel="preload" href="/article-pages/_nuxt/a5e7651.js" as="script"><link rel="preload" href="/article-pages/_nuxt/css/e5cdfa1.css" as="style"><link rel="preload" href="/article-pages/_nuxt/f548f7f.js" as="script"><link rel="preload" href="/article-pages/_nuxt/css/868b092.css" as="style"><link rel="preload" href="/article-pages/_nuxt/e3c5a8f.js" as="script"><link rel="preload" href="/article-pages/_nuxt/css/0ae7120.css" as="style"><link rel="preload" href="/article-pages/_nuxt/d89174d.js" as="script"><link rel="preload" href="/article-pages/_nuxt/ed7fc59.js" as="script"><link rel="stylesheet" href="/article-pages/_nuxt/css/66101cf.css"><link rel="stylesheet" href="/article-pages/_nuxt/css/dac93f2.css"><link rel="stylesheet" href="/article-pages/_nuxt/css/e5cdfa1.css"><link rel="stylesheet" href="/article-pages/_nuxt/css/868b092.css"><link rel="stylesheet" href="/article-pages/_nuxt/css/0ae7120.css"> <meta property="fb:admins" content="1841006843"> </head> <body > <button class="BypassBlock__firstEl"></button> <a href="#main-content" class="BypassBlock__wrapper"> <span class="BypassBlock__button">Skip to main content</span> </a> <!-- Google Tag Manager (noscript) --> <noscript> <iframe src="https://tag-manager.frontiersin.org/ns.html?id=GTM-M322FV2&gtm_auth=owVbWxfaJr21yQv1fe1cAQ&gtm_preview=env-1&gtm_cookies_win=x" height="0" width="0" style="display:none;visibility:hidden"></iframe> </noscript> <!-- End Google Tag Manager (noscript) --> <div data-server-rendered="true" id="__nuxt"><div id="__layout"><div theme="red" class="ArticleLayout"><nav class="Ibar"><div class="Ibar__main"><div class="Ibar__wrapper"><button aria-label="Open Menu" data-event="iBar-btn-openMenu" class="Ibar__burger"></button> <div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg" class="Ibar__logo__svg"><path d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF" class="Ibar__logo__text"></path> <path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path> <path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path> <path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path> <path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path> <path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path> <path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path> <path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path> <path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path> <path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div> <a aria-label="Frontiers in Endocrinology" href="//www.frontiersin.org/journals/endocrinology" data-event="iBar-a-journalHome" class="Ibar__journalName"><div logoClass="Ibar__logo--mixed" class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img src="" class="Ibar__journal__logo"></div> <div class="Ibar__journalName"><span>Frontiers in</span> <span> Endocrinology</span></div></div></a> <div parent-data-event="iBar" class="Ibar__dropdown Ibar__dropdown--aboutUs"><button class="Ibar__dropdown__trigger"><!----> About us </button> <div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button aria-label="Close Dropdown" class="Ibar__dropdown__menu__header__title"> About us </button> <button aria-label="Close Dropdown" class="Ibar__close"></button></div> <div class="Ibar__dropdown__about"><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li> <li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li> <li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers' impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://progressreport.frontiersin.org/?utm_source=fweb&amp;utm_medium=frep&amp;utm_campaign=pr20" target="_blank" data-event="iBar-aboutUs_1-a_impactAndProgress">Progress Report 2022</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/progress-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">All progress reports</a></li></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li> <li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li> <li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li> <li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersplanetprize.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.orgabout/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li></ul></div></div></div> <a href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals" class="Ibar__link">All journals</a><a href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles" class="Ibar__link">All articles</a> <a href="https://www.frontiersin.org/submission/submit?domainid=2&amp;fieldid=23&amp;specialtyid=0&amp;entitytype=2&amp;entityid=106" data-event="iBar-a-submit" class="Ibar__button Ibar__submit">Submit your research</a> <div class="Ibar__spacer"></div> <a href="/search" aria-label="Search" data-event="iBar-a-search" class="Ibar__icon Ibar__icon--search"><span>Search</span></a> <!----> <!----> <!----> <div class="Ibar__userArea"></div></div></div> <div class="Ibar__menu Ibar__menu--journal"><div class="Ibar__menu__header"><div class="Ibar__logo"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg" class="Ibar__logo__svg"><path d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF" class="Ibar__logo__text"></path> <path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path> <path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path> <path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path> <path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path> <path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path> <path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path> <path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path> <path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path> <path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div></div> <button aria-label="Close Menu" data-event="iBarMenu-btn-closeMenu" class="Ibar__close"></button></div> <div class="Ibar__menu__wrapper"><div class="Ibar__menu__journal"><a href="//www.frontiersin.org/journals/endocrinology" data-event="iBarMenu-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img src="" class="Ibar__journal__logo"></div> <div class="Ibar__journalName"><span>Frontiers in</span> <span> Endocrinology</span></div></div></a> <div parent-data-event="iBarMenu" class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections </button> <div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button aria-label="Close Dropdown" class="Ibar__dropdown__menu__header__title"> Sections </button> <button aria-label="Close Dropdown" class="Ibar__close"></button></div> <ul class="Ibar__dropdown__sections"><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/adrenal-endocrinology" data-event="iBarJournal-sections-a_id_2258">Adrenal Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/bone-research" data-event="iBarJournal-sections-a_id_457">Bone Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cancer-endocrinology" data-event="iBarJournal-sections-a_id_116">Cancer Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cardiovascular-endocrinology" data-event="iBarJournal-sections-a_id_2259">Cardiovascular Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cellular-endocrinology" data-event="iBarJournal-sections-a_id_120">Cellular Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/clinical-diabetes" data-event="iBarJournal-sections-a_id_107">Clinical Diabetes</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/developmental-endocrinology" data-event="iBarJournal-sections-a_id_2261">Developmental Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/diabetes-molecular-mechanisms" data-event="iBarJournal-sections-a_id_1548">Diabetes: Molecular Mechanisms</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/endocrinology-of-aging" data-event="iBarJournal-sections-a_id_127">Endocrinology of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/experimental-endocrinology" data-event="iBarJournal-sections-a_id_121">Experimental Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/gut-endocrinology" data-event="iBarJournal-sections-a_id_1770">Gut Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/molecular-and-structural-endocrinology" data-event="iBarJournal-sections-a_id_118">Molecular and Structural Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/neuroendocrine-science" data-event="iBarJournal-sections-a_id_113">Neuroendocrine Science</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/obesity" data-event="iBarJournal-sections-a_id_458">Obesity</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/pediatric-endocrinology" data-event="iBarJournal-sections-a_id_124">Pediatric Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/pituitary-endocrinology" data-event="iBarJournal-sections-a_id_112">Pituitary Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/renal-endocrinology" data-event="iBarJournal-sections-a_id_2257">Renal Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/reproduction" data-event="iBarJournal-sections-a_id_126">Reproduction</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/systems-endocrinology" data-event="iBarJournal-sections-a_id_117">Systems Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/thyroid-endocrinology" data-event="iBarJournal-sections-a_id_128">Thyroid Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/translational-and-clinical-endocrinology" data-event="iBarJournal-sections-a_id_122">Translational and Clinical Endocrinology</a></li></ul></div></div> <a href="//www.frontiersin.org/journals/endocrinology/articles" data-event="iBar-a-articles" class="Ibar__link">Articles</a><a href="//www.frontiersin.org/journals/endocrinology/research-topics" data-event="iBar-a-researchTopics" class="Ibar__link">Research Topics</a><a href="//www.frontiersin.org/journals/endocrinology/editors" data-event="iBar-a-editorialBoard" class="Ibar__link">Editorial board</a> <div parent-data-event="iBarMenu" class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal </button> <div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button aria-label="Close Dropdown" class="Ibar__dropdown__menu__header__title"> About journal </button> <button aria-label="Close Dropdown" class="Ibar__close"></button></div> <div class="Ibar__dropdown__about"><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Scope</li> <li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_scope">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-scope" target="_self" data-event="iBar-aboutJournal_0-a_scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-facts" target="_self" data-event="iBar-aboutJournal_0-a_scope">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-submission" target="_self" data-event="iBar-aboutJournal_0-a_scope">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-open" target="_self" data-event="iBar-aboutJournal_0-a_scope">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_0-a_scope">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-quality" target="_self" data-event="iBar-aboutJournal_0-a_scope">Quality</a></li></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">For authors</li> <li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Contact editorial office</a></li></ul></div></div></div></div> <div parent-data-event="iBarMenu" class="Ibar__dropdown Ibar__dropdown--aboutUs"><button class="Ibar__dropdown__trigger"><!----> About us </button> <div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button aria-label="Close Dropdown" class="Ibar__dropdown__menu__header__title"> About us </button> <button aria-label="Close Dropdown" class="Ibar__close"></button></div> <div class="Ibar__dropdown__about"><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li> <li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li> <li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers' impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://progressreport.frontiersin.org/?utm_source=fweb&amp;utm_medium=frep&amp;utm_campaign=pr20" target="_blank" data-event="iBar-aboutUs_1-a_impactAndProgress">Progress Report 2022</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/progress-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">All progress reports</a></li></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li> <li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li> <li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li> <li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersplanetprize.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.orgabout/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li></ul></div></div></div> <a href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals" class="Ibar__link">All journals</a><a href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles" class="Ibar__link">All articles</a> <!----> <!----> <!----> <a href="https://www.frontiersin.org/submission/submit?domainid=2&amp;fieldid=23&amp;specialtyid=0&amp;entitytype=2&amp;entityid=106" data-event="iBarMenu-a-submit" class="Ibar__button Ibar__submit">Submit your research</a></div></div> <div class="Ibar__journal"><div class="Ibar__wrapper Ibar__wrapper--journal"><a aria-label="Frontiers in Endocrinology" href="//www.frontiersin.org/journals/endocrinology" data-event="iBarJournal-a-journalHome" class="Ibar__journalName"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img src="" class="Ibar__journal__logo"></div> <div class="Ibar__journalName"><span>Frontiers in</span> <span> Endocrinology</span></div></div></a> <div parent-data-event="iBarJournal" class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections </button> <div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button aria-label="Close Dropdown" class="Ibar__dropdown__menu__header__title"> Sections </button> <button aria-label="Close Dropdown" class="Ibar__close"></button></div> <ul class="Ibar__dropdown__sections"><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/adrenal-endocrinology" data-event="iBarJournal-sections-a_id_2258">Adrenal Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/bone-research" data-event="iBarJournal-sections-a_id_457">Bone Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cancer-endocrinology" data-event="iBarJournal-sections-a_id_116">Cancer Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cardiovascular-endocrinology" data-event="iBarJournal-sections-a_id_2259">Cardiovascular Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cellular-endocrinology" data-event="iBarJournal-sections-a_id_120">Cellular Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/clinical-diabetes" data-event="iBarJournal-sections-a_id_107">Clinical Diabetes</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/developmental-endocrinology" data-event="iBarJournal-sections-a_id_2261">Developmental Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/diabetes-molecular-mechanisms" data-event="iBarJournal-sections-a_id_1548">Diabetes: Molecular Mechanisms</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/endocrinology-of-aging" data-event="iBarJournal-sections-a_id_127">Endocrinology of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/experimental-endocrinology" data-event="iBarJournal-sections-a_id_121">Experimental Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/gut-endocrinology" data-event="iBarJournal-sections-a_id_1770">Gut Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/molecular-and-structural-endocrinology" data-event="iBarJournal-sections-a_id_118">Molecular and Structural Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/neuroendocrine-science" data-event="iBarJournal-sections-a_id_113">Neuroendocrine Science</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/obesity" data-event="iBarJournal-sections-a_id_458">Obesity</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/pediatric-endocrinology" data-event="iBarJournal-sections-a_id_124">Pediatric Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/pituitary-endocrinology" data-event="iBarJournal-sections-a_id_112">Pituitary Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/renal-endocrinology" data-event="iBarJournal-sections-a_id_2257">Renal Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/reproduction" data-event="iBarJournal-sections-a_id_126">Reproduction</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/systems-endocrinology" data-event="iBarJournal-sections-a_id_117">Systems Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/thyroid-endocrinology" data-event="iBarJournal-sections-a_id_128">Thyroid Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/translational-and-clinical-endocrinology" data-event="iBarJournal-sections-a_id_122">Translational and Clinical Endocrinology</a></li></ul></div></div> <a href="//www.frontiersin.org/journals/endocrinology/articles" data-event="iBar-a-articles" class="Ibar__link">Articles</a><a href="//www.frontiersin.org/journals/endocrinology/research-topics" data-event="iBar-a-researchTopics" class="Ibar__link">Research Topics</a><a href="//www.frontiersin.org/journals/endocrinology/editors" data-event="iBar-a-editorialBoard" class="Ibar__link">Editorial board</a> <div parent-data-event="iBarJournal" class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal </button> <div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button aria-label="Close Dropdown" class="Ibar__dropdown__menu__header__title"> About journal </button> <button aria-label="Close Dropdown" class="Ibar__close"></button></div> <div class="Ibar__dropdown__about"><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Scope</li> <li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_scope">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-scope" target="_self" data-event="iBar-aboutJournal_0-a_scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-facts" target="_self" data-event="iBar-aboutJournal_0-a_scope">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-submission" target="_self" data-event="iBar-aboutJournal_0-a_scope">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-open" target="_self" data-event="iBar-aboutJournal_0-a_scope">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_0-a_scope">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-quality" target="_self" data-event="iBar-aboutJournal_0-a_scope">Quality</a></li></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">For authors</li> <li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Contact editorial office</a></li></ul></div></div></div> <div class="Ibar__spacer"></div></div></div> <div class="Ibar__journal Ibar__journal--mix"><div class="Ibar__wrapper Ibar__wrapper--journal"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg" class="Ibar__logo__svg"><path d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF" class="Ibar__logo__text"></path> <path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path> <path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path> <path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path> <path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path> <path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path> <path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path> <path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path> <path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path> <path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div> <a aria-label="Frontiers in Endocrinology" href="//www.frontiersin.org/journals/endocrinology" data-event="iBarJournal-a-journalHome" class="Ibar__journalName"><div logoClass="Ibar__logo--mixed" class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img src="" class="Ibar__journal__logo"></div> <div class="Ibar__journalName"><span>Frontiers in</span> <span> Endocrinology</span></div></div></a> <div class="Ibar__spacer"></div> <div parent-data-event="iBarJournal" class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections </button> <div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button aria-label="Close Dropdown" class="Ibar__dropdown__menu__header__title"> Sections </button> <button aria-label="Close Dropdown" class="Ibar__close"></button></div> <ul class="Ibar__dropdown__sections"><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/adrenal-endocrinology" data-event="iBarJournal-sections-a_id_2258">Adrenal Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/bone-research" data-event="iBarJournal-sections-a_id_457">Bone Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cancer-endocrinology" data-event="iBarJournal-sections-a_id_116">Cancer Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cardiovascular-endocrinology" data-event="iBarJournal-sections-a_id_2259">Cardiovascular Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cellular-endocrinology" data-event="iBarJournal-sections-a_id_120">Cellular Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/clinical-diabetes" data-event="iBarJournal-sections-a_id_107">Clinical Diabetes</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/developmental-endocrinology" data-event="iBarJournal-sections-a_id_2261">Developmental Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/diabetes-molecular-mechanisms" data-event="iBarJournal-sections-a_id_1548">Diabetes: Molecular Mechanisms</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/endocrinology-of-aging" data-event="iBarJournal-sections-a_id_127">Endocrinology of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/experimental-endocrinology" data-event="iBarJournal-sections-a_id_121">Experimental Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/gut-endocrinology" data-event="iBarJournal-sections-a_id_1770">Gut Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/molecular-and-structural-endocrinology" data-event="iBarJournal-sections-a_id_118">Molecular and Structural Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/neuroendocrine-science" data-event="iBarJournal-sections-a_id_113">Neuroendocrine Science</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/obesity" data-event="iBarJournal-sections-a_id_458">Obesity</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/pediatric-endocrinology" data-event="iBarJournal-sections-a_id_124">Pediatric Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/pituitary-endocrinology" data-event="iBarJournal-sections-a_id_112">Pituitary Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/renal-endocrinology" data-event="iBarJournal-sections-a_id_2257">Renal Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/reproduction" data-event="iBarJournal-sections-a_id_126">Reproduction</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/systems-endocrinology" data-event="iBarJournal-sections-a_id_117">Systems Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/thyroid-endocrinology" data-event="iBarJournal-sections-a_id_128">Thyroid Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/translational-and-clinical-endocrinology" data-event="iBarJournal-sections-a_id_122">Translational and Clinical Endocrinology</a></li></ul></div></div> <a href="//www.frontiersin.org/journals/endocrinology/articles" data-event="iBar-a-articles" class="Ibar__link">Articles</a><a href="//www.frontiersin.org/journals/endocrinology/research-topics" data-event="iBar-a-researchTopics" class="Ibar__link">Research Topics</a><a href="//www.frontiersin.org/journals/endocrinology/editors" data-event="iBar-a-editorialBoard" class="Ibar__link">Editorial board</a> <div parent-data-event="iBarJournal" class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal </button> <div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button aria-label="Close Dropdown" class="Ibar__dropdown__menu__header__title"> About journal </button> <button aria-label="Close Dropdown" class="Ibar__close"></button></div> <div class="Ibar__dropdown__about"><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Scope</li> <li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_scope">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-scope" target="_self" data-event="iBar-aboutJournal_0-a_scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-facts" target="_self" data-event="iBar-aboutJournal_0-a_scope">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-submission" target="_self" data-event="iBar-aboutJournal_0-a_scope">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-open" target="_self" data-event="iBar-aboutJournal_0-a_scope">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_0-a_scope">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-quality" target="_self" data-event="iBar-aboutJournal_0-a_scope">Quality</a></li></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">For authors</li> <li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_1-a_forAuthors">Contact editorial office</a></li></ul></div></div></div> <div class="Ibar__spacer"></div> <a href="https://www.frontiersin.org/submission/submit?domainid=2&amp;fieldid=23&amp;specialtyid=0&amp;entitytype=2&amp;entityid=106" data-event="iBarJournal-a-submit" class="Ibar__button Ibar__submit"><span>Submit</span> <span> your research</span></a> <a href="/search" aria-label="Search" data-event="iBar-a-search" class="Ibar__icon Ibar__icon--search"><span>Search</span></a> <!----> <!----> <!----> <div class="Ibar__userArea"></div></div></div></nav> <div class="ArticlePage"><div><div class="Layout Layout--withAside Layout--withIbarMix ArticleDetails"><!----> <main class="Layout__main"><!----> <div class="ArticleDetails__main"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><p class="ArticleLayoutHeader__info__title"> ORIGINAL RESEARCH article </p> <p class="ArticleLayoutHeader__info__journalDate"><span>Front. Endocrinol.</span> <span>, 27 October 2021</span></p> <p class="ArticleLayoutHeader__info__journalDate"> Sec. Clinical Diabetes </p> <p class="ArticleLayoutHeader__info__doiVolume"><span> Volume 12 - 2021 | </span> <a href="https://doi.org/10.3389/fendo.2021.759843" class="ArticleLayoutHeader__info__doi"> https://doi.org/10.3389/fendo.2021.759843 </a></p> <!----></div> <!----> <p class="ArticleLayoutHeader__isPartOfRT"><span class="ArticleLayoutHeader__isPartOfRT__label">This article is part of the Research Topic</span> <span class="ArticleLayoutHeader__isPartOfRT__title">Diabetes and Bone - From Cell to Human</span> <span class="Link__wrapper"><a aria-label="View all 11 articles" href="https://www.frontiersin.org/research-topics/23162/diabetes-and-bone---from-cell-to-human/articles" target="_self" data-event="customLink-link-a_viewAll11Articles" class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right"><span>View all 11 articles</span></a></span></p></div> <div class="ArticleDetails__main__content"><div class="ArticleDetails__main__content__main ArticleDetails__main__content__main--fullArticle"><div class="JournalAbstract"><div class="JournalAbstract__titleWrapper"><h1>Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure <i>via</i> Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism</h1> <!----></div> <!----></div> <div class="JournalFullText"><div class="JournalAbstract"><a id="h1" name="h1"></a><div class="authors"><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/889583" class="user-id-889583"><img class="pr5" src="https://loop.frontiersin.org/images/profile/889583/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Shan Shan Qi,,">Shan Shan Qi</a><sup>1,2,3</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Meng Li Shao," onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Meng Li Shao<sup>2,3</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Ze Sun," onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Ze Sun<sup>2,4</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Si Min Chen" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Si Min Chen<sup>2</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Ying Jun Hu" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Ying Jun Hu<sup>2</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Xin Sheng Li," onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Xin Sheng Li<sup>2,5</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="De Jing Chen,*" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">De Jing Chen<sup>2,3*</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/1397318" class="user-id-1397318"><img class="pr5" src="https://loop.frontiersin.org/images/profile/1397318/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Hong Xing Zheng,,*">Hong Xing Zheng</a><sup>2,3,5*</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Tian Li Yue,*" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Tian Li Yue<sup>1,6*</sup></span></div><ul class="notes"><li><span><sup>1</sup></span>College of Food Science and Engineering, Northwest Agriculture and Forestry (A&amp;F) University, Yangling, China</li><li><span><sup>2</sup></span>College of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong, China</li><li><span><sup>3</sup></span>Qinba State Key Laboratory of Biological Resources and Ecological Environment, Hanzhong, China</li><li><span><sup>4</sup></span>QinLing-Bashan Mountains Bioresources Comprehensive Development C.I.C., Hanzhong, China</li><li><span><sup>5</sup></span>Shaanxi Key Laboratory of Resource Biology, Hanzhong, China</li><li><span><sup>6</sup></span>College of Food Science and Technology, Northwest University, Xi&#x2019;an, China</li></ul><p>Diabetic osteoporosis (DOP) belongs to secondary osteoporosis caused by diabetes; it has the characteristics of high morbidity and high disability. In the present study, we constructed a type 1 diabetic rat model and administered chondroitin sulfate (200 mg/kg) for 10 weeks to observe the preventive effect of chondroitin sulfate on the bone loss of diabetic rats. The results showed that chondroitin sulfate can reduce blood glucose and relieve symptoms of diabetic rats; in addition, it can significantly increase the bone mineral density, improve bone microstructure, and reduce bone marrow adipocyte number in diabetic rats; after 10 weeks of chondroitin sulfate administration, the SOD activity level was upregulated, as well as CAT levels, indicating that chondroitin sulfate can alleviate oxidative stress in diabetic rats. Chondroitin sulfate was also found to reduce the level of serum inflammatory cytokines (TNF-&#x3b1;, IL-1, IL-6, and MCP-1) and alleviate the inflammation in diabetic rats; bone metabolism marker detection results showed that chondroitin sulfate can reduce bone turnover in diabetic rats (decreased RANKL, CTX-1, ALP, and TRACP 5b levels were observed after 10 weeks of chondroitin sulfate administration). At the same time, the bone OPG and RUNX 2 expression levels were higher after chondroitin sulfate treatment, the bone RANKL expression was lowered, and the OPG/RANKL ratio was upregulated. All of the above indicated that chondroitin sulfate could prevent STZ-induced DOP and repair bone microstructure; the main mechanism was through anti-oxidation, anti-inflammatory, and regulating bone metabolism. Chondroitin sulfate could be used to develop anti-DOP functional foods and diet interventions for diabetes.</p><div class="clear"></div></div><div class="JournalFullText"><a id="h2" name="h2"></a><h2>Introduction</h2><p class="mb15">There are 463 million people with diabetes worldwide currently, an average of 1 in 11 adults (20&#x2013;79 years old), and by 2045, the diabetes population will jump to 700 million (<a href="#B1">1</a>, <a href="#B2">2</a>). Long-term high blood glucose can cause microvascular injury, endangering the kidneys, heart, eyes, peripheral nerves, brain, feet, as well as bone (<a href="#B3">3</a>).</p><p class="mb15">Diabetic osteoporosis (DOP) is a bone complication caused by diabetes, characterized by lowered bone mineral density (BMD), changes of bone microstructure, and raised bone fragility. DOP greatly reduces the quality of living of patients, subjecting them to heavy economic burden (<a href="#B4">4</a>). As the number of people with diabetes increases globally, the number of DOP is also increasing annually. Clinical data showed that about 50% to 65% of people with diabetes have decreased BMD and increased incidence of fractures, and nearly 35% of them have been diagnosed as osteoporosis (<a href="#B5">5</a>).</p><p class="mb15">The present approaches for DOP are oral hypoglycemic drugs or insulin injections, supplemented by calcium preparations, bisphosphonates, etc. (<a href="#B6">6</a>). However, adverse drug reactions have always been a major challenge related to drug treatment goals. Therefore, exploring more safer and effective strategies are highly crucial.</p><p class="mb0">Chondroitin sulfate (CS) is a natural sticky polysaccharide made from the cartilage of animals. The content of CS is different in the cartilage of different species and ages. As a drug for the treatment of joint diseases, it was used in conjunction with glucosamine to relieve pain and promote cartilage regeneration, which can fundamentally improve joint problems (<a href="#B7">7</a>). It was reported that CS has anti-inflammation effects (<a href="#B8">8</a>), has anti-psoriasis effects (<a href="#B9">9</a>), enhances immunity (<a href="#B10">10</a>), lowers blood lipid (<a href="#B11">11</a>), and has anti-tumor effects (<a href="#B12">12</a>). It also has a preventive effect on diabetic nephropathy.in streptozotocin (STZ)-induced diabetic mice (<a href="#B13">13</a>), and CS was also reported to increase bone formation in ovariectomized rats (<a href="#B14">14</a>). Whether it has a protective effect on DOP has not been studied. Our previous study found that the CS could increase the BMD of diabetic rats, but the mechanisms were not clear. So, in present study, we researched the protective effect and mechanisms of CS on DOP, which will provide a new approach for DOP treatment.</p><a id="h3" name="h3"></a><h2>Materials and Methods</h2><h3>Chemicals</h3><p class="mb0">CS power was isolated and purified from the cartilage of giant salamander according to the method of Zhu (<a href="#B15">15</a>); the content of CS in the experimental materials was 95%. STZ was obtained from Acmec Biochemical Company (Shanghai, China).</p><h3>Animals</h3><p class="mb0">Fifty-six-day old male rats were obtained from Cheng Du Dashuo Experimental Animal Company (Cheng Du, China, license no. SCXK 2020-030). Animals were kept in independent ventilated cages in a standardized animal room with constant temperature and humidity. Water and food intake of animals was not restricted. Animals were feed with diets prepared by the American Society of Nutrition (AIN93) standard. Animal experiment operations were approved by Shaanxi University of Technology Animal Ethics Committee (approval No. 2020-74).</p><h3>Diabetes Induction in SD Rats, Animal Grouping, and Treatment</h3><p class="mb15">After 7 days of acclimatization, except for 10 animals in the control group, the remaining animals were intraperitoneally injected with 45 mg/kg of STZ after fasting overnight, and the dosage of STZ was based on our previous study (<a href="#B16">16</a>, <a href="#B17">17</a>); STZ was dissolved in citric acid buffer solution at pH 4.3, and 10 animals in the control group were injected with citric acid buffer solution. After 72 h, animal&#x2019;s blood glucose was detected, and animals with blood glucose higher than 11.1 mmol/L were selected for subsequent experiments.</p><p class="mb15">Then, animals were regrouped into four groups: Group 1, control group (<i>n</i> = 10), rats were given deionized water by gavage every day; Group 2, type 1 diabetic group (<i>n</i> = 10), named T1DM group, type 1 diabetic rats were given deionized water by gavage every day; Group 3, CS-treated group (<i>n</i> = 10), named CS group, type 1 diabetic rats were given CS (200 mg/kg/day) by gavage every day; Group 4, metformin group (<i>n</i> = 10), named Met group, type 1 diabetic rats were given metformin (200 mg/kg/day) by gavage every day. The dose of CS was selected by pre-experiment.</p><p class="mb0">During the experiment, animals were weighed every week, water and diet of animals were recorded, and the blood glucose of animals was measured every week. After 10 weeks of administration, animals were anesthetized with isoflurane and were sacrificed by cervical dislocation; blood was collected, and serum was separated and stored at &#x2212;80&#xb0;C. At the same time, femurs, vertebrae, and tibias of animals were collected.</p><h3>BMD Measurement</h3><p class="mb0">The BMD of femur and vertebrae of each rat were obtained by using small-animal dual-energy X-ray absorptiometry (InAlzyer, Korea).</p><h3>Bone Micro-CT Measurement</h3><p class="mb0">Femur tissues of rats were collected and scanned by a Locus SP micro-CT (GE Healthcare, Danderyd, Sweden) with a resolution of 6.5&#x3bc;m. The processing and analysis software were MICVIEW 3D reconstruction processing software and ABA-specific bone analysis software. The data of cortex volume, bone surface area, trabecular number, and bone volume were obtained by using ABA-specific bone analysis software.</p><h3>Bone Turnover Marker Detection</h3><p class="mb0">According to instructions listed in ELISA test kits (Elabscience, Wuhan, China), a microplate reader (Elx808, Winooski, USA) was used to detect the content of bone turnover markers (CTX-1, OPG, ALP, TRACP 5b, RANKL, osteocalcin, and RUNX 2) in serum of each group of rats.</p><h3>Oxidative Stress Index Detection</h3><p class="mb0">According to instructions listed in kits (Beyotime, Shanghai, China), SOD activity, MDA content, CAT activity, and GSH content in serum were detected by an ultraviolet and visible spectrophotometer (Alpha1860S, Shanghai, China).</p><h3>Inflammatory Cytokine Detection</h3><p class="mb0">Based on instructions listed in ELISA test kits (Elabscience, Wuhan, China), the microplate reader (Elx808, Winooski, USA) was used to detect the content of serum inflammatory cytokines (IL-6, TNF-&#x3b1;, MCP-1, and IL-1).</p><h3>Pathological Analysis of Femur Bone Tissue</h3><p class="mb0">Femur of each rat was fixed in 3.8% paraformaldehyde solution for 48 h, then rinsed with PBS, placed in 10% EDTA solution for 5 weeks, and then made into 4-micron-thick paraffin sections by a tissue slicer (Leica, Wetzlar, Germany), and the sections were stained with hematoxylin and eosin, sealed with neutral gum. After that, a slide was placed under a microscope to observe femur pathological changes. Bone morphometric parameters including trabecular separation (Tb&#xb7;Sp), bone volume per tissue volume (BV/TV), and trabecular thickness (Tb&#xb7;Th) were analyzed by image pro plus (IPP) 6.0 software.</p><h3>Pathological Observation of Tibia Bone Marrow Adipocytes</h3><p class="mb0">Tibia of each rat was fixed in 3.8% paraformaldehyde solution for 48 h, then rinsed with PBS; femur was placed in 10% EDTA solution for 5 weeks and then made into 4-micron-thick paraffin sections by a tissue slicer (Leica, Wetzlar, Germany), and sections were stained with hematoxylin and eosin, sealed with neutral gum. After that, the slide was placed under a microscope to observe bone marrow adipocytes in tibia. Adipocytes were counted in each field, and the diameter of adipocytes was measured with IPP 6.0 software.</p><h3>Femur Osteoclast Observation-TRAP Staining</h3><p class="mb0">Four-micron-thick femur paraffin sections were stained with TRAP staining kit, based on the instructions listed in the kit. The stained slides were sealed with neutral gum. After that, a slide was placed under a microscope (200&#xd7; magnification) to observe osteoclasts in the femur. Osteoclasts were purple-red after staining, five fields of view were selected for each slice, and the number of osteoclasts in each field was counted.</p><h3>Immunohistochemical</h3><p class="mb0">Femur paraffin slides (4 &#x3bc;m thick) were soaked in xylene for 20 min, and then slides were dehydrated with gradient ethanol and placed in a water bath at 95&#xb0;C in citrate antigen retrieval solution (pH 6) for 1 h. After cooling to room temperature, slides were washed with PBS; 1% BSA solution was added to the slides to block endogenous peroxidase, and then the slides were washed with PBS, incubated with primary antibodies (OPG, RANKL, and RUNX2, respectively) (Santa Cruz Biotech, USA) for 1.5 h at 37&#xb0;C in a constant temperature incubator, double washed with PBS, incubated with secondary antibody (Santa Cruz Biotech, USA) for 2 h, washed with PBS three times, and then incubated with DAB. After that, slides were counterstained with hematoxylin, and sealed with neutral gum. IHC-stained slides were observed under a microscope (Olympus, Germany) with 200&#xd7; magnification. Five fields of view were chosen for each slice, and IPP software was used to count the area of positive staining, and percentage of positive area was calculated.</p><h3>Statistical Analysis</h3><p class="mb0">Statistical analyses were performed with ANOVA by SPASS 19.0; all of the data were shown as mean &#xb1; SD, and statistical significance was compared between groups using the LSD method. <i>p</i> &lt; 0.05 was considered significant, and <i>p</i> &lt; 0.01 was considered extremely significant.</p><a id="h4" name="h4"></a><h2>Results</h2><h3>Chondroitin Sulfate Relieved the Symptoms of Hyperglycemia, Polydipsia, and Polyphagia Caused by Diabetes in SD Rats</h3><p class="mb0">The blood glucose, water intake, and food intake in type 1 diabetic rats were significantly increased compared with control (<i>p</i> &lt; 0.01) (<a href="#f1">Figures&#xa0;1A, C, D</a>), while the body weight was decreased (<a href="#f1">Figure&#xa0;1B</a>); this result was consistent with basic pathological changes of diabetes, indicating that the type 1 diabetes animal model was successfully established. After 10 weeks of CS or metformin administration, the symptoms of diabetes in rats were effectively alleviated, reflected in lowered blood glucose, increased body weight, and reduced water and food intake. This indicates that CS can reduce blood glucose of diabetic rats and relieve the symptoms of diabetes.</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE&#xa0;1</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g001.jpg" name="" target="_blank"> <picture> <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g001.jpg" alt="www.frontiersin.org" id="f1" loading="lazy"> </picture> </a><p><strong>Figure&#xa0;1</strong> Blood glucose, body weight, food intake, and water intake at the end of the 10th week in different groups. <strong>(A)</strong> Blood glucose in different groups. <strong>(B)</strong> Body weight in different groups. <strong>(C)</strong> Food intake in different groups. <strong>(D)</strong> Water intake in different groups. <sup>##</sup>indicates <i>p</i> &lt; 0.01 compared with control; **indicates <i>p</i> &lt; 0.01 compared with the diabetic group; *indicates <i>p</i> &lt; 0.05 compared with the diabetic group.</p></div><div class="DottedLine"></div><h3>Chondroitin Sulfate Increased BMD of Type 1 Diabetic Rats</h3><p class="mb0">Compared with control group, the BMD (lumbar vertebrae and femur) in diabetic rats was lowered significantly (<i>p</i> &lt; 0.01) (<a href="#f2">Figure&#xa0;2</a>). After 10 weeks of CS or metformin administration, the BMD in lumbar vertebrae and femur was increased (CS <i>vs</i>. T1DM group, <i>p</i> &lt; 0.01; Metformin <i>vs</i>. T1DM groups, <i>p</i> &lt; 0.01) (<a href="#f2">Figure&#xa0;2</a>), indicating that CS could increase the BMD of type 1 diabetic rats.</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE&#xa0;2</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g002.jpg" name="" target="_blank"> <picture> <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g002.jpg" alt="www.frontiersin.org" id="f2" loading="lazy"> </picture> </a><p><strong>Figure&#xa0;2</strong> The bone mineral density of different groups at the end of the 10th week. <strong>(A)</strong> The BMD of lumbar vertebrae in different groups. <strong>(B)</strong> The femoral BMD in different groups. <sup>##</sup>indicates <i>p</i> &lt; 0.01 compared with control. **indicates <i>p</i> &lt; 0.01 compared with the diabetic group.</p></div><div class="DottedLine"></div><h3>Chondroitin Sulfate Repaired Bone Micro-CT Structure of Type 1 Diabetic Rats</h3><p class="mb0">Femur micro-CT scanning results showed that trabecular structure in the model group was sparse, and some trabecular areas disappeared (<a href="#f3">Figure&#xa0;3A</a>). After 10 weeks of administration of CS or metformin, trabecular structure was repaired. Micro-CT metrological data (<a href="#f3">Figures&#xa0;3A&#x2013;E</a>) showed that cortical bone volume, bone surface area, number of bone trabecular, and bone volume in type 1 diabetic group were significantly lower than those in the control group (<i>p</i> &lt; 0.01). After 10 weeks of CS or metformin administration, the above indexes were upregulated, and the differences were significant compared with the diabetic group.</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE&#xa0;3</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g003.jpg" name="" target="_blank"> <picture> <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g003.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g003.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g003.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g003.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g003.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g003.jpg" alt="www.frontiersin.org" id="f3" loading="lazy"> </picture> </a><p><strong>Figure&#xa0;3</strong> <strong>(A)</strong> The femur micro-CT structure of different groups at the end of the 10th week. <strong>(B)</strong> Cortex volume in different groups. <strong>(C)</strong> Bone surface area in different groups. <strong>(D)</strong> Trabecular number in different groups. <strong>(E)</strong> Bone volume in different groups. <sup>##</sup>indicates <i>p</i> &lt; 0.01 compared with control. **indicates <i>p</i> &lt; 0.01 compared with the diabetic group.</p></div><div class="DottedLine"></div><h3>Chondroitin Sulfate Regulated Bone Turnover of Type 1 Diabetic Rats</h3><p class="mb0">As <a href="#T1">Table&#xa0;1</a> shows, some of the serum bone turnover markers (OPG, RUNX 2, osteocalcin, and TRACP 5b) and OPG/RANKL ratio levels were lowered in type 1 diabetic rats compared with control (<i>p</i> &lt; 0.01), and those were significantly increased in the CS and Met group compared with the type 1 diabetic group. Other serum bone turnover markers such as RANKL, CTX 1, and ALP levels were higher in the type 1 diabetic group compared with the control (<i>p</i> &lt; 0.01), which were significantly decreased in CS and Met groups, indicating that CS could regulate bone turnover of type 1 diabetic rats.</p><div class="DottedLine"></div><div class="Imageheaders">TABLE&#xa0;1</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-t001.jpg" name="table&#xa0;1" target="_blank"> <picture> <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-t001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-t001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-t001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-t001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-t001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-t001.jpg" alt="www.frontiersin.org" id="T1" loading="lazy"> </picture> </a><p><strong>Table&#xa0;1</strong> Bone turnover markers in different groups at the end of the 10th week.</p></div><div class="DottedLine"></div><h3>Chondroitin Sulfate Downregulated Inflammatory Cytokines of Type 1 Diabetic Rats</h3><p class="mb0">Serum inflammatory cytokine levels in type 1 diabetic rats increased dramatically compared with the control group (<i>p</i> &lt; 0.01). After 10 weeks of CS or metformin treatment, the serum inflammatory cytokine levels were lowered in CS or Met groups (CS <i>vs</i>. T1DM group, <i>p</i> &lt; 0.01; Metformin <i>vs</i>. T1DM groups, <i>p</i> &lt; 0.01) (<a href="#f4">Figure&#xa0;4</a>), indicating that CS has an inhibitory effect on inflammation induced by type 1 diabetes in SD rats.</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE&#xa0;4</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g004.jpg" name="" target="_blank"> <picture> <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g004.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g004.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g004.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g004.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g004.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g004.jpg" alt="www.frontiersin.org" id="f4" loading="lazy"> </picture> </a><p><strong>Figure&#xa0;4</strong> The serum inflammatory cytokine levels in different groups at the end of the 10th week. <strong>(A)</strong> MCP-1 levels in serum; <strong>(B)</strong> IL-6 levels in serum; <strong>(C)</strong> IL-1 levels in serum; <strong>(D)</strong> TNF-a levels in serum. <sup>##</sup>indicates <i>p</i> &lt; 0.01 compared with control. **indicates <i>p</i> &lt; 0.01 compared with the diabetic group.</p></div><div class="DottedLine"></div><h3>Chondroitin Sulfate Alleviated Oxidative Stress in Type 1 Diabetic Rats</h3><p class="mb0">Oxidative stress existed in diabetic rats; serum SOD, GPX, and CAT activity levels were lowered, and MDA level was raised in type 1 diabetic rats. Ten weeks after CS or metformin treatment, SOD, GPX, and CAT activity levels were raised, and MDA level was lowered (CS <i>vs</i>. T1DM, <i>p</i> &lt; 0.01; Met <i>vs</i>. T1DM, <i>p</i> &lt; 0.01) (<a href="#f5">Figure&#xa0;5</a>). The results indicated that CS could alleviate oxidative stress in T1DM rats.</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE&#xa0;5</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g005.jpg" name="" target="_blank"> <picture> <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g005.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g005.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g005.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g005.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g005.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g005.jpg" alt="www.frontiersin.org" id="f5" loading="lazy"> </picture> </a><p><strong>Figure&#xa0;5</strong> The level of serum oxidative stress parameters in different groups at the end of the 10th week. <strong>(A)</strong> The level of SOD activities in different groups. <strong>(B)</strong> The level of glutathione peroxidase (GPX) activities in different groups. <strong>(C)</strong> The level of catalase (CAT) activities in different groups. <strong>(D)</strong> The level of malondialdehyde (MDA) content in different groups; <sup>##</sup>indicates <i>p</i> &lt; 0.01 compared with control, **indicates <i>p</i> &lt; 0.01 compared with the diabetic group.</p></div><div class="DottedLine"></div><h3>Chondroitin Sulfate Repaired Bone Microstructure of Type 1 Diabetic Rats</h3><p class="mb0">Compared with the control group, the femoral bone of diabetic rats was sparse and fractured, the spacing of trabecular bone became wider, and the trabecular bone became thinner (<a href="#f6">Figures&#xa0;6A&#x2013;D</a>). The femoral structure was repaired after 10 weeks of CS or metformin administration. The results of bone morphometric data (<a href="#f6">Figures&#xa0;6E&#x2013;G</a>) showed that the femoral thickness (Tb&#xb7;Th) and the percentage of bone trabecular area (BV/TV) in CS or metformin treatment groups were significantly increased compared with the type 1 diabetic group (<i>p</i> &lt; 0.01), and the trabecular separation (Tb&#xb7;Sp) was decreased in CS or metformin treatment groups compared with the type 1 diabetic group (<i>p</i> &lt; 0.01).</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE&#xa0;6</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g006.jpg" name="" target="_blank"> <picture> <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g006.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g006.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g006.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g006.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g006.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g006.jpg" alt="www.frontiersin.org" id="f6" loading="lazy"> </picture> </a><p><strong>Figure&#xa0;6</strong> The pathological sections of femur of rats in each group at the end of the 10th week; paraffin section of femur was stained with hematoxylin and eosin, 400&#xd7;. <strong>(A)</strong> The control group femur. <strong>(B)</strong> The diabetic group femur. <strong>(C)</strong> The CS group femur. <strong>(D)</strong> The Met group femur. <strong>(E)</strong> The trabecular separation (Tb&#xb7;Sp) in different groups. <strong>(F)</strong> The femoral thickness (Tb&#xb7;Th) in different groups. <strong>(G)</strong> The percentage of bone trabecular area (BV/TV) in different groups; <sup>##</sup>indicates <i>p</i> &lt; 0.01 compared with control. **indicates <i>p</i> &lt; 0.01 compared with the diabetic group. BM. Bone marrow; Tb. Trabecular bone.</p></div><div class="DottedLine"></div><h3>Chondroitin Sulfate Inhibited Bone Marrow Lipogenesis of Type 1 Diabetic Rats</h3><p class="mb0">Compared with the control group, the number of bone marrow adipocytes of diabetic rats increased significantly, and the bone marrow adipocyte density and adipocyte diameter were larger than the control (<i>p</i> &lt; 0.01) (<a href="#f7">Figure&#xa0;7</a>). Ten weeks after CS or metformin treatment, the bone marrow adipocyte density and adipocyte diameter decreased (CS <i>vs</i>. T1DM, <i>p</i> &lt; 0.01; Met <i>vs</i>. T1DM, <i>p</i> &lt; 0.01) (<a href="#f7">Figure&#xa0;7</a>). The results indicated that CS could inhibit bone marrow lipogenesis of type 1 diabetic rats.</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE&#xa0;7</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g007.jpg" name="" target="_blank"> <picture> <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g007.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g007.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g007.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g007.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g007.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g007.jpg" alt="www.frontiersin.org" id="f7" loading="lazy"> </picture> </a><p><strong>Figure&#xa0;7</strong> Adipocytes in the bone marrow cavity of the tibia in different groups at the end of the 10th week, H&amp;E staining. <strong>(A)</strong> The control group tibia bone marrow. <strong>(B)</strong> The diabetic group tibia bone marrow. <strong>(C)</strong> The CS group tibia bone marrow. <strong>(D)</strong> The Met group tibia bone marrow. <strong>(E)</strong> Adipocyte density in different groups. <strong>(F)</strong> Adipocyte diameter in different groups. <sup>##</sup>indicates <i>p</i> &lt; 0.01 compared with control. **indicates <i>p</i> &lt; 0.01 compared with the diabetic group. Red arrows indicate adipocytes.</p></div><div class="DottedLine"></div><h3>Chondroitin Sulfate Inhibited Osteoclastogenesis of Type 1 Diabetic Rats</h3><p class="mb0">After TRAP staining, the osteoclasts were stained purplish red. There was an increased number of femoral osteoclasts in type 1 diabetic group rats compared with control (<i>p</i> &lt; 0.01) (<a href="#f8">Figure&#xa0;8</a>). Ten weeks after CS or metformin treatment, osteoclast number was decreased in the CS or Met group (CS group <i>vs</i>. T1DM group, <i>p</i> &lt; 0.01; Met group <i>vs</i>. T1DM group, <i>p</i> &lt; 0.01) (<a href="#f8">Figure&#xa0;8E</a>), indicating that CS could inhibit osteoclasts proliferation in type 1 diabetic rats.</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE&#xa0;8</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g008.jpg" name="" target="_blank"> <picture> <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g008.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g008.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g008.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g008.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g008.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g008.jpg" alt="www.frontiersin.org" id="f8" loading="lazy"> </picture> </a><p><strong>Figure&#xa0;8</strong> The osteoclasts in femoral bone tissues of different groups at the end day of the 10th week. <strong>(A)</strong> The femoral bone tissues of control group rat. <strong>(B)</strong> The femoral bone tissues of diabetic group rat. <strong>(C)</strong> The femoral bone tissues of CS group rat. <strong>(D)</strong> The femoral bone tissues of Met group rat. <strong>(E)</strong> Number of osteoclasts per unit field in different groups. Bone tissues were stained by TRACP method, osteoclasts are multinucleate cells, and the red arrows point to osteoclasts. <sup>##</sup>indicates <i>p</i> &lt; 0.01 compared with control. **indicates <i>p</i> &lt; 0.01 compared with the diabetic group.</p></div><div class="DottedLine"></div><h3>Chondroitin Sulfate Upregulated OPG and RUNX 2 and Downregulated RANKL Expression in Bone Tissues</h3><p class="mb0">Pathological analysis showed that bone OPG and RUNX 2 expression levels were lowered in type 1 diabetic rats (T1DM <i>vs</i>. Control, <i>p</i> &lt; 0.01); RANKL level in bone tissue was higher in type 1 diabetic rats (T1DM <i>vs</i>. Control, <i>p</i> &lt; 0.01) (<a href="#f9">Figure&#xa0;9</a>). After 10 weeks of CS or metformin administration, the bone OPG and RUNX 2 levels increased (CS or Met group <i>vs</i>. T1DM group, <i>p</i> &lt; 0.01) and the RANKL level decreased (CS or Met <i>vs</i>. T1DM group, <i>p</i> &lt; 0.01) (<a href="#f9">Figures&#xa0;9A&#x2013;C</a>).</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE&#xa0;9</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g009.jpg" name="" target="_blank"> <picture> <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g009.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g009.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g009.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g009.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g009.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/759843/fendo-12-759843-HTML/image_m/fendo-12-759843-g009.jpg" alt="www.frontiersin.org" id="f9" loading="lazy"> </picture> </a><p><strong>Figure&#xa0;9</strong> Immunohistochemical staining of femur and positive staining percentage of OPG, RUNX2, and RANKL in each group. <strong>(A)</strong> The positive staining percentage of OPG in the femur of each group. <strong>(B)</strong> The positive staining percentage of RUNX 2 in the femur of each group. <strong>(C)</strong> The positive staining percentage of RANKL in the femur of each group. <sup>##</sup>indicates <i>p</i> &lt; 0.01 compared with control. **indicates <i>p</i> &lt; 0.01 compared with the diabetic group.</p></div><div class="DottedLine"></div><a id="h5" name="h5"></a><h2>Discussion</h2><p class="mb15">DOP is a serious metabolic bone disease associated with diabetes. It has the characteristics of reduced BMD, destruction of bone microstructure, increased brittleness, reduced strength, and easy to fracture, which seriously affects the quality of life of people with diabetes (<a href="#B18">18</a>, <a href="#B19">19</a>). Clinical treatment of DOP is to use chemical drugs such as vitamin D3, diphosphonate, calcitonin, and calcium to inhibit bone absorption, promote bone formation, and improve bone mineralization on the premise of controlling blood glucose. However, using chemical drugs long term can also lead to side effects, such as gastrointestinal diseases (<a href="#B20">20</a>). Therefore, natural anti-osteoporosis drugs are much popular.</p><p class="mb15">In the present study, we used the method of STZ injection to construct a rat model of type 1 diabetes, and intragastric administration of CS for 10 weeks. We detected the BMD, bone micro-CT, and bone pathology, and the results indicated that CS could inhibit bone loss, increase BMD, repair bone microstructure of type 1 diabetic rats, and thus prevent DOP.</p><p class="mb15">DOP is closely related to oxidative stress. Hyperglycemia induced reactive oxygen species (ROS) production <i>in vivo</i> and hindered the proliferation and differentiation of osteoblasts (<a href="#B21">21</a>&#x2013;<a href="#B23">23</a>). It has been confirmed that a sharp increase in the level of ROS induces death of osteoblasts, resulting in bone structure damage and BMD reduction (<a href="#B24">24</a>). In the present study, we found that the SOD, GPX, and CAT activity levels were upregulated after 10 weeks of CS administration, indicating that CS could inhibit oxidative stress in type 1 diabetic rats; this may be one of important reasons why CS could prevent bone loss in type 1 diabetic rats.</p><p class="mb15">Inflammation is closely related to osteoporosis, which is another main cause of DOP (<a href="#B25">25</a>). The level of inflammatory cytokines in diabetes was significantly higher than that in healthy people, and accumulation of inflammatory cytokines could mediate oxidative stress damage, prompting osteoclast proliferation, increasing bone absorption, and thus causing osteoporosis (<a href="#B26">26</a>). In this study, we found that CS could inhibit the inflammation in type 1 diabetic rats, and inflammatory cytokines were downregulated by CS. Many other natural products have also been reported to relieve DOP through an anti-inflammatory manner (<a href="#B23">23</a>, <a href="#B27">27</a>&#x2013;<a href="#B29">29</a>).</p><p class="mb15">Both osteoblasts and bone marrow adipocytes were derived from bone marrow mesenchymal stem cells (<a href="#B30">30</a>). As the number of bone marrow adipocytes increased, that of osteoblasts will decrease. Changes in the number and size of bone marrow adipocytes were positively correlated with osteoporosis, so they were important criteria for evaluating the efficacy of osteoporosis drugs (<a href="#B31">31</a>&#x2013;<a href="#B33">33</a>). In diabetes, hyperglycemia promotes the differentiation of bone marrow adipocytes and inhibits osteoblast differentiation (<a href="#B34">34</a>). As indicated in the present study, the bone marrow adipocyte number and size in type 1 diabetic rats were higher than those in control group rats, which were downregulated by 10 weeks of CS administration. Our previous study also found that trace elements of zinc, black rice anthocyanin, and lycopene were all having a preventive effect on DOP, and all of them can inhibit bone marrow adipocyte generation (<a href="#B4">4</a>, <a href="#B23">23</a>, <a href="#B35">35</a>), which is consistent with the results of this study.</p><p class="mb15">Bone tissue structure is an important basis for evaluating bone health (<a href="#B36">36</a>). In this study, we applied bone micro-CT and bone tissue pathology techniques to evaluate bone structure; the results indicated that CS can improve bone structure lesions caused by diabetes, and it can effectively restore bone morphological parameters and upregulate BMD.</p><p class="mb15">The biochemical markers of bone turnover (BMBT) were metabolite of bone tissue. BMBT includes bone formation and bone resorption markers, which were important indicators for laboratory diagnosis of osteoporosis (<a href="#B37">37</a>, <a href="#B38">38</a>). Not only can it quickly reflect the process of bone formation and bone resorption, but it also can be used to reveal pathogenesis of metabolic bone disease, predict the rate of bone loss and fracture risk, and diagnose osteoporosis; at the same time, it can be used to quickly reflect the therapeutic effect of anti-osteoporosis drugs (<a href="#B39">39</a>). In our present study, the bone formation markers (osteocalcin and ALP) as well as bone resorption markers (TRACP 5b and CTX 1) all increased in type 1 diabetic rats, which indicated that diabetic rats had a higher bone turnover rate. This study showed that CS could downregulate the BMBT in diabetic rats and inhibit the higher bone turnover rate.</p><p class="mb15">RANKL was a member of the TNF superfamily involved in immune regulation and bone metabolism, and it was an important activator of osteoclast differentiation and maturation (<a href="#B40">40</a>). RANKL activates osteoclast differentiation, thus promoting bone resorption by competing with OPG to bind to receptor RANK. Overexpression of RANKL can lead to excessive activation of osteoclasts, which can lead to osteoporosis (<a href="#B41">41</a>). OPG was also a member of the TNF superfamily. It was highly expressed in testis and bone marrow (<a href="#B42">42</a>). OPG binds to RANKL and blocks binding of RANKL to RANK. At the same time, OPG can inhibit osteoclast differentiation and maturation, and promote osteoclasts apoptosis (<a href="#B43">43</a>). When the ratio of OPG to RANKL increases, bone formation activity of osteoblasts increases, and bone metabolism tends to be in a positive balance. When the ratio of OPG to RANKL decreases, the bone resorption activity of osteoclasts increases, and bone metabolism tends to be in a negative balance (<a href="#B44">44</a>). In the present study, the level of OPG/RANKL ratio in diabetic rats was greatly decreased compared with control, indicating increased bone resorption activity; after 10 weeks of CS treatment, the OPG/RANKL ratio was upregulated, indicating increased bone formation activity. One of the mechanisms of CS against DOP is by upregulating the OPG/RANKL ratio. In this study, we detected the bone OPG, RANKL, and RUNX 2 proteins using an immunohistochemical method, which has the advantage of localizing the protein, but in a quantitative aspect, it is inferior to Western blotting; in subsequent experiments, we will supplement the Western blotting experiment to confirm the above results.</p><p class="mb0">As a first-line drug for diabetes, metformin is a chemically synthesized drug. The main side effects are gastrointestinal reactions, such as nausea and vomiting (<a href="#B45">45</a>), as well as gut microbiota dysbiosis (<a href="#B46">46</a>). Secondly, metformin will interfere with the absorption of vitamin B12 and folic acid. Studies have shown that up to 30% of patients taking metformin have B12 deficiency (<a href="#B47">47</a>, <a href="#B48">48</a>). In this study, CS showed a good anti-DOP effect, similar to metformin. However, the CS used in this study was naturally extracted and has the advantages of high safety and less side effects compared with metformin. This study revealed the role of CS in DOP treatment through animal experiments. Later, we will further reveal its molecular mechanism through <i>in vitro</i> cell experiments and further confirm its effect through human experiments.</p><a id="h6" name="h6"></a><h2>Data Availability Statement</h2><p class="mb0">The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding authors.</p><a id="h7" name="h7"></a><h2>Ethics Statement</h2><p class="mb0">The animal study was reviewed and approved by Shaanxi University of Technology Animal Ethics Committee.</p><a id="h8" name="h8"></a><h2>Author Contributions</h2><p class="mb0">Study design: SQ, HZ, DC, TY, and XL. Study conduct: SQ, HZ, MS, ZS, YH, and SC. Data collection and analysis: SQ, HZ, MS, ZS, YH, and SC. Animal model construction: SQ and HZ. Histopathological experiment: SQ, MS, ZS, and SC. Manuscript draft: SQ. Manuscript revision: HZ. All authors contributed to the article and approved the submitted version.</p><a id="h9" name="h9"></a><h2>Funding</h2><p class="mb0">This research was funded by the Postdoctoral Program in Shaanxi University of Technology (SLGBH16-03), &#x201c;Shaanxi Sanqin Scholar&#x201d; Innovation Team, the Key Research Projects of Shaanxi Provincial Department of Education (20JY005), Shaanxi University of Technology Project (SLGKY2010), and the Key projects of Shaanxi Science and Technology Department (2021FP-14), and Shaanxi University of Technology Project (SLGKY2004).</p><a id="h10" name="h10"></a><h2>Conflict of Interest</h2><p class="mb0">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p><a id="h11" name="h11"></a><h2>Publisher&#x2019;s Note</h2><p class="mb15">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p><a id="h12" name="h12"></a><h2>References</h2><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B1" id="B1"></a> 1. Kamusheva M, Tachkov K, Dimitrova M, Mitkova Z, Garc&#xed;a-S&#xe1;ez G, Hernando ME, et al. A Systematic Review of Collective Evidences Investigating the Effect of Diabetes Monitoring Systems and Their Application in Health Care. <i>Front Endocrinol</i> (2021) 12:636959. doi: 10.3389/fendo.2021.636959</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.3389/fendo.2021.636959" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M+Kamusheva&amp;author=K+Tachkov&amp;author=M+Dimitrova&amp;author=Z+Mitkova&amp;author=G+Garc%C3%ADa-S%C3%A1ez&amp;author=ME+Hernando&amp;publication_year=2021&amp;title=A%20Systematic%20Review%20of%20Collective%20Evidences%20Investigating%20the%20Effect%20of%20Diabetes%20Monitoring%20Systems%20and%20Their%20Application%20in%20Health%20Care&amp;journal=Front+Endocrinol&amp;volume=12&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B2" id="B2"></a> 2. Avil&#xe9;s-Santa ML, Monroig-Rivera A, Soto-Soto A, Lindberg NM. Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Iatin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent. <i>Curr Diabetes Rep</i> (2020) 20:62&#x2013;2. doi: 10.1007/s11892-020-01341-9</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1007/s11892-020-01341-9" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=ML+Avil%C3%A9s-Santa&amp;author=A+Monroig-Rivera&amp;author=A+Soto-Soto&amp;author=NM+Lindberg&amp;publication_year=2020&amp;title=Current%20State%20of%20Diabetes%20Mellitus%20Prevalence%2C%20Awareness%2C%20Treatment%2C%20and%20Control%20in%20Iatin%20America%3A%20Challenges%20and%20Innovative%20Solutions%20to%20Improve%20Health%20Outcomes%20Across%20the%20Continent&amp;journal=Curr+Diabetes+Rep&amp;volume=20&amp;pages=62-2" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B3" id="B3"></a> 3. Iacobini C, Vitale M, Pesce C, Pugliese G, Menini S. Diabetic Complications and Oxidative Stress: A 20-Year Voyage Back in Time and Back to the Future. <i>Antioxidants</i> (2021) 10:727&#x2013;39. doi: 10.3390/antiox10050727</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/34063078/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/antiox10050727" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C+Iacobini&amp;author=M+Vitale&amp;author=C+Pesce&amp;author=G+Pugliese&amp;author=S+Menini&amp;publication_year=2021&amp;title=Diabetic%20Complications%20and%20Oxidative%20Stress%3A%20A%2020-Year%20Voyage%20Back%20in%20Time%20and%20Back%20to%20the%20Future&amp;journal=Antioxidants&amp;volume=10&amp;pages=727-39" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B4" id="B4"></a> 4. Qi SS, He J, Han H, Zheng HX, Jiang H, Hu CY, et al. Anthocyanin-Rich Extract From Black Rice (<i>Oryza Sativa L. Japonica</i>) Ameliorates Diabetic Osteoporosis in Rats. <i>Food Funct</i> (2019) 10:5350&#x2013;60. doi: 10.1039/C9FO00681H</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/31393485/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1039/C9FO00681H" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SS+Qi&amp;author=J+He&amp;author=H+Han&amp;author=HX+Zheng&amp;author=H+Jiang&amp;author=CY+Hu&amp;publication_year=2019&amp;title=Anthocyanin-Rich%20Extract%20From%20Black%20Rice%20%28Oryza%20Sativa%20L.%20Japonica%29%20Ameliorates%20Diabetic%20Osteoporosis%20in%20Rats&amp;journal=Food+Funct&amp;volume=10&amp;pages=5350-60" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B5" id="B5"></a> 5. Ma R, Zhu R, Wang L, Guo Y, Liu C, Liu H, et al. Diabetic Osteoporosis: A Review of its Traditional Chinese Medicinal Use and Clinical and Preclinical Research. <i>Evid Based Complement Alternat Med</i> (2016) 5:1&#x2013;13. doi: 10.1155/2016/3218313</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1155/2016/3218313" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R+Ma&amp;author=R+Zhu&amp;author=L+Wang&amp;author=Y+Guo&amp;author=C+Liu&amp;author=H+Liu&amp;publication_year=2016&amp;title=Diabetic%20Osteoporosis%3A%20A%20Review%20of%20its%20Traditional%20Chinese%20Medicinal%20Use%20and%20Clinical%20and%20Preclinical%20Research&amp;journal=Evid+Based+Complement+Alternat+Med&amp;volume=5&amp;pages=1" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B6" id="B6"></a> 6. Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, et al. Diagnosis and Management of Bone Fragility in Diabetes: An Emerging Challenge. <i>Osteoporosis Int</i> (2018) 29:2585&#x2013;96. doi: 10.1007/s00198-018-4650-2</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1007/s00198-018-4650-2" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SL+Ferrari&amp;author=B+Abrahamsen&amp;author=N+Napoli&amp;author=K+Akesson&amp;author=M+Chandran&amp;author=R+Eastell&amp;publication_year=2018&amp;title=Diagnosis%20and%20Management%20of%20Bone%20Fragility%20in%20Diabetes%3A%20An%20Emerging%20Challenge&amp;journal=Osteoporosis+Int&amp;volume=29&amp;pages=2585-96" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B7" id="B7"></a> 7. Li L, Li Y, Feng D, Xu L, Yin F, Zang H, et al. Preparation of Low Molecular Weight Chondroitin Sulfates, Screening of a High Anti-Complement Capacity of Low Molecular Weight Chondroitin Sulfate and Its Biological Activity Studies in Attenuating Osteoarthritis. <i>Int J Mol Sci</i> (2016) 17:1685&#x2013;700. doi: 10.3390/ijms17101685</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.3390/ijms17101685" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=L+Li&amp;author=Y+Li&amp;author=D+Feng&amp;author=L+Xu&amp;author=F+Yin&amp;author=H+Zang&amp;publication_year=2016&amp;title=Preparation%20of%20Low%20Molecular%20Weight%20Chondroitin%20Sulfates%2C%20Screening%20of%20a%20High%20Anti-Complement%20Capacity%20of%20Low%20Molecular%20Weight%20Chondroitin%20Sulfate%20and%20Its%20Biological%20Activity%20Studies%20in%20Attenuating%20Osteoarthritis&amp;journal=Int+J+Mol+Sci&amp;volume=17&amp;pages=1685-700" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B8" id="B8"></a> 8. Melgar-Lesmes P, Garcia-Polite F, Del-Rey-Puech P, Rosas E, Dreyfuss JL, Montell E, et al. Treatment With Chondroitin Sulfate to Modulate Inflammation and Atherogenesis in Obesity. <i>Atherosclerosis</i> (2016) 245:82&#x2013;7. doi: 10.1016/j.atherosclerosis.2015.12.016</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/26714044/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.atherosclerosis.2015.12.016" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=P+Melgar-Lesmes&amp;author=F+Garcia-Polite&amp;author=P+Del-Rey-Puech&amp;author=E+Rosas&amp;author=JL+Dreyfuss&amp;author=E+Montell&amp;publication_year=2016&amp;title=Treatment%20With%20Chondroitin%20Sulfate%20to%20Modulate%20Inflammation%20and%20Atherogenesis%20in%20Obesity&amp;journal=Atherosclerosis&amp;volume=245&amp;pages=82-7" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B9" id="B9"></a> 9. Verg&#xe9;s J, Montell E, Herrero M, Perna C, Cuevas J, Dalmau J, et al. Clinical and Histopathological Improvement of Psoriasis With Oral Chondroitin Sulfate: A Serendipitous Finding. <i>Dermatol Online J</i> (2005) 11:31&#x2013;44. doi: 10.5070/D32zh8x3vf</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/15748570/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.5070/D32zh8x3vf" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J+Verg%C3%A9s&amp;author=E+Montell&amp;author=M+Herrero&amp;author=C+Perna&amp;author=J+Cuevas&amp;author=J+Dalmau&amp;publication_year=2005&amp;title=Clinical%20and%20Histopathological%20Improvement%20of%20Psoriasis%20With%20Oral%20Chondroitin%20Sulfate%3A%20A%20Serendipitous%20Finding&amp;journal=Dermatol+Online+J&amp;volume=11&amp;pages=31" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B10" id="B10"></a> 10. Hatano S, Watanabe H. Regulation of Macrophage and Dendritic Cell Function by Chondroitin Sulfate in Innate to Antigen-Sspecific Adaptive Immunity. <i>Front Immunol</i> (2020) 11:232&#x2013;2. doi: 10.3389/fimmu.2020.00232</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/32194548/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fimmu.2020.00232" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S+Hatano&amp;author=H+Watanabe&amp;publication_year=2020&amp;title=Regulation%20of%20Macrophage%20and%20Dendritic%20Cell%20Function%20by%20Chondroitin%20Sulfate%20in%20Innate%20to%20Antigen-Sspecific%20Adaptive%20Immunity&amp;journal=Front+Immunol&amp;volume=11&amp;pages=232-2" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B11" id="B11"></a> 11. Seol BG, Kim JH, Woo M, Song YO, Choi YH, Noh JS, et al. Skate Cartilage Extracts Containing Chondroitin Sulfate Ameliorates Hyperlipidemia-Induced Inflammation and Oxidative Stress in High Cholesterol Diet-Fed LDL Receptor Knockout Mice in Comparison With Shark Chondroitin Sulfate. <i>Nutr Res Pract</i> (2020) 14:175&#x2013;87. doi: 10.4162/nrp.2020.14.3.175</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/32528626/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.4162/nrp.2020.14.3.175" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=BG+Seol&amp;author=JH+Kim&amp;author=M+Woo&amp;author=YO+Song&amp;author=YH+Choi&amp;author=JS+Noh&amp;publication_year=2020&amp;title=Skate%20Cartilage%20Extracts%20Containing%20Chondroitin%20Sulfate%20Ameliorates%20Hyperlipidemia-Induced%20Inflammation%20and%20Oxidative%20Stress%20in%20High%20Cholesterol%20Diet-Fed%20LDL%20Receptor%20Knockout%20Mice%20in%20Comparison%20With%20Shark%20Chondroitin%20Sulfate&amp;journal=Nutr+Res+Pract&amp;volume=14&amp;pages=175-87" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B12" id="B12"></a> 12. Pude&#x142;ko A, Wisowski G, Olczyk K, Ko&#x17a;ma EM. The Dual Role of the Glycosaminoglycan Chondroitin-6-Sulfate in the Development, Progression and Metastasis of Cancer. <i>FEBS J</i> (2019) 286:1815&#x2013;37. doi: 10.1111/febs.14748</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/30637950/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/febs.14748" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A+Pude%C5%82ko&amp;author=G+Wisowski&amp;author=K+Olczyk&amp;author=EM+Ko%C5%BAma&amp;publication_year=2019&amp;title=The%20Dual%20Role%20of%20the%20Glycosaminoglycan%20Chondroitin-6-Sulfate%20in%20the%20Development%2C%20Progression%20and%20Metastasis%20of%20Cancer&amp;journal=FEBS+J&amp;volume=286&amp;pages=1815-37" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B13" id="B13"></a> 13. Gomes CL, Le&#xe3;o CL, Venturotti C, Barreira AL, Guimar&#xe3;es G, Fonseca RJ, et al. The Protective Role of Fucosylated Chondroitin Sulfate, a Distinct Glycosaminoglycan, in a Murine Model of Streptozotocin-Induced Diabetic Nephropathy. <i>PloS One</i> (2014) 9:e106929. doi: 10.1371/journal.pone.0106929</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/25192337/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pone.0106929" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=CL+Gomes&amp;author=CL+Le%C3%A3o&amp;author=C+Venturotti&amp;author=AL+Barreira&amp;author=G+Guimar%C3%A3es&amp;author=RJ+Fonseca&amp;publication_year=2014&amp;title=The%20Protective%20Role%20of%20Fucosylated%20Chondroitin%20Sulfate%2C%20a%20Distinct%20Glycosaminoglycan%2C%20in%20a%20Murine%20Model%20of%20Streptozotocin-Induced%20Diabetic%20Nephropathy&amp;journal=PloS+One&amp;volume=9&amp;pages=e106929" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B14" id="B14"></a> 14. Wolff RB. Glucosamine and Chondroitin Sulfate Association Increases Tibial Epiphyseal Growth Plate Proliferation and Bone Formation in Ovariectomized Rats. <i>Clinics</i> (2014) 12:847&#x2013;53. doi: 10.6061/clinics/2014(12)10</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.6061/clinics/2014(12)10" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=RB+Wolff&amp;publication_year=2014&amp;title=Glucosamine%20and%20Chondroitin%20Sulfate%20Association%20Increases%20Tibial%20Epiphyseal%20Growth%20Plate%20Proliferation%20and%20Bone%20Formation%20in%20Ovariectomized%20Rats&amp;journal=Clinics&amp;volume=12&amp;pages=847-53" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B15" id="B15"></a> 15. Zhu WM, Ji Y, Wang YD, He YY, Su N, Zhang C, et al. Structural Characterization and <i>In Vitro</i> Antioxidant Activities of Chondroitin Sulfate Purified From Andrias Davidianus Cartilage. <i>Carbohyd Polym</i> (2018) 5:398&#x2013;404. doi: 10.1016/j.carbpol.2018.05.047</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1016/j.carbpol.2018.05.047" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=WM+Zhu&amp;author=Y+Ji&amp;author=YD+Wang&amp;author=YY+He&amp;author=N+Su&amp;author=C+Zhang&amp;publication_year=2018&amp;title=Structural%20Characterization%20and%20In%20Vitro%20Antioxidant%20Activities%20of%20Chondroitin%20Sulfate%20Purified%20From%20Andrias%20Davidianus%20Cartilage&amp;journal=Carbohyd+Polym&amp;volume=5&amp;pages=398" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B16" id="B16"></a> 16. Qi SS, Shao ML, Sun Z, Chen SM, Hu YJ, Wang HT, et al. Lycopene Ameliorates Diabetic Osteoporosis <i>via</i> Anti-Inflammatory, Anti-Oxidation, and Increasing Osteoprotegerin/RANKL Expression Ratio. <i>J Funct Foods</i> (2021) 83:1756&#x2013;4646. doi: 10.1016/j.jff.2021.104539</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1016/j.jff.2021.104539" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SS+Qi&amp;author=ML+Shao&amp;author=Z+Sun&amp;author=SM+Chen&amp;author=YJ+Hu&amp;author=HT+Wang&amp;publication_year=2021&amp;title=Lycopene%20Ameliorates%20Diabetic%20Osteoporosis%20via%20Anti-Inflammatory%2C%20Anti-Oxidation%2C%20and%20Increasing%20Osteoprotegerin%2FRANKL%20Expression%20Ratio&amp;journal=J+Funct+Foods&amp;volume=83&amp;pages=1756" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B17" id="B17"></a> 17. Qi SS, He J, Chen C, Zheng HX, Zhang ZJ. Du-Zhong (<i>Eucommia Ulmoides Oliv.</i>) Cortex Extract Prevents Bone Loss in Ovariectomized Diabetic Rats by Suppressing Bone Turnover and Up-Regulating the OPG/RANKL Ratio. <i>Int J Clin Exp Med</i> (2019) 12:579&#x2013;90. doi: 10.1007/s12011-018-1362-6</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1007/s12011-018-1362-6" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SS+Qi&amp;author=J+He&amp;author=C+Chen&amp;author=HX+Zheng&amp;author=ZJ+Zhang&amp;publication_year=2019&amp;title=Du-Zhong%20%28Eucommia%20Ulmoides%20Oliv.%29%20Cortex%20Extract%20Prevents%20Bone%20Loss%20in%20Ovariectomized%20Diabetic%20Rats%20by%20Suppressing%20Bone%20Turnover%20and%20Up-Regulating%20the%20OPG%2FRANKL%20Ratio&amp;journal=Int+J+Clin+Exp+Med&amp;volume=12&amp;pages=579-90" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B18" id="B18"></a> 18. Wen Y, Li H, Zhang X, Liu P, Ma J, Zhang L, et al. Correlation of Osteoporosis in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Study in Chinese Population. <i>Front Eedocrinol</i> (2021) 12:531904&#x2013;4. doi: 10.3389/fendo.2021.531904</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.3389/fendo.2021.531904" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y+Wen&amp;author=H+Li&amp;author=X+Zhang&amp;author=P+Liu&amp;author=J+Ma&amp;author=L+Zhang&amp;publication_year=2021&amp;title=Correlation%20of%20Osteoporosis%20in%20Patients%20With%20Newly%20Diagnosed%20Type%202%20Diabetes%3A%20A%20Retrospective%20Study%20in%20Chinese%20Population&amp;journal=Front+Eedocrinol&amp;volume=12&amp;pages=531904-4" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B19" id="B19"></a> 19. Shah VN, Shah CS, Snell-Bergeon JK. Type 1 Diabetes and Risk of Fracture: Meta-Analysis and Review of the Literature. <i>Diabetes Med</i> (2015) 32:1134&#x2013;42. doi: 10.1111/dme.12734</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1111/dme.12734" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=VN+Shah&amp;author=CS+Shah&amp;author=JK+Snell-Bergeon&amp;publication_year=2015&amp;title=Type%201%20Diabetes%20and%20Risk%20of%20Fracture%3A%20Meta-Analysis%20and%20Review%20of%20the%20Literature&amp;journal=Diabetes+Med&amp;volume=32&amp;pages=1134-42" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B20" id="B20"></a> 20. Chandra A, Rajawat J. Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics. <i>Int J Mol Sci</i> (2021) 22:3553&#x2013;3. doi: 10.3390/ijms22073553</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/33805567/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/ijms22073553" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A+Chandra&amp;author=J+Rajawat&amp;publication_year=2021&amp;title=Skeletal%20Aging%20and%20Osteoporosis%3A%20Mechanisms%20and%20Therapeutics&amp;journal=Int+J+Mol+Sci&amp;volume=22&amp;pages=3553-3" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B21" id="B21"></a> 21. Palui R, Pramanik S, Mondal S, Ray S. Critical Review of Bone Health, Fracture Risk and Management of Bone Fragility in Diabetes Mellitus. <i>World J Diabetes</i> (2021) 12:706&#x2013;29. doi: 10.4239/wjd.v12.i6.706</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/34168723/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.4239/wjd.v12.i6.706" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R+Palui&amp;author=S+Pramanik&amp;author=S+Mondal&amp;author=S+Ray&amp;publication_year=2021&amp;title=Critical%20Review%20of%20Bone%20Health%2C%20Fracture%20Risk%20and%20Management%20of%20Bone%20Fragility%20in%20Diabetes%20Mellitus&amp;journal=World+J+Diabetes&amp;volume=12&amp;pages=706-29" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B22" id="B22"></a> 22. Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL. Bone and Diabetes Working Group. Mmechanisms of Diabetes Mellitus-Induced Bone Fragility. <i>Nat Rev Endocrinol</i> (2017) 13:208&#x2013;19. doi: 10.1038/nrendo.2016.153</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/27658727/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrendo.2016.153" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=N+Napoli&amp;author=M+Chandran&amp;author=DD+Pierroz&amp;author=B+Abrahamsen&amp;author=AV+Schwartz&amp;author=SL+Ferrari&amp;publication_year=2017&amp;title=Bone%20and%20Diabetes%20Working%20Group.%20Mmechanisms%20of%20Diabetes%20Mellitus-Induced%20Bone%20Fragility&amp;journal=Nat+Rev+Endocrinol&amp;volume=13&amp;pages=208-19" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B23" id="B23"></a> 23. Wang X, Wang H, Zhang T, Cai L, Kong C, He J. Current Knowledge Regarding the Interaction Between Oral Bone Metabolic Disorders and Diabetes Mellitus. <i>Front Endocrinol</i> (2020) 11:536&#x2013;45. doi: 10.3389/fendo.2020.00536</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.3389/fendo.2020.00536" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=X+Wang&amp;author=H+Wang&amp;author=T+Zhang&amp;author=L+Cai&amp;author=C+Kong&amp;author=J+He&amp;publication_year=2020&amp;title=Current%20Knowledge%20Regarding%20the%20Interaction%20Between%20Oral%20Bone%20Metabolic%20Disorders%20and%20Diabetes%20Mellitus&amp;journal=Front+Endocrinol&amp;volume=11&amp;pages=536-45" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B24" id="B24"></a> 24. Agidigbi TS, Kim C. Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases. <i>Int J Mol Sci</i> (2019) 14:3576&#x2013;88. doi: 10.3390/ijms20143576</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.3390/ijms20143576" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=TS+Agidigbi&amp;author=C+Kim&amp;publication_year=2019&amp;title=Reactive%20Oxygen%20Species%20in%20Osteoclast%20Differentiation%20and%20Possible%20Pharmaceutical%20Targets%20of%20ROS-Mediated%20Osteoclast%20Diseases&amp;journal=Int+J+Mol+Sci&amp;volume=14&amp;pages=3576-88" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B25" id="B25"></a> 25. Sellmeyer DE, Civitelli R, Hofbauer LC, Khosla S, Lecka-Czernik B, Schwartz AV. Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes. <i>Diabetes</i> (2016) 65:1757&#x2013;66. doi: 10.2337/db16-0063</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/27329951/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.2337/db16-0063" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=DE+Sellmeyer&amp;author=R+Civitelli&amp;author=LC+Hofbauer&amp;author=S+Khosla&amp;author=B+Lecka-Czernik&amp;author=AV+Schwartz&amp;publication_year=2016&amp;title=Skeletal%20Metabolism%2C%20Fracture%20Risk%2C%20and%20Fracture%20Outcomes%20in%20Type%201%20and%20Type%202%20Diabetes&amp;journal=Diabetes&amp;volume=65&amp;pages=1757-66" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B26" id="B26"></a> 26. De Vries TJ, El Bakkali I, Kamradt T, Schett G, Jansen I, D'Amelio P. What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss? <i>Front Immumol</i> (2019) 10:505. doi: 10.3389/fimmu.2019.00505</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.3389/fimmu.2019.00505" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=TJ+De%20Vries&amp;author=I+El%20Bakkali&amp;author=T+Kamradt&amp;author=G+Schett&amp;author=I+Jansen&amp;author=P+D%27Amelio&amp;publication_year=2019&amp;title=What%20Are%20the%20Peripheral%20Blood%20Determinants%20for%20Increased%20Osteoclast%20Formation%20in%20the%20Various%20Inflammatory%20Diseases%20Associated%20With%20Bone%20Loss&amp;journal=Front+Immumol&amp;volume=10&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B27" id="B27"></a> 27. Li XJ, Zhu Z, Han SL, Zhang ZL. Bergapten Exerts Inhibitory Effects on Diabetes-Related Osteoporosis <i>via</i> the Regulation of the PI3K/AKT, JNK/MAPK and NF-&#x3ba;b Signaling Pathways in Osteoprotegerin Knockout Mice. <i>Int J Mol Med</i> (2016) 38:1661&#x2013;72. doi: 10.3892/ijmm.2016.2794</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/27840967/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3892/ijmm.2016.2794" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=XJ+Li&amp;author=Z+Zhu&amp;author=SL+Han&amp;author=ZL+Zhang&amp;publication_year=2016&amp;title=Bergapten%20Exerts%20Inhibitory%20Effects%20on%20Diabetes-Related%20Osteoporosis%20via%20the%20Regulation%20of%20the%20PI3K%2FAKT%2C%20JNK%2FMAPK%20and%20NF-%CE%BAb%20Signaling%20Pathways%20in%20Osteoprotegerin%20Knockout%20Mice&amp;journal=Int+J+Mol+Med&amp;volume=38&amp;pages=1661-72" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B28" id="B28"></a> 28. Wang W, Bai J, Zhang W, Ge G, Wang Q, Liang X, et al. Protective Effects of Punicalagin on Osteoporosis by Inhibiting Osteoclastogenesis and Inflammation <i>via</i> the NF-&#x3ba;b and MAPK Pathways. <i>Front Pharmacol</i> (2020) 11:696. doi: 10.3389/fphar.2020.00696</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/32477149/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fphar.2020.00696" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=W+Wang&amp;author=J+Bai&amp;author=W+Zhang&amp;author=G+Ge&amp;author=Q+Wang&amp;author=X+Liang&amp;publication_year=2020&amp;title=Protective%20Effects%20of%20Punicalagin%20on%20Osteoporosis%20by%20Inhibiting%20Osteoclastogenesis%20and%20Inflammation%20via%20the%20NF-%CE%BAb%20and%20MAPK%20Pathways&amp;journal=Front+Pharmacol&amp;volume=11&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B29" id="B29"></a> 29. Lu R, Zhen Z, Yin Y, Jiang Z. Genistein Prevents Bone Loss in Type 2 Diabetic Rats Induced by Streptozotocin. <i>Food Nutr Res</i> (2020) 64:29219. doi: 10.29219/fnr.v64.3666</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.29219/fnr.v64.3666" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R+Lu&amp;author=Z+Zhen&amp;author=Y+Yin&amp;author=Z+Jiang&amp;publication_year=2020&amp;title=Genistein%20Prevents%20Bone%20Loss%20in%20Type%202%20Diabetic%20Rats%20Induced%20by%20Streptozotocin&amp;journal=Food+Nutr+Res&amp;volume=64&amp;pages=29219" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B30" id="B30"></a> 30. Qi SS, He J, Zheng HX, Chen C, Lan SQ. Icariin Prevents Diabetes-Induced Bone Loss in Rats by Reducing Blood Glucose and Suppressing Bone Turnover. <i>Molecules</i> (2019) 24:1871&#x2013;85. doi: 10.3390/molecules24101871</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.3390/molecules24101871" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SS+Qi&amp;author=J+He&amp;author=HX+Zheng&amp;author=C+Chen&amp;author=SQ+Lan&amp;publication_year=2019&amp;title=Icariin%20Prevents%20Diabetes-Induced%20Bone%20Loss%20in%20Rats%20by%20Reducing%20Blood%20Glucose%20and%20Suppressing%20Bone%20Turnover&amp;journal=Molecules&amp;volume=24&amp;pages=1871-85" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B31" id="B31"></a> 31. Singhal V, Bredella MA. Marrow Adipose Tissue Imaging in Humans. <i>Bone</i> (2019) 54:69&#x2013;76. doi: 10.1016/j.bone.2018.01.009</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1016/j.bone.2018.01.009" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=V+Singhal&amp;author=MA+Bredella&amp;publication_year=2019&amp;title=Marrow%20Adipose%20Tissue%20Imaging%20in%20Humans&amp;journal=Bone&amp;volume=54&amp;pages=69" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B32" id="B32"></a> 32. Kim TY, Schafer AL. Diabetes and Bone Marrow Adiposity. <i>Curr Osteoporos Rep</i> (2016) 14:337&#x2013;44. doi: 10.1007/s11914-016-0336-x</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/27714580/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s11914-016-0336-x" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=TY+Kim&amp;author=AL+Schafer&amp;publication_year=2016&amp;title=Diabetes%20and%20Bone%20Marrow%20Adiposity&amp;journal=Curr+Osteoporos+Rep&amp;volume=14&amp;pages=337-44" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B33" id="B33"></a> 33. Coe LM, Irwin R, Lippner D, McCabe LR. The Bone Marrow Microenvironment Contributes to Type I Diabetes Induced Osteoblast Death. <i>J Cell Physiol</i> (2011) 22:477&#x2013;83. doi: 10.1002/jcp.22357</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1002/jcp.22357" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=LM+Coe&amp;author=R+Irwin&amp;author=D+Lippner&amp;author=LR+McCabe&amp;publication_year=2011&amp;title=The%20Bone%20Marrow%20Microenvironment%20Contributes%20to%20Type%20I%20Diabetes%20Induced%20Osteoblast%20Death&amp;journal=J+Cell+Physiol&amp;volume=22&amp;pages=477-83" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B34" id="B34"></a> 34. Cassidy FC, Shortiss C, Murphy CG, Kearns SR, Curtin W, De BC, et al. Impact of Type 2 Diabetes Mellitus on Human Bone Marrow Stromal Cell Number and Phenotypic Characteristics. <i>Int J Mol Sci</i> (2020) 21:2476&#x2013;86. doi: 10.3390/ijms21072476</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.3390/ijms21072476" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=FC+Cassidy&amp;author=C+Shortiss&amp;author=CG+Murphy&amp;author=SR+Kearns&amp;author=W+Curtin&amp;author=BC+De&amp;publication_year=2020&amp;title=Impact%20of%20Type%202%20Diabetes%20Mellitus%20on%20Human%20Bone%20Marrow%20Stromal%20Cell%20Number%20and%20Phenotypic%20Characteristics&amp;journal=Int+J+Mol+Sci&amp;volume=21&amp;pages=2476-86" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B35" id="B35"></a> 35. Qi SS, He J, Zheng HX, Chen C, Jiang H. Zinc Supplementation Increased Bone Mineral Density, Improves Bone Histomorphology, and Prevents Bone Loss in Diabetic Rat. <i>Biol Trace Elem Res</i> (2020) 19:493&#x2013;501. doi: 10.1007/s12011-019-01810-7</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1007/s12011-019-01810-7" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SS+Qi&amp;author=J+He&amp;author=HX+Zheng&amp;author=C+Chen&amp;author=H+Jiang&amp;publication_year=2020&amp;title=Zinc%20Supplementation%20Increased%20Bone%20Mineral%20Density%2C%20Improves%20Bone%20Histomorphology%2C%20and%20Prevents%20Bone%20Loss%20in%20Diabetic%20Rat&amp;journal=Biol+Trace+Elem+Res&amp;volume=19&amp;pages=493" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B36" id="B36"></a> 36. Kalaitzoglou E, Fowlkes JL, Popescu I, Thrailkill KM. Diabetes Pharmacotherapy and Effects on the Musculoskeletal System. <i>Diabetes-Metab Res</i> (2019) 35:e3100. doi: 10.1002/dmrr.3100</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1002/dmrr.3100" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=E+Kalaitzoglou&amp;author=JL+Fowlkes&amp;author=I+Popescu&amp;author=KM+Thrailkill&amp;publication_year=2019&amp;title=Diabetes%20Pharmacotherapy%20and%20Effects%20on%20the%20Musculoskeletal%20System&amp;journal=Diabetes-Metab+Res&amp;volume=35&amp;pages=e3100" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B37" id="B37"></a> 37. Taylor GS, Moser O, Smith K, Shaw A, Tang JCY, Fraser WD, et al. Bone Turnover and Metabolite Responses to Exercise in People With and Without Long-Duration Type 1 Diabetes: A Case-Control Study. <i>BMJ Open Diabetes Res CA</i> (2020) 8:e001779. doi: 10.1136/bmjdrc-2020-001779</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1136/bmjdrc-2020-001779" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=GS+Taylor&amp;author=O+Moser&amp;author=K+Smith&amp;author=A+Shaw&amp;author=JCY+Tang&amp;author=WD+Fraser&amp;publication_year=2020&amp;title=Bone%20Turnover%20and%20Metabolite%20Responses%20to%20Exercise%20in%20People%20With%20and%20Without%20Long-Duration%20Type%201%20Diabetes%3A%20A%20Case-Control%20Study&amp;journal=BMJ+Open+Diabetes+Res+CA&amp;volume=8&amp;pages=e001779" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B38" id="B38"></a> 38. Mederle OA, Balas M, Ioanoviciu SD, Gurban CV, Tudor ABorza C. Correlations Between Bone Turnover Markers, Serum Magnesium and Bone Mass Densityin Postmenopausal Osteoporosis. <i>Clin Interv Aging</i> (2018) 13:1383&#x2013;9. doi: 10.2147/CIA.S170111</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/30122910/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.2147/CIA.S170111" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=OA+Mederle&amp;author=M+Balas&amp;author=SD+Ioanoviciu&amp;author=CV+Gurban&amp;author=C+Tudor%20ABorza&amp;publication_year=2018&amp;title=Correlations%20Between%20Bone%20Turnover%20Markers%2C%20Serum%20Magnesium%20and%20Bone%20Mass%20Densityin%20Postmenopausal%20Osteoporosis&amp;journal=Clin+Interv+Aging&amp;volume=13&amp;pages=1383-9" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B39" id="B39"></a> 39. Lorentzon M, Branco J, Brandi ML, Bruy&#xe8;re O, Chapurlat R, Cooper C, et al. Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis. <i>Adv Ther</i> (2019) 36:2811&#x2013;24. doi: 10.1007/s12325-019-01063-9</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/31440982/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s12325-019-01063-9" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M+Lorentzon&amp;author=J+Branco&amp;author=ML+Brandi&amp;author=O+Bruy%C3%A8re&amp;author=R+Chapurlat&amp;author=C+Cooper&amp;publication_year=2019&amp;title=Algorithm%20for%20the%20Use%20of%20Biochemical%20Markers%20of%20Bone%20Turnover%20in%20the%20Diagnosis%2C%20Assessment%20and%20Follow-Up%20of%20Treatment%20for%20Osteoporosis&amp;journal=Adv+Ther&amp;volume=36&amp;pages=2811-24" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B40" id="B40"></a> 40. Zhao Y, Wang HL, Li TT, Yang F, Tzeng CM. Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway. <i>Drug Des Dev Ther</i> (2020) 14:195&#x2013;206. doi: 10.2147/DDDT.S225516</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.2147/DDDT.S225516" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y+Zhao&amp;author=HL+Wang&amp;author=TT+Li&amp;author=F+Yang&amp;author=CM+Tzeng&amp;publication_year=2020&amp;title=Baicalin%20Ameliorates%20Dexamethasone-Induced%20Osteoporosis%20by%20Regulation%20of%20the%20RANK%2FRANKL%2FOPG%20Signaling%20Pathway&amp;journal=Drug+Des+Dev+Ther&amp;volume=14&amp;pages=195" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B41" id="B41"></a> 41. Mo H, Zhang N, Li H, Li F, Pu R. Beneficial Effects of Cuscuta Chinensis Extract on Glucocorticoid-Induced Osteoporosis Through Modulation of RANKL/OPG Signals. <i>Braz J Med Biol Res</i> (2019) 52:e8754. doi: 10.1590/1414-431x20198754</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://pubmed.ncbi.nlm.nih.gov/31826180/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1590/1414-431x20198754" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=H+Mo&amp;author=N+Zhang&amp;author=H+Li&amp;author=F+Li&amp;author=R+Pu&amp;publication_year=2019&amp;title=Beneficial%20Effects%20of%20Cuscuta%20Chinensis%20Extract%20on%20Glucocorticoid-Induced%20Osteoporosis%20Through%20Modulation%20of%20RANKL%2FOPG%20Signals&amp;journal=Braz+J+Med+Biol+Res&amp;volume=52&amp;pages=e8754" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B42" id="B42"></a> 42. Noh JY, Yang Y, Jung H. Molecular Mechanisms and Emerging Therapeutics for Osteoporosis. <i>Int J Mol Sci</i> (2020) 21:7623. doi: 10.3390/ijms21207623</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.3390/ijms21207623" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=JY+Noh&amp;author=Y+Yang&amp;author=H+Jung&amp;publication_year=2020&amp;title=Molecular%20Mechanisms%20and%20Emerging%20Therapeutics%20for%20Osteoporosis&amp;journal=Int+J+Mol+Sci&amp;volume=21&amp;pages=7623" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B43" id="B43"></a> 43. Azizieh FY, Shehab D, Jarallah KA, Gupta R, Raghupathy R. Circulatory Levels of RANKL, OPG, and Oxidative Stress Markers in Postmenopausal Women With Normal or Low Bone Mineral Density. <i>Biomark Insights</i> (2019) 14:1&#x2013;7. doi: 10.1177/1177271919843825</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1177/1177271919843825" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=FY+Azizieh&amp;author=D+Shehab&amp;author=KA+Jarallah&amp;author=R+Gupta&amp;author=R+Raghupathy&amp;publication_year=2019&amp;title=Circulatory%20Levels%20of%20RANKL%2C%20OPG%2C%20and%20Oxidative%20Stress%20Markers%20in%20Postmenopausal%20Women%20With%20Normal%20or%20Low%20Bone%20Mineral%20Density&amp;journal=Biomark+Insights&amp;volume=14&amp;pages=1" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B44" id="B44"></a> 44. Zheng HX, Qi SS, Chen C. Salidroside Improves Bone Histomorphology and Prevents Bone Loss in Ovariectomized Diabetic Rats by Upregulating the OPG/RANKL Ratio. <i>Molecules</i> (2018) 23:2398&#x2013;8. doi: 10.3390/molecules23092398</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.3390/molecules23092398" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=HX+Zheng&amp;author=SS+Qi&amp;author=C+Chen&amp;publication_year=2018&amp;title=Salidroside%20Improves%20Bone%20Histomorphology%20and%20Prevents%20Bone%20Loss%20in%20Ovariectomized%20Diabetic%20Rats%20by%20Upregulating%20the%20OPG%2FRANKL%20Ratio&amp;journal=Molecules&amp;volume=23&amp;pages=2398-8" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B45" id="B45"></a> 45. Hostalek U, Gwilt M, Hildemann S. Therapeutic Use of Metformin inPrediabetes and Diabetes. <i>Prevention Drugs</i> (2015) 75:1071&#x2013;94. doi: 10.1007/s40265-015-0416-8</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1007/s40265-015-0416-8" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=U+Hostalek&amp;author=M+Gwilt&amp;author=S+Hildemann&amp;publication_year=2015&amp;title=Therapeutic%20Use%20of%20Metformin%20inPrediabetes%20and%20Diabetes&amp;journal=Prevention+Drugs&amp;volume=75&amp;pages=1071-94" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B46" id="B46"></a> 46. Elbere I, Kalnina I, Silamikelis I, Konrade I, Zaharenko L, Sekace K, et al. Association of Metformin Administration With Gut Microbiome Dysbiosis in Healthy Volunteers. <i>PloS One</i> (2018) 9:e0204317. doi: 10.1371/journal.pone.0204317</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1371/journal.pone.0204317" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=I+Elbere&amp;author=I+Kalnina&amp;author=I+Silamikelis&amp;author=I+Konrade&amp;author=L+Zaharenko&amp;author=K+Sekace&amp;publication_year=2018&amp;title=Association%20of%20Metformin%20Administration%20With%20Gut%20Microbiome%20Dysbiosis%20in%20Healthy%20Volunteers&amp;journal=PloS+One&amp;volume=9&amp;pages=e0204317" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B47" id="B47"></a> 47. Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, et al. Diabetes Prevention Program Research Group. Long-Term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. <i>J Clin Endocrinol Metab</i> (2016) 4:1754&#x2013;61. doi: 10.1210/jc.2015-3754</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.1210/jc.2015-3754" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=VR+Aroda&amp;author=SL+Edelstein&amp;author=RB+Goldberg&amp;author=WC+Knowler&amp;author=SM+Marcovina&amp;author=TJ+Orchard&amp;publication_year=2016&amp;title=Diabetes%20Prevention%20Program%20Research%20Group.%20Long-Term%20Metformin%20Use%20and%20Vitamin%20B12%20Deficiency%20in%20the%20Diabetes%20Prevention%20Program%20Outcomes%20Study&amp;journal=J+Clin+Endocrinol+Metab&amp;volume=4&amp;pages=1754-61" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:2em;"><p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B48" id="B48"></a> 48. Owen MD, Baker BC, Scott EM, Forbes K. Interaction Between Metformin, Folate and Vitamin B12 and the Potential Impact on Fetal Growth and Long-Term Metabolic Health in Diabetic Pregnancies. <i>Int J Mol Sci</i> (2021) 11:5759&#x2013;70. doi: 10.3390/ijms22115759</p><p class="ReferencesCopy2" style="margin-left:1em;"><a href="https://doi.org/10.3390/ijms22115759" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=MD+Owen&amp;author=BC+Baker&amp;author=EM+Scott&amp;author=K+Forbes&amp;publication_year=2021&amp;title=Interaction%20Between%20Metformin%2C%20Folate%20and%20Vitamin%20B12%20and%20the%20Potential%20Impact%20on%20Fetal%20Growth%20and%20Long-Term%20Metabolic%20Health%20in%20Diabetic%20Pregnancies&amp;journal=Int+J+Mol+Sci&amp;volume=11&amp;pages=5759-70" target="_blank">Google Scholar</a></p></div></div><div class="thinLineM20"></div><div class="AbstractSummary"><p><span>Keywords:</span> chondroitin sulfate, diabetes, osteoporosis, bone microstructure, bone metabolism</p><p><span>Citation:</span> Qi SS, Shao ML, Sun Z, Chen SM, Hu YJ, Li XS, Chen DJ, Zheng HX and Yue TL (2021) Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure <i>via</i> Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism. <i>Front. Endocrinol.</i> 12:759843. doi: 10.3389/fendo.2021.759843</p><p id="timestamps"><span>Received:</span> 17 August 2021; <span>Accepted:</span> 29 September 2021;<br><span>Published:</span> 27 October 2021.</p><div><p>Edited by:</p><a href="https://loop.frontiersin.org/people/42129">Peter Vestergaard</a>, Aalborg University Hospital, Denmark</div><div><p>Reviewed by:</p><a href="https://loop.frontiersin.org/people/742646">Ganesan Ramamoorthi</a>, Moffitt Cancer Center, United States<br><a href="https://loop.frontiersin.org/people/663338">Yaguang Li</a>, Central South University, China<br><a href="https://loop.frontiersin.org/people/1423801">Chen Chen</a>, Shaanxi University of Science and Technology, China</div><p><span>Copyright</span> &#xa9; 2021 Qi, Shao, Sun, Chen, Hu, Li, Chen, Zheng and Yue. This is an open-access article distributed under the terms of the <a rel="license" href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY)</a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p><p><span>*Correspondence:</span> Tian Li Yue, <a id="encmail">eXVldGxAbndhZnUuZWR1LmNu</a>; Hong Xing Zheng, <a id="encmail">emhlbmdob25neGluZ0BzbnV0LmVkdS5jbg==</a>; De Jing Chen, <a id="encmail">Y2Rqc2xnQDEyNi5jb20=</a></p><div class="clear"></div></div></div></div> <p class="AbstractSummary__disclaimer"><span>Disclaimer: </span> All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. </p></div></div></main> <aside class="Layout__aside"><div class="ArticleDetails__wrapper"><div class="ArticleDetails__aside"><div class="ArticleDetails__aside__responsiveButtons"><div id="FloatingButtonsEl" class="ActionsDropDown"><button aria-label="Open dropdown" data-event="actionsDropDown-button-toggle" class="ActionsDropDown__button ActionsDropDown__button--type ActionsDropDown__button--icon"><span class="ActionsDropDown__button__label">Download article</span></button> <div class="ActionsDropDown__menuWrapper"><!----> <ul class="ActionsDropDown__menu"><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/pdf" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-pdf" class="ActionsDropDown__option"> Download PDF </a></li><li><a href="http://www.readcube.com/articles/10.3389/fendo.2021.759843" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-readCube" class="ActionsDropDown__option"> ReadCube </a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/epub" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-epub" class="ActionsDropDown__option"> EPUB </a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/xml/nlm" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-nlmXml" class="ActionsDropDown__option"> XML (NLM) </a></li></ul> <button aria-label="Close modal" data-event="actionsDropDown-button-close" class="ActionsDropDown__mobileClose"></button></div></div> <div class="ArticleDetails__aside__responsiveButtons__items"><!----> <div class="ArticleDetailsShare__responsive"><button aria-label="Open share options" class="ArticleDetailsShare__trigger"></button> <div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p> <ul class="ArticleDetailsShare__list"><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.759843/full" target="_blank" title="Share on X" aria-label="Share on X" class="ArticleDetailsShare__link ArticleDetailsShare__link--x"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.759843/full" target="_blank" title="Share on Linkedin" aria-label="Share on Linkedin" class="ArticleDetailsShare__link ArticleDetailsShare__link--linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.759843/full" target="_blank" title="Share on Facebook" aria-label="Share on Facebook" class="ArticleDetailsShare__link ArticleDetailsShare__link--facebook"></a></li></ul></div></div> <div class="ActionsDropDown"><button aria-label="Open dropdown" data-event="actionsDropDown-button-toggle" class="ActionsDropDown__button ActionsDropDown__button--typeIconButton ActionsDropDown__button--iconQuote"><!----></button> <div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle"> Export citation </div> <ul class="ActionsDropDown__menu"><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/endNote" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-endNote" class="ActionsDropDown__option"> EndNote </a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/reference" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-referenceManager" class="ActionsDropDown__option"> Reference Manager </a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/text" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-simpleTextFile" class="ActionsDropDown__option"> Simple Text file </a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/bibTex" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-bibTex" class="ActionsDropDown__option"> BibTex </a></li></ul> <button aria-label="Close modal" data-event="actionsDropDown-button-close" class="ActionsDropDown__mobileClose"></button></div></div></div></div> <div class="TotalViews"><div class="TotalViews__data"><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number"> 7,1K </div> <div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Total views</div></div></div> <div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number"> 3,7K </div> <div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Downloads</div></div></div> <div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number"> 26 </div> <div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Citations</div></div></div> <div class="ImpactMetricsInfoPopover"><button aria-label="Open impact metrics info" class="ImpactMetricsInfoPopover__button"></button> <div class="ImpactMetricsInfoPopover__tooltip"><button aria-label="Close impact metrics info" class="ImpactMetricsInfoPopover__tooltip__closeButton"></button> <div class="ImpactMetricsInfoPopover__tooltip__text"> Citation numbers are available from Dimensions </div></div></div></div> <div class="TotalViews__viewImpactLink"><span class="Link__wrapper"><a aria-label="View article impact" href="http://loop-impact.frontiersin.org/impact/article/759843#totalviews/views" target="_blank" data-event="customLink-link-a_viewArticleImpact" class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right"><span>View article impact</span></a></span></div> <div class="TotalViews__altmetric"><div data-badge-popover="bottom" data-badge-type="donut" data-doi="10.3389/fendo.2021.759843" data-condensed="true" data-link-target="new" class="altmetric-embed"></div> <span class="Link__wrapper"><a aria-label="View altmetric score" href="https://www.altmetric.com/details/doi/10.3389/fendo.2021.759843" target="_blank" data-event="customLink-link-a_viewAltmetricScore" class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right"><span>View altmetric score</span></a></span></div></div> <div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p> <ul class="ArticleDetailsShare__list"><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.759843/full" target="_blank" title="Share on X" aria-label="Share on X" class="ArticleDetailsShare__link ArticleDetailsShare__link--x"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.759843/full" target="_blank" title="Share on Linkedin" aria-label="Share on Linkedin" class="ArticleDetailsShare__link ArticleDetailsShare__link--linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.759843/full" target="_blank" title="Share on Facebook" aria-label="Share on Facebook" class="ArticleDetailsShare__link ArticleDetailsShare__link--facebook"></a></li></ul></div> <div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Edited by</div> <a href="https://loop.frontiersin.org/people/42129/overview" data-event="editorInfo-a-peterVestergaard" class="ArticleDetailsEditors__ediorInfo"><figure class="Avatar Avatar--size-32"><img src="https://loop.frontiersin.org/images/profile/42129/32" alt="Peter Vestergaard" class="Avatar__img is-inside-mask"></figure> <div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate"> Peter Vestergaard </div> <div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate"> Aalborg University Hospital, Denmark </div></div></a></div></div> <div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Reviewed by</div> <a href="https://loop.frontiersin.org/people/663338/overview" data-event="editorInfo-a-yaguangLi" class="ArticleDetailsEditors__ediorInfo"><figure class="Avatar Avatar--size-32"><img src="https://loop.frontiersin.org/images/profile/663338/32" alt="Yaguang Li" class="Avatar__img is-inside-mask"></figure> <div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate"> Yaguang Li </div> <div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate"> Second Xiangya Hospital, Central South University, China </div></div></a><a href="https://loop.frontiersin.org/people/742646/overview" data-event="editorInfo-a-ganesanRamamoorthi" class="ArticleDetailsEditors__ediorInfo"><figure class="Avatar Avatar--size-32"><img src="https://loop.frontiersin.org/images/profile/742646/32" alt="Ganesan Ramamoorthi" class="Avatar__img is-inside-mask"></figure> <div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate"> Ganesan Ramamoorthi </div> <div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate"> Moffitt Cancer Center, United States </div></div></a><a href="https://loop.frontiersin.org/people/1423801/overview" data-event="editorInfo-a-chenChen" class="ArticleDetailsEditors__ediorInfo"><figure class="Avatar Avatar--size-32"><img src="https://loop.frontiersin.org/images/profile/1423801/32" alt="Chen Chen" class="Avatar__img is-inside-mask"></figure> <div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate"> Chen Chen </div> <div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate"> Shaanxi University of Science and Technology, China </div></div></a></div></div> <div class="ArticleDetailsGlossary ArticleDetailsGlossary--open"><button class="ArticleDetailsGlossary__header"><div class="ArticleDetailsGlossary__header__title">Table of contents</div> <div class="ArticleDetailsGlossary__header__arrow"></div></button> <div class="ArticleDetailsGlossary__content"><ul class="flyoutJournal"><li><a href="#h1">Abstract</a></li><li><a href="#h2">Introduction</a></li><li><a href="#h3">Materials and Methods</a></li><li><a href="#h4">Results</a></li><li><a href="#h5">Discussion</a></li><li><a href="#h6">Data Availability Statement</a></li><li><a href="#h7">Ethics Statement</a></li><li><a href="#h8">Author Contributions</a></li><li><a href="#h9">Funding</a></li><li><a href="#h10">Conflict of Interest</a></li><li><a href="#h11">Publisher&#x2019;s Note</a></li><li><a href="#h12">References</a></li></ul></div></div> <!----> <div class="ActionsDropDown"><button aria-label="Open dropdown" data-event="actionsDropDown-button-toggle" class="ActionsDropDown__button ActionsDropDown__button--typeOutline ActionsDropDown__button--iconQuote"><span class="ActionsDropDown__button__label">Export citation</span></button> <div class="ActionsDropDown__menuWrapper"><!----> <ul class="ActionsDropDown__menu"><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/endNote" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-endNote" class="ActionsDropDown__option"> EndNote </a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/reference" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-referenceManager" class="ActionsDropDown__option"> Reference Manager </a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/text" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-simpleTextFile" class="ActionsDropDown__option"> Simple Text file </a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/bibTex" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-bibTex" class="ActionsDropDown__option"> BibTex </a></li></ul> <button aria-label="Close modal" data-event="actionsDropDown-button-close" class="ActionsDropDown__mobileClose"></button></div></div> <div class="CheckForUpdates"><button data-target="crossmark" data-event="checkForUpdates-btn-openModal" class="CheckForUpdates__link"><img src="/article-pages/_nuxt/img/crossmark.5c8ec60.svg" alt="Crossmark icon" class="CheckForUpdates__link__img"> <div class="CheckForUpdates__link__text">Check for updates</div></button></div> <div class="Announcement"><p class="Announcement__title"> Research integrity at Frontiers </p> <article class="CardA"><div class="CardA__wrapper CardA__wrapper--vertical"><figure class="FrontiersImage CardA__img"><picture class="FrontiersImage"><source srcset="https://images-provider.frontiersin.org/api/ipx/w=440&amp;f=webp/https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png" media="(max-width: 563px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=320x400&amp;fit=outside&amp;f=webp/https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png" media="(max-width: 1024px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=268x280&amp;fit=outside&amp;f=webp/https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png" media="(max-width: 1441px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=webp/https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png" media=""><source srcset="https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png" media=""> <img src="https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png" alt="Man ultramarathon runner in the mountains he trains at sunset" loading="lazy" class="is-inside-mask"></picture> <!----></figure> <div class="CardA__info"><h2 class="CardA__title">94% of researchers rate our articles as excellent or good</h2> <p class="CardA__text">Learn more about the work of our research integrity team to safeguard the quality of each article we publish.</p> <br> <span class="Link__wrapper"><a aria-label="About our research integrity team" href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="customLink-link-a_findOutMore" class="Link Link--linkType Link--maincolor Link--small Link--icon Link--chevronRight Link--right"><span>Find out more </span></a></span></div></div></article></div> <!----> <!----></div> <!----> <div><div class="FloatingButtons"><!----> <div class="ActionsDropDown"><button aria-label="Open dropdown" data-event="actionsDropDown-button-toggle" class="ActionsDropDown__button ActionsDropDown__button--type ActionsDropDown__button--iconDownload"><span class="ActionsDropDown__button__label">Download article</span></button> <div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle"> Download </div> <ul class="ActionsDropDown__menu"><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/pdf" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-pdf" class="ActionsDropDown__option"> Download PDF </a></li><li><a href="http://www.readcube.com/articles/10.3389/fendo.2021.759843" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-readCube" class="ActionsDropDown__option"> ReadCube </a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/epub" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-epub" class="ActionsDropDown__option"> EPUB </a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2021.759843/xml/nlm" target="_blank" rel="noopener noreferrer" data-event="actionsDropDown-a-nlmXml" class="ActionsDropDown__option"> XML (NLM) </a></li></ul> <button aria-label="Close modal" data-event="actionsDropDown-button-close" class="ActionsDropDown__mobileClose"></button></div></div></div> <!----></div></div></aside></div> <div class="Announcement Announcement--Responsive"><p class="Announcement__title"> Research integrity at Frontiers </p> <article class="CardA"><div class="CardA__wrapper CardA__wrapper--vertical"><figure class="FrontiersImage CardA__img"><picture class="FrontiersImage"><source srcset="https://images-provider.frontiersin.org/api/ipx/w=440&amp;f=webp/https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png" media="(max-width: 563px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=320x400&amp;fit=outside&amp;f=webp/https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png" media="(max-width: 1024px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=268x280&amp;fit=outside&amp;f=webp/https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png" media="(max-width: 1441px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=webp/https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png" media=""><source srcset="https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png" media=""> <img src="https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png" alt="Man ultramarathon runner in the mountains he trains at sunset" loading="lazy" class="is-inside-mask"></picture> <!----></figure> <div class="CardA__info"><h2 class="CardA__title">94% of researchers rate our articles as excellent or good</h2> <p class="CardA__text">Learn more about the work of our research integrity team to safeguard the quality of each article we publish.</p> <br> <span class="Link__wrapper"><a aria-label="About our research integrity team" href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="customLink-link-a_findOutMore" class="Link Link--linkType Link--maincolor Link--small Link--icon Link--chevronRight Link--right"><span>Find out more </span></a></span></div></div></article></div> <div><!----></div></div></div> <!----> <footer class="Footer"><div class="Footer__wrapper"><div class="Footer__sections"><ul class="Accordion"><li class="Accordion__item"><button class="Accordion__headline"><!----> <div class="Accordion__title">Guidelines</div> <div class="Accordion__space"></div> <div class="Accordion__arrow"></div></button> <div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><ul><li><a href="https://www.frontiersin.org/guidelines/author-guidelines" target="_self" data-event="footer-block_0-a_authorGuidelines">Author guidelines</a></li><li><a href="https://www.frontiersin.org/guidelines/editor-guidelines" target="_self" data-event="footer-block_0-a_editorGuidelines">Editor guidelines</a></li><li><a href="https://www.frontiersin.org/guidelines/policies-and-publication-ethics" target="_self" data-event="footer-block_0-a_policiesAndPublicationE">Policies and publication ethics</a></li><li><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="footer-block_0-a_feePolicy">Fee policy</a></li></ul></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----> <div class="Accordion__title">Explore</div> <div class="Accordion__space"></div> <div class="Accordion__arrow"></div></button> <div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><ul><li><a href="https://www.frontiersin.org/articles" target="_self" data-event="footer-block_1-a_articles">Articles</a></li><li><a href="https://www.frontiersin.org/research-topics" target="_self" data-event="footer-block_1-a_researchTopics">Research Topics </a></li><li><a href="https://www.frontiersin.org/journals" target="_self" data-event="footer-block_1-a_journals">Journals</a></li><li><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="footer-block_1-a_howWePublish">How we publish</a></li></ul></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----> <div class="Accordion__title">Outreach</div> <div class="Accordion__space"></div> <div class="Accordion__arrow"></div></button> <div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><ul><li><a href="https://forum.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForum">Frontiers Forum </a></li><li><a href="https://policylabs.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersPolicyLabs">Frontiers Policy Labs </a></li><li><a href="https://kids.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForYoungMinds">Frontiers for Young Minds</a></li><li><a href="https://www.frontiersplanetprize.org/" target="_blank" data-event="footer-block_2-a_frontiersPlanetPrize">Frontiers Planet Prize</a></li></ul></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----> <div class="Accordion__title">Connect</div> <div class="Accordion__space"></div> <div class="Accordion__arrow"></div></button> <div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><ul><li><a href="https://helpcenter.frontiersin.org" target="_blank" data-event="footer-block_3-a_helpCenter">Help center</a></li><li><a href="https://loop.frontiersin.org/settings/email-preferences?a=publishers" target="_blank" data-event="footer-block_3-a_emailsAndAlerts">Emails and alerts </a></li><li><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="footer-block_3-a_contactUs">Contact us </a></li><li><a href="https://www.frontiersin.org/submission/submit" target="_self" data-event="footer-block_3-a_submit">Submit</a></li><li><a href="https://careers.frontiersin.org/" target="_blank" data-event="footer-block_3-a_careerOpportunities">Career opportunities</a></li></ul></div></li></ul> <div class="Footer__socialLinks"><div class="Footer__socialLinks__title">Follow us</div> <span class="Link__wrapper"><a aria-label="Frontiers Facebook" href="https://www.facebook.com/Frontiersin" target="_blank" data-event="footer-facebook-a_" class="Link Link--linkType Link--grey Link--medium Link--icon Link--facebook Link--right"><span></span></a></span><span class="Link__wrapper"><a aria-label="Frontiers Twitter" href="https://twitter.com/frontiersin" target="_blank" data-event="footer-twitter-a_" class="Link Link--linkType Link--grey Link--medium Link--icon Link--twitter Link--right"><span></span></a></span><span class="Link__wrapper"><a aria-label="Frontiers LinkedIn" href="https://www.linkedin.com/company/frontiers" target="_blank" data-event="footer-linkedIn-a_" class="Link Link--linkType Link--grey Link--medium Link--icon Link--linkedin Link--right"><span></span></a></span><span class="Link__wrapper"><a aria-label="Frontiers Instagram" href="https://www.instagram.com/frontiersin_" target="_blank" data-event="footer-instagram-a_" class="Link Link--linkType Link--grey Link--medium Link--icon Link--instagram Link--right"><span></span></a></span></div></div> <div class="Footer__copyright"><div><span>© 2025 Frontiers Media S.A. All rights reserved</span></div> <div><a href="https://www.frontiersin.org/legal/privacy-policy" target="_blank">Privacy policy</a> <span>|</span> <a href="https://www.frontiersin.org/legal/terms-and-conditions" target="_blank">Terms and conditions</a></div></div></div></footer> <div class="SnackbarWrapper"><ul class="SnackbarContainer"></ul></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax,ay,az,aA,aB,aC,aD,aE,aF,aG,aH,aI,aJ,aK,aL,aM,aN,aO,aP,aQ,aR,aS,aT,aU,aV,aW,aX,aY,aZ,a_,a$,ba,bb,bc,bd,be,bf,bg,bh,bi,bj,bk,bl,bm,bn,bo,bp,bq,br,bs,bt,bu,bv,bw,bx,by,bz,bA,bB,bC,bD,bE,bF,bG,bH,bI,bJ,bK,bL,bM,bN,bO,bP,bQ,bR,bS,bT,bU,bV,bW,bX,bY,bZ,b_,b$,ca,cb,cc,cd,ce,cf,cg,ch,ci,cj,ck,cl,cm,cn,co,cp,cq,cr,cs,ct,cu,cv,cw,cx,cy,cz,cA,cB,cC,cD,cE,cF,cG,cH,cI,cJ,cK,cL,cM,cN,cO,cP,cQ,cR,cS,cT,cU){aD.id=aE;aD.name=aF;aD.slug=aG;aD.specialtyId=181;aD.__typename="journal_section";return {layout:"ArticleLayout",data:[{}],fetch:{},error:f,state:{currentJournal:{identifier:x,name:t,slug:u,banner:[{id:"1AAA1237-EA54-405E-B5292056FC2FC63E",src:Y,name:"FENDO_Main Visual_Red_Website",tags:["medical","endocrine","microscope","tissue",u,"parathyroid","metabolism","thyroid","thyroxine","microscopic","metabolic",Z,_,"histological"],type:J,width:3264,height:2448,idHash:"68bd53008f8c9c81",archive:i,brandId:$,limited:i,fileSize:1779340,isPublic:c,original:"https:\u002F\u002Fbrand.frontiersin.org\u002Fm\u002F68bd53008f8c9c81\u002Foriginal\u002FFENDO_Main-Visual_Red_Website.jpg",copyright:e,extension:[aa],thumbnails:{mini:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F1AAA1237-EA54-405E-B5292056FC2FC63E\u002Fmini-F06B3107-6E85-422B-BB0176C677702BA6.png",thul:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F1AAA1237-EA54-405E-B5292056FC2FC63E\u002Fthul-3D3A758F-7CD2-4F27-82D7E7E46E0E8893.png",webimage:Y,Guidelines:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F1AAA1237-EA54-405E-B5292056FC2FC63E\u002FDEA0356A-2D97-438F-99CB1B022967DFB5\u002FGuidelines-FENDO_Main Visual_Red_Website.png",WebsiteJpg_XL:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F1AAA1237-EA54-405E-B5292056FC2FC63E\u002FDEA0356A-2D97-438F-99CB1B022967DFB5\u002FWebsiteJpg_XL-FENDO_Main Visual_Red_Website.jpg",WebsiteWebP_L:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F1AAA1237-EA54-405E-B5292056FC2FC63E\u002FDEA0356A-2D97-438F-99CB1B022967DFB5\u002FWebsiteWebP_L-FENDO_Main Visual_Red_Website.webp",WebsiteWebP_M:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F1AAA1237-EA54-405E-B5292056FC2FC63E\u002FDEA0356A-2D97-438F-99CB1B022967DFB5\u002FWebsiteWebP_M-FENDO_Main Visual_Red_Website.webp",WebsiteWebP_XL:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F1AAA1237-EA54-405E-B5292056FC2FC63E\u002FDEA0356A-2D97-438F-99CB1B022967DFB5\u002FWebsiteWebP_XL-FENDO_Main Visual_Red_Website.webp"},dateCreated:ab,description:"Thyroid tissue 100X; Shutterstock ID 21695071; purchase_order: Main Visual; job: ; client: ; other:",orientation:K,userCreated:"Caroline Sutter",watermarked:i,dateModified:ab,datePublished:"2022-06-27T09:27:09Z",ecsArchiveFiles:[],propertyOptions:["414FB2D4-2283-43FD-BE14E534ECA67928","6C18119B-14BD-4951-B437696F4357BD33","7C692885-DB25-4858-B1FB4FF47B241E9B","D88C0047-EC30-4506-A7DF28A4D765E1CF"],property_Channel:["frontiersin_org"],"property_Sub-Type":["Main_Visual"],property_Asset_Type:["Photography"],activeOriginalFocusPoint:{x:1632,y:1224},property_Office_Department:["Publishing"]}],description:"The most cited endocrinology and metabolism journal, which advances our understanding of the endocrine system. It uncovers new therapies for prevalent health issues such as obesity, diabetes, reproduction, and aging.",mission:"\u003Cp\u003EFrontiers in Endocrinology is a journal that advances our understanding of the endocrine system and publishes research in novel therapies for prevalent health issues such as obesity, diabetes, disorders affecting the reproductive system, and the endocrinology of aging.\u003C\u002Fp\u003E \n\u003Cp\u003ELed by Field Chief Editor Jeff M. P. Holly (University of Bristol, UK), Frontiers in Endocrinology is indexed in MEDLINE, PubMed Central (PMC), Scopus and Web of Science (SCIE), among others, and welcomes research contributions in the various domains of endocrinology, bridging the gap between basic molecular structure and cellular communication, to clinical care. Topics include:\u003C\u002Fp\u003E\n\n\u003Cdiv\u003E &bull; adrenal endocrinology\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; bone research\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; cancer endocrinology\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; cardiovascular endocrinology \u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; cellular endocrinology \u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; clinical diabetes\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; developmental endocrinology\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; diabetes: molecular mechanisms\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; endocrinology of aging\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; experimental endocrinology\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; gut endocrinology\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; molecular and structural endocrinology\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; neuroendocrine science\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; obesity\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; pediatric endocrinology \u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; pituitary endocrinology\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; renal endocrinology\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; reproduction\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; systems endocrinology\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; thyroid endocrinology\u003C\u002Fdiv\u003E\n\u003Cdiv\u003E &bull; translational and clinical endocrinology\u003C\u002Fdiv\u003E\n\u003Cbr\u003E\n  \n\u003Cp\u003EIn particular, the journal welcomes submissions which support and advance the UN’s Sustainable Development Goal (SDG), notably SDG 3: good health and well-being, in the effort to further our understanding as well as the prevention and treatment of hormonal disorders.\u003Cp\u003E\n\n\u003Cp\u003EManuscripts relating to diseases or disorders that do not relate to hormones are not suitable for publication in this journal. Manuscripts reporting bibliometric analyses will not be considered. In addition, manuscripts consisting solely of bioinformatics analysis of public in silico databases are not considered suitable unless supported by independent experimental verification.\u003Cp\u003E\n\n\u003Cp\u003EAuthors are still welcome to submit Systematic Reviews using publicly available data, but these must adhere to the PRISMA guidelines and include a completed \u003Ca href=\"http:\u002F\u002Fprisma-statement.org\u002Fdocuments\u002FPRISMA_2020_checklist.pdf\u002F\"\u003Echecklist\u003C\u002Fa\u003E with submission and have a conclusion related to endocrinology. Similarly meta-analyses must adhere to the PRISMA extension guidelines and include a completed \u003Ca href=\"http:\u002F\u002Fwww.prisma-statement.org\u002Fdocuments\u002FPRISMA%20NMA%20checklist.pdf\u002F\"\u003Echecklist\u003C\u002Fa\u003E with submission.\u003Cp\u003E\n\n\u003Cp\u003EFrontiers in Endocrinology is committed to advancing developments in the field of endocrinology by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public. This multidisciplinary open-access journal is at the forefront of disseminating impactful discoveries to researchers, academics, clinicians, and the public worldwide.\u003Cp\u003E\n\n",palette:"red",impactFactor:"5.2",citeScore:"5.6",citations:"188000",showTagline:f,twitter:"@FrontEndocrinol",__typename:"Journal"},currentFrontiersJournal:{id:x,name:t,slug:u,printISSN:f,shortName:L,electronicISSN:M,abbreviation:ac,specialtyId:f,publicationDate:f,isOnline:h,isOpenForSubmissions:h,spaceId:c,field:{id:ad,domainId:r,__typename:ae},__typename:a},articleHubSlug:e,articleHubPage:N,currentArticle:{id:759843,doi:af,title:ag,acceptanceDate:new Date(1632904830000),receptionDate:new Date(1629179177000),publicationDate:new Date(1635292800000),isPublished:h,abstract:ah,researchTopic:{id:23162,title:"Diabetes and Bone - From Cell to Human",articlesCount:O,isMagazinePage:m,slug:"diabetes-and-bone---from-cell-to-human",isOpenForSubmission:m},articleType:{id:24,name:"Original Research"},stage:{id:P,name:e},keywords:["chondroitin sulfate","diabetes","Osteoporosis","Bone microstructure","bone metabolism"],authors:[{id:ai,firstName:aj,lastName:"Qi",givenNames:aj,isCorresponding:m,isProfilePublic:h,userId:ai,affiliations:[{organizationName:ak,countryName:k,cityName:e,stateName:e,zipCode:e},{organizationName:q,countryName:k,cityName:e,stateName:e,zipCode:e},{organizationName:B,countryName:k,cityName:e,stateName:e,zipCode:e}]},{id:i,firstName:al,lastName:"Shao",givenNames:al,isCorresponding:h,isProfilePublic:m,userId:i,affiliations:[{organizationName:q,countryName:k,cityName:e,stateName:e,zipCode:e},{organizationName:B,countryName:k,cityName:e,stateName:e,zipCode:e}]},{id:i,firstName:am,lastName:"Sun",givenNames:am,isCorresponding:h,isProfilePublic:m,userId:i,affiliations:[{organizationName:q,countryName:k,cityName:e,stateName:e,zipCode:e},{organizationName:"QinLing-Bashan Mountains Bioresources Comprehensive Development C.I.C.",countryName:k,cityName:e,stateName:e,zipCode:e}]},{id:i,firstName:an,lastName:y,givenNames:an,isCorresponding:h,isProfilePublic:m,userId:i,affiliations:[{organizationName:q,countryName:k,cityName:e,stateName:e,zipCode:e}]},{id:i,firstName:ao,lastName:"Hu",givenNames:ao,isCorresponding:h,isProfilePublic:m,userId:i,affiliations:[{organizationName:q,countryName:k,cityName:e,stateName:e,zipCode:e}]},{id:i,firstName:ap,lastName:aq,givenNames:ap,isCorresponding:h,isProfilePublic:m,userId:i,affiliations:[{organizationName:q,countryName:k,cityName:e,stateName:e,zipCode:e},{organizationName:ar,countryName:k,cityName:e,stateName:e,zipCode:e}]},{id:i,firstName:as,lastName:y,givenNames:as,isCorresponding:h,isProfilePublic:m,userId:i,affiliations:[{organizationName:q,countryName:k,cityName:e,stateName:e,zipCode:e},{organizationName:B,countryName:k,cityName:e,stateName:e,zipCode:e}]},{id:at,firstName:au,lastName:"Zheng",givenNames:au,isCorresponding:h,isProfilePublic:h,userId:at,affiliations:[{organizationName:q,countryName:k,cityName:e,stateName:e,zipCode:e},{organizationName:B,countryName:k,cityName:e,stateName:e,zipCode:e},{organizationName:ar,countryName:k,cityName:e,stateName:e,zipCode:e}]},{id:i,firstName:av,lastName:"Yue",givenNames:av,isCorresponding:h,isProfilePublic:m,userId:i,affiliations:[{organizationName:ak,countryName:k,cityName:e,stateName:e,zipCode:e},{organizationName:"College of Food Science and Technology, Northwest University",countryName:k,cityName:e,stateName:e,zipCode:e}]}],editors:[{id:aw,firstName:ax,lastName:"Vestergaard",givenNames:ax,isCorresponding:m,isProfilePublic:h,userId:aw,affiliations:[{organizationName:"Aalborg University Hospital",countryName:"Denmark",cityName:e,stateName:e,zipCode:e}]}],reviewers:[{id:ay,firstName:az,lastName:aq,givenNames:az,isCorresponding:m,isProfilePublic:h,userId:ay,affiliations:[{organizationName:"Second Xiangya Hospital, Central South University",countryName:k,cityName:e,stateName:e,zipCode:e}]},{id:aA,firstName:aB,lastName:"Ramamoorthi",givenNames:aB,isCorresponding:m,isProfilePublic:h,userId:aA,affiliations:[{organizationName:"Moffitt Cancer Center",countryName:"United States",cityName:e,stateName:e,zipCode:e}]},{id:aC,firstName:y,lastName:y,givenNames:y,isCorresponding:m,isProfilePublic:h,userId:aC,affiliations:[{organizationName:"Shaanxi University of Science and Technology",countryName:k,cityName:e,stateName:e,zipCode:e}]}],journal:{id:x,slug:u,name:t,shortName:L,electronicISSN:M,field:{id:ad,domainId:r,__typename:ae},specialtyId:f,journalSectionPaths:[{section:aD,__typename:"journal_journalSectionPath"}],__typename:a},section:aD,impactMetrics:{views:7064,downloads:3722,citations:26},volume:Q,articleVolume:"Volume 12 - 2021",relatedArticles:[],isPublishedV2:m,contents:{titleHtml:"Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure \u003Ci\u003Evia\u003C\u002Fi\u003E Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism",fullTextHtml:"\u003Cdiv class=\"JournalAbstract\"\u003E\u003Ca id=\"h1\" name=\"h1\"\u003E\u003C\u002Fa\u003E\u003Cdiv class=\"authors\"\u003E\u003Cspan class=\"author-wrapper notranslate\"\u003E\u003Ca href=\"https:\u002F\u002Floop.frontiersin.org\u002Fpeople\u002F889583\" class=\"user-id-889583\"\u003E\u003Cimg class=\"pr5\" src=\"https:\u002F\u002Floop.frontiersin.org\u002Fimages\u002Fprofile\u002F889583\u002F74\" onerror=\"this.onerror=null;this.src='https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg';\" alt=\"Shan Shan Qi,,\"\u003EShan Shan Qi\u003C\u002Fa\u003E\u003Csup\u003E1,2,3\u003C\u002Fsup\u003E\u003C\u002Fspan\u003E\u003Cspan class=\"author-wrapper notranslate\"\u003E\u003Cimg class=\"pr5\" src=\"https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg\" alt=\"Meng Li Shao,\" onerror=\"this.onerror=null;this.src='https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg';\"\u003EMeng Li Shao\u003Csup\u003E2,3\u003C\u002Fsup\u003E\u003C\u002Fspan\u003E\u003Cspan class=\"author-wrapper notranslate\"\u003E\u003Cimg class=\"pr5\" src=\"https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg\" alt=\"Ze Sun,\" onerror=\"this.onerror=null;this.src='https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg';\"\u003EZe Sun\u003Csup\u003E2,4\u003C\u002Fsup\u003E\u003C\u002Fspan\u003E\u003Cspan class=\"author-wrapper notranslate\"\u003E\u003Cimg class=\"pr5\" src=\"https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg\" alt=\"Si Min Chen\" onerror=\"this.onerror=null;this.src='https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg';\"\u003ESi Min Chen\u003Csup\u003E2\u003C\u002Fsup\u003E\u003C\u002Fspan\u003E\u003Cspan class=\"author-wrapper notranslate\"\u003E\u003Cimg class=\"pr5\" src=\"https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg\" alt=\"Ying Jun Hu\" onerror=\"this.onerror=null;this.src='https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg';\"\u003EYing Jun Hu\u003Csup\u003E2\u003C\u002Fsup\u003E\u003C\u002Fspan\u003E\u003Cspan class=\"author-wrapper notranslate\"\u003E\u003Cimg class=\"pr5\" src=\"https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg\" alt=\"Xin Sheng Li,\" onerror=\"this.onerror=null;this.src='https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg';\"\u003EXin Sheng Li\u003Csup\u003E2,5\u003C\u002Fsup\u003E\u003C\u002Fspan\u003E\u003Cspan class=\"author-wrapper notranslate\"\u003E\u003Cimg class=\"pr5\" src=\"https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg\" alt=\"De Jing Chen,*\" onerror=\"this.onerror=null;this.src='https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg';\"\u003EDe Jing Chen\u003Csup\u003E2,3*\u003C\u002Fsup\u003E\u003C\u002Fspan\u003E\u003Cspan class=\"author-wrapper notranslate\"\u003E\u003Ca href=\"https:\u002F\u002Floop.frontiersin.org\u002Fpeople\u002F1397318\" class=\"user-id-1397318\"\u003E\u003Cimg class=\"pr5\" src=\"https:\u002F\u002Floop.frontiersin.org\u002Fimages\u002Fprofile\u002F1397318\u002F74\" onerror=\"this.onerror=null;this.src='https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg';\" alt=\"Hong Xing Zheng,,*\"\u003EHong Xing Zheng\u003C\u002Fa\u003E\u003Csup\u003E2,3,5*\u003C\u002Fsup\u003E\u003C\u002Fspan\u003E\u003Cspan class=\"author-wrapper notranslate\"\u003E\u003Cimg class=\"pr5\" src=\"https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg\" alt=\"Tian Li Yue,*\" onerror=\"this.onerror=null;this.src='https:\u002F\u002Floop.frontiersin.org\u002Fcdn\u002Fimages\u002Fprofile\u002Fdefault_32.jpg';\"\u003ETian Li Yue\u003Csup\u003E1,6*\u003C\u002Fsup\u003E\u003C\u002Fspan\u003E\u003C\u002Fdiv\u003E\u003Cul class=\"notes\"\u003E\u003Cli\u003E\u003Cspan\u003E\u003Csup\u003E1\u003C\u002Fsup\u003E\u003C\u002Fspan\u003ECollege of Food Science and Engineering, Northwest Agriculture and Forestry (A&amp;F) University, Yangling, China\u003C\u002Fli\u003E\u003Cli\u003E\u003Cspan\u003E\u003Csup\u003E2\u003C\u002Fsup\u003E\u003C\u002Fspan\u003ECollege of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong, China\u003C\u002Fli\u003E\u003Cli\u003E\u003Cspan\u003E\u003Csup\u003E3\u003C\u002Fsup\u003E\u003C\u002Fspan\u003EQinba State Key Laboratory of Biological Resources and Ecological Environment, Hanzhong, China\u003C\u002Fli\u003E\u003Cli\u003E\u003Cspan\u003E\u003Csup\u003E4\u003C\u002Fsup\u003E\u003C\u002Fspan\u003EQinLing-Bashan Mountains Bioresources Comprehensive Development C.I.C., Hanzhong, China\u003C\u002Fli\u003E\u003Cli\u003E\u003Cspan\u003E\u003Csup\u003E5\u003C\u002Fsup\u003E\u003C\u002Fspan\u003EShaanxi Key Laboratory of Resource Biology, Hanzhong, China\u003C\u002Fli\u003E\u003Cli\u003E\u003Cspan\u003E\u003Csup\u003E6\u003C\u002Fsup\u003E\u003C\u002Fspan\u003ECollege of Food Science and Technology, Northwest University, Xi&#x2019;an, China\u003C\u002Fli\u003E\u003C\u002Ful\u003E\u003Cp\u003EDiabetic osteoporosis (DOP) belongs to secondary osteoporosis caused by diabetes; it has the characteristics of high morbidity and high disability. In the present study, we constructed a type 1 diabetic rat model and administered chondroitin sulfate (200 mg\u002Fkg) for 10 weeks to observe the preventive effect of chondroitin sulfate on the bone loss of diabetic rats. The results showed that chondroitin sulfate can reduce blood glucose and relieve symptoms of diabetic rats; in addition, it can significantly increase the bone mineral density, improve bone microstructure, and reduce bone marrow adipocyte number in diabetic rats; after 10 weeks of chondroitin sulfate administration, the SOD activity level was upregulated, as well as CAT levels, indicating that chondroitin sulfate can alleviate oxidative stress in diabetic rats. Chondroitin sulfate was also found to reduce the level of serum inflammatory cytokines (TNF-&#x3b1;, IL-1, IL-6, and MCP-1) and alleviate the inflammation in diabetic rats; bone metabolism marker detection results showed that chondroitin sulfate can reduce bone turnover in diabetic rats (decreased RANKL, CTX-1, ALP, and TRACP 5b levels were observed after 10 weeks of chondroitin sulfate administration). At the same time, the bone OPG and RUNX 2 expression levels were higher after chondroitin sulfate treatment, the bone RANKL expression was lowered, and the OPG\u002FRANKL ratio was upregulated. All of the above indicated that chondroitin sulfate could prevent STZ-induced DOP and repair bone microstructure; the main mechanism was through anti-oxidation, anti-inflammatory, and regulating bone metabolism. Chondroitin sulfate could be used to develop anti-DOP functional foods and diet interventions for diabetes.\u003C\u002Fp\u003E\u003Cdiv class=\"clear\"\u003E\u003C\u002Fdiv\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"JournalFullText\"\u003E\u003Ca id=\"h2\" name=\"h2\"\u003E\u003C\u002Fa\u003E\u003Ch2\u003EIntroduction\u003C\u002Fh2\u003E\u003Cp class=\"mb15\"\u003EThere are 463 million people with diabetes worldwide currently, an average of 1 in 11 adults (20&#x2013;79 years old), and by 2045, the diabetes population will jump to 700 million (\u003Ca href=\"#B1\"\u003E1\u003C\u002Fa\u003E, \u003Ca href=\"#B2\"\u003E2\u003C\u002Fa\u003E). Long-term high blood glucose can cause microvascular injury, endangering the kidneys, heart, eyes, peripheral nerves, brain, feet, as well as bone (\u003Ca href=\"#B3\"\u003E3\u003C\u002Fa\u003E).\u003C\u002Fp\u003E\u003Cp class=\"mb15\"\u003EDiabetic osteoporosis (DOP) is a bone complication caused by diabetes, characterized by lowered bone mineral density (BMD), changes of bone microstructure, and raised bone fragility. DOP greatly reduces the quality of living of patients, subjecting them to heavy economic burden (\u003Ca href=\"#B4\"\u003E4\u003C\u002Fa\u003E). As the number of people with diabetes increases globally, the number of DOP is also increasing annually. Clinical data showed that about 50% to 65% of people with diabetes have decreased BMD and increased incidence of fractures, and nearly 35% of them have been diagnosed as osteoporosis (\u003Ca href=\"#B5\"\u003E5\u003C\u002Fa\u003E).\u003C\u002Fp\u003E\u003Cp class=\"mb15\"\u003EThe present approaches for DOP are oral hypoglycemic drugs or insulin injections, supplemented by calcium preparations, bisphosphonates, etc. (\u003Ca href=\"#B6\"\u003E6\u003C\u002Fa\u003E). However, adverse drug reactions have always been a major challenge related to drug treatment goals. Therefore, exploring more safer and effective strategies are highly crucial.\u003C\u002Fp\u003E\u003Cp class=\"mb0\"\u003EChondroitin sulfate (CS) is a natural sticky polysaccharide made from the cartilage of animals. The content of CS is different in the cartilage of different species and ages. As a drug for the treatment of joint diseases, it was used in conjunction with glucosamine to relieve pain and promote cartilage regeneration, which can fundamentally improve joint problems (\u003Ca href=\"#B7\"\u003E7\u003C\u002Fa\u003E). It was reported that CS has anti-inflammation effects (\u003Ca href=\"#B8\"\u003E8\u003C\u002Fa\u003E), has anti-psoriasis effects (\u003Ca href=\"#B9\"\u003E9\u003C\u002Fa\u003E), enhances immunity (\u003Ca href=\"#B10\"\u003E10\u003C\u002Fa\u003E), lowers blood lipid (\u003Ca href=\"#B11\"\u003E11\u003C\u002Fa\u003E), and has anti-tumor effects (\u003Ca href=\"#B12\"\u003E12\u003C\u002Fa\u003E). It also has a preventive effect on diabetic nephropathy.in streptozotocin (STZ)-induced diabetic mice (\u003Ca href=\"#B13\"\u003E13\u003C\u002Fa\u003E), and CS was also reported to increase bone formation in ovariectomized rats (\u003Ca href=\"#B14\"\u003E14\u003C\u002Fa\u003E). Whether it has a protective effect on DOP has not been studied. Our previous study found that the CS could increase the BMD of diabetic rats, but the mechanisms were not clear. So, in present study, we researched the protective effect and mechanisms of CS on DOP, which will provide a new approach for DOP treatment.\u003C\u002Fp\u003E\u003Ca id=\"h3\" name=\"h3\"\u003E\u003C\u002Fa\u003E\u003Ch2\u003EMaterials and Methods\u003C\u002Fh2\u003E\u003Ch3\u003EChemicals\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003ECS power was isolated and purified from the cartilage of giant salamander according to the method of Zhu (\u003Ca href=\"#B15\"\u003E15\u003C\u002Fa\u003E); the content of CS in the experimental materials was 95%. STZ was obtained from Acmec Biochemical Company (Shanghai, China).\u003C\u002Fp\u003E\u003Ch3\u003EAnimals\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EFifty-six-day old male rats were obtained from Cheng Du Dashuo Experimental Animal Company (Cheng Du, China, license no. SCXK 2020-030). Animals were kept in independent ventilated cages in a standardized animal room with constant temperature and humidity. Water and food intake of animals was not restricted. Animals were feed with diets prepared by the American Society of Nutrition (AIN93) standard. Animal experiment operations were approved by Shaanxi University of Technology Animal Ethics Committee (approval No. 2020-74).\u003C\u002Fp\u003E\u003Ch3\u003EDiabetes Induction in SD Rats, Animal Grouping, and Treatment\u003C\u002Fh3\u003E\u003Cp class=\"mb15\"\u003EAfter 7 days of acclimatization, except for 10 animals in the control group, the remaining animals were intraperitoneally injected with 45 mg\u002Fkg of STZ after fasting overnight, and the dosage of STZ was based on our previous study (\u003Ca href=\"#B16\"\u003E16\u003C\u002Fa\u003E, \u003Ca href=\"#B17\"\u003E17\u003C\u002Fa\u003E); STZ was dissolved in citric acid buffer solution at pH 4.3, and 10 animals in the control group were injected with citric acid buffer solution. After 72 h, animal&#x2019;s blood glucose was detected, and animals with blood glucose higher than 11.1 mmol\u002FL were selected for subsequent experiments.\u003C\u002Fp\u003E\u003Cp class=\"mb15\"\u003EThen, animals were regrouped into four groups: Group 1, control group (\u003Ci\u003En\u003C\u002Fi\u003E = 10), rats were given deionized water by gavage every day; Group 2, type 1 diabetic group (\u003Ci\u003En\u003C\u002Fi\u003E = 10), named T1DM group, type 1 diabetic rats were given deionized water by gavage every day; Group 3, CS-treated group (\u003Ci\u003En\u003C\u002Fi\u003E = 10), named CS group, type 1 diabetic rats were given CS (200 mg\u002Fkg\u002Fday) by gavage every day; Group 4, metformin group (\u003Ci\u003En\u003C\u002Fi\u003E = 10), named Met group, type 1 diabetic rats were given metformin (200 mg\u002Fkg\u002Fday) by gavage every day. The dose of CS was selected by pre-experiment.\u003C\u002Fp\u003E\u003Cp class=\"mb0\"\u003EDuring the experiment, animals were weighed every week, water and diet of animals were recorded, and the blood glucose of animals was measured every week. After 10 weeks of administration, animals were anesthetized with isoflurane and were sacrificed by cervical dislocation; blood was collected, and serum was separated and stored at &#x2212;80&#xb0;C. At the same time, femurs, vertebrae, and tibias of animals were collected.\u003C\u002Fp\u003E\u003Ch3\u003EBMD Measurement\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EThe BMD of femur and vertebrae of each rat were obtained by using small-animal dual-energy X-ray absorptiometry (InAlzyer, Korea).\u003C\u002Fp\u003E\u003Ch3\u003EBone Micro-CT Measurement\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EFemur tissues of rats were collected and scanned by a Locus SP micro-CT (GE Healthcare, Danderyd, Sweden) with a resolution of 6.5&#x3bc;m. The processing and analysis software were MICVIEW 3D reconstruction processing software and ABA-specific bone analysis software. The data of cortex volume, bone surface area, trabecular number, and bone volume were obtained by using ABA-specific bone analysis software.\u003C\u002Fp\u003E\u003Ch3\u003EBone Turnover Marker Detection\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EAccording to instructions listed in ELISA test kits (Elabscience, Wuhan, China), a microplate reader (Elx808, Winooski, USA) was used to detect the content of bone turnover markers (CTX-1, OPG, ALP, TRACP 5b, RANKL, osteocalcin, and RUNX 2) in serum of each group of rats.\u003C\u002Fp\u003E\u003Ch3\u003EOxidative Stress Index Detection\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EAccording to instructions listed in kits (Beyotime, Shanghai, China), SOD activity, MDA content, CAT activity, and GSH content in serum were detected by an ultraviolet and visible spectrophotometer (Alpha1860S, Shanghai, China).\u003C\u002Fp\u003E\u003Ch3\u003EInflammatory Cytokine Detection\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EBased on instructions listed in ELISA test kits (Elabscience, Wuhan, China), the microplate reader (Elx808, Winooski, USA) was used to detect the content of serum inflammatory cytokines (IL-6, TNF-&#x3b1;, MCP-1, and IL-1).\u003C\u002Fp\u003E\u003Ch3\u003EPathological Analysis of Femur Bone Tissue\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EFemur of each rat was fixed in 3.8% paraformaldehyde solution for 48 h, then rinsed with PBS, placed in 10% EDTA solution for 5 weeks, and then made into 4-micron-thick paraffin sections by a tissue slicer (Leica, Wetzlar, Germany), and the sections were stained with hematoxylin and eosin, sealed with neutral gum. After that, a slide was placed under a microscope to observe femur pathological changes. Bone morphometric parameters including trabecular separation (Tb&#xb7;Sp), bone volume per tissue volume (BV\u002FTV), and trabecular thickness (Tb&#xb7;Th) were analyzed by image pro plus (IPP) 6.0 software.\u003C\u002Fp\u003E\u003Ch3\u003EPathological Observation of Tibia Bone Marrow Adipocytes\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003ETibia of each rat was fixed in 3.8% paraformaldehyde solution for 48 h, then rinsed with PBS; femur was placed in 10% EDTA solution for 5 weeks and then made into 4-micron-thick paraffin sections by a tissue slicer (Leica, Wetzlar, Germany), and sections were stained with hematoxylin and eosin, sealed with neutral gum. After that, the slide was placed under a microscope to observe bone marrow adipocytes in tibia. Adipocytes were counted in each field, and the diameter of adipocytes was measured with IPP 6.0 software.\u003C\u002Fp\u003E\u003Ch3\u003EFemur Osteoclast Observation-TRAP Staining\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EFour-micron-thick femur paraffin sections were stained with TRAP staining kit, based on the instructions listed in the kit. The stained slides were sealed with neutral gum. After that, a slide was placed under a microscope (200&#xd7; magnification) to observe osteoclasts in the femur. Osteoclasts were purple-red after staining, five fields of view were selected for each slice, and the number of osteoclasts in each field was counted.\u003C\u002Fp\u003E\u003Ch3\u003EImmunohistochemical\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EFemur paraffin slides (4 &#x3bc;m thick) were soaked in xylene for 20 min, and then slides were dehydrated with gradient ethanol and placed in a water bath at 95&#xb0;C in citrate antigen retrieval solution (pH 6) for 1 h. After cooling to room temperature, slides were washed with PBS; 1% BSA solution was added to the slides to block endogenous peroxidase, and then the slides were washed with PBS, incubated with primary antibodies (OPG, RANKL, and RUNX2, respectively) (Santa Cruz Biotech, USA) for 1.5 h at 37&#xb0;C in a constant temperature incubator, double washed with PBS, incubated with secondary antibody (Santa Cruz Biotech, USA) for 2 h, washed with PBS three times, and then incubated with DAB. After that, slides were counterstained with hematoxylin, and sealed with neutral gum. IHC-stained slides were observed under a microscope (Olympus, Germany) with 200&#xd7; magnification. Five fields of view were chosen for each slice, and IPP software was used to count the area of positive staining, and percentage of positive area was calculated.\u003C\u002Fp\u003E\u003Ch3\u003EStatistical Analysis\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EStatistical analyses were performed with ANOVA by SPASS 19.0; all of the data were shown as mean &#xb1; SD, and statistical significance was compared between groups using the LSD method. \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.05 was considered significant, and \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 was considered extremely significant.\u003C\u002Fp\u003E\u003Ca id=\"h4\" name=\"h4\"\u003E\u003C\u002Fa\u003E\u003Ch2\u003EResults\u003C\u002Fh2\u003E\u003Ch3\u003EChondroitin Sulfate Relieved the Symptoms of Hyperglycemia, Polydipsia, and Polyphagia Caused by Diabetes in SD Rats\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EThe blood glucose, water intake, and food intake in type 1 diabetic rats were significantly increased compared with control (\u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01) (\u003Ca href=\"#f1\"\u003EFigures&#xa0;1A, C, D\u003C\u002Fa\u003E), while the body weight was decreased (\u003Ca href=\"#f1\"\u003EFigure&#xa0;1B\u003C\u002Fa\u003E); this result was consistent with basic pathological changes of diabetes, indicating that the type 1 diabetes animal model was successfully established. After 10 weeks of CS or metformin administration, the symptoms of diabetes in rats were effectively alleviated, reflected in lowered blood glucose, increased body weight, and reduced water and food intake. This indicates that CS can reduce blood glucose of diabetic rats and relieve the symptoms of diabetes.\u003C\u002Fp\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"Imageheaders\"\u003EFIGURE&#xa0;1\u003C\u002Fdiv\u003E\u003Cdiv class=\"FigureDesc\"\u003E\u003Ca href=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g001.jpg\" name=\"\" target=\"_blank\"\u003E\n \u003Cpicture\u003E\n \u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=480&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g001.jpg\" media=\"(max-width: 563px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=370&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g001.jpg\" media=\"(max-width: 1024px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=290&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g001.jpg\" media=\"(max-width: 1441px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=410&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g001.jpg\" media=\"\"\u003E\u003Csource type=\"image\u002Fjpg\" srcset=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g001.jpg\" media=\"\"\u003E \u003Cimg src=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g001.jpg\" alt=\"www.frontiersin.org\" id=\"f1\" loading=\"lazy\"\u003E\n \u003C\u002Fpicture\u003E\n\u003C\u002Fa\u003E\u003Cp\u003E\u003Cstrong\u003EFigure&#xa0;1\u003C\u002Fstrong\u003E Blood glucose, body weight, food intake, and water intake at the end of the 10th week in different groups. \u003Cstrong\u003E(A)\u003C\u002Fstrong\u003E Blood glucose in different groups. \u003Cstrong\u003E(B)\u003C\u002Fstrong\u003E Body weight in different groups. \u003Cstrong\u003E(C)\u003C\u002Fstrong\u003E Food intake in different groups. \u003Cstrong\u003E(D)\u003C\u002Fstrong\u003E Water intake in different groups. \u003Csup\u003E##\u003C\u002Fsup\u003Eindicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with control; **indicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with the diabetic group; *indicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.05 compared with the diabetic group.\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Ch3\u003EChondroitin Sulfate Increased BMD of Type 1 Diabetic Rats\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003ECompared with control group, the BMD (lumbar vertebrae and femur) in diabetic rats was lowered significantly (\u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01) (\u003Ca href=\"#f2\"\u003EFigure&#xa0;2\u003C\u002Fa\u003E). After 10 weeks of CS or metformin administration, the BMD in lumbar vertebrae and femur was increased (CS \u003Ci\u003Evs\u003C\u002Fi\u003E. T1DM group, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01; Metformin \u003Ci\u003Evs\u003C\u002Fi\u003E. T1DM groups, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01) (\u003Ca href=\"#f2\"\u003EFigure&#xa0;2\u003C\u002Fa\u003E), indicating that CS could increase the BMD of type 1 diabetic rats.\u003C\u002Fp\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"Imageheaders\"\u003EFIGURE&#xa0;2\u003C\u002Fdiv\u003E\u003Cdiv class=\"FigureDesc\"\u003E\u003Ca href=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g002.jpg\" name=\"\" target=\"_blank\"\u003E\n \u003Cpicture\u003E\n \u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=480&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g002.jpg\" media=\"(max-width: 563px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=370&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g002.jpg\" media=\"(max-width: 1024px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=290&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g002.jpg\" media=\"(max-width: 1441px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=410&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g002.jpg\" media=\"\"\u003E\u003Csource type=\"image\u002Fjpg\" srcset=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g002.jpg\" media=\"\"\u003E \u003Cimg src=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g002.jpg\" alt=\"www.frontiersin.org\" id=\"f2\" loading=\"lazy\"\u003E\n \u003C\u002Fpicture\u003E\n\u003C\u002Fa\u003E\u003Cp\u003E\u003Cstrong\u003EFigure&#xa0;2\u003C\u002Fstrong\u003E The bone mineral density of different groups at the end of the 10th week. \u003Cstrong\u003E(A)\u003C\u002Fstrong\u003E The BMD of lumbar vertebrae in different groups. \u003Cstrong\u003E(B)\u003C\u002Fstrong\u003E The femoral BMD in different groups. \u003Csup\u003E##\u003C\u002Fsup\u003Eindicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with control. **indicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with the diabetic group.\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Ch3\u003EChondroitin Sulfate Repaired Bone Micro-CT Structure of Type 1 Diabetic Rats\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EFemur micro-CT scanning results showed that trabecular structure in the model group was sparse, and some trabecular areas disappeared (\u003Ca href=\"#f3\"\u003EFigure&#xa0;3A\u003C\u002Fa\u003E). After 10 weeks of administration of CS or metformin, trabecular structure was repaired. Micro-CT metrological data (\u003Ca href=\"#f3\"\u003EFigures&#xa0;3A&#x2013;E\u003C\u002Fa\u003E) showed that cortical bone volume, bone surface area, number of bone trabecular, and bone volume in type 1 diabetic group were significantly lower than those in the control group (\u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01). After 10 weeks of CS or metformin administration, the above indexes were upregulated, and the differences were significant compared with the diabetic group.\u003C\u002Fp\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"Imageheaders\"\u003EFIGURE&#xa0;3\u003C\u002Fdiv\u003E\u003Cdiv class=\"FigureDesc\"\u003E\u003Ca href=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g003.jpg\" name=\"\" target=\"_blank\"\u003E\n \u003Cpicture\u003E\n \u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=480&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g003.jpg\" media=\"(max-width: 563px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=370&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g003.jpg\" media=\"(max-width: 1024px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=290&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g003.jpg\" media=\"(max-width: 1441px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=410&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g003.jpg\" media=\"\"\u003E\u003Csource type=\"image\u002Fjpg\" srcset=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g003.jpg\" media=\"\"\u003E \u003Cimg src=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g003.jpg\" alt=\"www.frontiersin.org\" id=\"f3\" loading=\"lazy\"\u003E\n \u003C\u002Fpicture\u003E\n\u003C\u002Fa\u003E\u003Cp\u003E\u003Cstrong\u003EFigure&#xa0;3\u003C\u002Fstrong\u003E \u003Cstrong\u003E(A)\u003C\u002Fstrong\u003E The femur micro-CT structure of different groups at the end of the 10th week. \u003Cstrong\u003E(B)\u003C\u002Fstrong\u003E Cortex volume in different groups. \u003Cstrong\u003E(C)\u003C\u002Fstrong\u003E Bone surface area in different groups. \u003Cstrong\u003E(D)\u003C\u002Fstrong\u003E Trabecular number in different groups. \u003Cstrong\u003E(E)\u003C\u002Fstrong\u003E Bone volume in different groups. \u003Csup\u003E##\u003C\u002Fsup\u003Eindicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with control. **indicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with the diabetic group.\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Ch3\u003EChondroitin Sulfate Regulated Bone Turnover of Type 1 Diabetic Rats\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EAs \u003Ca href=\"#T1\"\u003ETable&#xa0;1\u003C\u002Fa\u003E shows, some of the serum bone turnover markers (OPG, RUNX 2, osteocalcin, and TRACP 5b) and OPG\u002FRANKL ratio levels were lowered in type 1 diabetic rats compared with control (\u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01), and those were significantly increased in the CS and Met group compared with the type 1 diabetic group. Other serum bone turnover markers such as RANKL, CTX 1, and ALP levels were higher in the type 1 diabetic group compared with the control (\u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01), which were significantly decreased in CS and Met groups, indicating that CS could regulate bone turnover of type 1 diabetic rats.\u003C\u002Fp\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"Imageheaders\"\u003ETABLE&#xa0;1\u003C\u002Fdiv\u003E\u003Cdiv class=\"FigureDesc\"\u003E\u003Ca href=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-t001.jpg\" name=\"table&#xa0;1\" target=\"_blank\"\u003E\n \u003Cpicture\u003E\n \u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=480&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-t001.jpg\" media=\"(max-width: 563px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=370&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-t001.jpg\" media=\"(max-width: 1024px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=290&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-t001.jpg\" media=\"(max-width: 1441px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=410&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-t001.jpg\" media=\"\"\u003E\u003Csource type=\"image\u002Fjpg\" srcset=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-t001.jpg\" media=\"\"\u003E \u003Cimg src=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-t001.jpg\" alt=\"www.frontiersin.org\" id=\"T1\" loading=\"lazy\"\u003E\n \u003C\u002Fpicture\u003E\n\u003C\u002Fa\u003E\u003Cp\u003E\u003Cstrong\u003ETable&#xa0;1\u003C\u002Fstrong\u003E Bone turnover markers in different groups at the end of the 10th week.\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Ch3\u003EChondroitin Sulfate Downregulated Inflammatory Cytokines of Type 1 Diabetic Rats\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003ESerum inflammatory cytokine levels in type 1 diabetic rats increased dramatically compared with the control group (\u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01). After 10 weeks of CS or metformin treatment, the serum inflammatory cytokine levels were lowered in CS or Met groups (CS \u003Ci\u003Evs\u003C\u002Fi\u003E. T1DM group, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01; Metformin \u003Ci\u003Evs\u003C\u002Fi\u003E. T1DM groups, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01) (\u003Ca href=\"#f4\"\u003EFigure&#xa0;4\u003C\u002Fa\u003E), indicating that CS has an inhibitory effect on inflammation induced by type 1 diabetes in SD rats.\u003C\u002Fp\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"Imageheaders\"\u003EFIGURE&#xa0;4\u003C\u002Fdiv\u003E\u003Cdiv class=\"FigureDesc\"\u003E\u003Ca href=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g004.jpg\" name=\"\" target=\"_blank\"\u003E\n \u003Cpicture\u003E\n \u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=480&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g004.jpg\" media=\"(max-width: 563px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=370&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g004.jpg\" media=\"(max-width: 1024px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=290&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g004.jpg\" media=\"(max-width: 1441px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=410&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g004.jpg\" media=\"\"\u003E\u003Csource type=\"image\u002Fjpg\" srcset=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g004.jpg\" media=\"\"\u003E \u003Cimg src=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g004.jpg\" alt=\"www.frontiersin.org\" id=\"f4\" loading=\"lazy\"\u003E\n \u003C\u002Fpicture\u003E\n\u003C\u002Fa\u003E\u003Cp\u003E\u003Cstrong\u003EFigure&#xa0;4\u003C\u002Fstrong\u003E The serum inflammatory cytokine levels in different groups at the end of the 10th week. \u003Cstrong\u003E(A)\u003C\u002Fstrong\u003E MCP-1 levels in serum; \u003Cstrong\u003E(B)\u003C\u002Fstrong\u003E IL-6 levels in serum; \u003Cstrong\u003E(C)\u003C\u002Fstrong\u003E IL-1 levels in serum; \u003Cstrong\u003E(D)\u003C\u002Fstrong\u003E TNF-a levels in serum. \u003Csup\u003E##\u003C\u002Fsup\u003Eindicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with control. **indicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with the diabetic group.\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Ch3\u003EChondroitin Sulfate Alleviated Oxidative Stress in Type 1 Diabetic Rats\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EOxidative stress existed in diabetic rats; serum SOD, GPX, and CAT activity levels were lowered, and MDA level was raised in type 1 diabetic rats. Ten weeks after CS or metformin treatment, SOD, GPX, and CAT activity levels were raised, and MDA level was lowered (CS \u003Ci\u003Evs\u003C\u002Fi\u003E. T1DM, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01; Met \u003Ci\u003Evs\u003C\u002Fi\u003E. T1DM, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01) (\u003Ca href=\"#f5\"\u003EFigure&#xa0;5\u003C\u002Fa\u003E). The results indicated that CS could alleviate oxidative stress in T1DM rats.\u003C\u002Fp\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"Imageheaders\"\u003EFIGURE&#xa0;5\u003C\u002Fdiv\u003E\u003Cdiv class=\"FigureDesc\"\u003E\u003Ca href=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g005.jpg\" name=\"\" target=\"_blank\"\u003E\n \u003Cpicture\u003E\n \u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=480&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g005.jpg\" media=\"(max-width: 563px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=370&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g005.jpg\" media=\"(max-width: 1024px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=290&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g005.jpg\" media=\"(max-width: 1441px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=410&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g005.jpg\" media=\"\"\u003E\u003Csource type=\"image\u002Fjpg\" srcset=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g005.jpg\" media=\"\"\u003E \u003Cimg src=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g005.jpg\" alt=\"www.frontiersin.org\" id=\"f5\" loading=\"lazy\"\u003E\n \u003C\u002Fpicture\u003E\n\u003C\u002Fa\u003E\u003Cp\u003E\u003Cstrong\u003EFigure&#xa0;5\u003C\u002Fstrong\u003E The level of serum oxidative stress parameters in different groups at the end of the 10th week. \u003Cstrong\u003E(A)\u003C\u002Fstrong\u003E The level of SOD activities in different groups. \u003Cstrong\u003E(B)\u003C\u002Fstrong\u003E The level of glutathione peroxidase (GPX) activities in different groups. \u003Cstrong\u003E(C)\u003C\u002Fstrong\u003E The level of catalase (CAT) activities in different groups. \u003Cstrong\u003E(D)\u003C\u002Fstrong\u003E The level of malondialdehyde (MDA) content in different groups; \u003Csup\u003E##\u003C\u002Fsup\u003Eindicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with control, **indicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with the diabetic group.\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Ch3\u003EChondroitin Sulfate Repaired Bone Microstructure of Type 1 Diabetic Rats\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003ECompared with the control group, the femoral bone of diabetic rats was sparse and fractured, the spacing of trabecular bone became wider, and the trabecular bone became thinner (\u003Ca href=\"#f6\"\u003EFigures&#xa0;6A&#x2013;D\u003C\u002Fa\u003E). The femoral structure was repaired after 10 weeks of CS or metformin administration. The results of bone morphometric data (\u003Ca href=\"#f6\"\u003EFigures&#xa0;6E&#x2013;G\u003C\u002Fa\u003E) showed that the femoral thickness (Tb&#xb7;Th) and the percentage of bone trabecular area (BV\u002FTV) in CS or metformin treatment groups were significantly increased compared with the type 1 diabetic group (\u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01), and the trabecular separation (Tb&#xb7;Sp) was decreased in CS or metformin treatment groups compared with the type 1 diabetic group (\u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01).\u003C\u002Fp\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"Imageheaders\"\u003EFIGURE&#xa0;6\u003C\u002Fdiv\u003E\u003Cdiv class=\"FigureDesc\"\u003E\u003Ca href=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g006.jpg\" name=\"\" target=\"_blank\"\u003E\n \u003Cpicture\u003E\n \u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=480&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g006.jpg\" media=\"(max-width: 563px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=370&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g006.jpg\" media=\"(max-width: 1024px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=290&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g006.jpg\" media=\"(max-width: 1441px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=410&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g006.jpg\" media=\"\"\u003E\u003Csource type=\"image\u002Fjpg\" srcset=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g006.jpg\" media=\"\"\u003E \u003Cimg src=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g006.jpg\" alt=\"www.frontiersin.org\" id=\"f6\" loading=\"lazy\"\u003E\n \u003C\u002Fpicture\u003E\n\u003C\u002Fa\u003E\u003Cp\u003E\u003Cstrong\u003EFigure&#xa0;6\u003C\u002Fstrong\u003E The pathological sections of femur of rats in each group at the end of the 10th week; paraffin section of femur was stained with hematoxylin and eosin, 400&#xd7;. \u003Cstrong\u003E(A)\u003C\u002Fstrong\u003E The control group femur. \u003Cstrong\u003E(B)\u003C\u002Fstrong\u003E The diabetic group femur. \u003Cstrong\u003E(C)\u003C\u002Fstrong\u003E The CS group femur. \u003Cstrong\u003E(D)\u003C\u002Fstrong\u003E The Met group femur. \u003Cstrong\u003E(E)\u003C\u002Fstrong\u003E The trabecular separation (Tb&#xb7;Sp) in different groups. \u003Cstrong\u003E(F)\u003C\u002Fstrong\u003E The femoral thickness (Tb&#xb7;Th) in different groups. \u003Cstrong\u003E(G)\u003C\u002Fstrong\u003E The percentage of bone trabecular area (BV\u002FTV) in different groups; \u003Csup\u003E##\u003C\u002Fsup\u003Eindicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with control. **indicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with the diabetic group. BM. Bone marrow; Tb. Trabecular bone.\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Ch3\u003EChondroitin Sulfate Inhibited Bone Marrow Lipogenesis of Type 1 Diabetic Rats\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003ECompared with the control group, the number of bone marrow adipocytes of diabetic rats increased significantly, and the bone marrow adipocyte density and adipocyte diameter were larger than the control (\u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01) (\u003Ca href=\"#f7\"\u003EFigure&#xa0;7\u003C\u002Fa\u003E). Ten weeks after CS or metformin treatment, the bone marrow adipocyte density and adipocyte diameter decreased (CS \u003Ci\u003Evs\u003C\u002Fi\u003E. T1DM, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01; Met \u003Ci\u003Evs\u003C\u002Fi\u003E. T1DM, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01) (\u003Ca href=\"#f7\"\u003EFigure&#xa0;7\u003C\u002Fa\u003E). The results indicated that CS could inhibit bone marrow lipogenesis of type 1 diabetic rats.\u003C\u002Fp\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"Imageheaders\"\u003EFIGURE&#xa0;7\u003C\u002Fdiv\u003E\u003Cdiv class=\"FigureDesc\"\u003E\u003Ca href=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g007.jpg\" name=\"\" target=\"_blank\"\u003E\n \u003Cpicture\u003E\n \u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=480&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g007.jpg\" media=\"(max-width: 563px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=370&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g007.jpg\" media=\"(max-width: 1024px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=290&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g007.jpg\" media=\"(max-width: 1441px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=410&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g007.jpg\" media=\"\"\u003E\u003Csource type=\"image\u002Fjpg\" srcset=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g007.jpg\" media=\"\"\u003E \u003Cimg src=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g007.jpg\" alt=\"www.frontiersin.org\" id=\"f7\" loading=\"lazy\"\u003E\n \u003C\u002Fpicture\u003E\n\u003C\u002Fa\u003E\u003Cp\u003E\u003Cstrong\u003EFigure&#xa0;7\u003C\u002Fstrong\u003E Adipocytes in the bone marrow cavity of the tibia in different groups at the end of the 10th week, H&amp;E staining. \u003Cstrong\u003E(A)\u003C\u002Fstrong\u003E The control group tibia bone marrow. \u003Cstrong\u003E(B)\u003C\u002Fstrong\u003E The diabetic group tibia bone marrow. \u003Cstrong\u003E(C)\u003C\u002Fstrong\u003E The CS group tibia bone marrow. \u003Cstrong\u003E(D)\u003C\u002Fstrong\u003E The Met group tibia bone marrow. \u003Cstrong\u003E(E)\u003C\u002Fstrong\u003E Adipocyte density in different groups. \u003Cstrong\u003E(F)\u003C\u002Fstrong\u003E Adipocyte diameter in different groups. \u003Csup\u003E##\u003C\u002Fsup\u003Eindicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with control. **indicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with the diabetic group. Red arrows indicate adipocytes.\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Ch3\u003EChondroitin Sulfate Inhibited Osteoclastogenesis of Type 1 Diabetic Rats\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EAfter TRAP staining, the osteoclasts were stained purplish red. There was an increased number of femoral osteoclasts in type 1 diabetic group rats compared with control (\u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01) (\u003Ca href=\"#f8\"\u003EFigure&#xa0;8\u003C\u002Fa\u003E). Ten weeks after CS or metformin treatment, osteoclast number was decreased in the CS or Met group (CS group \u003Ci\u003Evs\u003C\u002Fi\u003E. T1DM group, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01; Met group \u003Ci\u003Evs\u003C\u002Fi\u003E. T1DM group, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01) (\u003Ca href=\"#f8\"\u003EFigure&#xa0;8E\u003C\u002Fa\u003E), indicating that CS could inhibit osteoclasts proliferation in type 1 diabetic rats.\u003C\u002Fp\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"Imageheaders\"\u003EFIGURE&#xa0;8\u003C\u002Fdiv\u003E\u003Cdiv class=\"FigureDesc\"\u003E\u003Ca href=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g008.jpg\" name=\"\" target=\"_blank\"\u003E\n \u003Cpicture\u003E\n \u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=480&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g008.jpg\" media=\"(max-width: 563px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=370&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g008.jpg\" media=\"(max-width: 1024px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=290&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g008.jpg\" media=\"(max-width: 1441px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=410&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g008.jpg\" media=\"\"\u003E\u003Csource type=\"image\u002Fjpg\" srcset=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g008.jpg\" media=\"\"\u003E \u003Cimg src=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g008.jpg\" alt=\"www.frontiersin.org\" id=\"f8\" loading=\"lazy\"\u003E\n \u003C\u002Fpicture\u003E\n\u003C\u002Fa\u003E\u003Cp\u003E\u003Cstrong\u003EFigure&#xa0;8\u003C\u002Fstrong\u003E The osteoclasts in femoral bone tissues of different groups at the end day of the 10th week. \u003Cstrong\u003E(A)\u003C\u002Fstrong\u003E The femoral bone tissues of control group rat. \u003Cstrong\u003E(B)\u003C\u002Fstrong\u003E The femoral bone tissues of diabetic group rat. \u003Cstrong\u003E(C)\u003C\u002Fstrong\u003E The femoral bone tissues of CS group rat. \u003Cstrong\u003E(D)\u003C\u002Fstrong\u003E The femoral bone tissues of Met group rat. \u003Cstrong\u003E(E)\u003C\u002Fstrong\u003E Number of osteoclasts per unit field in different groups. Bone tissues were stained by TRACP method, osteoclasts are multinucleate cells, and the red arrows point to osteoclasts. \u003Csup\u003E##\u003C\u002Fsup\u003Eindicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with control. **indicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with the diabetic group.\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Ch3\u003EChondroitin Sulfate Upregulated OPG and RUNX 2 and Downregulated RANKL Expression in Bone Tissues\u003C\u002Fh3\u003E\u003Cp class=\"mb0\"\u003EPathological analysis showed that bone OPG and RUNX 2 expression levels were lowered in type 1 diabetic rats (T1DM \u003Ci\u003Evs\u003C\u002Fi\u003E. Control, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01); RANKL level in bone tissue was higher in type 1 diabetic rats (T1DM \u003Ci\u003Evs\u003C\u002Fi\u003E. Control, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01) (\u003Ca href=\"#f9\"\u003EFigure&#xa0;9\u003C\u002Fa\u003E). After 10 weeks of CS or metformin administration, the bone OPG and RUNX 2 levels increased (CS or Met group \u003Ci\u003Evs\u003C\u002Fi\u003E. T1DM group, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01) and the RANKL level decreased (CS or Met \u003Ci\u003Evs\u003C\u002Fi\u003E. T1DM group, \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01) (\u003Ca href=\"#f9\"\u003EFigures&#xa0;9A&#x2013;C\u003C\u002Fa\u003E).\u003C\u002Fp\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"Imageheaders\"\u003EFIGURE&#xa0;9\u003C\u002Fdiv\u003E\u003Cdiv class=\"FigureDesc\"\u003E\u003Ca href=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g009.jpg\" name=\"\" target=\"_blank\"\u003E\n \u003Cpicture\u003E\n \u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=480&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g009.jpg\" media=\"(max-width: 563px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=370&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g009.jpg\" media=\"(max-width: 1024px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=290&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g009.jpg\" media=\"(max-width: 1441px)\"\u003E\u003Csource type=\"image\u002Fwebp\" srcset=\"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=410&f=webp\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g009.jpg\" media=\"\"\u003E\u003Csource type=\"image\u002Fjpg\" srcset=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g009.jpg\" media=\"\"\u003E \u003Cimg src=\"https:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g009.jpg\" alt=\"www.frontiersin.org\" id=\"f9\" loading=\"lazy\"\u003E\n \u003C\u002Fpicture\u003E\n\u003C\u002Fa\u003E\u003Cp\u003E\u003Cstrong\u003EFigure&#xa0;9\u003C\u002Fstrong\u003E Immunohistochemical staining of femur and positive staining percentage of OPG, RUNX2, and RANKL in each group. \u003Cstrong\u003E(A)\u003C\u002Fstrong\u003E The positive staining percentage of OPG in the femur of each group. \u003Cstrong\u003E(B)\u003C\u002Fstrong\u003E The positive staining percentage of RUNX 2 in the femur of each group. \u003Cstrong\u003E(C)\u003C\u002Fstrong\u003E The positive staining percentage of RANKL in the femur of each group. \u003Csup\u003E##\u003C\u002Fsup\u003Eindicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with control. **indicates \u003Ci\u003Ep\u003C\u002Fi\u003E &lt; 0.01 compared with the diabetic group.\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"DottedLine\"\u003E\u003C\u002Fdiv\u003E\u003Ca id=\"h5\" name=\"h5\"\u003E\u003C\u002Fa\u003E\u003Ch2\u003EDiscussion\u003C\u002Fh2\u003E\u003Cp class=\"mb15\"\u003EDOP is a serious metabolic bone disease associated with diabetes. It has the characteristics of reduced BMD, destruction of bone microstructure, increased brittleness, reduced strength, and easy to fracture, which seriously affects the quality of life of people with diabetes (\u003Ca href=\"#B18\"\u003E18\u003C\u002Fa\u003E, \u003Ca href=\"#B19\"\u003E19\u003C\u002Fa\u003E). Clinical treatment of DOP is to use chemical drugs such as vitamin D3, diphosphonate, calcitonin, and calcium to inhibit bone absorption, promote bone formation, and improve bone mineralization on the premise of controlling blood glucose. However, using chemical drugs long term can also lead to side effects, such as gastrointestinal diseases (\u003Ca href=\"#B20\"\u003E20\u003C\u002Fa\u003E). Therefore, natural anti-osteoporosis drugs are much popular.\u003C\u002Fp\u003E\u003Cp class=\"mb15\"\u003EIn the present study, we used the method of STZ injection to construct a rat model of type 1 diabetes, and intragastric administration of CS for 10 weeks. We detected the BMD, bone micro-CT, and bone pathology, and the results indicated that CS could inhibit bone loss, increase BMD, repair bone microstructure of type 1 diabetic rats, and thus prevent DOP.\u003C\u002Fp\u003E\u003Cp class=\"mb15\"\u003EDOP is closely related to oxidative stress. Hyperglycemia induced reactive oxygen species (ROS) production \u003Ci\u003Ein vivo\u003C\u002Fi\u003E and hindered the proliferation and differentiation of osteoblasts (\u003Ca href=\"#B21\"\u003E21\u003C\u002Fa\u003E&#x2013;\u003Ca href=\"#B23\"\u003E23\u003C\u002Fa\u003E). It has been confirmed that a sharp increase in the level of ROS induces death of osteoblasts, resulting in bone structure damage and BMD reduction (\u003Ca href=\"#B24\"\u003E24\u003C\u002Fa\u003E). In the present study, we found that the SOD, GPX, and CAT activity levels were upregulated after 10 weeks of CS administration, indicating that CS could inhibit oxidative stress in type 1 diabetic rats; this may be one of important reasons why CS could prevent bone loss in type 1 diabetic rats.\u003C\u002Fp\u003E\u003Cp class=\"mb15\"\u003EInflammation is closely related to osteoporosis, which is another main cause of DOP (\u003Ca href=\"#B25\"\u003E25\u003C\u002Fa\u003E). The level of inflammatory cytokines in diabetes was significantly higher than that in healthy people, and accumulation of inflammatory cytokines could mediate oxidative stress damage, prompting osteoclast proliferation, increasing bone absorption, and thus causing osteoporosis (\u003Ca href=\"#B26\"\u003E26\u003C\u002Fa\u003E). In this study, we found that CS could inhibit the inflammation in type 1 diabetic rats, and inflammatory cytokines were downregulated by CS. Many other natural products have also been reported to relieve DOP through an anti-inflammatory manner (\u003Ca href=\"#B23\"\u003E23\u003C\u002Fa\u003E, \u003Ca href=\"#B27\"\u003E27\u003C\u002Fa\u003E&#x2013;\u003Ca href=\"#B29\"\u003E29\u003C\u002Fa\u003E).\u003C\u002Fp\u003E\u003Cp class=\"mb15\"\u003EBoth osteoblasts and bone marrow adipocytes were derived from bone marrow mesenchymal stem cells (\u003Ca href=\"#B30\"\u003E30\u003C\u002Fa\u003E). As the number of bone marrow adipocytes increased, that of osteoblasts will decrease. Changes in the number and size of bone marrow adipocytes were positively correlated with osteoporosis, so they were important criteria for evaluating the efficacy of osteoporosis drugs (\u003Ca href=\"#B31\"\u003E31\u003C\u002Fa\u003E&#x2013;\u003Ca href=\"#B33\"\u003E33\u003C\u002Fa\u003E). In diabetes, hyperglycemia promotes the differentiation of bone marrow adipocytes and inhibits osteoblast differentiation (\u003Ca href=\"#B34\"\u003E34\u003C\u002Fa\u003E). As indicated in the present study, the bone marrow adipocyte number and size in type 1 diabetic rats were higher than those in control group rats, which were downregulated by 10 weeks of CS administration. Our previous study also found that trace elements of zinc, black rice anthocyanin, and lycopene were all having a preventive effect on DOP, and all of them can inhibit bone marrow adipocyte generation (\u003Ca href=\"#B4\"\u003E4\u003C\u002Fa\u003E, \u003Ca href=\"#B23\"\u003E23\u003C\u002Fa\u003E, \u003Ca href=\"#B35\"\u003E35\u003C\u002Fa\u003E), which is consistent with the results of this study.\u003C\u002Fp\u003E\u003Cp class=\"mb15\"\u003EBone tissue structure is an important basis for evaluating bone health (\u003Ca href=\"#B36\"\u003E36\u003C\u002Fa\u003E). In this study, we applied bone micro-CT and bone tissue pathology techniques to evaluate bone structure; the results indicated that CS can improve bone structure lesions caused by diabetes, and it can effectively restore bone morphological parameters and upregulate BMD.\u003C\u002Fp\u003E\u003Cp class=\"mb15\"\u003EThe biochemical markers of bone turnover (BMBT) were metabolite of bone tissue. BMBT includes bone formation and bone resorption markers, which were important indicators for laboratory diagnosis of osteoporosis (\u003Ca href=\"#B37\"\u003E37\u003C\u002Fa\u003E, \u003Ca href=\"#B38\"\u003E38\u003C\u002Fa\u003E). Not only can it quickly reflect the process of bone formation and bone resorption, but it also can be used to reveal pathogenesis of metabolic bone disease, predict the rate of bone loss and fracture risk, and diagnose osteoporosis; at the same time, it can be used to quickly reflect the therapeutic effect of anti-osteoporosis drugs (\u003Ca href=\"#B39\"\u003E39\u003C\u002Fa\u003E). In our present study, the bone formation markers (osteocalcin and ALP) as well as bone resorption markers (TRACP 5b and CTX 1) all increased in type 1 diabetic rats, which indicated that diabetic rats had a higher bone turnover rate. This study showed that CS could downregulate the BMBT in diabetic rats and inhibit the higher bone turnover rate.\u003C\u002Fp\u003E\u003Cp class=\"mb15\"\u003ERANKL was a member of the TNF superfamily involved in immune regulation and bone metabolism, and it was an important activator of osteoclast differentiation and maturation (\u003Ca href=\"#B40\"\u003E40\u003C\u002Fa\u003E). RANKL activates osteoclast differentiation, thus promoting bone resorption by competing with OPG to bind to receptor RANK. Overexpression of RANKL can lead to excessive activation of osteoclasts, which can lead to osteoporosis (\u003Ca href=\"#B41\"\u003E41\u003C\u002Fa\u003E). OPG was also a member of the TNF superfamily. It was highly expressed in testis and bone marrow (\u003Ca href=\"#B42\"\u003E42\u003C\u002Fa\u003E). OPG binds to RANKL and blocks binding of RANKL to RANK. At the same time, OPG can inhibit osteoclast differentiation and maturation, and promote osteoclasts apoptosis (\u003Ca href=\"#B43\"\u003E43\u003C\u002Fa\u003E). When the ratio of OPG to RANKL increases, bone formation activity of osteoblasts increases, and bone metabolism tends to be in a positive balance. When the ratio of OPG to RANKL decreases, the bone resorption activity of osteoclasts increases, and bone metabolism tends to be in a negative balance (\u003Ca href=\"#B44\"\u003E44\u003C\u002Fa\u003E). In the present study, the level of OPG\u002FRANKL ratio in diabetic rats was greatly decreased compared with control, indicating increased bone resorption activity; after 10 weeks of CS treatment, the OPG\u002FRANKL ratio was upregulated, indicating increased bone formation activity. One of the mechanisms of CS against DOP is by upregulating the OPG\u002FRANKL ratio. In this study, we detected the bone OPG, RANKL, and RUNX 2 proteins using an immunohistochemical method, which has the advantage of localizing the protein, but in a quantitative aspect, it is inferior to Western blotting; in subsequent experiments, we will supplement the Western blotting experiment to confirm the above results.\u003C\u002Fp\u003E\u003Cp class=\"mb0\"\u003EAs a first-line drug for diabetes, metformin is a chemically synthesized drug. The main side effects are gastrointestinal reactions, such as nausea and vomiting (\u003Ca href=\"#B45\"\u003E45\u003C\u002Fa\u003E), as well as gut microbiota dysbiosis (\u003Ca href=\"#B46\"\u003E46\u003C\u002Fa\u003E). Secondly, metformin will interfere with the absorption of vitamin B12 and folic acid. Studies have shown that up to 30% of patients taking metformin have B12 deficiency (\u003Ca href=\"#B47\"\u003E47\u003C\u002Fa\u003E, \u003Ca href=\"#B48\"\u003E48\u003C\u002Fa\u003E). In this study, CS showed a good anti-DOP effect, similar to metformin. However, the CS used in this study was naturally extracted and has the advantages of high safety and less side effects compared with metformin. This study revealed the role of CS in DOP treatment through animal experiments. Later, we will further reveal its molecular mechanism through \u003Ci\u003Ein vitro\u003C\u002Fi\u003E cell experiments and further confirm its effect through human experiments.\u003C\u002Fp\u003E\u003Ca id=\"h6\" name=\"h6\"\u003E\u003C\u002Fa\u003E\u003Ch2\u003EData Availability Statement\u003C\u002Fh2\u003E\u003Cp class=\"mb0\"\u003EThe original contributions presented in the study are included in the article\u002FSupplementary Material. Further inquiries can be directed to the corresponding authors.\u003C\u002Fp\u003E\u003Ca id=\"h7\" name=\"h7\"\u003E\u003C\u002Fa\u003E\u003Ch2\u003EEthics Statement\u003C\u002Fh2\u003E\u003Cp class=\"mb0\"\u003EThe animal study was reviewed and approved by Shaanxi University of Technology Animal Ethics Committee.\u003C\u002Fp\u003E\u003Ca id=\"h8\" name=\"h8\"\u003E\u003C\u002Fa\u003E\u003Ch2\u003EAuthor Contributions\u003C\u002Fh2\u003E\u003Cp class=\"mb0\"\u003EStudy design: SQ, HZ, DC, TY, and XL. Study conduct: SQ, HZ, MS, ZS, YH, and SC. Data collection and analysis: SQ, HZ, MS, ZS, YH, and SC. Animal model construction: SQ and HZ. Histopathological experiment: SQ, MS, ZS, and SC. Manuscript draft: SQ. Manuscript revision: HZ. All authors contributed to the article and approved the submitted version.\u003C\u002Fp\u003E\u003Ca id=\"h9\" name=\"h9\"\u003E\u003C\u002Fa\u003E\u003Ch2\u003EFunding\u003C\u002Fh2\u003E\u003Cp class=\"mb0\"\u003EThis research was funded by the Postdoctoral Program in Shaanxi University of Technology (SLGBH16-03), &#x201c;Shaanxi Sanqin Scholar&#x201d; Innovation Team, the Key Research Projects of Shaanxi Provincial Department of Education (20JY005), Shaanxi University of Technology Project (SLGKY2010), and the Key projects of Shaanxi Science and Technology Department (2021FP-14), and Shaanxi University of Technology Project (SLGKY2004).\u003C\u002Fp\u003E\u003Ca id=\"h10\" name=\"h10\"\u003E\u003C\u002Fa\u003E\u003Ch2\u003EConflict of Interest\u003C\u002Fh2\u003E\u003Cp class=\"mb0\"\u003EThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003C\u002Fp\u003E\u003Ca id=\"h11\" name=\"h11\"\u003E\u003C\u002Fa\u003E\u003Ch2\u003EPublisher&#x2019;s Note\u003C\u002Fh2\u003E\u003Cp class=\"mb15\"\u003EAll claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003C\u002Fp\u003E\u003Ca id=\"h12\" name=\"h12\"\u003E\u003C\u002Fa\u003E\u003Ch2\u003EReferences\u003C\u002Fh2\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B1\" id=\"B1\"\u003E\u003C\u002Fa\u003E 1. Kamusheva M, Tachkov K, Dimitrova M, Mitkova Z, Garc&#xed;a-S&#xe1;ez G, Hernando ME, et al. A Systematic Review of Collective Evidences Investigating the Effect of Diabetes Monitoring Systems and Their Application in Health Care. \u003Ci\u003EFront Endocrinol\u003C\u002Fi\u003E (2021) 12:636959. doi: 10.3389\u002Ffendo.2021.636959\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3389\u002Ffendo.2021.636959\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=M+Kamusheva&amp;author=K+Tachkov&amp;author=M+Dimitrova&amp;author=Z+Mitkova&amp;author=G+Garc%C3%ADa-S%C3%A1ez&amp;author=ME+Hernando&amp;publication_year=2021&amp;title=A%20Systematic%20Review%20of%20Collective%20Evidences%20Investigating%20the%20Effect%20of%20Diabetes%20Monitoring%20Systems%20and%20Their%20Application%20in%20Health%20Care&amp;journal=Front+Endocrinol&amp;volume=12&amp;\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B2\" id=\"B2\"\u003E\u003C\u002Fa\u003E 2. Avil&#xe9;s-Santa ML, Monroig-Rivera A, Soto-Soto A, Lindberg NM. Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Iatin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent. \u003Ci\u003ECurr Diabetes Rep\u003C\u002Fi\u003E (2020) 20:62&#x2013;2. doi: 10.1007\u002Fs11892-020-01341-9\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1007\u002Fs11892-020-01341-9\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=ML+Avil%C3%A9s-Santa&amp;author=A+Monroig-Rivera&amp;author=A+Soto-Soto&amp;author=NM+Lindberg&amp;publication_year=2020&amp;title=Current%20State%20of%20Diabetes%20Mellitus%20Prevalence%2C%20Awareness%2C%20Treatment%2C%20and%20Control%20in%20Iatin%20America%3A%20Challenges%20and%20Innovative%20Solutions%20to%20Improve%20Health%20Outcomes%20Across%20the%20Continent&amp;journal=Curr+Diabetes+Rep&amp;volume=20&amp;pages=62-2\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B3\" id=\"B3\"\u003E\u003C\u002Fa\u003E 3. Iacobini C, Vitale M, Pesce C, Pugliese G, Menini S. Diabetic Complications and Oxidative Stress: A 20-Year Voyage Back in Time and Back to the Future. \u003Ci\u003EAntioxidants\u003C\u002Fi\u003E (2021) 10:727&#x2013;39. doi: 10.3390\u002Fantiox10050727\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F34063078\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3390\u002Fantiox10050727\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=C+Iacobini&amp;author=M+Vitale&amp;author=C+Pesce&amp;author=G+Pugliese&amp;author=S+Menini&amp;publication_year=2021&amp;title=Diabetic%20Complications%20and%20Oxidative%20Stress%3A%20A%2020-Year%20Voyage%20Back%20in%20Time%20and%20Back%20to%20the%20Future&amp;journal=Antioxidants&amp;volume=10&amp;pages=727-39\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B4\" id=\"B4\"\u003E\u003C\u002Fa\u003E 4. Qi SS, He J, Han H, Zheng HX, Jiang H, Hu CY, et al. Anthocyanin-Rich Extract From Black Rice (\u003Ci\u003EOryza Sativa L. Japonica\u003C\u002Fi\u003E) Ameliorates Diabetic Osteoporosis in Rats. \u003Ci\u003EFood Funct\u003C\u002Fi\u003E (2019) 10:5350&#x2013;60. doi: 10.1039\u002FC9FO00681H\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F31393485\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1039\u002FC9FO00681H\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=SS+Qi&amp;author=J+He&amp;author=H+Han&amp;author=HX+Zheng&amp;author=H+Jiang&amp;author=CY+Hu&amp;publication_year=2019&amp;title=Anthocyanin-Rich%20Extract%20From%20Black%20Rice%20%28Oryza%20Sativa%20L.%20Japonica%29%20Ameliorates%20Diabetic%20Osteoporosis%20in%20Rats&amp;journal=Food+Funct&amp;volume=10&amp;pages=5350-60\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B5\" id=\"B5\"\u003E\u003C\u002Fa\u003E 5. Ma R, Zhu R, Wang L, Guo Y, Liu C, Liu H, et al. Diabetic Osteoporosis: A Review of its Traditional Chinese Medicinal Use and Clinical and Preclinical Research. \u003Ci\u003EEvid Based Complement Alternat Med\u003C\u002Fi\u003E (2016) 5:1&#x2013;13. doi: 10.1155\u002F2016\u002F3218313\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1155\u002F2016\u002F3218313\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=R+Ma&amp;author=R+Zhu&amp;author=L+Wang&amp;author=Y+Guo&amp;author=C+Liu&amp;author=H+Liu&amp;publication_year=2016&amp;title=Diabetic%20Osteoporosis%3A%20A%20Review%20of%20its%20Traditional%20Chinese%20Medicinal%20Use%20and%20Clinical%20and%20Preclinical%20Research&amp;journal=Evid+Based+Complement+Alternat+Med&amp;volume=5&amp;pages=1\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B6\" id=\"B6\"\u003E\u003C\u002Fa\u003E 6. Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, et al. Diagnosis and Management of Bone Fragility in Diabetes: An Emerging Challenge. \u003Ci\u003EOsteoporosis Int\u003C\u002Fi\u003E (2018) 29:2585&#x2013;96. doi: 10.1007\u002Fs00198-018-4650-2\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1007\u002Fs00198-018-4650-2\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=SL+Ferrari&amp;author=B+Abrahamsen&amp;author=N+Napoli&amp;author=K+Akesson&amp;author=M+Chandran&amp;author=R+Eastell&amp;publication_year=2018&amp;title=Diagnosis%20and%20Management%20of%20Bone%20Fragility%20in%20Diabetes%3A%20An%20Emerging%20Challenge&amp;journal=Osteoporosis+Int&amp;volume=29&amp;pages=2585-96\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B7\" id=\"B7\"\u003E\u003C\u002Fa\u003E 7. Li L, Li Y, Feng D, Xu L, Yin F, Zang H, et al. Preparation of Low Molecular Weight Chondroitin Sulfates, Screening of a High Anti-Complement Capacity of Low Molecular Weight Chondroitin Sulfate and Its Biological Activity Studies in Attenuating Osteoarthritis. \u003Ci\u003EInt J Mol Sci\u003C\u002Fi\u003E (2016) 17:1685&#x2013;700. doi: 10.3390\u002Fijms17101685\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3390\u002Fijms17101685\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=L+Li&amp;author=Y+Li&amp;author=D+Feng&amp;author=L+Xu&amp;author=F+Yin&amp;author=H+Zang&amp;publication_year=2016&amp;title=Preparation%20of%20Low%20Molecular%20Weight%20Chondroitin%20Sulfates%2C%20Screening%20of%20a%20High%20Anti-Complement%20Capacity%20of%20Low%20Molecular%20Weight%20Chondroitin%20Sulfate%20and%20Its%20Biological%20Activity%20Studies%20in%20Attenuating%20Osteoarthritis&amp;journal=Int+J+Mol+Sci&amp;volume=17&amp;pages=1685-700\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B8\" id=\"B8\"\u003E\u003C\u002Fa\u003E 8. Melgar-Lesmes P, Garcia-Polite F, Del-Rey-Puech P, Rosas E, Dreyfuss JL, Montell E, et al. Treatment With Chondroitin Sulfate to Modulate Inflammation and Atherogenesis in Obesity. \u003Ci\u003EAtherosclerosis\u003C\u002Fi\u003E (2016) 245:82&#x2013;7. doi: 10.1016\u002Fj.atherosclerosis.2015.12.016\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F26714044\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.atherosclerosis.2015.12.016\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=P+Melgar-Lesmes&amp;author=F+Garcia-Polite&amp;author=P+Del-Rey-Puech&amp;author=E+Rosas&amp;author=JL+Dreyfuss&amp;author=E+Montell&amp;publication_year=2016&amp;title=Treatment%20With%20Chondroitin%20Sulfate%20to%20Modulate%20Inflammation%20and%20Atherogenesis%20in%20Obesity&amp;journal=Atherosclerosis&amp;volume=245&amp;pages=82-7\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B9\" id=\"B9\"\u003E\u003C\u002Fa\u003E 9. Verg&#xe9;s J, Montell E, Herrero M, Perna C, Cuevas J, Dalmau J, et al. Clinical and Histopathological Improvement of Psoriasis With Oral Chondroitin Sulfate: A Serendipitous Finding. \u003Ci\u003EDermatol Online J\u003C\u002Fi\u003E (2005) 11:31&#x2013;44. doi: 10.5070\u002FD32zh8x3vf\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F15748570\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.5070\u002FD32zh8x3vf\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=J+Verg%C3%A9s&amp;author=E+Montell&amp;author=M+Herrero&amp;author=C+Perna&amp;author=J+Cuevas&amp;author=J+Dalmau&amp;publication_year=2005&amp;title=Clinical%20and%20Histopathological%20Improvement%20of%20Psoriasis%20With%20Oral%20Chondroitin%20Sulfate%3A%20A%20Serendipitous%20Finding&amp;journal=Dermatol+Online+J&amp;volume=11&amp;pages=31\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B10\" id=\"B10\"\u003E\u003C\u002Fa\u003E 10. Hatano S, Watanabe H. Regulation of Macrophage and Dendritic Cell Function by Chondroitin Sulfate in Innate to Antigen-Sspecific Adaptive Immunity. \u003Ci\u003EFront Immunol\u003C\u002Fi\u003E (2020) 11:232&#x2013;2. doi: 10.3389\u002Ffimmu.2020.00232\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F32194548\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3389\u002Ffimmu.2020.00232\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=S+Hatano&amp;author=H+Watanabe&amp;publication_year=2020&amp;title=Regulation%20of%20Macrophage%20and%20Dendritic%20Cell%20Function%20by%20Chondroitin%20Sulfate%20in%20Innate%20to%20Antigen-Sspecific%20Adaptive%20Immunity&amp;journal=Front+Immunol&amp;volume=11&amp;pages=232-2\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B11\" id=\"B11\"\u003E\u003C\u002Fa\u003E 11. Seol BG, Kim JH, Woo M, Song YO, Choi YH, Noh JS, et al. Skate Cartilage Extracts Containing Chondroitin Sulfate Ameliorates Hyperlipidemia-Induced Inflammation and Oxidative Stress in High Cholesterol Diet-Fed LDL Receptor Knockout Mice in Comparison With Shark Chondroitin Sulfate. \u003Ci\u003ENutr Res Pract\u003C\u002Fi\u003E (2020) 14:175&#x2013;87. doi: 10.4162\u002Fnrp.2020.14.3.175\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F32528626\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.4162\u002Fnrp.2020.14.3.175\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=BG+Seol&amp;author=JH+Kim&amp;author=M+Woo&amp;author=YO+Song&amp;author=YH+Choi&amp;author=JS+Noh&amp;publication_year=2020&amp;title=Skate%20Cartilage%20Extracts%20Containing%20Chondroitin%20Sulfate%20Ameliorates%20Hyperlipidemia-Induced%20Inflammation%20and%20Oxidative%20Stress%20in%20High%20Cholesterol%20Diet-Fed%20LDL%20Receptor%20Knockout%20Mice%20in%20Comparison%20With%20Shark%20Chondroitin%20Sulfate&amp;journal=Nutr+Res+Pract&amp;volume=14&amp;pages=175-87\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B12\" id=\"B12\"\u003E\u003C\u002Fa\u003E 12. Pude&#x142;ko A, Wisowski G, Olczyk K, Ko&#x17a;ma EM. The Dual Role of the Glycosaminoglycan Chondroitin-6-Sulfate in the Development, Progression and Metastasis of Cancer. \u003Ci\u003EFEBS J\u003C\u002Fi\u003E (2019) 286:1815&#x2013;37. doi: 10.1111\u002Ffebs.14748\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F30637950\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1111\u002Ffebs.14748\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=A+Pude%C5%82ko&amp;author=G+Wisowski&amp;author=K+Olczyk&amp;author=EM+Ko%C5%BAma&amp;publication_year=2019&amp;title=The%20Dual%20Role%20of%20the%20Glycosaminoglycan%20Chondroitin-6-Sulfate%20in%20the%20Development%2C%20Progression%20and%20Metastasis%20of%20Cancer&amp;journal=FEBS+J&amp;volume=286&amp;pages=1815-37\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B13\" id=\"B13\"\u003E\u003C\u002Fa\u003E 13. Gomes CL, Le&#xe3;o CL, Venturotti C, Barreira AL, Guimar&#xe3;es G, Fonseca RJ, et al. The Protective Role of Fucosylated Chondroitin Sulfate, a Distinct Glycosaminoglycan, in a Murine Model of Streptozotocin-Induced Diabetic Nephropathy. \u003Ci\u003EPloS One\u003C\u002Fi\u003E (2014) 9:e106929. doi: 10.1371\u002Fjournal.pone.0106929\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F25192337\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1371\u002Fjournal.pone.0106929\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=CL+Gomes&amp;author=CL+Le%C3%A3o&amp;author=C+Venturotti&amp;author=AL+Barreira&amp;author=G+Guimar%C3%A3es&amp;author=RJ+Fonseca&amp;publication_year=2014&amp;title=The%20Protective%20Role%20of%20Fucosylated%20Chondroitin%20Sulfate%2C%20a%20Distinct%20Glycosaminoglycan%2C%20in%20a%20Murine%20Model%20of%20Streptozotocin-Induced%20Diabetic%20Nephropathy&amp;journal=PloS+One&amp;volume=9&amp;pages=e106929\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B14\" id=\"B14\"\u003E\u003C\u002Fa\u003E 14. Wolff RB. Glucosamine and Chondroitin Sulfate Association Increases Tibial Epiphyseal Growth Plate Proliferation and Bone Formation in Ovariectomized Rats. \u003Ci\u003EClinics\u003C\u002Fi\u003E (2014) 12:847&#x2013;53. doi: 10.6061\u002Fclinics\u002F2014(12)10\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.6061\u002Fclinics\u002F2014(12)10\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=RB+Wolff&amp;publication_year=2014&amp;title=Glucosamine%20and%20Chondroitin%20Sulfate%20Association%20Increases%20Tibial%20Epiphyseal%20Growth%20Plate%20Proliferation%20and%20Bone%20Formation%20in%20Ovariectomized%20Rats&amp;journal=Clinics&amp;volume=12&amp;pages=847-53\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B15\" id=\"B15\"\u003E\u003C\u002Fa\u003E 15. Zhu WM, Ji Y, Wang YD, He YY, Su N, Zhang C, et al. Structural Characterization and \u003Ci\u003EIn Vitro\u003C\u002Fi\u003E Antioxidant Activities of Chondroitin Sulfate Purified From Andrias Davidianus Cartilage. \u003Ci\u003ECarbohyd Polym\u003C\u002Fi\u003E (2018) 5:398&#x2013;404. doi: 10.1016\u002Fj.carbpol.2018.05.047\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.carbpol.2018.05.047\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=WM+Zhu&amp;author=Y+Ji&amp;author=YD+Wang&amp;author=YY+He&amp;author=N+Su&amp;author=C+Zhang&amp;publication_year=2018&amp;title=Structural%20Characterization%20and%20In%20Vitro%20Antioxidant%20Activities%20of%20Chondroitin%20Sulfate%20Purified%20From%20Andrias%20Davidianus%20Cartilage&amp;journal=Carbohyd+Polym&amp;volume=5&amp;pages=398\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B16\" id=\"B16\"\u003E\u003C\u002Fa\u003E 16. Qi SS, Shao ML, Sun Z, Chen SM, Hu YJ, Wang HT, et al. Lycopene Ameliorates Diabetic Osteoporosis \u003Ci\u003Evia\u003C\u002Fi\u003E Anti-Inflammatory, Anti-Oxidation, and Increasing Osteoprotegerin\u002FRANKL Expression Ratio. \u003Ci\u003EJ Funct Foods\u003C\u002Fi\u003E (2021) 83:1756&#x2013;4646. doi: 10.1016\u002Fj.jff.2021.104539\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.jff.2021.104539\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=SS+Qi&amp;author=ML+Shao&amp;author=Z+Sun&amp;author=SM+Chen&amp;author=YJ+Hu&amp;author=HT+Wang&amp;publication_year=2021&amp;title=Lycopene%20Ameliorates%20Diabetic%20Osteoporosis%20via%20Anti-Inflammatory%2C%20Anti-Oxidation%2C%20and%20Increasing%20Osteoprotegerin%2FRANKL%20Expression%20Ratio&amp;journal=J+Funct+Foods&amp;volume=83&amp;pages=1756\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B17\" id=\"B17\"\u003E\u003C\u002Fa\u003E 17. Qi SS, He J, Chen C, Zheng HX, Zhang ZJ. Du-Zhong (\u003Ci\u003EEucommia Ulmoides Oliv.\u003C\u002Fi\u003E) Cortex Extract Prevents Bone Loss in Ovariectomized Diabetic Rats by Suppressing Bone Turnover and Up-Regulating the OPG\u002FRANKL Ratio. \u003Ci\u003EInt J Clin Exp Med\u003C\u002Fi\u003E (2019) 12:579&#x2013;90. doi: 10.1007\u002Fs12011-018-1362-6\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1007\u002Fs12011-018-1362-6\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=SS+Qi&amp;author=J+He&amp;author=C+Chen&amp;author=HX+Zheng&amp;author=ZJ+Zhang&amp;publication_year=2019&amp;title=Du-Zhong%20%28Eucommia%20Ulmoides%20Oliv.%29%20Cortex%20Extract%20Prevents%20Bone%20Loss%20in%20Ovariectomized%20Diabetic%20Rats%20by%20Suppressing%20Bone%20Turnover%20and%20Up-Regulating%20the%20OPG%2FRANKL%20Ratio&amp;journal=Int+J+Clin+Exp+Med&amp;volume=12&amp;pages=579-90\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B18\" id=\"B18\"\u003E\u003C\u002Fa\u003E 18. Wen Y, Li H, Zhang X, Liu P, Ma J, Zhang L, et al. Correlation of Osteoporosis in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Study in Chinese Population. \u003Ci\u003EFront Eedocrinol\u003C\u002Fi\u003E (2021) 12:531904&#x2013;4. doi: 10.3389\u002Ffendo.2021.531904\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3389\u002Ffendo.2021.531904\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=Y+Wen&amp;author=H+Li&amp;author=X+Zhang&amp;author=P+Liu&amp;author=J+Ma&amp;author=L+Zhang&amp;publication_year=2021&amp;title=Correlation%20of%20Osteoporosis%20in%20Patients%20With%20Newly%20Diagnosed%20Type%202%20Diabetes%3A%20A%20Retrospective%20Study%20in%20Chinese%20Population&amp;journal=Front+Eedocrinol&amp;volume=12&amp;pages=531904-4\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B19\" id=\"B19\"\u003E\u003C\u002Fa\u003E 19. Shah VN, Shah CS, Snell-Bergeon JK. Type 1 Diabetes and Risk of Fracture: Meta-Analysis and Review of the Literature. \u003Ci\u003EDiabetes Med\u003C\u002Fi\u003E (2015) 32:1134&#x2013;42. doi: 10.1111\u002Fdme.12734\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1111\u002Fdme.12734\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=VN+Shah&amp;author=CS+Shah&amp;author=JK+Snell-Bergeon&amp;publication_year=2015&amp;title=Type%201%20Diabetes%20and%20Risk%20of%20Fracture%3A%20Meta-Analysis%20and%20Review%20of%20the%20Literature&amp;journal=Diabetes+Med&amp;volume=32&amp;pages=1134-42\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B20\" id=\"B20\"\u003E\u003C\u002Fa\u003E 20. Chandra A, Rajawat J. Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics. \u003Ci\u003EInt J Mol Sci\u003C\u002Fi\u003E (2021) 22:3553&#x2013;3. doi: 10.3390\u002Fijms22073553\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F33805567\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3390\u002Fijms22073553\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=A+Chandra&amp;author=J+Rajawat&amp;publication_year=2021&amp;title=Skeletal%20Aging%20and%20Osteoporosis%3A%20Mechanisms%20and%20Therapeutics&amp;journal=Int+J+Mol+Sci&amp;volume=22&amp;pages=3553-3\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B21\" id=\"B21\"\u003E\u003C\u002Fa\u003E 21. Palui R, Pramanik S, Mondal S, Ray S. Critical Review of Bone Health, Fracture Risk and Management of Bone Fragility in Diabetes Mellitus. \u003Ci\u003EWorld J Diabetes\u003C\u002Fi\u003E (2021) 12:706&#x2013;29. doi: 10.4239\u002Fwjd.v12.i6.706\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F34168723\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.4239\u002Fwjd.v12.i6.706\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=R+Palui&amp;author=S+Pramanik&amp;author=S+Mondal&amp;author=S+Ray&amp;publication_year=2021&amp;title=Critical%20Review%20of%20Bone%20Health%2C%20Fracture%20Risk%20and%20Management%20of%20Bone%20Fragility%20in%20Diabetes%20Mellitus&amp;journal=World+J+Diabetes&amp;volume=12&amp;pages=706-29\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B22\" id=\"B22\"\u003E\u003C\u002Fa\u003E 22. Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL. Bone and Diabetes Working Group. Mmechanisms of Diabetes Mellitus-Induced Bone Fragility. \u003Ci\u003ENat Rev Endocrinol\u003C\u002Fi\u003E (2017) 13:208&#x2013;19. doi: 10.1038\u002Fnrendo.2016.153\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F27658727\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1038\u002Fnrendo.2016.153\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=N+Napoli&amp;author=M+Chandran&amp;author=DD+Pierroz&amp;author=B+Abrahamsen&amp;author=AV+Schwartz&amp;author=SL+Ferrari&amp;publication_year=2017&amp;title=Bone%20and%20Diabetes%20Working%20Group.%20Mmechanisms%20of%20Diabetes%20Mellitus-Induced%20Bone%20Fragility&amp;journal=Nat+Rev+Endocrinol&amp;volume=13&amp;pages=208-19\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B23\" id=\"B23\"\u003E\u003C\u002Fa\u003E 23. Wang X, Wang H, Zhang T, Cai L, Kong C, He J. Current Knowledge Regarding the Interaction Between Oral Bone Metabolic Disorders and Diabetes Mellitus. \u003Ci\u003EFront Endocrinol\u003C\u002Fi\u003E (2020) 11:536&#x2013;45. doi: 10.3389\u002Ffendo.2020.00536\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3389\u002Ffendo.2020.00536\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=X+Wang&amp;author=H+Wang&amp;author=T+Zhang&amp;author=L+Cai&amp;author=C+Kong&amp;author=J+He&amp;publication_year=2020&amp;title=Current%20Knowledge%20Regarding%20the%20Interaction%20Between%20Oral%20Bone%20Metabolic%20Disorders%20and%20Diabetes%20Mellitus&amp;journal=Front+Endocrinol&amp;volume=11&amp;pages=536-45\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B24\" id=\"B24\"\u003E\u003C\u002Fa\u003E 24. Agidigbi TS, Kim C. Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases. \u003Ci\u003EInt J Mol Sci\u003C\u002Fi\u003E (2019) 14:3576&#x2013;88. doi: 10.3390\u002Fijms20143576\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3390\u002Fijms20143576\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=TS+Agidigbi&amp;author=C+Kim&amp;publication_year=2019&amp;title=Reactive%20Oxygen%20Species%20in%20Osteoclast%20Differentiation%20and%20Possible%20Pharmaceutical%20Targets%20of%20ROS-Mediated%20Osteoclast%20Diseases&amp;journal=Int+J+Mol+Sci&amp;volume=14&amp;pages=3576-88\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B25\" id=\"B25\"\u003E\u003C\u002Fa\u003E 25. Sellmeyer DE, Civitelli R, Hofbauer LC, Khosla S, Lecka-Czernik B, Schwartz AV. Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes. \u003Ci\u003EDiabetes\u003C\u002Fi\u003E (2016) 65:1757&#x2013;66. doi: 10.2337\u002Fdb16-0063\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F27329951\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.2337\u002Fdb16-0063\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=DE+Sellmeyer&amp;author=R+Civitelli&amp;author=LC+Hofbauer&amp;author=S+Khosla&amp;author=B+Lecka-Czernik&amp;author=AV+Schwartz&amp;publication_year=2016&amp;title=Skeletal%20Metabolism%2C%20Fracture%20Risk%2C%20and%20Fracture%20Outcomes%20in%20Type%201%20and%20Type%202%20Diabetes&amp;journal=Diabetes&amp;volume=65&amp;pages=1757-66\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B26\" id=\"B26\"\u003E\u003C\u002Fa\u003E 26. De Vries TJ, El Bakkali I, Kamradt T, Schett G, Jansen I, D'Amelio P. What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss? \u003Ci\u003EFront Immumol\u003C\u002Fi\u003E (2019) 10:505. doi: 10.3389\u002Ffimmu.2019.00505\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3389\u002Ffimmu.2019.00505\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=TJ+De%20Vries&amp;author=I+El%20Bakkali&amp;author=T+Kamradt&amp;author=G+Schett&amp;author=I+Jansen&amp;author=P+D%27Amelio&amp;publication_year=2019&amp;title=What%20Are%20the%20Peripheral%20Blood%20Determinants%20for%20Increased%20Osteoclast%20Formation%20in%20the%20Various%20Inflammatory%20Diseases%20Associated%20With%20Bone%20Loss&amp;journal=Front+Immumol&amp;volume=10&amp;\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B27\" id=\"B27\"\u003E\u003C\u002Fa\u003E 27. Li XJ, Zhu Z, Han SL, Zhang ZL. Bergapten Exerts Inhibitory Effects on Diabetes-Related Osteoporosis \u003Ci\u003Evia\u003C\u002Fi\u003E the Regulation of the PI3K\u002FAKT, JNK\u002FMAPK and NF-&#x3ba;b Signaling Pathways in Osteoprotegerin Knockout Mice. \u003Ci\u003EInt J Mol Med\u003C\u002Fi\u003E (2016) 38:1661&#x2013;72. doi: 10.3892\u002Fijmm.2016.2794\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F27840967\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3892\u002Fijmm.2016.2794\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=XJ+Li&amp;author=Z+Zhu&amp;author=SL+Han&amp;author=ZL+Zhang&amp;publication_year=2016&amp;title=Bergapten%20Exerts%20Inhibitory%20Effects%20on%20Diabetes-Related%20Osteoporosis%20via%20the%20Regulation%20of%20the%20PI3K%2FAKT%2C%20JNK%2FMAPK%20and%20NF-%CE%BAb%20Signaling%20Pathways%20in%20Osteoprotegerin%20Knockout%20Mice&amp;journal=Int+J+Mol+Med&amp;volume=38&amp;pages=1661-72\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B28\" id=\"B28\"\u003E\u003C\u002Fa\u003E 28. Wang W, Bai J, Zhang W, Ge G, Wang Q, Liang X, et al. Protective Effects of Punicalagin on Osteoporosis by Inhibiting Osteoclastogenesis and Inflammation \u003Ci\u003Evia\u003C\u002Fi\u003E the NF-&#x3ba;b and MAPK Pathways. \u003Ci\u003EFront Pharmacol\u003C\u002Fi\u003E (2020) 11:696. doi: 10.3389\u002Ffphar.2020.00696\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F32477149\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3389\u002Ffphar.2020.00696\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=W+Wang&amp;author=J+Bai&amp;author=W+Zhang&amp;author=G+Ge&amp;author=Q+Wang&amp;author=X+Liang&amp;publication_year=2020&amp;title=Protective%20Effects%20of%20Punicalagin%20on%20Osteoporosis%20by%20Inhibiting%20Osteoclastogenesis%20and%20Inflammation%20via%20the%20NF-%CE%BAb%20and%20MAPK%20Pathways&amp;journal=Front+Pharmacol&amp;volume=11&amp;\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B29\" id=\"B29\"\u003E\u003C\u002Fa\u003E 29. Lu R, Zhen Z, Yin Y, Jiang Z. Genistein Prevents Bone Loss in Type 2 Diabetic Rats Induced by Streptozotocin. \u003Ci\u003EFood Nutr Res\u003C\u002Fi\u003E (2020) 64:29219. doi: 10.29219\u002Ffnr.v64.3666\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.29219\u002Ffnr.v64.3666\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=R+Lu&amp;author=Z+Zhen&amp;author=Y+Yin&amp;author=Z+Jiang&amp;publication_year=2020&amp;title=Genistein%20Prevents%20Bone%20Loss%20in%20Type%202%20Diabetic%20Rats%20Induced%20by%20Streptozotocin&amp;journal=Food+Nutr+Res&amp;volume=64&amp;pages=29219\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B30\" id=\"B30\"\u003E\u003C\u002Fa\u003E 30. Qi SS, He J, Zheng HX, Chen C, Lan SQ. Icariin Prevents Diabetes-Induced Bone Loss in Rats by Reducing Blood Glucose and Suppressing Bone Turnover. \u003Ci\u003EMolecules\u003C\u002Fi\u003E (2019) 24:1871&#x2013;85. doi: 10.3390\u002Fmolecules24101871\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3390\u002Fmolecules24101871\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=SS+Qi&amp;author=J+He&amp;author=HX+Zheng&amp;author=C+Chen&amp;author=SQ+Lan&amp;publication_year=2019&amp;title=Icariin%20Prevents%20Diabetes-Induced%20Bone%20Loss%20in%20Rats%20by%20Reducing%20Blood%20Glucose%20and%20Suppressing%20Bone%20Turnover&amp;journal=Molecules&amp;volume=24&amp;pages=1871-85\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B31\" id=\"B31\"\u003E\u003C\u002Fa\u003E 31. Singhal V, Bredella MA. Marrow Adipose Tissue Imaging in Humans. \u003Ci\u003EBone\u003C\u002Fi\u003E (2019) 54:69&#x2013;76. doi: 10.1016\u002Fj.bone.2018.01.009\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.bone.2018.01.009\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=V+Singhal&amp;author=MA+Bredella&amp;publication_year=2019&amp;title=Marrow%20Adipose%20Tissue%20Imaging%20in%20Humans&amp;journal=Bone&amp;volume=54&amp;pages=69\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B32\" id=\"B32\"\u003E\u003C\u002Fa\u003E 32. Kim TY, Schafer AL. Diabetes and Bone Marrow Adiposity. \u003Ci\u003ECurr Osteoporos Rep\u003C\u002Fi\u003E (2016) 14:337&#x2013;44. doi: 10.1007\u002Fs11914-016-0336-x\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F27714580\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1007\u002Fs11914-016-0336-x\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=TY+Kim&amp;author=AL+Schafer&amp;publication_year=2016&amp;title=Diabetes%20and%20Bone%20Marrow%20Adiposity&amp;journal=Curr+Osteoporos+Rep&amp;volume=14&amp;pages=337-44\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B33\" id=\"B33\"\u003E\u003C\u002Fa\u003E 33. Coe LM, Irwin R, Lippner D, McCabe LR. The Bone Marrow Microenvironment Contributes to Type I Diabetes Induced Osteoblast Death. \u003Ci\u003EJ Cell Physiol\u003C\u002Fi\u003E (2011) 22:477&#x2013;83. doi: 10.1002\u002Fjcp.22357\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1002\u002Fjcp.22357\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=LM+Coe&amp;author=R+Irwin&amp;author=D+Lippner&amp;author=LR+McCabe&amp;publication_year=2011&amp;title=The%20Bone%20Marrow%20Microenvironment%20Contributes%20to%20Type%20I%20Diabetes%20Induced%20Osteoblast%20Death&amp;journal=J+Cell+Physiol&amp;volume=22&amp;pages=477-83\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B34\" id=\"B34\"\u003E\u003C\u002Fa\u003E 34. Cassidy FC, Shortiss C, Murphy CG, Kearns SR, Curtin W, De BC, et al. Impact of Type 2 Diabetes Mellitus on Human Bone Marrow Stromal Cell Number and Phenotypic Characteristics. \u003Ci\u003EInt J Mol Sci\u003C\u002Fi\u003E (2020) 21:2476&#x2013;86. doi: 10.3390\u002Fijms21072476\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3390\u002Fijms21072476\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=FC+Cassidy&amp;author=C+Shortiss&amp;author=CG+Murphy&amp;author=SR+Kearns&amp;author=W+Curtin&amp;author=BC+De&amp;publication_year=2020&amp;title=Impact%20of%20Type%202%20Diabetes%20Mellitus%20on%20Human%20Bone%20Marrow%20Stromal%20Cell%20Number%20and%20Phenotypic%20Characteristics&amp;journal=Int+J+Mol+Sci&amp;volume=21&amp;pages=2476-86\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B35\" id=\"B35\"\u003E\u003C\u002Fa\u003E 35. Qi SS, He J, Zheng HX, Chen C, Jiang H. Zinc Supplementation Increased Bone Mineral Density, Improves Bone Histomorphology, and Prevents Bone Loss in Diabetic Rat. \u003Ci\u003EBiol Trace Elem Res\u003C\u002Fi\u003E (2020) 19:493&#x2013;501. doi: 10.1007\u002Fs12011-019-01810-7\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1007\u002Fs12011-019-01810-7\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=SS+Qi&amp;author=J+He&amp;author=HX+Zheng&amp;author=C+Chen&amp;author=H+Jiang&amp;publication_year=2020&amp;title=Zinc%20Supplementation%20Increased%20Bone%20Mineral%20Density%2C%20Improves%20Bone%20Histomorphology%2C%20and%20Prevents%20Bone%20Loss%20in%20Diabetic%20Rat&amp;journal=Biol+Trace+Elem+Res&amp;volume=19&amp;pages=493\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B36\" id=\"B36\"\u003E\u003C\u002Fa\u003E 36. Kalaitzoglou E, Fowlkes JL, Popescu I, Thrailkill KM. Diabetes Pharmacotherapy and Effects on the Musculoskeletal System. \u003Ci\u003EDiabetes-Metab Res\u003C\u002Fi\u003E (2019) 35:e3100. doi: 10.1002\u002Fdmrr.3100\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1002\u002Fdmrr.3100\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=E+Kalaitzoglou&amp;author=JL+Fowlkes&amp;author=I+Popescu&amp;author=KM+Thrailkill&amp;publication_year=2019&amp;title=Diabetes%20Pharmacotherapy%20and%20Effects%20on%20the%20Musculoskeletal%20System&amp;journal=Diabetes-Metab+Res&amp;volume=35&amp;pages=e3100\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B37\" id=\"B37\"\u003E\u003C\u002Fa\u003E 37. Taylor GS, Moser O, Smith K, Shaw A, Tang JCY, Fraser WD, et al. Bone Turnover and Metabolite Responses to Exercise in People With and Without Long-Duration Type 1 Diabetes: A Case-Control Study. \u003Ci\u003EBMJ Open Diabetes Res CA\u003C\u002Fi\u003E (2020) 8:e001779. doi: 10.1136\u002Fbmjdrc-2020-001779\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1136\u002Fbmjdrc-2020-001779\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=GS+Taylor&amp;author=O+Moser&amp;author=K+Smith&amp;author=A+Shaw&amp;author=JCY+Tang&amp;author=WD+Fraser&amp;publication_year=2020&amp;title=Bone%20Turnover%20and%20Metabolite%20Responses%20to%20Exercise%20in%20People%20With%20and%20Without%20Long-Duration%20Type%201%20Diabetes%3A%20A%20Case-Control%20Study&amp;journal=BMJ+Open+Diabetes+Res+CA&amp;volume=8&amp;pages=e001779\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B38\" id=\"B38\"\u003E\u003C\u002Fa\u003E 38. Mederle OA, Balas M, Ioanoviciu SD, Gurban CV, Tudor ABorza C. Correlations Between Bone Turnover Markers, Serum Magnesium and Bone Mass Densityin Postmenopausal Osteoporosis. \u003Ci\u003EClin Interv Aging\u003C\u002Fi\u003E (2018) 13:1383&#x2013;9. doi: 10.2147\u002FCIA.S170111\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F30122910\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.2147\u002FCIA.S170111\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=OA+Mederle&amp;author=M+Balas&amp;author=SD+Ioanoviciu&amp;author=CV+Gurban&amp;author=C+Tudor%20ABorza&amp;publication_year=2018&amp;title=Correlations%20Between%20Bone%20Turnover%20Markers%2C%20Serum%20Magnesium%20and%20Bone%20Mass%20Densityin%20Postmenopausal%20Osteoporosis&amp;journal=Clin+Interv+Aging&amp;volume=13&amp;pages=1383-9\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B39\" id=\"B39\"\u003E\u003C\u002Fa\u003E 39. Lorentzon M, Branco J, Brandi ML, Bruy&#xe8;re O, Chapurlat R, Cooper C, et al. Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis. \u003Ci\u003EAdv Ther\u003C\u002Fi\u003E (2019) 36:2811&#x2013;24. doi: 10.1007\u002Fs12325-019-01063-9\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F31440982\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1007\u002Fs12325-019-01063-9\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=M+Lorentzon&amp;author=J+Branco&amp;author=ML+Brandi&amp;author=O+Bruy%C3%A8re&amp;author=R+Chapurlat&amp;author=C+Cooper&amp;publication_year=2019&amp;title=Algorithm%20for%20the%20Use%20of%20Biochemical%20Markers%20of%20Bone%20Turnover%20in%20the%20Diagnosis%2C%20Assessment%20and%20Follow-Up%20of%20Treatment%20for%20Osteoporosis&amp;journal=Adv+Ther&amp;volume=36&amp;pages=2811-24\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B40\" id=\"B40\"\u003E\u003C\u002Fa\u003E 40. Zhao Y, Wang HL, Li TT, Yang F, Tzeng CM. Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK\u002FRANKL\u002FOPG Signaling Pathway. \u003Ci\u003EDrug Des Dev Ther\u003C\u002Fi\u003E (2020) 14:195&#x2013;206. doi: 10.2147\u002FDDDT.S225516\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.2147\u002FDDDT.S225516\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=Y+Zhao&amp;author=HL+Wang&amp;author=TT+Li&amp;author=F+Yang&amp;author=CM+Tzeng&amp;publication_year=2020&amp;title=Baicalin%20Ameliorates%20Dexamethasone-Induced%20Osteoporosis%20by%20Regulation%20of%20the%20RANK%2FRANKL%2FOPG%20Signaling%20Pathway&amp;journal=Drug+Des+Dev+Ther&amp;volume=14&amp;pages=195\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B41\" id=\"B41\"\u003E\u003C\u002Fa\u003E 41. Mo H, Zhang N, Li H, Li F, Pu R. Beneficial Effects of Cuscuta Chinensis Extract on Glucocorticoid-Induced Osteoporosis Through Modulation of RANKL\u002FOPG Signals. \u003Ci\u003EBraz J Med Biol Res\u003C\u002Fi\u003E (2019) 52:e8754. doi: 10.1590\u002F1414-431x20198754\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F31826180\u002F\" target=\"_blank\"\u003EPubMed Abstract\u003C\u002Fa\u003E | \u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1590\u002F1414-431x20198754\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=H+Mo&amp;author=N+Zhang&amp;author=H+Li&amp;author=F+Li&amp;author=R+Pu&amp;publication_year=2019&amp;title=Beneficial%20Effects%20of%20Cuscuta%20Chinensis%20Extract%20on%20Glucocorticoid-Induced%20Osteoporosis%20Through%20Modulation%20of%20RANKL%2FOPG%20Signals&amp;journal=Braz+J+Med+Biol+Res&amp;volume=52&amp;pages=e8754\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B42\" id=\"B42\"\u003E\u003C\u002Fa\u003E 42. Noh JY, Yang Y, Jung H. Molecular Mechanisms and Emerging Therapeutics for Osteoporosis. \u003Ci\u003EInt J Mol Sci\u003C\u002Fi\u003E (2020) 21:7623. doi: 10.3390\u002Fijms21207623\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3390\u002Fijms21207623\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=JY+Noh&amp;author=Y+Yang&amp;author=H+Jung&amp;publication_year=2020&amp;title=Molecular%20Mechanisms%20and%20Emerging%20Therapeutics%20for%20Osteoporosis&amp;journal=Int+J+Mol+Sci&amp;volume=21&amp;pages=7623\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B43\" id=\"B43\"\u003E\u003C\u002Fa\u003E 43. Azizieh FY, Shehab D, Jarallah KA, Gupta R, Raghupathy R. Circulatory Levels of RANKL, OPG, and Oxidative Stress Markers in Postmenopausal Women With Normal or Low Bone Mineral Density. \u003Ci\u003EBiomark Insights\u003C\u002Fi\u003E (2019) 14:1&#x2013;7. doi: 10.1177\u002F1177271919843825\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1177\u002F1177271919843825\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=FY+Azizieh&amp;author=D+Shehab&amp;author=KA+Jarallah&amp;author=R+Gupta&amp;author=R+Raghupathy&amp;publication_year=2019&amp;title=Circulatory%20Levels%20of%20RANKL%2C%20OPG%2C%20and%20Oxidative%20Stress%20Markers%20in%20Postmenopausal%20Women%20With%20Normal%20or%20Low%20Bone%20Mineral%20Density&amp;journal=Biomark+Insights&amp;volume=14&amp;pages=1\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B44\" id=\"B44\"\u003E\u003C\u002Fa\u003E 44. Zheng HX, Qi SS, Chen C. Salidroside Improves Bone Histomorphology and Prevents Bone Loss in Ovariectomized Diabetic Rats by Upregulating the OPG\u002FRANKL Ratio. \u003Ci\u003EMolecules\u003C\u002Fi\u003E (2018) 23:2398&#x2013;8. doi: 10.3390\u002Fmolecules23092398\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3390\u002Fmolecules23092398\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=HX+Zheng&amp;author=SS+Qi&amp;author=C+Chen&amp;publication_year=2018&amp;title=Salidroside%20Improves%20Bone%20Histomorphology%20and%20Prevents%20Bone%20Loss%20in%20Ovariectomized%20Diabetic%20Rats%20by%20Upregulating%20the%20OPG%2FRANKL%20Ratio&amp;journal=Molecules&amp;volume=23&amp;pages=2398-8\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B45\" id=\"B45\"\u003E\u003C\u002Fa\u003E 45. Hostalek U, Gwilt M, Hildemann S. Therapeutic Use of Metformin inPrediabetes and Diabetes. \u003Ci\u003EPrevention Drugs\u003C\u002Fi\u003E (2015) 75:1071&#x2013;94. doi: 10.1007\u002Fs40265-015-0416-8\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1007\u002Fs40265-015-0416-8\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=U+Hostalek&amp;author=M+Gwilt&amp;author=S+Hildemann&amp;publication_year=2015&amp;title=Therapeutic%20Use%20of%20Metformin%20inPrediabetes%20and%20Diabetes&amp;journal=Prevention+Drugs&amp;volume=75&amp;pages=1071-94\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B46\" id=\"B46\"\u003E\u003C\u002Fa\u003E 46. Elbere I, Kalnina I, Silamikelis I, Konrade I, Zaharenko L, Sekace K, et al. Association of Metformin Administration With Gut Microbiome Dysbiosis in Healthy Volunteers. \u003Ci\u003EPloS One\u003C\u002Fi\u003E (2018) 9:e0204317. doi: 10.1371\u002Fjournal.pone.0204317\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1371\u002Fjournal.pone.0204317\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=I+Elbere&amp;author=I+Kalnina&amp;author=I+Silamikelis&amp;author=I+Konrade&amp;author=L+Zaharenko&amp;author=K+Sekace&amp;publication_year=2018&amp;title=Association%20of%20Metformin%20Administration%20With%20Gut%20Microbiome%20Dysbiosis%20in%20Healthy%20Volunteers&amp;journal=PloS+One&amp;volume=9&amp;pages=e0204317\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B47\" id=\"B47\"\u003E\u003C\u002Fa\u003E 47. Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, et al. Diabetes Prevention Program Research Group. Long-Term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. \u003Ci\u003EJ Clin Endocrinol Metab\u003C\u002Fi\u003E (2016) 4:1754&#x2013;61. doi: 10.1210\u002Fjc.2015-3754\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.1210\u002Fjc.2015-3754\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=VR+Aroda&amp;author=SL+Edelstein&amp;author=RB+Goldberg&amp;author=WC+Knowler&amp;author=SM+Marcovina&amp;author=TJ+Orchard&amp;publication_year=2016&amp;title=Diabetes%20Prevention%20Program%20Research%20Group.%20Long-Term%20Metformin%20Use%20and%20Vitamin%20B12%20Deficiency%20in%20the%20Diabetes%20Prevention%20Program%20Outcomes%20Study&amp;journal=J+Clin+Endocrinol+Metab&amp;volume=4&amp;pages=1754-61\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\"\u003E\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\"\u003E\u003Ca name=\"B48\" id=\"B48\"\u003E\u003C\u002Fa\u003E 48. Owen MD, Baker BC, Scott EM, Forbes K. Interaction Between Metformin, Folate and Vitamin B12 and the Potential Impact on Fetal Growth and Long-Term Metabolic Health in Diabetic Pregnancies. \u003Ci\u003EInt J Mol Sci\u003C\u002Fi\u003E (2021) 11:5759&#x2013;70. doi: 10.3390\u002Fijms22115759\u003C\u002Fp\u003E\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:1em;\"\u003E\u003Ca href=\"https:\u002F\u002Fdoi.org\u002F10.3390\u002Fijms22115759\" target=\"_blank\"\u003ECrossRef Full Text\u003C\u002Fa\u003E | \u003Ca href=\"http:\u002F\u002Fscholar.google.com\u002Fscholar_lookup?author=MD+Owen&amp;author=BC+Baker&amp;author=EM+Scott&amp;author=K+Forbes&amp;publication_year=2021&amp;title=Interaction%20Between%20Metformin%2C%20Folate%20and%20Vitamin%20B12%20and%20the%20Potential%20Impact%20on%20Fetal%20Growth%20and%20Long-Term%20Metabolic%20Health%20in%20Diabetic%20Pregnancies&amp;journal=Int+J+Mol+Sci&amp;volume=11&amp;pages=5759-70\" target=\"_blank\"\u003EGoogle Scholar\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003C\u002Fdiv\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"thinLineM20\"\u003E\u003C\u002Fdiv\u003E\u003Cdiv class=\"AbstractSummary\"\u003E\u003Cp\u003E\u003Cspan\u003EKeywords:\u003C\u002Fspan\u003E chondroitin sulfate, diabetes, osteoporosis, bone microstructure, bone metabolism\u003C\u002Fp\u003E\u003Cp\u003E\u003Cspan\u003ECitation:\u003C\u002Fspan\u003E Qi SS, Shao ML, Sun Z, Chen SM, Hu YJ, Li XS, Chen DJ, Zheng HX and Yue TL (2021) Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure \u003Ci\u003Evia\u003C\u002Fi\u003E Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism. \u003Ci\u003EFront. Endocrinol.\u003C\u002Fi\u003E 12:759843. doi: 10.3389\u002Ffendo.2021.759843\u003C\u002Fp\u003E\u003Cp id=\"timestamps\"\u003E\u003Cspan\u003EReceived:\u003C\u002Fspan\u003E 17 August 2021; \u003Cspan\u003EAccepted:\u003C\u002Fspan\u003E 29 September 2021;\u003Cbr\u003E\u003Cspan\u003EPublished:\u003C\u002Fspan\u003E 27 October 2021.\u003C\u002Fp\u003E\u003Cdiv\u003E\u003Cp\u003EEdited by:\u003C\u002Fp\u003E\u003Ca href=\"https:\u002F\u002Floop.frontiersin.org\u002Fpeople\u002F42129\"\u003EPeter Vestergaard\u003C\u002Fa\u003E, Aalborg University Hospital, Denmark\u003C\u002Fdiv\u003E\u003Cdiv\u003E\u003Cp\u003EReviewed by:\u003C\u002Fp\u003E\u003Ca href=\"https:\u002F\u002Floop.frontiersin.org\u002Fpeople\u002F742646\"\u003EGanesan Ramamoorthi\u003C\u002Fa\u003E, Moffitt Cancer Center, United States\u003Cbr\u003E\u003Ca href=\"https:\u002F\u002Floop.frontiersin.org\u002Fpeople\u002F663338\"\u003EYaguang Li\u003C\u002Fa\u003E, Central South University, China\u003Cbr\u003E\u003Ca href=\"https:\u002F\u002Floop.frontiersin.org\u002Fpeople\u002F1423801\"\u003EChen Chen\u003C\u002Fa\u003E, Shaanxi University of Science and Technology, China\u003C\u002Fdiv\u003E\u003Cp\u003E\u003Cspan\u003ECopyright\u003C\u002Fspan\u003E &#xa9; 2021 Qi, Shao, Sun, Chen, Hu, Li, Chen, Zheng and Yue. This is an open-access article distributed under the terms of the \u003Ca rel=\"license\" href=\"http:\u002F\u002Fcreativecommons.org\u002Flicenses\u002Fby\u002F4.0\u002F\" target=\"_blank\"\u003ECreative Commons Attribution License (CC BY)\u003C\u002Fa\u003E. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\u003C\u002Fp\u003E\u003Cp\u003E\u003Cspan\u003E*Correspondence:\u003C\u002Fspan\u003E Tian Li Yue, \u003Ca id=\"encmail\"\u003EeXVldGxAbndhZnUuZWR1LmNu\u003C\u002Fa\u003E; Hong Xing Zheng, \u003Ca id=\"encmail\"\u003Eemhlbmdob25neGluZ0BzbnV0LmVkdS5jbg==\u003C\u002Fa\u003E; De Jing Chen, \u003Ca id=\"encmail\"\u003EY2Rqc2xnQDEyNi5jb20=\u003C\u002Fa\u003E\u003C\u002Fp\u003E\u003Cdiv class=\"clear\"\u003E\u003C\u002Fdiv\u003E\u003C\u002Fdiv\u003E",menuHtml:"\u003Cul class=\"flyoutJournal\"\u003E\u003Cli\u003E\u003Ca href=\"#h1\"\u003EAbstract\u003C\u002Fa\u003E\u003C\u002Fli\u003E\u003Cli\u003E\u003Ca href=\"#h2\"\u003EIntroduction\u003C\u002Fa\u003E\u003C\u002Fli\u003E\u003Cli\u003E\u003Ca href=\"#h3\"\u003EMaterials and Methods\u003C\u002Fa\u003E\u003C\u002Fli\u003E\u003Cli\u003E\u003Ca href=\"#h4\"\u003EResults\u003C\u002Fa\u003E\u003C\u002Fli\u003E\u003Cli\u003E\u003Ca href=\"#h5\"\u003EDiscussion\u003C\u002Fa\u003E\u003C\u002Fli\u003E\u003Cli\u003E\u003Ca href=\"#h6\"\u003EData Availability Statement\u003C\u002Fa\u003E\u003C\u002Fli\u003E\u003Cli\u003E\u003Ca href=\"#h7\"\u003EEthics Statement\u003C\u002Fa\u003E\u003C\u002Fli\u003E\u003Cli\u003E\u003Ca href=\"#h8\"\u003EAuthor Contributions\u003C\u002Fa\u003E\u003C\u002Fli\u003E\u003Cli\u003E\u003Ca href=\"#h9\"\u003EFunding\u003C\u002Fa\u003E\u003C\u002Fli\u003E\u003Cli\u003E\u003Ca href=\"#h10\"\u003EConflict of Interest\u003C\u002Fa\u003E\u003C\u002Fli\u003E\u003Cli\u003E\u003Ca href=\"#h11\"\u003EPublisher&#x2019;s Note\u003C\u002Fa\u003E\u003C\u002Fli\u003E\u003Cli\u003E\u003Ca href=\"#h12\"\u003EReferences\u003C\u002Fa\u003E\u003C\u002Fli\u003E\u003C\u002Ful\u003E"},files:[{name:"EPUB.epub",fileServerPackageEntryId:e,type:{code:aH,name:aH}},{name:R,fileServerPackageEntryId:R,type:{code:v,name:v}},{name:R,fileServerPackageEntryId:e,type:{code:v,name:v}},{name:aI,fileServerPackageEntryId:aI,type:{code:"NLM_XML",name:"XML"}},{name:"Provisional PDF.pdf",fileServerPackageEntryId:e,type:{code:v,name:v}}]},currentArticlePageMetaInfo:{title:aJ,link:[{rel:"canonical",href:aK}],meta:[{hid:C,property:C,name:C,content:aL},{hid:aM,property:aM,name:"title",content:aJ},{hid:aN,property:aN,name:C,content:aL},{hid:aO,name:aO,content:"chondroitin sulfate,diabetes,Osteoporosis,Bone microstructure,bone metabolism"},{hid:aP,property:aP,name:"site_name",content:D},{hid:aQ,property:aQ,name:J,content:"https:\u002F\u002Fimages-provider.frontiersin.org\u002Fapi\u002Fipx\u002Fw=1200&f=png\u002Fhttps:\u002F\u002Fwww.frontiersin.org\u002Ffiles\u002FArticles\u002F759843\u002Ffendo-12-759843-HTML\u002Fimage_m\u002Ffendo-12-759843-g001.jpg"},{hid:aR,property:aR,name:"type",content:"article"},{hid:aS,property:aS,name:"url",content:aK},{hid:aT,name:aT,content:"summary_large_image"},{hid:aU,name:aU,content:"12"},{hid:aV,name:aV,content:t},{hid:aW,name:aW,content:D},{hid:aX,name:aX,content:L},{hid:aY,name:aY,content:M},{hid:aZ,name:aZ,content:af},{hid:a_,name:a_,content:"759843"},{hid:a$,name:a$,content:"English"},{hid:ba,name:ba,content:ag},{hid:bb,name:bb,content:"chondroitin sulfate; diabetes; Osteoporosis; Bone microstructure; bone metabolism"},{hid:bc,name:bc,content:ah},{hid:bd,name:bd,content:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Farticles\u002F10.3389\u002Ffendo.2021.759843\u002Fpdf"},{hid:be,name:be,content:"2021\u002F09\u002F29"},{hid:bf,name:bf,content:"2021\u002F10\u002F27"},{hid:"citation_author_0",name:o,content:"Qi, Shan Shan"},{hid:"citation_author_institution_0",name:p,content:bg},{hid:"citation_author_1",name:o,content:"Shao, Meng Li"},{hid:"citation_author_institution_1",name:p,content:s},{hid:"citation_author_2",name:o,content:"Sun, Ze"},{hid:"citation_author_institution_2",name:p,content:s},{hid:"citation_author_3",name:o,content:"Chen, Si Min"},{hid:"citation_author_institution_3",name:p,content:s},{hid:"citation_author_4",name:o,content:"Hu, Ying Jun"},{hid:"citation_author_institution_4",name:p,content:s},{hid:"citation_author_5",name:o,content:"Li, Xin Sheng"},{hid:"citation_author_institution_5",name:p,content:s},{hid:"citation_author_6",name:o,content:"Chen, De Jing"},{hid:"citation_author_institution_6",name:p,content:s},{hid:"citation_author_7",name:o,content:"Zheng, Hong Xing"},{hid:"citation_author_institution_7",name:p,content:s},{hid:"citation_author_8",name:o,content:"Yue, Tian Li"},{hid:"citation_author_institution_8",name:p,content:bg},{hid:bh,name:bh,content:"doi:10.3389\u002Ffendo.2021.759843"}],script:[{src:"https:\u002F\u002Fcdnjs.cloudflare.com\u002Fpolyfill\u002Fv3\u002Fpolyfill.min.js?features=es6",body:h,async:h},{src:"https:\u002F\u002Fcdnjs.cloudflare.com\u002Fajax\u002Flibs\u002Fmathjax\u002F2.7.1\u002FMathJax.js?config=TeX-MML-AM_CHTML",body:h,async:h},{src:"https:\u002F\u002Fd1bxh8uas1mnw7.cloudfront.net\u002Fassets\u002Faltmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",body:h,async:h},{src:"https:\u002F\u002Fapi.altmetric.com\u002Fv1\u002Fdoi\u002F10.3389\u002Ffendo.2021.759843?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",body:h,async:h},{src:"https:\u002F\u002Fcrossmark-cdn.crossref.org\u002Fwidget\u002Fv2.0\u002Fwidget.js",body:h,async:h}]},articleHubArticlesList:[],showCrossmarkWidget:h,hasSupplementalData:m,isPreviewArticlePage:m,settingsFeaturesSwitchers:{displayTitlePillLabels:h,displayRelatedArticlesBox:h,showEditors:h,showReviewers:h,showLoopImpactLink:h,enableFigshare:m},tenantConfig:{spaceId:c,name:D,availableJournalPages:[bi,bj,bk,"volumes","about"],announcement:{sys:{id:"2tE5oIdYfULBQILAgR2OSx",__typename:"Sys"},preHeader:"Research integrity at Frontiers",title:"94% of researchers rate our articles as excellent or good",description:"Learn more about the work of our research integrity team to safeguard the quality of each article we publish.",image:[{id:"0B4B1380-42EB-4FD5-9D7E2DBC603E79F8",src:bl,name:bm,tags:["ultra","sunset","achieving","summer","challenge","winning","extreme","workout","hike","path","action","uphill","effort","athlete","physical","height","activity","mountaineering","endurance","mount","runner","nordic","race","male","achieve","nature","run","adventure",K,"perseverance","freedom","fitness","backcountry","altitude","sports","man","hill","mountain","outdoor","exercise","energetic","trail","climb","skyrunning","lifestyle"],type:J,width:7100,height:4733,archive:i,brandId:$,limited:i,fileSize:16838862,isPublic:i,original:f,copyright:f,extension:[aa],thumbnails:{mini:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F0B4B1380-42EB-4FD5-9D7E2DBC603E79F8\u002Fmini-C4875379-1478-416F-B03DF68FE3D8DBB5.png",thul:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F0B4B1380-42EB-4FD5-9D7E2DBC603E79F8\u002Fthul-C4875379-1478-416F-B03DF68FE3D8DBB5.png",webimage:bl,Guidelines:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F0B4B1380-42EB-4FD5-9D7E2DBC603E79F8\u002FGuidelines-C4875379-1478-416F-B03DF68FE3D8DBB5.png",WebsiteJpg_XL:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F0B4B1380-42EB-4FD5-9D7E2DBC603E79F8\u002FWebsiteJpg_XL-C4875379-1478-416F-B03DF68FE3D8DBB5.jpg",WebsiteWebP_L:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F0B4B1380-42EB-4FD5-9D7E2DBC603E79F8\u002FWebsiteWebP_L-C4875379-1478-416F-B03DF68FE3D8DBB5.webp",WebsiteWebP_M:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F0B4B1380-42EB-4FD5-9D7E2DBC603E79F8\u002FWebsiteWebP_M-C4875379-1478-416F-B03DF68FE3D8DBB5.webp",WebsiteWebP_XL:"https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F0B4B1380-42EB-4FD5-9D7E2DBC603E79F8\u002FWebsiteWebP_XL-C4875379-1478-416F-B03DF68FE3D8DBB5.webp"},dateCreated:"2022-12-14T15:44:00Z",description:bm,orientation:K,watermarked:i,dateModified:"2023-01-26T09:08:47Z",datePublished:"2022-12-14T16:40:06Z",videoPreviewURLs:[],textMetaproperties:[]}],link:{text:"Find out more ",url:bn,target:g,ariaLabel:"About our research integrity team",__typename:z},__typename:"Announcement"}},components:{ibar:{tenantLogo:e,journalLogo:e,aboutUs:[{title:"Who we are",links:[{text:"Mission and values",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fmission",target:g,ariaLabel:f},{text:"History",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fhistory",target:g,ariaLabel:f},{text:"Leadership",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fleadership",target:g,ariaLabel:f},{text:"Awards",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fawards",target:g,ariaLabel:f}]},{title:"Impact and progress",links:[{text:"Frontiers' impact",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fimpact",target:g,ariaLabel:f},{text:"Progress Report 2022",url:"https:\u002F\u002Fprogressreport.frontiersin.org\u002F?utm_source=fweb&utm_medium=frep&utm_campaign=pr20",target:n,ariaLabel:f},{text:"All progress reports",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fprogress-reports",target:g,ariaLabel:f}]},{title:"Publishing model",links:[{text:bo,url:bp,target:g,ariaLabel:f},{text:"Open access",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fopen-access",target:g,ariaLabel:f},{text:bq,url:br,target:g,ariaLabel:f},{text:"Peer review",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fpeer-review",target:g,ariaLabel:f},{text:"Research integrity",url:bn,target:g,ariaLabel:f},{text:bs,url:"https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fresearch-topics",target:g,ariaLabel:f}]},{title:"Services",links:[{text:"Societies",url:"https:\u002F\u002Fpublishingpartnerships.frontiersin.org\u002F",target:n,ariaLabel:f},{text:"National consortia",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fopen-access-agreements\u002Fconsortia",target:g,ariaLabel:f},{text:"Institutional partnerships",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fopen-access-agreements",target:g,ariaLabel:f},{text:"Collaborators",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fcollaborators",target:g,ariaLabel:f}]},{title:"More from Frontiers",links:[{text:"Frontiers Forum",url:bt,target:n,ariaLabel:"this link will take you to the Frontiers Forum website"},{text:bu,url:bv,target:n,ariaLabel:bw},{text:"Press office",url:"https:\u002F\u002Fpressoffice.frontiersin.org\u002F",target:n,ariaLabel:"this link will take you to the Frontiers press office website"},{text:"Sustainability",url:"https:\u002F\u002Fwww.frontiersin.orgabout\u002Fsustainability",target:g,ariaLabel:"link to information about Frontiers' sustainability"},{text:bx,url:by,target:n,ariaLabel:"this link will take you to the Frontiers careers website"},{text:"Contact us",url:bz,target:g,ariaLabel:"this link will take you to the help pages to contact our support team"}]}],submitUrl:"https:\u002F\u002Fwww.frontiersin.org\u002Fsubmission\u002Fsubmit?domainid=2&fieldid=23&specialtyid=0&entitytype=2&entityid=106",showSubmitButton:h,journal:{id:x,name:t,slug:u,sections:[{id:2258,name:"Adrenal Endocrinology",slug:"adrenal-endocrinology"},{id:457,name:"Bone Research",slug:"bone-research"},{id:116,name:"Cancer Endocrinology",slug:"cancer-endocrinology"},{id:2259,name:"Cardiovascular Endocrinology",slug:"cardiovascular-endocrinology"},{id:120,name:"Cellular Endocrinology",slug:"cellular-endocrinology"},{id:aE,name:aF,slug:aG},{id:2261,name:"Developmental Endocrinology",slug:"developmental-endocrinology"},{id:1548,name:"Diabetes: Molecular Mechanisms",slug:"diabetes-molecular-mechanisms"},{id:127,name:"Endocrinology of Aging",slug:"endocrinology-of-aging"},{id:121,name:"Experimental Endocrinology",slug:"experimental-endocrinology"},{id:1770,name:"Gut Endocrinology",slug:"gut-endocrinology"},{id:118,name:"Molecular and Structural Endocrinology",slug:"molecular-and-structural-endocrinology"},{id:113,name:"Neuroendocrine Science",slug:"neuroendocrine-science"},{id:458,name:"Obesity",slug:"obesity"},{id:124,name:"Pediatric Endocrinology",slug:"pediatric-endocrinology"},{id:112,name:"Pituitary Endocrinology",slug:"pituitary-endocrinology"},{id:2257,name:"Renal Endocrinology",slug:"renal-endocrinology"},{id:126,name:"Reproduction",slug:"reproduction"},{id:117,name:"Systems Endocrinology",slug:"systems-endocrinology"},{id:128,name:"Thyroid Endocrinology",slug:"thyroid-endocrinology"},{id:122,name:"Translational and Clinical Endocrinology",slug:"translational-and-clinical-endocrinology"}]},sectionTerm:"Sections",aboutJournal:[{title:"Scope",links:[{text:"Field chief editors",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Fabout#about-editors",target:g,ariaLabel:f},{text:"Mission & scope",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Fabout#about-scope",target:g,ariaLabel:f},{text:"Facts",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Fabout#about-facts",target:g,ariaLabel:f},{text:"Journal sections",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Fabout#about-submission",target:g,ariaLabel:f},{text:"Open access statement",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Fabout#about-open",target:g,ariaLabel:f},{text:"Copyright statement",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Fabout#copyright-statement",target:g,ariaLabel:f},{text:"Quality",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Fabout#about-quality",target:g,ariaLabel:f}]},{title:"For authors",links:[{text:"Why submit?",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Ffor-authors\u002Fwhy-submit",target:g,ariaLabel:f},{text:"Article types",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Ffor-authors\u002Farticle-types",target:g,ariaLabel:f},{text:bA,url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Ffor-authors\u002Fauthor-guidelines",target:g,ariaLabel:f},{text:bB,url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Ffor-authors\u002Feditor-guidelines",target:g,ariaLabel:f},{text:"Publishing fees",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Ffor-authors\u002Fpublishing-fees",target:g,ariaLabel:f},{text:"Submission checklist",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Ffor-authors\u002Fsubmission-checklist",target:g,ariaLabel:f},{text:"Contact editorial office",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Ffor-authors\u002Fcontact-editorial-office",target:g,ariaLabel:f}]}],mainLinks:[{text:"All journals",url:bC,target:g,ariaLabel:f},{text:"All articles",url:bD,target:g,ariaLabel:f}],journalLinks:[{text:bE,url:bi,target:g,ariaLabel:f},{text:bs,url:bk,target:g,ariaLabel:f},{text:"Editorial board",url:bj,target:g,ariaLabel:f}],helpCenterLink:{text:E,url:bF,target:n,ariaLabel:E}},footer:{blocks:[{title:"Guidelines",links:[{text:bA,url:"https:\u002F\u002Fwww.frontiersin.org\u002Fguidelines\u002Fauthor-guidelines",target:g,ariaLabel:f},{text:bB,url:"https:\u002F\u002Fwww.frontiersin.org\u002Fguidelines\u002Feditor-guidelines",target:g,ariaLabel:f},{text:"Policies and publication ethics",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fguidelines\u002Fpolicies-and-publication-ethics",target:g,ariaLabel:f},{text:bq,url:br,target:g,ariaLabel:f}]},{title:"Explore",links:[{text:bE,url:bD,target:g,ariaLabel:f},{text:"Research Topics ",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fresearch-topics",target:g,ariaLabel:f},{text:"Journals",url:bC,target:g,ariaLabel:f},{text:bo,url:bp,target:g,ariaLabel:f}]},{title:"Outreach",links:[{text:"Frontiers Forum ",url:bt,target:n,ariaLabel:"Frontiers Forum website"},{text:"Frontiers Policy Labs ",url:"https:\u002F\u002Fpolicylabs.frontiersin.org\u002F",target:n,ariaLabel:f},{text:bG,url:"https:\u002F\u002Fkids.frontiersin.org\u002F",target:n,ariaLabel:"Frontiers for Young Minds journal"},{text:bu,url:bv,target:n,ariaLabel:bw}]},{title:"Connect",links:[{text:E,url:bF,target:n,ariaLabel:E},{text:"Emails and alerts ",url:"https:\u002F\u002Floop.frontiersin.org\u002Fsettings\u002Femail-preferences?a=publishers",target:n,ariaLabel:"Subscribe to Frontiers emails"},{text:"Contact us ",url:bz,target:g,ariaLabel:"Subscribe to newsletter"},{text:"Submit",url:"https:\u002F\u002Fwww.frontiersin.org\u002Fsubmission\u002Fsubmit",target:g,ariaLabel:f},{text:bx,url:by,target:n,ariaLabel:f}]}],socialLinks:[{link:{text:bH,url:"https:\u002F\u002Fwww.facebook.com\u002FFrontiersin",target:n,ariaLabel:bH},type:z,color:F,icon:"Facebook",size:G,hiddenText:h},{link:{text:"Frontiers Twitter",url:"https:\u002F\u002Ftwitter.com\u002Ffrontiersin",target:n,ariaLabel:f},type:z,color:F,icon:"Twitter",size:G,hiddenText:h},{link:{text:"Frontiers LinkedIn",url:"https:\u002F\u002Fwww.linkedin.com\u002Fcompany\u002Ffrontiers",target:n,ariaLabel:f},type:z,color:F,icon:"LinkedIn",size:G,hiddenText:h},{link:{text:"Frontiers Instagram",url:"https:\u002F\u002Fwww.instagram.com\u002Ffrontiersin_",target:n,ariaLabel:f},type:z,color:F,icon:"Instagram",size:G,hiddenText:h}],copyright:"Frontiers Media S.A. All rights reserved",termsAndConditionsUrl:"https:\u002F\u002Fwww.frontiersin.org\u002Flegal\u002Fterms-and-conditions",privacyPolicyUrl:"https:\u002F\u002Fwww.frontiersin.org\u002Flegal\u002Fprivacy-policy"},newsletterComponent:f,snackbarItems:[]},mainHeader:{title:e,image:N,breadcrumbs:[],linksCollection:{total:i,items:[]},metricsCollection:{total:i,items:[]}},user:{loggedUserInfo:N},journals:[{id:bI,name:bJ,slug:bK,abbreviation:bL,space:{id:j,domainName:l,__typename:b},__typename:a},{id:2445,name:bJ,slug:bK,abbreviation:bL,space:{id:c,domainName:d,__typename:b},__typename:a},{id:S,name:"Test SSPH Journal",slug:"test-ssph-journal",abbreviation:"testjournal",space:{id:w,domainName:H,__typename:b},__typename:a},{id:bM,name:"TEST ALF Journal",slug:"test-alf-journal",abbreviation:"talfj",space:{id:A,domainName:T,__typename:b},__typename:a},{id:j,name:bN,slug:bO,abbreviation:bP,space:{id:j,domainName:l,__typename:b},__typename:a},{id:2360,name:bN,slug:bO,abbreviation:bP,space:{id:c,domainName:d,__typename:b},__typename:a},{id:c,name:"Smoke Test Field",slug:"smoke-test-field",abbreviation:"FJST",space:{id:U,domainName:bQ,__typename:b},__typename:a},{id:bM,name:bR,slug:bS,abbreviation:bT,space:{id:w,domainName:H,__typename:b},__typename:a},{id:2077,name:bR,slug:bS,abbreviation:bT,space:{id:c,domainName:d,__typename:b},__typename:a},{id:S,name:bU,slug:bV,abbreviation:bW,space:{id:A,domainName:T,__typename:b},__typename:a},{id:S,name:bU,slug:bV,abbreviation:bW,space:{id:c,domainName:d,__typename:b},__typename:a},{id:bX,name:bY,slug:bZ,abbreviation:b_,space:{id:j,domainName:l,__typename:b},__typename:a},{id:3776,name:bY,slug:bZ,abbreviation:b_,space:{id:c,domainName:d,__typename:b},__typename:a},{id:O,name:b$,slug:ca,abbreviation:cb,space:{id:j,domainName:l,__typename:b},__typename:a},{id:3765,name:b$,slug:ca,abbreviation:cb,space:{id:c,domainName:d,__typename:b},__typename:a},{id:14,name:cc,slug:cd,abbreviation:ce,space:{id:j,domainName:l,__typename:b},__typename:a},{id:3414,name:cc,slug:cd,abbreviation:ce,space:{id:c,domainName:d,__typename:b},__typename:a},{id:20,name:cf,slug:cg,abbreviation:ch,space:{id:j,domainName:l,__typename:b},__typename:a},{id:3754,name:cf,slug:cg,abbreviation:ch,space:{id:c,domainName:d,__typename:b},__typename:a},{id:U,name:ci,slug:cj,abbreviation:ck,space:{id:j,domainName:l,__typename:b},__typename:a},{id:2444,name:ci,slug:cj,abbreviation:ck,space:{id:c,domainName:d,__typename:b},__typename:a},{id:cl,name:cm,slug:cn,abbreviation:co,space:{id:w,domainName:H,__typename:b},__typename:a},{id:cl,name:cm,slug:cn,abbreviation:co,space:{id:c,domainName:d,__typename:b},__typename:a},{id:j,name:"GSL Test",slug:"gsl-test",abbreviation:"gslt",space:{id:r,domainName:V,__typename:b},__typename:a},{id:2356,name:"Frontiers in the Internet of Things",slug:"the-internet-of-things",abbreviation:"friot",space:{id:c,domainName:d,__typename:b},__typename:a},{id:656,name:"Frontiers in Zoological Science",slug:"zoological-science",abbreviation:"fzoos",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1720,name:"Frontiers in Zoological Research",slug:"zoological-research",abbreviation:"fzolr",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3162,name:"Frontiers in Wound Care",slug:"wound-care",abbreviation:"fwoca",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3136,name:"Frontiers in Worm Science",slug:"worm-science",abbreviation:"fwors",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3583,name:"Frontiers in Wind Energy",slug:"wind-energy",abbreviation:"fwinde",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1451,name:"Frontiers in Water",slug:"water",abbreviation:"frwa",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1561,name:"Frontiers in Virtual Reality",slug:"virtual-reality",abbreviation:"frvir",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2000,name:"Frontiers in Virology",slug:"virology",abbreviation:"fviro",space:{id:c,domainName:d,__typename:b},__typename:a},{id:649,name:"Frontiers in Veterinary Science",slug:"veterinary-science",abbreviation:"fvets",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2176,name:"Frontiers in Urology",slug:"urology",abbreviation:"fruro",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3099,name:"Frontiers in Tuberculosis",slug:"tuberculosis",abbreviation:"ftubr",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1843,name:"Frontiers in Tropical Diseases",slug:"tropical-diseases",abbreviation:"fitd",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2417,name:"Frontiers in Transplantation",slug:"transplantation",abbreviation:"frtra",space:{id:c,domainName:d,__typename:b},__typename:a},{id:473,name:"Frontiers in Toxicology",slug:"toxicology",abbreviation:"ftox",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2105,name:"Frontiers in Thermal Engineering",slug:"thermal-engineering",abbreviation:"fther",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3190,name:"Frontiers in The Neurobiology of Pain",slug:"the-neurobiology-of-pain",abbreviation:e,space:{id:c,domainName:d,__typename:b},__typename:a},{id:1967,name:"Frontiers in Test_Field_Science_Archive",slug:"testfieldsciencearchive",abbreviation:"fntesc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1347,name:"Frontiers in Test_Field_Humanities_Archive",slug:"testfieldhumanitiesarchive",abbreviation:"fntes",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3573,name:"Frontiers in Taxonomy",slug:"taxonomy",abbreviation:"Front. Taxon.",space:{id:c,domainName:d,__typename:b},__typename:a},{id:w,name:"Frontiers in Systems Neuroscience",slug:"systems-neuroscience",abbreviation:"fnsys",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1721,name:"Frontiers in Systems Biology",slug:"systems-biology",abbreviation:"fsysb",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3381,name:"Frontiers in Synthetic Biology",slug:"synthetic-biology",abbreviation:"fsybi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:22,name:"Frontiers in Synaptic Neuroscience",slug:"synaptic-neuroscience",abbreviation:"fnsyn",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2299,name:"Frontiers in Sustainable Tourism",slug:"sustainable-tourism",abbreviation:"frsut",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2483,name:"Frontiers in Sustainable Resource Management",slug:"sustainable-resource-management",abbreviation:"fsrma",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1335,name:"Frontiers in Sustainable Food Systems",slug:"sustainable-food-systems",abbreviation:"fsufs",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2726,name:"Frontiers in Sustainable Energy Policy",slug:"sustainable-energy-policy",abbreviation:"fsuep",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1468,name:"Frontiers in Sustainable Cities",slug:"sustainable-cities",abbreviation:"frsc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1397,name:"Frontiers in Sustainable Business",slug:"sustainable-business",abbreviation:"fisb",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1547,name:"Frontiers in Sustainability",slug:"sustainability",abbreviation:"frsus",space:{id:c,domainName:d,__typename:b},__typename:a},{id:604,name:"Frontiers in Surgery",slug:"surgery",abbreviation:"fsurg",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2504,name:"Frontiers in Structural Biology",slug:"structural-biology",abbreviation:"frsbi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2497,name:"Frontiers in Stroke",slug:"stroke",abbreviation:"fstro",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3434,name:"Frontiers in Stem Cells",slug:"stem-cells",abbreviation:"fstce",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1482,name:"Frontiers in Sports and Active Living",slug:"sports-and-active-living",abbreviation:"fspor",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1695,name:"Frontiers in Space Technologies",slug:"space-technologies",abbreviation:"frspt",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3519,name:"Frontiers in Solar Energy",slug:"solar-energy",abbreviation:"fsoln",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1718,name:"Frontiers in Soil Science",slug:"soil-science",abbreviation:"fsoil",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2346,name:"Frontiers in Soft Matter",slug:"soft-matter",abbreviation:"frsfm",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1213,name:"Frontiers in Sociology",slug:"sociology",abbreviation:"fsoc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:W,name:"Frontiers in Society Journal Archive",slug:"society-journal-archive",abbreviation:X,space:{id:c,domainName:d,__typename:b},__typename:a},{id:2690,name:"Frontiers in Social Psychology",slug:"social-psychology",abbreviation:"frsps",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2819,name:"Frontiers in Smart Grids",slug:"smart-grids",abbreviation:"frsgr",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2288,name:"Frontiers in Sleep",slug:"sleep",abbreviation:"frsle",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2552,name:"Frontiers in Skin Cancer",slug:"skin-cancer",abbreviation:"fskcr",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1786,name:"Frontiers in Signal Processing",slug:"signal-processing",abbreviation:"frsip",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1704,name:"Frontiers in Sensors",slug:"sensors",abbreviation:"fsens",space:{id:c,domainName:d,__typename:b},__typename:a},{id:w,name:"Frontiers in Science archive",slug:"science-archive",abbreviation:I,space:{id:j,domainName:l,__typename:b},__typename:a},{id:3737,name:"Frontiers in Science Diplomacy",slug:"science-diplomacy",abbreviation:"fsdip",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2766,name:"Frontiers in Science",slug:"science",abbreviation:"fsci",space:{id:c,domainName:d,__typename:b},__typename:a},{id:657,name:"Frontiers in Robotics and AI",slug:"robotics-and-ai",abbreviation:"frobt",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1606,name:"Frontiers in Research Metrics and Analytics",slug:"research-metrics-and-analytics",abbreviation:"frma",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1479,name:"Frontiers in Reproductive Health",slug:"reproductive-health",abbreviation:"frph",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1830,name:"Frontiers in Remote Sensing",slug:"remote-sensing",abbreviation:"frsen",space:{id:c,domainName:d,__typename:b},__typename:a},{id:659,name:"Frontiers in Rehabilitation Sciences",slug:"rehabilitation-sciences",abbreviation:"fresc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3550,name:"Frontiers in Regenerative Medicine",slug:"regenerative-medicine",abbreviation:"fregm",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1949,name:"Frontiers in Radiology",slug:"radiology",abbreviation:"fradi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3189,name:"Frontiers in RNA Research",slug:"rna-research",abbreviation:"frnar",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2306,name:"Frontiers in Quantum Science and Technology",slug:"quantum-science-and-technology",abbreviation:"frqst",space:{id:c,domainName:d,__typename:b},__typename:a},{id:W,name:"Frontiers in Public Health Archive",slug:"public-health-archive",abbreviation:X,space:{id:w,domainName:H,__typename:b},__typename:a},{id:609,name:"Frontiers in Public Health",slug:"public-health",abbreviation:"fpubh",space:{id:c,domainName:d,__typename:b},__typename:a},{id:36,name:"Frontiers in Psychology",slug:"psychology",abbreviation:"fpsyg",space:{id:c,domainName:d,__typename:b},__typename:a},{id:71,name:"Frontiers in Psychiatry",slug:"psychiatry",abbreviation:"fpsyt",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3267,name:"Frontiers in Protistology",slug:"protistology",abbreviation:"frpro",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2452,name:"Frontiers in Proteomics",slug:"proteomics",abbreviation:"fprot",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3171,name:"Frontiers in Prosthetics and Orthotics",slug:"prosthetics-and-orthotics",abbreviation:"fpror ",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3643,name:"Frontiers in Polymer Science",slug:"polymer-science",abbreviation:"fplms",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1558,name:"Frontiers in Political Science",slug:"political-science",abbreviation:"fpos",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3615,name:"Frontiers in Polar Science",slug:"polar-science",abbreviation:"fposc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:373,name:"Frontiers in Plant Science",slug:"plant-science",abbreviation:"fpls",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3477,name:"Frontiers in Plant Physiology",slug:"plant-physiology",abbreviation:"fphgy",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3589,name:"Frontiers in Plant Genomics",slug:"plant-genomics",abbreviation:"fpgen",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3579,name:"Frontiers in Plant Ecology",slug:"plant-ecology",abbreviation:"fpley",space:{id:c,domainName:d,__typename:b},__typename:a},{id:210,name:"Frontiers in Physiology",slug:"physiology",abbreviation:"fphys",space:{id:c,domainName:d,__typename:b},__typename:a},{id:616,name:"Frontiers in Physics",slug:"physics",abbreviation:"fphy",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1803,name:"Frontiers in Photonics",slug:"photonics",abbreviation:"fphot",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3604,name:"Frontiers in Photobiology",slug:"photobiology",abbreviation:"fphbi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:176,name:"Frontiers in Pharmacology",slug:"pharmacology",abbreviation:"fphar",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3388,name:"Frontiers in Personality Disorders",slug:"personality-disorders",abbreviation:"fprsd",space:{id:c,domainName:d,__typename:b},__typename:a},{id:606,name:"Frontiers in Pediatrics",slug:"pediatrics",abbreviation:"fped",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2554,name:"Frontiers in Pediatric Dermatology",slug:"pediatric-dermatology",abbreviation:"fpdm",space:{id:c,domainName:d,__typename:b},__typename:a},{id:W,name:"Frontiers in Pathology and Oncology Archive",slug:"pathology-and-oncology-archive",abbreviation:X,space:{id:A,domainName:T,__typename:b},__typename:a},{id:610,name:cp,slug:cq,abbreviation:cr,space:{id:c,domainName:d,__typename:b},__typename:a},{id:3351,name:cp,slug:cq,abbreviation:cr,space:{id:c,domainName:d,__typename:b},__typename:a},{id:2705,name:"Frontiers in Parasitology",slug:"parasitology",abbreviation:"fpara",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1727,name:"Frontiers in Pain Research",slug:"pain-research",abbreviation:"fpain",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2679,name:"Frontiers in Organizational Psychology",slug:"organizational-psychology",abbreviation:"forgp",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1702,name:"Frontiers in Oral Health",slug:"oral-health",abbreviation:"froh",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2232,name:"Frontiers in Ophthalmology",slug:"ophthalmology",abbreviation:"fopht",space:{id:c,domainName:d,__typename:b},__typename:a},{id:451,name:"Frontiers in Oncology",slug:"oncology",abbreviation:"fonc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3123,name:"Frontiers in Ocean Sustainability",slug:"ocean-sustainability",abbreviation:"focsu",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2612,name:"Frontiers in Occupational Therapy",slug:"occupational-therapy",abbreviation:"froct",space:{id:c,domainName:d,__typename:b},__typename:a},{id:628,name:"Frontiers in Nutrition",slug:"nutrition",abbreviation:"fnut",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2062,name:"Frontiers in Nuclear Medicine",slug:"nuclear-medicine",abbreviation:"fnume",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2172,name:"Frontiers in Nuclear Engineering",slug:"nuclear-engineering",abbreviation:"fnuen",space:{id:c,domainName:d,__typename:b},__typename:a},{id:c,name:"Frontiers in Neuroscience",slug:"neuroscience",abbreviation:"fnins",space:{id:c,domainName:d,__typename:b},__typename:a},{id:cs,name:"Frontiers in Neurorobotics",slug:"neurorobotics",abbreviation:"fnbot",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3056,name:"Frontiers in Neuropsychiatry",slug:"neuropsychiatry",abbreviation:"fnpsy",space:{id:c,domainName:d,__typename:b},__typename:a},{id:141,name:"Frontiers in Neurology",slug:"neurology",abbreviation:"fneur",space:{id:c,domainName:d,__typename:b},__typename:a},{id:Q,name:"Frontiers in Neuroinformatics",slug:"neuroinformatics",abbreviation:"fninf",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3283,name:"Frontiers in Neuroinflammation",slug:"neuroinflammation",abbreviation:"fnein",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1973,name:"Frontiers in Neuroimaging",slug:"neuroimaging",abbreviation:"fnimg",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1833,name:"Frontiers in Neuroergonomics",slug:"neuroergonomics",abbreviation:"fnrgo",space:{id:c,domainName:d,__typename:b},__typename:a},{id:P,name:"Frontiers in Neuroengineering",slug:"neuroengineering",abbreviation:"fneng",space:{id:c,domainName:d,__typename:b},__typename:a},{id:ct,name:"Frontiers in Neuroenergetics",slug:"neuroenergetics",abbreviation:"fnene",space:{id:c,domainName:d,__typename:b},__typename:a},{id:A,name:"Frontiers in Neuroanatomy",slug:"neuroanatomy",abbreviation:"fnana",space:{id:c,domainName:d,__typename:b},__typename:a},{id:O,name:"Frontiers in Neural Circuits",slug:"neural-circuits",abbreviation:"fncir",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2021,name:"Frontiers in Network Physiology",slug:"network-physiology",abbreviation:"fnetp",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3130,name:"Frontiers in Network Neuroscience",slug:"network-neuroscience",abbreviation:"fnnsc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2357,name:"Frontiers in Nephrology",slug:"nephrology",abbreviation:"fneph",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2320,name:"Frontiers in Natural Products",slug:"natural-products",abbreviation:"fntpr",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1528,name:"Frontiers in Nanotechnology",slug:"nanotechnology",abbreviation:"fnano",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2882,name:"Frontiers in Musculoskeletal Disorders",slug:"musculoskeletal-disorders",abbreviation:"fmscd",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3275,name:"Frontiers in Multiple Sclerosis",slug:"multiple-sclerosis",abbreviation:"fmscr",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3152,name:"Frontiers in Mollusk Science",slug:"mollusk-science",abbreviation:"fmlsc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2031,name:"Frontiers in Molecular Neuroscience",slug:"molecular-neuroscience",abbreviation:"fnmol",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2086,name:"Frontiers in Molecular Medicine",slug:"molecular-medicine",abbreviation:"fmmed",space:{id:c,domainName:d,__typename:b},__typename:a},{id:698,name:"Frontiers in Molecular Biosciences",slug:"molecular-biosciences",abbreviation:"fmolb",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2807,name:"Frontiers in Microbiomes",slug:"microbiomes",abbreviation:"frmbi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:310,name:"Frontiers in Microbiology",slug:"microbiology",abbreviation:"fmicb",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2327,name:"Frontiers in Metals and Alloys",slug:"metals-and-alloys",abbreviation:"ftmal",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2307,name:"Frontiers in Membrane Science and Technology",slug:"membrane-science-and-technology",abbreviation:"frmst",space:{id:c,domainName:d,__typename:b},__typename:a},{id:602,name:"Frontiers in Medicine",slug:_,abbreviation:"fmed",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1573,name:"Frontiers in Medical Technology",slug:"medical-technology",abbreviation:"fmedt",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3135,name:"Frontiers in Medical Engineering",slug:"medical-engineering",abbreviation:"fmede",space:{id:c,domainName:d,__typename:b},__typename:a},{id:950,name:"Frontiers in Mechanical Engineering",slug:"mechanical-engineering",abbreviation:"fmech",space:{id:c,domainName:d,__typename:b},__typename:a},{id:608,name:"Frontiers in Materials",slug:"materials",abbreviation:"fmats",space:{id:c,domainName:d,__typename:b},__typename:a},{id:655,name:"Frontiers in Marine Science",slug:"marine-science",abbreviation:"fmars",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2100,name:"Frontiers in Manufacturing Technology",slug:"manufacturing-technology",abbreviation:"fmtec",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2931,name:"Frontiers in Mammal Science",slug:"mammal-science",abbreviation:"fmamm",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2896,name:"Frontiers in Malaria",slug:"malaria",abbreviation:"fmala",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3107,name:"Frontiers in Lupus",slug:"lupus",abbreviation:"flupu",space:{id:c,domainName:d,__typename:b},__typename:a},{id:435,name:"Frontiers in Linguistics",slug:"linguistics",abbreviation:"fling",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2636,name:"Frontiers in Language Sciences",slug:"language-sciences",abbreviation:"flang",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2670,name:"Frontiers in Lab on a Chip Technologies",slug:"lab-on-a-chip-technologies",abbreviation:"frlct",space:{id:c,domainName:d,__typename:b},__typename:a},{id:cu,name:"Frontiers in Integrative Neuroscience",slug:"integrative-neuroscience",abbreviation:"fnint",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1723,name:"Frontiers in Insect Science",slug:"insect-science",abbreviation:"finsc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3093,name:"Frontiers in Influenza",slug:"influenza",abbreviation:"finfl",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3073,name:"Frontiers in Inflammation",slug:"inflammation",abbreviation:"finmn",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3200,name:"Frontiers in Industrial Microbiology",slug:"industrial-microbiology",abbreviation:"finmi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3291,name:"Frontiers in Industrial Engineering",slug:"industrial-engineering",abbreviation:"fieng",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2765,name:"Frontiers in Impact Journals",slug:"impact-journals",abbreviation:e,space:{id:c,domainName:d,__typename:b},__typename:a},{id:3078,name:"Frontiers in Immunotherapeutics",slug:"immunotherapeutics",abbreviation:"fimms",space:{id:c,domainName:d,__typename:b},__typename:a},{id:276,name:"Frontiers in Immunology",slug:"immunology",abbreviation:"fimmu",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2379,name:"Frontiers in Imaging",slug:"imaging",abbreviation:"fimag",space:{id:c,domainName:d,__typename:b},__typename:a},{id:629,name:"Frontiers in ICT",slug:"ict",abbreviation:"fict",space:{id:c,domainName:d,__typename:b},__typename:a},{id:16,name:"Frontiers in Humanities and Social Sciences Archive",slug:"humanities-and-social-sciences-archive",abbreviation:I,space:{id:j,domainName:l,__typename:b},__typename:a},{id:3759,name:"Frontiers in Human Rights",slug:"human-rights",abbreviation:e,space:{id:c,domainName:d,__typename:b},__typename:a},{id:1588,name:"Frontiers in Human Neuroscience",slug:"human-neuroscience",abbreviation:"fnhum",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1533,name:"Frontiers in Human Dynamics",slug:"human-dynamics",abbreviation:"fhumd",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2733,name:"Frontiers in Horticulture",slug:"horticulture",abbreviation:"fhort",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3316,name:"Frontiers in Histology",slug:Z,abbreviation:"frhis",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2378,name:"Frontiers in High Performance Computing",slug:"high-performance-computing",abbreviation:"fhpcp",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2456,name:"Frontiers in Hematology",slug:"hematology",abbreviation:"frhem",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2063,name:"Frontiers in Health Services",slug:"health-services",abbreviation:"frhs",space:{id:c,domainName:d,__typename:b},__typename:a},{id:A,name:"Frontiers in Health Archive",slug:"health-archive",abbreviation:I,space:{id:j,domainName:l,__typename:b},__typename:a},{id:3508,name:"Frontiers in Green Chemistry",slug:"green-chemistry",abbreviation:"fgrch",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1728,name:"Frontiers in Global Women's Health",slug:"global-womens-health",abbreviation:"fgwh",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2918,name:"Frontiers in Geochemistry",slug:"geochemistry",abbreviation:"fgeoc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1540,name:"Frontiers in Genome Editing",slug:"genome-editing",abbreviation:"fgeed",space:{id:c,domainName:d,__typename:b},__typename:a},{id:240,name:"Frontiers in Genetics",slug:"genetics",abbreviation:"fgene",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3496,name:"Frontiers in Genetic Microbiology",slug:"genetic-microbiology",abbreviation:"fgemi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3227,name:"Frontiers in Genetic Disorders",slug:"genetic-disorders",abbreviation:"frged",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2333,name:"Frontiers in Gastroenterology",slug:"gastroenterology",abbreviation:"fgstr",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1529,name:"Frontiers in Future Transportation",slug:"future-transportation",abbreviation:"ffutr",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1725,name:"Frontiers in Fungal Biology",slug:"fungal-biology",abbreviation:"ffunb",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2826,name:"Frontiers in Fuels",slug:"fuels",abbreviation:"ffuel",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3207,name:"Frontiers in Freshwater Science",slug:"freshwater-science",abbreviation:"ffwsc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1366,name:"Frontiers in Forests and Global Change",slug:"forests-and-global-change",abbreviation:"ffgc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2689,name:"Frontiers in Forensic Science",slug:"forensic-science",abbreviation:e,space:{id:c,domainName:d,__typename:b},__typename:a},{id:2289,name:"Frontiers in Food Science and Technology",slug:"food-science-and-technology",abbreviation:"frfst",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3559,name:"Frontiers in Fluorescence",slug:"fluorescence",abbreviation:"fflur",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2987,name:"Frontiers in Fish Science",slug:"fish-science",abbreviation:"frish",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3489,name:"Frontiers in Fire Science and Technology",slug:"fire-science-and-technology",abbreviation:"firtc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2749,name:"Frontiers in Financial Economics",slug:"financial-economics",abbreviation:"ffecn",space:{id:c,domainName:d,__typename:b},__typename:a},{id:c,name:"Frontiers in FSHIP Test Journal",slug:"fship-test-journal",abbreviation:"ftest",space:{id:j,domainName:l,__typename:b},__typename:a},{id:bX,name:"Frontiers in Evolutionary Neuroscience",slug:"evolutionary-neuroscience",abbreviation:"fnevo",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2955,name:"Frontiers in Ethology",slug:"ethology",abbreviation:"fetho",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3032,name:"Frontiers in Epigenetics and Epigenomics",slug:"epigenetics-and-epigenomics",abbreviation:"freae",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2394,name:"Frontiers in Epidemiology",slug:"epidemiology",abbreviation:"fepid",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3450,name:"Frontiers in Environmental Toxicology",slug:"environmental-toxicology",abbreviation:"fentx",space:{id:c,domainName:d,__typename:b},__typename:a},{id:627,name:"Frontiers in Environmental Science",slug:"environmental-science",abbreviation:"fenvs",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2888,name:"Frontiers in Environmental Health",slug:"environmental-health",abbreviation:"fenvh",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2851,name:"Frontiers in Environmental Engineering",slug:"environmental-engineering",abbreviation:"fenve",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2547,name:"Frontiers in Environmental Economics",slug:"environmental-economics",abbreviation:"frevc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1697,name:"Frontiers in Environmental Chemistry",slug:"environmental-chemistry",abbreviation:"fenvc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2756,name:"Frontiers in Environmental Archaeology",slug:"environmental-archaeology",abbreviation:"fearc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:15,name:"Frontiers in Engineering archive",slug:"engineering-archive",abbreviation:I,space:{id:j,domainName:l,__typename:b},__typename:a},{id:626,name:"Frontiers in Energy Research",slug:"energy-research",abbreviation:"fenrg",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3115,name:"Frontiers in Energy Efficiency",slug:"energy-efficiency",abbreviation:"fenef",space:{id:c,domainName:d,__typename:b},__typename:a},{id:x,name:t,slug:u,abbreviation:ac,space:{id:c,domainName:d,__typename:b},__typename:a},{id:1696,name:"Frontiers in Electronics",slug:"electronics",abbreviation:"felec",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1800,name:"Frontiers in Electronic Materials",slug:"electronic-materials",abbreviation:"femat",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2998,name:"Frontiers in Educational Psychology",slug:"educational-psychology",abbreviation:"fepys",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1239,name:"Frontiers in Education",slug:"education",abbreviation:"feduc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:625,name:"Frontiers in Economics",slug:"economics",abbreviation:"fecon",space:{id:c,domainName:d,__typename:b},__typename:a},{id:471,name:"Frontiers in Ecology and Evolution",slug:"ecology-and-evolution",abbreviation:"fevo",space:{id:c,domainName:d,__typename:b},__typename:a},{id:c,name:"Frontiers in Earth Science Archive",slug:"earth-science-archive",abbreviation:"gslfj",space:{id:r,domainName:V,__typename:b},__typename:a},{id:654,name:"Frontiers in Earth Science",slug:"earth-science",abbreviation:"feart",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3309,name:"Frontiers in Earth Observation and Land Monitoring",slug:"earth-observation-and-land-monitoring",abbreviation:"feolm",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2161,name:"Frontiers in Drug Safety and Regulation",slug:"drug-safety-and-regulation",abbreviation:"fdsfr",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2137,name:"Frontiers in Drug Discovery",slug:"drug-discovery",abbreviation:"fddsv",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2136,name:"Frontiers in Drug Delivery",slug:"drug-delivery",abbreviation:"fddev",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2775,name:"Frontiers in Disaster and Emergency Medicine",slug:"disaster-and-emergency-medicine",abbreviation:"femer",space:{id:c,domainName:d,__typename:b},__typename:a},{id:788,name:"Frontiers in Digital Humanities",slug:"digital-humanities",abbreviation:"fdigh",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1534,name:"Frontiers in Digital Health",slug:"digital-health",abbreviation:"fdgth",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2999,name:"Frontiers in Developmental Psychology",slug:"developmental-psychology",abbreviation:"fdpys",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2873,name:"Frontiers in Detector Science and Technology",slug:"detector-science-and-technology",abbreviation:"fdest",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3611,name:"Frontiers in Design Engineering",slug:"design-engineering",abbreviation:"fdese",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2550,name:"Frontiers in Dermatological Research",slug:"dermatological-research",abbreviation:"fdmre",space:{id:c,domainName:d,__typename:b},__typename:a},{id:607,name:"Frontiers in Dental Medicine",slug:"dental-medicine",abbreviation:"fdmed",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2597,name:"Frontiers in Dementia",slug:"dementia",abbreviation:"frdem",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1785,name:"Frontiers in Control Engineering",slug:"control-engineering",abbreviation:"fcteg",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1724,name:"Frontiers in Conservation Science",slug:"conservation-science",abbreviation:"fcosc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3454,name:"Frontiers in Condensed Matter",slug:"condensed-matter",abbreviation:"fconm",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1511,name:"Frontiers in Computer Science",slug:"computer-science",abbreviation:"fcomp",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3566,name:"Frontiers in Computational Physiology",slug:"computational-physiology",abbreviation:"fcphy",space:{id:c,domainName:d,__typename:b},__typename:a},{id:bI,name:"Frontiers in Computational Neuroscience",slug:"computational-neuroscience",abbreviation:"fncom",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3234,name:"Frontiers in Complex Systems",slug:"complex-systems",abbreviation:"fcpxs",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1787,name:"Frontiers in Communications and Networks",slug:"communications-and-networks",abbreviation:"frcmn",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1238,name:"Frontiers in Communication",slug:"communication",abbreviation:"fcomm",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2535,name:"Frontiers in Cognition",slug:"cognition",abbreviation:"fcogn",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2857,name:"Frontiers in Coatings, Dyes and Interface Engineering",slug:"coatings-dyes-and-interface-engineering",abbreviation:"frcdi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3222,name:"Frontiers in Clinical Microbiology",slug:"clinical-microbiology",abbreviation:"fclmi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1729,name:"Frontiers in Clinical Diabetes and Healthcare",slug:"clinical-diabetes-and-healthcare",abbreviation:"fcdhc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2551,name:"Frontiers in Clinical Dermatology",slug:"clinical-dermatology",abbreviation:"fcldm",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1490,name:"Frontiers in Climate",slug:"climate",abbreviation:"fclim",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3338,name:"Frontiers in Chromosome Research",slug:"chromosome-research",abbreviation:e,space:{id:c,domainName:d,__typename:b},__typename:a},{id:2587,name:"Frontiers in Child and Adolescent Psychiatry",slug:"child-and-adolescent-psychiatry",abbreviation:"frcha",space:{id:c,domainName:d,__typename:b},__typename:a},{id:601,name:"Frontiers in Chemistry",slug:"chemistry",abbreviation:"fchem",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1532,name:"Frontiers in Chemical Engineering",slug:"chemical-engineering",abbreviation:"fceng",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3038,name:"Frontiers in Chemical Biology",slug:"chemical-biology",abbreviation:"fchbi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3322,name:"Frontiers in Ceramics",slug:"ceramics",abbreviation:"fceic",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1440,name:"Frontiers in Cellular and Infection Microbiology",slug:"cellular-and-infection-microbiology",abbreviation:"fcimb",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1523,name:"Frontiers in Cellular Neuroscience",slug:"cellular-neuroscience",abbreviation:"fncel",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3084,name:"Frontiers in Cellular Immunology",slug:"cellular-immunology",abbreviation:"fcimy",space:{id:c,domainName:d,__typename:b},__typename:a},{id:403,name:"Frontiers in Cell and Developmental Biology",slug:"cell-and-developmental-biology",abbreviation:"fcell",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3178,name:"Frontiers in Cell Signaling",slug:"cell-signaling",abbreviation:"fcsig",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2655,name:"Frontiers in Cell Death",slug:"cell-death",abbreviation:"fceld",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1901,name:"Frontiers in Catalysis",slug:"catalysis",abbreviation:"fctls",space:{id:c,domainName:d,__typename:b},__typename:a},{id:755,name:"Frontiers in Cardiovascular Medicine",slug:"cardiovascular-medicine",abbreviation:"fcvm",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2662,name:"Frontiers in Carbon",slug:"carbon",abbreviation:"frcrb",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3513,name:"Frontiers in Cancer Interception",slug:"cancer-interception",abbreviation:"fcint",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3433,name:"Frontiers in Cancer Control and Society",slug:"cancer-control-and-society",abbreviation:"fcacs",space:{id:c,domainName:d,__typename:b},__typename:a},{id:921,name:"Frontiers in Built Environment",slug:"built-environment",abbreviation:"fbuil",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1418,name:"Frontiers in Blockchain",slug:"blockchain",abbreviation:"fbloc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2971,name:"Frontiers in Bird Science",slug:"bird-science",abbreviation:"fbirs",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3300,name:"Frontiers in Biophysics",slug:"biophysics",abbreviation:"frbis",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2222,name:"Frontiers in Biomaterials Science",slug:"biomaterials-science",abbreviation:"fbiom",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1722,name:"Frontiers in Bioinformatics",slug:"bioinformatics",abbreviation:"fbinf",space:{id:c,domainName:d,__typename:b},__typename:a},{id:452,name:"Frontiers in Bioengineering and Biotechnology",slug:"bioengineering-and-biotechnology",abbreviation:"fbioe",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1380,name:"Frontiers in Big Data",slug:"big-data",abbreviation:"fdata",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1589,name:"Frontiers in Behavioral Neuroscience",slug:"behavioral-neuroscience",abbreviation:"fnbeh",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2432,name:"Frontiers in Behavioral Economics",slug:"behavioral-economics",abbreviation:"frbhe",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2796,name:"Frontiers in Bee Science",slug:"bee-science",abbreviation:"frbee",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3214,name:"Frontiers in Batteries and Electrochemistry",slug:"batteries-and-electrochemistry",abbreviation:"fbael",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3011,name:"Frontiers in Bacteriology",slug:"bacteriology",abbreviation:"fbrio",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3040,name:"Frontiers in Audiology and Otology",slug:"audiology-and-otology",abbreviation:"fauot",space:{id:c,domainName:d,__typename:b},__typename:a},{id:603,name:"Frontiers in Astronomy and Space Sciences",slug:"astronomy-and-space-sciences",abbreviation:"fspas",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1437,name:"Frontiers in Artificial Intelligence",slug:"artificial-intelligence",abbreviation:"frai",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2940,name:"Frontiers in Arachnid Science",slug:"arachnid-science",abbreviation:"frchs",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2834,name:"Frontiers in Aquaculture",slug:"aquaculture",abbreviation:"faquc",space:{id:c,domainName:d,__typename:b},__typename:a},{id:981,name:"Frontiers in Applied Mathematics and Statistics",slug:"applied-mathematics-and-statistics",abbreviation:"fams",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3417,name:"Frontiers in Applied Environmental Microbiology",slug:"applied-environmental-microbiology",abbreviation:"faemi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2714,name:"Frontiers in Antibiotics",slug:"antibiotics",abbreviation:"frabi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3443,name:"Frontiers in Anti-Cancer Therapies",slug:"anti-cancer-therapies",abbreviation:"facth",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3253,name:"Frontiers in Antennas and Propagation",slug:"antennas-and-propagation",abbreviation:"fanpr",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1719,name:"Frontiers in Animal Science",slug:"animal-science",abbreviation:"fanim",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2513,name:"Frontiers in Anesthesiology",slug:"anesthesiology",abbreviation:"fanes",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1989,name:"Frontiers in Analytical Science",slug:"analytical-science",abbreviation:"frans",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2909,name:"Frontiers in Amphibian and Reptile Science",slug:"amphibian-and-reptile-science",abbreviation:"famrs",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1705,name:"Frontiers in Allergy",slug:"allergy",abbreviation:"falgy",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1541,name:"Frontiers in Agronomy",slug:"agronomy",abbreviation:"fagro",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3631,name:"Frontiers in Agricultural Engineering",slug:"agricultural-engineering",abbreviation:"faeng",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2477,name:"Frontiers in Aging Neuroscience",slug:"aging-neuroscience",abbreviation:"fnagi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:1566,name:"Frontiers in Aging",slug:"aging",abbreviation:"fragi",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2449,name:"Frontiers in Aerospace Engineering",slug:"aerospace-engineering",abbreviation:"fpace",space:{id:c,domainName:d,__typename:b},__typename:a},{id:2195,name:"Frontiers in Adolescent Medicine",slug:"adolescent-medicine",abbreviation:"fradm",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3426,name:"Frontiers in Acoustics",slug:"acoustics",abbreviation:"facou",space:{id:c,domainName:d,__typename:b},__typename:a},{id:979,name:bG,slug:"frontiers-for-young-minds",abbreviation:"frym",space:{id:c,domainName:d,__typename:b},__typename:a},{id:3260,name:"Frontiers In Ocean Engineering",slug:"frontiers-in-ocean-engineering",abbreviation:"focen",space:{id:c,domainName:d,__typename:b},__typename:a},{id:cs,name:"FSHIP Test Journal 2",slug:"fship-test-journal-2",abbreviation:"FTJ2",space:{id:j,domainName:l,__typename:b},__typename:a},{id:j,name:cv,slug:cw,abbreviation:cx,space:{id:U,domainName:bQ,__typename:b},__typename:a},{id:3746,name:cv,slug:cw,abbreviation:cx,space:{id:c,domainName:d,__typename:b},__typename:a},{id:Q,name:cy,slug:cz,abbreviation:cA,space:{id:j,domainName:l,__typename:b},__typename:a},{id:3231,name:cy,slug:cz,abbreviation:cA,space:{id:c,domainName:d,__typename:b},__typename:a},{id:r,name:cB,slug:cC,abbreviation:cD,space:{id:r,domainName:V,__typename:b},__typename:a},{id:2078,name:cB,slug:cC,abbreviation:cD,space:{id:c,domainName:d,__typename:b},__typename:a},{id:cu,name:cE,slug:cF,abbreviation:cG,space:{id:j,domainName:l,__typename:b},__typename:a},{id:2359,name:cE,slug:cF,abbreviation:cG,space:{id:c,domainName:d,__typename:b},__typename:a},{id:8,name:cH,slug:cI,abbreviation:cJ,space:{id:j,domainName:l,__typename:b},__typename:a},{id:2446,name:cH,slug:cI,abbreviation:cJ,space:{id:c,domainName:d,__typename:b},__typename:a},{id:10,name:cK,slug:cL,abbreviation:cM,space:{id:j,domainName:l,__typename:b},__typename:a},{id:3230,name:cK,slug:cL,abbreviation:cM,space:{id:c,domainName:d,__typename:b},__typename:a},{id:r,name:cN,slug:cO,abbreviation:cP,space:{id:j,domainName:l,__typename:b},__typename:a},{id:2358,name:cN,slug:cO,abbreviation:cP,space:{id:c,domainName:d,__typename:b},__typename:a},{id:3660,name:"Advanced Optical Technologies",slug:"advanced-optical-technologies",abbreviation:"aot",space:{id:c,domainName:d,__typename:b},__typename:a},{id:ct,name:cQ,slug:cR,abbreviation:cS,space:{id:j,domainName:l,__typename:b},__typename:a},{id:3659,name:cQ,slug:cR,abbreviation:cS,space:{id:c,domainName:d,__typename:b},__typename:a},{id:P,name:cT,slug:cU,abbreviation:"abp",space:{id:j,domainName:l,__typename:b},__typename:a},{id:3695,name:cT,slug:cU,abbreviation:"ABP",space:{id:c,domainName:d,__typename:b},__typename:a}]},serverRendered:h,routePath:"\u002Fjournals\u002Fendocrinology\u002Farticles\u002F10.3389\u002Ffendo.2021.759843\u002Ffull",config:{baseUrl:"https:\u002F\u002Fwww.frontiersin.org",appName:"article-pages-2022",spaceId:c,spaceName:D,domain:d,loopUrl:"https:\u002F\u002Floop.frontiersin.org",ssMainDomain:d,googleRecaptchaKeyName:"FrontiersRecaptchaV2",googleRecaptchaSiteKey:"6LdG3i0UAAAAAOC4qUh35ubHgJotEHp_STXHgr_v",linkedArticleCopyText:"'{\"articleTypeCopyText\":[{\"articleTypeId\":0,\"originalArticleCopyText\":\"Part of this article's content has been mentioned in:\",\"linkedArticleCopyText\":\"This article mentions parts of:\"},{\"articleTypeId\":122,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an erratum on:\"},{\"articleTypeId\":129,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an addendum to:\"},{\"articleTypeId\":128,\"originalArticleCopyText\":\"A correction has been applied to this article in:\",\"linkedArticleCopyText\":\"This article is a correction to:\"},{\"articleTypeId\":134,\"originalArticleCopyText\":\"A retraction of this article was approved in:\",\"linkedArticleCopyText\":\"This article is a retraction of:\"},{\"articleTypeId\":29,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"},{\"articleTypeId\":30,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"}],\"articleIdCopyText\":[]}'\n",articleTypeConfigurableLabel:"\u003C\u003Carticle-type:uppercase\u003E\u003E article",terminologySettings:"'{\"terms\":[{\"sequenceNumber\":1,\"key\":\"frontiers\",\"tenantTerm\":\"Frontiers\",\"frontiersDefaultTerm\":\"Frontiers\",\"category\":\"Customer\"},{\"sequenceNumber\":2,\"key\":\"submission_system\",\"tenantTerm\":\"submission system\",\"frontiersDefaultTerm\":\"submission system\",\"category\":\"Product\"},{\"sequenceNumber\":3,\"key\":\"public_pages\",\"tenantTerm\":\"public pages\",\"frontiersDefaultTerm\":\"public pages\",\"category\":\"Product\"},{\"sequenceNumber\":4,\"key\":\"my_frontiers\",\"tenantTerm\":\"my frontiers\",\"frontiersDefaultTerm\":\"my frontiers\",\"category\":\"Product\"},{\"sequenceNumber\":5,\"key\":\"digital_editorial_office\",\"tenantTerm\":\"digital editorial office\",\"frontiersDefaultTerm\":\"digital editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":6,\"key\":\"deo\",\"tenantTerm\":\"DEO\",\"frontiersDefaultTerm\":\"DEO\",\"category\":\"Product\"},{\"sequenceNumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantTerm\":\"digital editorial office for chiefs\",\"frontiersDefaultTerm\":\"digital editorial office for chiefs\",\"category\":\"Product\"},{\"sequenceNumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantTerm\":\"digital editorial office for eof\",\"frontiersDefaultTerm\":\"digital editorial office for eof\",\"category\":\"Product\"},{\"sequenceNumber\":9,\"key\":\"editorial_office\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":10,\"key\":\"eof\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"Product\"},{\"sequenceNumber\":11,\"key\":\"research_topic_management\",\"tenantTerm\":\"research topic management\",\"frontiersDefaultTerm\":\"research topic management\",\"category\":\"Product\"},{\"sequenceNumber\":12,\"key\":\"review_forum\",\"tenantTerm\":\"review forum\",\"frontiersDefaultTerm\":\"review forum\",\"category\":\"Product\"},{\"sequenceNumber\":13,\"key\":\"accounting_office\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"Product\"},{\"sequenceNumber\":14,\"key\":\"aof\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"Product\"},{\"sequenceNumber\":15,\"key\":\"publishing_office\",\"tenantTerm\":\"publishing office\",\"frontiersDefaultTerm\":\"publishing office\",\"category\":\"Product\"},{\"sequenceNumber\":16,\"key\":\"production_office\",\"tenantTerm\":\"production office forum\",\"frontiersDefaultTerm\":\"production office forum\",\"category\":\"Product\"},{\"sequenceNumber\":17,\"key\":\"pof\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"Product\"},{\"sequenceNumber\":18,\"key\":\"book_office_forum\",\"tenantTerm\":\"book office forum\",\"frontiersDefaultTerm\":\"book office forum\",\"category\":\"Product\"},{\"sequenceNumber\":19,\"key\":\"bof\",\"tenantTerm\":\"BOF\",\"frontiersDefaultTerm\":\"BOF\",\"category\":\"Product\"},{\"sequenceNumber\":20,\"key\":\"aira\",\"tenantTerm\":\"AIRA\",\"frontiersDefaultTerm\":\"AIRA\",\"category\":\"Product\"},{\"sequenceNumber\":21,\"key\":\"editorial_board_management\",\"tenantTerm\":\"editorial board management\",\"frontiersDefaultTerm\":\"editorial board management\",\"category\":\"Product\"},{\"sequenceNumber\":22,\"key\":\"ebm\",\"tenantTerm\":\"EBM\",\"frontiersDefaultTerm\":\"EBM\",\"category\":\"Product\"},{\"sequenceNumber\":23,\"key\":\"domain\",\"tenantTerm\":\"domain\",\"frontiersDefaultTerm\":\"domain\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":24,\"key\":\"journal\",\"tenantTerm\":\"journal\",\"frontiersDefaultTerm\":\"journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":25,\"key\":\"section\",\"tenantTerm\":\"section\",\"frontiersDefaultTerm\":\"section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":26,\"key\":\"domains\",\"tenantTerm\":\"domains\",\"frontiersDefaultTerm\":\"domains\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":27,\"key\":\"specialty_section\",\"tenantTerm\":\"specialty section\",\"frontiersDefaultTerm\":\"specialty section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":28,\"key\":\"specialty_journal\",\"tenantTerm\":\"specialty journal\",\"frontiersDefaultTerm\":\"specialty journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":29,\"key\":\"journals\",\"tenantTerm\":\"journals\",\"frontiersDefaultTerm\":\"journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":30,\"key\":\"sections\",\"tenantTerm\":\"sections\",\"frontiersDefaultTerm\":\"sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":31,\"key\":\"specialty_sections\",\"tenantTerm\":\"specialty sections\",\"frontiersDefaultTerm\":\"specialty sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":32,\"key\":\"specialty_journals\",\"tenantTerm\":\"specialty journals\",\"frontiersDefaultTerm\":\"specialty journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":33,\"key\":\"manuscript\",\"tenantTerm\":\"manuscript\",\"frontiersDefaultTerm\":\"manuscript\",\"category\":\"Core\"},{\"sequenceNumber\":34,\"key\":\"manuscripts\",\"tenantTerm\":\"manuscripts\",\"frontiersDefaultTerm\":\"manuscripts\",\"category\":\"Core\"},{\"sequenceNumber\":35,\"key\":\"article\",\"tenantTerm\":\"article\",\"frontiersDefaultTerm\":\"article\",\"category\":\"Core\"},{\"sequenceNumber\":36,\"key\":\"articles\",\"tenantTerm\":\"articles\",\"frontiersDefaultTerm\":\"articles\",\"category\":\"Core\"},{\"sequenceNumber\":37,\"key\":\"article_type\",\"tenantTerm\":\"article type\",\"frontiersDefaultTerm\":\"article type\",\"category\":\"Core\"},{\"sequenceNumber\":38,\"key\":\"article_types\",\"tenantTerm\":\"article types\",\"frontiersDefaultTerm\":\"article types\",\"category\":\"Core\"},{\"sequenceNumber\":39,\"key\":\"author\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":40,\"key\":\"authors\",\"tenantTerm\":\"authors\",\"frontiersDefaultTerm\":\"authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":41,\"key\":\"authoring\",\"tenantTerm\":\"authoring\",\"frontiersDefaultTerm\":\"authoring\",\"category\":\"Core\"},{\"sequenceNumber\":42,\"key\":\"authored\",\"tenantTerm\":\"authored\",\"frontiersDefaultTerm\":\"authored\",\"category\":\"Core\"},{\"sequenceNumber\":43,\"key\":\"accept\",\"tenantTerm\":\"accept\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":44,\"key\":\"accepted\",\"tenantTerm\":\"accepted\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantTerm\":\"Assistant Field Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editor\",\"description\":\"An editorial role on a Field Journal that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantTerm\":\"Assistant Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantTerm\":\"Assistant Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":48,\"key\":\"associate_editor\",\"tenantTerm\":\"Associate Editor\",\"frontiersDefaultTerm\":\"Associate Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":49,\"key\":\"specialty_chief_editor\",\"tenantTerm\":\"Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":50,\"key\":\"specialty_chief_editors\",\"tenantTerm\":\"Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":51,\"key\":\"chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":52,\"key\":\"chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":53,\"key\":\"call_for_participation\",\"tenantTerm\":\"call for participation\",\"frontiersDefaultTerm\":\"call for participation\",\"category\":\"Process\"},{\"sequenceNumber\":54,\"key\":\"citation\",\"tenantTerm\":\"citation\",\"frontiersDefaultTerm\":\"citation\",\"category\":\"Misc.\"},{\"sequenceNumber\":55,\"key\":\"citations\",\"tenantTerm\":\"citations\",\"frontiersDefaultTerm\":\"citations\",\"category\":\"Misc.\"},{\"sequenceNumber\":56,\"key\":\"contributor\",\"tenantTerm\":\"contributor\",\"frontiersDefaultTerm\":\"contributor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":57,\"key\":\"contributors\",\"tenantTerm\":\"contributors\",\"frontiersDefaultTerm\":\"contributors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":58,\"key\":\"corresponding_author\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":59,\"key\":\"corresponding_authors\",\"tenantTerm\":\"corresponding authors\",\"frontiersDefaultTerm\":\"corresponding authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":60,\"key\":\"decline\",\"tenantTerm\":\"decline\",\"frontiersDefaultTerm\":\"decline\",\"category\":\"Process\"},{\"sequenceNumber\":61,\"key\":\"declined\",\"tenantTerm\":\"declined\",\"frontiersDefaultTerm\":\"declined\",\"category\":\"Process\"},{\"sequenceNumber\":62,\"key\":\"reject\",\"tenantTerm\":\"reject\",\"frontiersDefaultTerm\":\"reject\",\"category\":\"Process\"},{\"sequenceNumber\":63,\"key\":\"rejected\",\"tenantTerm\":\"rejected\",\"frontiersDefaultTerm\":\"rejected\",\"category\":\"Process\"},{\"sequenceNumber\":64,\"key\":\"publish\",\"tenantTerm\":\"publish\",\"frontiersDefaultTerm\":\"publish\",\"category\":\"Core\"},{\"sequenceNumber\":65,\"key\":\"published\",\"tenantTerm\":\"published\",\"frontiersDefaultTerm\":\"published\",\"category\":\"Core\"},{\"sequenceNumber\":66,\"key\":\"publication\",\"tenantTerm\":\"publication\",\"frontiersDefaultTerm\":\"publication\",\"category\":\"Core\"},{\"sequenceNumber\":67,\"key\":\"peer_review\",\"tenantTerm\":\"peer review\",\"frontiersDefaultTerm\":\"peer review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":68,\"key\":\"peer_reviewed\",\"tenantTerm\":\"peer reviewed\",\"frontiersDefaultTerm\":\"peer reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":69,\"key\":\"initial_validation\",\"tenantTerm\":\"initial validation\",\"frontiersDefaultTerm\":\"initial validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":70,\"key\":\"editorial_assignment\",\"tenantTerm\":\"editorial assignment\",\"frontiersDefaultTerm\":\"editorial assignment\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":71,\"key\":\"independent_review\",\"tenantTerm\":\"independent review\",\"frontiersDefaultTerm\":\"independent review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":72,\"key\":\"interactive_review\",\"tenantTerm\":\"interactive review\",\"frontiersDefaultTerm\":\"interactive review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":73,\"key\":\"review\",\"tenantTerm\":\"review\",\"frontiersDefaultTerm\":\"review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":74,\"key\":\"reviewing\",\"tenantTerm\":\"reviewing\",\"frontiersDefaultTerm\":\"reviewing\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":75,\"key\":\"reviewer\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":76,\"key\":\"reviewers\",\"tenantTerm\":\"reviewers\",\"frontiersDefaultTerm\":\"reviewers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":77,\"key\":\"review_finalized\",\"tenantTerm\":\"review finalized\",\"frontiersDefaultTerm\":\"review finalized\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":78,\"key\":\"final_decision\",\"tenantTerm\":\"final decision\",\"frontiersDefaultTerm\":\"final decision\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":79,\"key\":\"final_validation\",\"tenantTerm\":\"final validation\",\"frontiersDefaultTerm\":\"final validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantTerm\":\"recommend to accept manuscript\",\"frontiersDefaultTerm\":\"accept manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":81,\"key\":\"fee\",\"tenantTerm\":\"fee\",\"frontiersDefaultTerm\":\"fee\",\"category\":\"Accounting\"},{\"sequenceNumber\":82,\"key\":\"fees\",\"tenantTerm\":\"fees\",\"frontiersDefaultTerm\":\"fees\",\"category\":\"Accounting\"},{\"sequenceNumber\":83,\"key\":\"guest_associate_editor\",\"tenantTerm\":\"Guest Associate Editor\",\"frontiersDefaultTerm\":\"Guest Associate Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":84,\"key\":\"guest_associate_editors\",\"tenantTerm\":\"Guest Associate Editors\",\"frontiersDefaultTerm\":\"Guest Associate Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":85,\"key\":\"in_review\",\"tenantTerm\":\"in review\",\"frontiersDefaultTerm\":\"in review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":86,\"key\":\"institutional_member\",\"tenantTerm\":\"institutional partner\",\"frontiersDefaultTerm\":\"institutional partner\",\"category\":\"Accounting\"},{\"sequenceNumber\":87,\"key\":\"institutional_membership\",\"tenantTerm\":\"institutional partnership\",\"frontiersDefaultTerm\":\"institutional partnership\",\"category\":\"Accounting\"},{\"sequenceNumber\":88,\"key\":\"article_processing_charge\",\"tenantTerm\":\"article processing charge\",\"frontiersDefaultTerm\":\"article processing charge\",\"category\":\"Accounting\"},{\"sequenceNumber\":89,\"key\":\"article_processing_charges\",\"tenantTerm\":\"article processing charges\",\"frontiersDefaultTerm\":\"article processing charges\",\"category\":\"Accounting\"},{\"sequenceNumber\":90,\"key\":\"apcs\",\"tenantTerm\":\"APCs\",\"frontiersDefaultTerm\":\"APCs\",\"category\":\"Accounting\"},{\"sequenceNumber\":91,\"key\":\"apc\",\"tenantTerm\":\"APC\",\"frontiersDefaultTerm\":\"APC\",\"category\":\"Accounting\"},{\"sequenceNumber\":92,\"key\":\"received\",\"tenantTerm\":\"received\",\"frontiersDefaultTerm\":\"received\",\"description\":\"Date manuscript was received on.\",\"category\":\"Core\"},{\"sequenceNumber\":93,\"key\":\"transferred\",\"tenantTerm\":\"transferred\",\"frontiersDefaultTerm\":\"transferred\",\"category\":\"Core\"},{\"sequenceNumber\":94,\"key\":\"transfer\",\"tenantTerm\":\"transfer\",\"frontiersDefaultTerm\":\"transfer\",\"category\":\"Core\"},{\"sequenceNumber\":95,\"key\":\"research_topic\",\"tenantTerm\":\"research topic\",\"frontiersDefaultTerm\":\"research topic\",\"category\":\"Core\"},{\"sequenceNumber\":96,\"key\":\"research_topics\",\"tenantTerm\":\"research topics\",\"frontiersDefaultTerm\":\"research topics\",\"category\":\"Core\"},{\"sequenceNumber\":97,\"key\":\"topic_editor\",\"tenantTerm\":\"Topic Editor\",\"frontiersDefaultTerm\":\"Topic Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":98,\"key\":\"review_editor\",\"tenantTerm\":\"Review Editor\",\"frontiersDefaultTerm\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":99,\"key\":\"title\",\"tenantTerm\":\"title\",\"frontiersDefaultTerm\":\"title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":100,\"key\":\"running_title\",\"tenantTerm\":\"running title\",\"frontiersDefaultTerm\":\"running title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":101,\"key\":\"submit\",\"tenantTerm\":\"submit\",\"frontiersDefaultTerm\":\"submit\",\"category\":\"Process\"},{\"sequenceNumber\":102,\"key\":\"submitted\",\"tenantTerm\":\"submitted\",\"frontiersDefaultTerm\":\"submitted\",\"category\":\"Process\"},{\"sequenceNumber\":103,\"key\":\"submitting\",\"tenantTerm\":\"submitting\",\"frontiersDefaultTerm\":\"submitting\",\"category\":\"Process\"},{\"sequenceNumber\":104,\"key\":\"t_e\",\"tenantTerm\":\"TE\",\"frontiersDefaultTerm\":\"TE\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":105,\"key\":\"topic\",\"tenantTerm\":\"topic\",\"frontiersDefaultTerm\":\"topic\",\"category\":\"Process\"},{\"sequenceNumber\":106,\"key\":\"topic_summary\",\"tenantTerm\":\"topic summary\",\"frontiersDefaultTerm\":\"topic summary\",\"category\":\"Process\"},{\"sequenceNumber\":107,\"key\":\"figure\",\"tenantTerm\":\"figure\",\"frontiersDefaultTerm\":\"figure\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":108,\"key\":\"figures\",\"tenantTerm\":\"figures\",\"frontiersDefaultTerm\":\"figures\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":109,\"key\":\"editorial_file\",\"tenantTerm\":\"editorial file\",\"frontiersDefaultTerm\":\"editorial file\",\"category\":\"Core\"},{\"sequenceNumber\":110,\"key\":\"editorial_files\",\"tenantTerm\":\"editorial files\",\"frontiersDefaultTerm\":\"editorial files\",\"category\":\"Core\"},{\"sequenceNumber\":111,\"key\":\"e_book\",\"tenantTerm\":\"e-book\",\"frontiersDefaultTerm\":\"e-book\",\"category\":\"Core\"},{\"sequenceNumber\":112,\"key\":\"organization\",\"tenantTerm\":\"organization\",\"frontiersDefaultTerm\":\"organization\",\"category\":\"Core\"},{\"sequenceNumber\":113,\"key\":\"institution\",\"tenantTerm\":\"institution\",\"frontiersDefaultTerm\":\"institution\",\"category\":\"Core\"},{\"sequenceNumber\":114,\"key\":\"reference\",\"tenantTerm\":\"reference\",\"frontiersDefaultTerm\":\"reference\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":115,\"key\":\"references\",\"tenantTerm\":\"references\",\"frontiersDefaultTerm\":\"references\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":116,\"key\":\"sce\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"description\":\"Abbreviation for Specialty Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":117,\"key\":\"submission\",\"tenantTerm\":\"submission\",\"frontiersDefaultTerm\":\"submission\",\"category\":\"Process\"},{\"sequenceNumber\":118,\"key\":\"submissions\",\"tenantTerm\":\"submissions\",\"frontiersDefaultTerm\":\"submissions\",\"category\":\"Process\"},{\"sequenceNumber\":119,\"key\":\"editing\",\"tenantTerm\":\"editing\",\"frontiersDefaultTerm\":\"editing\",\"category\":\"Process\"},{\"sequenceNumber\":120,\"key\":\"in_preparation\",\"tenantTerm\":\"in preparation\",\"frontiersDefaultTerm\":\"in preparation\",\"category\":\"Process\"},{\"sequenceNumber\":121,\"key\":\"country_region\",\"tenantTerm\":\"country\u002Fregion\",\"frontiersDefaultTerm\":\"country\u002Fregion\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":122,\"key\":\"countries_regions\",\"tenantTerm\":\"countries\u002Fregions\",\"frontiersDefaultTerm\":\"countries\u002Fregions\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":123,\"key\":\"specialty\",\"tenantTerm\":\"specialty\",\"frontiersDefaultTerm\":\"specialty\",\"category\":\"Core\"},{\"sequenceNumber\":124,\"key\":\"specialties\",\"tenantTerm\":\"specialties\",\"frontiersDefaultTerm\":\"specialties\",\"category\":\"Core\"},{\"sequenceNumber\":125,\"key\":\"associate_editors\",\"tenantTerm\":\"Associate Editors\",\"frontiersDefaultTerm\":\"Associate Editors\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":126,\"key\":\"reviewed\",\"tenantTerm\":\"reviewed\",\"frontiersDefaultTerm\":\"reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":127,\"key\":\"institutional_members\",\"tenantTerm\":\"institutional partners\",\"frontiersDefaultTerm\":\"institutional partners\",\"category\":\"Accounting\"},{\"sequenceNumber\":128,\"key\":\"institutional_memberships\",\"tenantTerm\":\"institutional partnerships\",\"frontiersDefaultTerm\":\"institutional partnerships\",\"category\":\"Accounting\"},{\"sequenceNumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantTerm\":\"Assistant Field Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":130,\"key\":\"publications\",\"tenantTerm\":\"publications\",\"frontiersDefaultTerm\":\"publications\",\"category\":\"Process\"},{\"sequenceNumber\":131,\"key\":\"ae_accepted\",\"tenantTerm\":\"recommended acceptance\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":132,\"key\":\"field_journal\",\"tenantTerm\":\"field journal\",\"frontiersDefaultTerm\":\"field journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":133,\"key\":\"field_journals\",\"tenantTerm\":\"field journals\",\"frontiersDefaultTerm\":\"field journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":134,\"key\":\"program_manager\",\"tenantTerm\":\"program manager\",\"frontiersDefaultTerm\":\"program manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":135,\"key\":\"journal_manager\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":136,\"key\":\"journal_specialist\",\"tenantTerm\":\"journal specialist\",\"frontiersDefaultTerm\":\"journal specialist\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":137,\"key\":\"program_managers\",\"tenantTerm\":\"program managers\",\"frontiersDefaultTerm\":\"program managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":138,\"key\":\"journal_managers\",\"tenantTerm\":\"journal managers\",\"frontiersDefaultTerm\":\"journal managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":139,\"key\":\"journal_specialists\",\"tenantTerm\":\"journal specialists\",\"frontiersDefaultTerm\":\"journal specialists\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":140,\"key\":\"cover_letter\",\"tenantTerm\":\"manuscript contribution to the field\",\"frontiersDefaultTerm\":\"manuscript contribution to the field\",\"category\":\"Process\"},{\"sequenceNumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantTerm\":\"recommended to accept manuscript\",\"frontiersDefaultTerm\":\"accepted manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":142,\"key\":\"recommend_for_rejection\",\"tenantTerm\":\"recommend for rejection\",\"frontiersDefaultTerm\":\"recommend for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":143,\"key\":\"recommended_for_rejection\",\"tenantTerm\":\"recommended for rejection\",\"frontiersDefaultTerm\":\"recommended for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":144,\"key\":\"ae\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"description\":\"Associate Editor - board member\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":145,\"key\":\"re\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"description\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":146,\"key\":\"rev\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"description\":\"Reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":147,\"key\":\"aut\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"description\":\"Author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":148,\"key\":\"coraut\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"description\":\"Corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":149,\"key\":\"saut\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"description\":\"Submitting author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":150,\"key\":\"coaut\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"description\":\"co-author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":151,\"key\":\"tsof\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"description\":\"Typesetter\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":152,\"key\":\"typesetting_office\",\"tenantTerm\":\"typesetting office\",\"frontiersDefaultTerm\":\"typesetting office\",\"category\":\"Product\"},{\"sequenceNumber\":153,\"key\":\"config\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"description\":\"Configuration office role\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":154,\"key\":\"jm\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"description\":\"Journal Manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":155,\"key\":\"rte\",\"tenantTerm\":\"RTE\",\"frontiersDefaultTerm\":\"RTE\",\"description\":\"Research topic editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":156,\"key\":\"organizations\",\"tenantTerm\":\"organizations\",\"frontiersDefaultTerm\":\"organizations\",\"category\":\"Core\"},{\"sequenceNumber\":157,\"key\":\"publishing\",\"tenantTerm\":\"publishing\",\"frontiersDefaultTerm\":\"publishing\",\"category\":\"Core\"},{\"sequenceNumber\":158,\"key\":\"acceptance\",\"tenantTerm\":\"acceptance\",\"frontiersDefaultTerm\":\"acceptance\",\"category\":\"Process\"},{\"sequenceNumber\":159,\"key\":\"preferred_associate_editor\",\"tenantTerm\":\"preferred associate editor\",\"frontiersDefaultTerm\":\"preferred associate editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":160,\"key\":\"topic_editors\",\"tenantTerm\":\"Topic Editors\",\"frontiersDefaultTerm\":\"Topic Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":161,\"key\":\"institutions\",\"tenantTerm\":\"institutions\",\"frontiersDefaultTerm\":\"institutions\",\"category\":\"Core\"},{\"sequenceNumber\":162,\"key\":\"author(s)\",\"tenantTerm\":\"author(s)\",\"frontiersDefaultTerm\":\"author(s)\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":163,\"key\":\"figure(s)\",\"tenantTerm\":\"figure(s)\",\"frontiersDefaultTerm\":\"figure(s)\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":164,\"key\":\"co-authors\",\"tenantTerm\":\"co-authors\",\"frontiersDefaultTerm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":165,\"key\":\"editorial_board_members\",\"tenantTerm\":\"editorial board members\",\"frontiersDefaultTerm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":166,\"key\":\"editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"Product\"},{\"sequenceNumber\":167,\"key\":\"co-authorship\",\"tenantTerm\":\"co-authorship\",\"frontiersDefaultTerm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"Misc.\"},{\"sequenceNumber\":168,\"key\":\"role_id_1\",\"tenantTerm\":\"registration office\",\"frontiersDefaultTerm\":\"registration office\",\"category\":\"User Role\"},{\"sequenceNumber\":169,\"key\":\"role_id_2\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"User Role\"},{\"sequenceNumber\":170,\"key\":\"role_id_7\",\"tenantTerm\":\"field chief editor\",\"frontiersDefaultTerm\":\"field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":171,\"key\":\"role_id_8\",\"tenantTerm\":\"assistant field chief editor\",\"frontiersDefaultTerm\":\"assistant field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":172,\"key\":\"role_id_9\",\"tenantTerm\":\"specialty chief editor\",\"frontiersDefaultTerm\":\"specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":173,\"key\":\"role_id_10\",\"tenantTerm\":\"assistant specialty chief editor\",\"frontiersDefaultTerm\":\"assistant specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":174,\"key\":\"role_id_11\",\"tenantTerm\":\"associate editor\",\"frontiersDefaultTerm\":\"associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":175,\"key\":\"role_id_12\",\"tenantTerm\":\"guest associate editor\",\"frontiersDefaultTerm\":\"guest associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":176,\"key\":\"role_id_13\",\"tenantTerm\":\"review editor\",\"frontiersDefaultTerm\":\"review editor\",\"category\":\"User Role\"},{\"sequenceNumber\":177,\"key\":\"role_id_14\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":178,\"key\":\"role_id_15\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"User Role\"},{\"sequenceNumber\":179,\"key\":\"role_id_16\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"User Role\"},{\"sequenceNumber\":180,\"key\":\"role_id_17\",\"tenantTerm\":\"submitting author\",\"frontiersDefaultTerm\":\"submitting author\",\"category\":\"User Role\"},{\"sequenceNumber\":181,\"key\":\"role_id_18\",\"tenantTerm\":\"co-author\",\"frontiersDefaultTerm\":\"co-author\",\"category\":\"User Role\"},{\"sequenceNumber\":182,\"key\":\"role_id_20\",\"tenantTerm\":\"production office\",\"frontiersDefaultTerm\":\"production office\",\"category\":\"User Role\"},{\"sequenceNumber\":183,\"key\":\"role_id_22\",\"tenantTerm\":\"typesetting office (typesetter)\",\"frontiersDefaultTerm\":\"typesetting office (typesetter)\",\"category\":\"User Role\"},{\"sequenceNumber\":184,\"key\":\"role_id_24\",\"tenantTerm\":\"registered user\",\"frontiersDefaultTerm\":\"registered user\",\"category\":\"User Role\"},{\"sequenceNumber\":185,\"key\":\"role_id_35\",\"tenantTerm\":\"job office\",\"frontiersDefaultTerm\":\"job office\",\"category\":\"User Role\"},{\"sequenceNumber\":186,\"key\":\"role_id_41\",\"tenantTerm\":\"special event administrator\",\"frontiersDefaultTerm\":\"special event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":187,\"key\":\"role_id_42\",\"tenantTerm\":\"special event reviewer\",\"frontiersDefaultTerm\":\"special event reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":188,\"key\":\"role_id_43\",\"tenantTerm\":\"submit abstract\",\"frontiersDefaultTerm\":\"submit abstract\",\"category\":\"User Role\"},{\"sequenceNumber\":189,\"key\":\"role_id_52\",\"tenantTerm\":\"events office\",\"frontiersDefaultTerm\":\"events office\",\"category\":\"User Role\"},{\"sequenceNumber\":190,\"key\":\"role_id_53\",\"tenantTerm\":\"event administrator\",\"frontiersDefaultTerm\":\"event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":191,\"key\":\"role_id_89\",\"tenantTerm\":\"content management office\",\"frontiersDefaultTerm\":\"content management office\",\"category\":\"User Role\"},{\"sequenceNumber\":192,\"key\":\"role_id_98\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"User Role\"},{\"sequenceNumber\":193,\"key\":\"role_id_99\",\"tenantTerm\":\"projects\",\"frontiersDefaultTerm\":\"projects\",\"category\":\"User Role\"},{\"sequenceNumber\":194,\"key\":\"role_id_103\",\"tenantTerm\":\"configuration office\",\"frontiersDefaultTerm\":\"configuration office\",\"category\":\"User Role\"},{\"sequenceNumber\":195,\"key\":\"role_id_104\",\"tenantTerm\":\"beta user\",\"frontiersDefaultTerm\":\"beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":196,\"key\":\"role_id_106\",\"tenantTerm\":\"wfconf\",\"frontiersDefaultTerm\":\"wfconf\",\"category\":\"User Role\"},{\"sequenceNumber\":197,\"key\":\"role_id_107\",\"tenantTerm\":\"rt management beta user\",\"frontiersDefaultTerm\":\"rt management beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":198,\"key\":\"role_id_108\",\"tenantTerm\":\"deo beta user\",\"frontiersDefaultTerm\":\"deo beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":199,\"key\":\"role_id_109\",\"tenantTerm\":\"search beta user\",\"frontiersDefaultTerm\":\"search beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":200,\"key\":\"role_id_110\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"User Role\"},{\"sequenceNumber\":201,\"key\":\"role_id_111\",\"tenantTerm\":\"myfrontiers beta user\",\"frontiersDefaultTerm\":\"myfrontiers beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":202,\"key\":\"role_id_21\",\"tenantTerm\":\"copy editor\",\"frontiersDefaultTerm\":\"copy editor\",\"category\":\"User Role\"},{\"sequenceNumber\":203,\"key\":\"role_id_1_abr\",\"tenantTerm\":\"ROF\",\"frontiersDefaultTerm\":\"ROF\",\"category\":\"User Role\"},{\"sequenceNumber\":204,\"key\":\"role_id_2_abr\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"User Role\"},{\"sequenceNumber\":205,\"key\":\"role_id_7_abr\",\"tenantTerm\":\"FCE\",\"frontiersDefaultTerm\":\"FCE\",\"category\":\"User Role\"},{\"sequenceNumber\":206,\"key\":\"role_id_8_abr\",\"tenantTerm\":\"AFCE\",\"frontiersDefaultTerm\":\"AFCE\",\"category\":\"User Role\"},{\"sequenceNumber\":207,\"key\":\"role_id_9_abr\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"category\":\"User Role\"},{\"sequenceNumber\":208,\"key\":\"role_id_10_abr\",\"tenantTerm\":\"ASCE\",\"frontiersDefaultTerm\":\"ASCE\",\"category\":\"User Role\"},{\"sequenceNumber\":209,\"key\":\"role_id_11_abr\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"category\":\"User Role\"},{\"sequenceNumber\":210,\"key\":\"role_id_12_abr\",\"tenantTerm\":\"GAE\",\"frontiersDefaultTerm\":\"GAE\",\"category\":\"User Role\"},{\"sequenceNumber\":211,\"key\":\"role_id_13_abr\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"category\":\"User Role\"},{\"sequenceNumber\":212,\"key\":\"role_id_14_abr\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"category\":\"User Role\"},{\"sequenceNumber\":213,\"key\":\"role_id_15_abr\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":214,\"key\":\"role_id_16_abr\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":215,\"key\":\"role_id_17_abr\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":216,\"key\":\"role_id_18_abr\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":217,\"key\":\"role_id_20_abr\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"User Role\"},{\"sequenceNumber\":218,\"key\":\"role_id_22_abr\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"category\":\"User Role\"},{\"sequenceNumber\":219,\"key\":\"role_id_24_abr\",\"tenantTerm\":\"RU\",\"frontiersDefaultTerm\":\"RU\",\"category\":\"User Role\"},{\"sequenceNumber\":220,\"key\":\"role_id_35_abr\",\"tenantTerm\":\"JOF\",\"frontiersDefaultTerm\":\"JOF\",\"category\":\"User Role\"},{\"sequenceNumber\":221,\"key\":\"role_id_41_abr\",\"tenantTerm\":\"SE-ADM\",\"frontiersDefaultTerm\":\"SE-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":222,\"key\":\"role_id_42_abr\",\"tenantTerm\":\"SE-REV\",\"frontiersDefaultTerm\":\"SE-REV\",\"category\":\"User Role\"},{\"sequenceNumber\":223,\"key\":\"role_id_43_abr\",\"tenantTerm\":\"SE-AUT\",\"frontiersDefaultTerm\":\"SE-AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":224,\"key\":\"role_id_52_abr\",\"tenantTerm\":\"EVOF\",\"frontiersDefaultTerm\":\"EVOF\",\"category\":\"User Role\"},{\"sequenceNumber\":225,\"key\":\"role_id_53_abr\",\"tenantTerm\":\"EV-ADM\",\"frontiersDefaultTerm\":\"EV-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":226,\"key\":\"role_id_89_abr\",\"tenantTerm\":\"COMOF\",\"frontiersDefaultTerm\":\"COMOF\",\"category\":\"User Role\"},{\"sequenceNumber\":227,\"key\":\"role_id_98_abr\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"User Role\"},{\"sequenceNumber\":228,\"key\":\"role_id_99_abr\",\"tenantTerm\":\"Projects\",\"frontiersDefaultTerm\":\"Projects\",\"category\":\"User Role\"},{\"sequenceNumber\":229,\"key\":\"role_id_103_abr\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"category\":\"User Role\"},{\"sequenceNumber\":230,\"key\":\"role_id_104_abr\",\"tenantTerm\":\"BETA\",\"frontiersDefaultTerm\":\"BETA\",\"category\":\"User Role\"},{\"sequenceNumber\":231,\"key\":\"role_id_106_abr\",\"tenantTerm\":\"WFCONF\",\"frontiersDefaultTerm\":\"WFCONF\",\"category\":\"User Role\"},{\"sequenceNumber\":232,\"key\":\"role_id_107_abr\",\"tenantTerm\":\"RTBETA\",\"frontiersDefaultTerm\":\"RTBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":233,\"key\":\"role_id_108_abr\",\"tenantTerm\":\"DEOBETA\",\"frontiersDefaultTerm\":\"DEOBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":234,\"key\":\"role_id_109_abr\",\"tenantTerm\":\"SEARCHBETA\",\"frontiersDefaultTerm\":\"SEARCHBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":235,\"key\":\"role_id_110_abr\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"category\":\"User Role\"},{\"sequenceNumber\":236,\"key\":\"role_id_111_abr\",\"tenantTerm\":\"MFBETA\",\"frontiersDefaultTerm\":\"MFBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":237,\"key\":\"role_id_21_abr\",\"tenantTerm\":\"COPED\",\"frontiersDefaultTerm\":\"COPED\",\"category\":\"User Role\"},{\"sequenceNumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"This is the label for the review editorial board\",\"category\":\"Label\"},{\"sequenceNumber\":239,\"key\":\"field_chief_editor\",\"tenantTerm\":\"Field Chief Editor\",\"frontiersDefaultTerm\":\"Field Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":240,\"key\":\"field_chief_editors\",\"tenantTerm\":\"Field Chief Editors\",\"frontiersDefaultTerm\":\"Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":241,\"key\":\"editor\",\"tenantTerm\":\"editor\",\"frontiersDefaultTerm\":\"editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":242,\"key\":\"editors\",\"tenantTerm\":\"editors\",\"frontiersDefaultTerm\":\"editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":243,\"key\":\"board\",\"tenantTerm\":\"board\",\"frontiersDefaultTerm\":\"board\",\"category\":\"Label\"},{\"sequenceNumber\":244,\"key\":\"boards\",\"tenantTerm\":\"boards\",\"frontiersDefaultTerm\":\"boards\",\"category\":\"Label\"},{\"sequenceNumber\":245,\"key\":\"article_collection\",\"tenantTerm\":\"article collection\",\"frontiersDefaultTerm\":\"article collection\",\"category\":\"Label\"},{\"sequenceNumber\":246,\"key\":\"article_collections\",\"tenantTerm\":\"article collections\",\"frontiersDefaultTerm\":\"article collections\",\"category\":\"Label\"},{\"sequenceNumber\":247,\"key\":\"handling_editor\",\"tenantTerm\":\"handling editor\",\"frontiersDefaultTerm\":\"associate editor\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":248,\"key\":\"handling_editors\",\"tenantTerm\":\"handling editors\",\"frontiersDefaultTerm\":\"associate editors\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":249,\"key\":\"ae_accept\",\"tenantTerm\":\"recommend acceptance\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":250,\"key\":\"rtm\",\"tenantTerm\":\"RTM\",\"frontiersDefaultTerm\":\"RTM\",\"category\":\"Product\"},{\"sequenceNumber\":251,\"key\":\"frontiers_media_sa\",\"tenantTerm\":\"Frontiers Media S.A\",\"frontiersDefaultTerm\":\"Frontiers Media S.A\",\"category\":\"Customer\"},{\"sequenceNumber\":252,\"key\":\"review_editors\",\"tenantTerm\":\"Review Editors\",\"frontiersDefaultTerm\":\"Review Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":255,\"key\":\"call_for_papers\",\"tenantTerm\":\"Call for papers\",\"frontiersDefaultTerm\":\"Call for papers\",\"category\":\"Label\"},{\"sequenceNumber\":256,\"key\":\"calls_for_papers\",\"tenantTerm\":\"Calls for papers\",\"frontiersDefaultTerm\":\"Calls for papers\",\"category\":\"Label\"},{\"sequenceNumber\":257,\"key\":\"supervising_editor\",\"tenantTerm\":\"Supervising Editor\",\"frontiersDefaultTerm\":\"Supervising Editor\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editor\"},{\"sequenceNumber\":258,\"key\":\"supervising_editors\",\"tenantTerm\":\"Supervising Editors\",\"frontiersDefaultTerm\":\"Supervising Editors\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editors\"},{\"sequenceNumber\":259,\"key\":\"reviewer_endorse\",\"tenantTerm\":\"endorse\",\"frontiersDefaultTerm\":\"endorse\",\"category\":\"Label\"},{\"sequenceNumber\":260,\"key\":\"reviewer_endorsed\",\"tenantTerm\":\"endorsed\",\"frontiersDefaultTerm\":\"endorsed\",\"category\":\"Label\"},{\"sequenceNumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantTerm\":\"endorse publication\",\"frontiersDefaultTerm\":\"endorse publication\",\"category\":\"Label\"},{\"sequenceNumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantTerm\":\"endorsed publication\",\"frontiersDefaultTerm\":\"endorsed publication\",\"category\":\"Label\"},{\"sequenceNumber\":263,\"key\":\"editor_role\",\"tenantTerm\":\"editor role\",\"frontiersDefaultTerm\":\"Editor Role\",\"category\":\"Label\"},{\"sequenceNumber\":264,\"key\":\"editor_roles\",\"tenantTerm\":\"editor roles\",\"frontiersDefaultTerm\":\"Editor Roles\",\"category\":\"Label\"},{\"sequenceNumber\":265,\"key\":\"editorial_role\",\"tenantTerm\":\"editorial role\",\"frontiersDefaultTerm\":\"Editorial Role\",\"category\":\"Label\"},{\"sequenceNumber\":266,\"key\":\"editorial_roles\",\"tenantTerm\":\"editorial roles\",\"frontiersDefaultTerm\":\"Editorial Roles\",\"category\":\"Label\"},{\"sequenceNumber\":267,\"key\":\"call_for_paper\",\"tenantTerm\":\"Call for paper\",\"frontiersDefaultTerm\":\"Call for paper\",\"category\":\"Label\"},{\"sequenceNumber\":268,\"key\":\"research_topic_abstract\",\"tenantTerm\":\"manuscript summary\",\"frontiersDefaultTerm\":\"manuscript summary\",\"category\":\"Process\"},{\"sequenceNumber\":269,\"key\":\"research_topic_abstracts\",\"tenantTerm\":\"manuscript summaries\",\"frontiersDefaultTerm\":\"manuscript summaries\",\"category\":\"Process\"},{\"sequenceNumber\":270,\"key\":\"submissions_team_manager\",\"tenantTerm\":\"Journal Manager\",\"frontiersDefaultTerm\":\"Content Manager\",\"category\":\"Process\"},{\"sequenceNumber\":271,\"key\":\"submissions_team\",\"tenantTerm\":\"Journal Team\",\"frontiersDefaultTerm\":\"Content Team\",\"category\":\"Process\"},{\"sequenceNumber\":272,\"key\":\"topic_coordinator\",\"tenantTerm\":\"topic coordinator\",\"frontiersDefaultTerm\":\"topic coordinator\",\"category\":\"Process\"},{\"sequenceNumber\":273,\"key\":\"topic_coordinators\",\"tenantTerm\":\"topic coordinators\",\"frontiersDefaultTerm\":\"topic coordinators\",\"category\":\"Process\"}]}'\n",gtmId:"GTM-M322FV2",gtmAuth:"owVbWxfaJr21yQv1fe1cAQ",gtmServerUrl:"https:\u002F\u002Ftag-manager.frontiersin.org",gtmPreview:"env-1",faviconSize512:"https:\u002F\u002Fbrand.frontiersin.org\u002Fm\u002Fed3f9ce840a03d7\u002Ffavicon_512-tenantFavicon-Frontiers.png",socialMediaImg:"https:\u002F\u002Fbrand.frontiersin.org\u002Fm\u002F1c8bcb536c789e11\u002FGuidelines-Frontiers_Logo_1200x628_1-91to1.png",_app:{basePath:"\u002F",assetsPath:"\u002Farticle-pages\u002F_nuxt\u002F",cdnURL:f}},apollo:{contentfulJournalsDelivery:Object.create(null),contentfulJournalsPreview:Object.create(null),contentfulHomeDelivery:Object.create(null),contentfulHomePreview:Object.create(null),frontiersGraph:Object.create(null)}}}("journal_journal","public_space",1,"frontiersin.org","",null,"_self",true,0,3,"China","frontierspartnerships.org",false,"_blank","citation_author","citation_author_institution","College of Biological Science and Engineering, Shaanxi University of Technology",2,"College of Biological Science and Engineering, Shaanxi University of Technology, China","Frontiers in Endocrinology","endocrinology","PDF",5,106,"Chen","Link",4,"Qinba State Key Laboratory of Biological Resources and Ecological Environment","description","Frontiers","Help center","Grey","Medium","ssph-journal.org","fship","image","landscape","Front. Endocrinol.","1664-2392",void 0,11,18,12,"fendo-12-759843.pdf",1920,"por-journal.com",7,"escubed.org",1918,"fipp","https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F1AAA1237-EA54-405E-B5292056FC2FC63E\u002Fwebimage-52CDCF24-D906-45A5-AFA5AA6D3AD70D22.png","histology","medicine","22C10171-81B3-4DA6-99342F272A32E8BB","jpg","2022-06-27T09:59:30Z","fendo",23,"journal_field","10.3389\u002Ffendo.2021.759843","Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure via Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism","\u003Cp\u003EDiabetic osteoporosis (DOP) belongs to secondary osteoporosis caused by diabetes; it has the characteristics of high morbidity and high disability. In the present study, we constructed a type 1 diabetic rat model and administered chondroitin sulfate (200 mg\u002Fkg) for 10 weeks to observe the preventive effect of chondroitin sulfate on the bone loss of diabetic rats. The results showed that chondroitin sulfate can reduce blood glucose and relieve symptoms of diabetic rats; in addition, it can significantly increase the bone mineral density, improve bone microstructure, and reduce bone marrow adipocyte number in diabetic rats; after 10 weeks of chondroitin sulfate administration, the SOD activity level was upregulated, as well as CAT levels, indicating that chondroitin sulfate can alleviate oxidative stress in diabetic rats. Chondroitin sulfate was also found to reduce the level of serum inflammatory cytokines (TNF-α, IL-1, IL-6, and MCP-1) and alleviate the inflammation in diabetic rats; bone metabolism marker detection results showed that chondroitin sulfate can reduce bone turnover in diabetic rats (decreased RANKL, CTX-1, ALP, and TRACP 5b levels were observed after 10 weeks of chondroitin sulfate administration). At the same time, the bone OPG and RUNX 2 expression levels were higher after chondroitin sulfate treatment, the bone RANKL expression was lowered, and the OPG\u002FRANKL ratio was upregulated. All of the above indicated that chondroitin sulfate could prevent STZ-induced DOP and repair bone microstructure; the main mechanism was through anti-oxidation, anti-inflammatory, and regulating bone metabolism. Chondroitin sulfate could be used to develop anti-DOP functional foods and diet interventions for diabetes.\u003C\u002Fp\u003E",889583,"Shan Shan","College of Food Science and Engineering, Northwest Agriculture and Forestry (A&F) University","Meng Li","Ze","Si Min","Ying Jun","Xin Sheng","Li","Shaanxi Key Laboratory of Resource Biology","De Jing",1397318,"Hong Xing","Tian Li",42129,"Peter",663338,"Yaguang",742646,"Ganesan",1423801,{},107,"Clinical Diabetes","clinical-diabetes","EPUB","fendo-12-759843.xml","Frontiers | Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure via Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism","https:\u002F\u002Fwww.frontiersin.org\u002Fjournals\u002Fendocrinology\u002Farticles\u002F10.3389\u002Ffendo.2021.759843\u002Ffull","Diabetic osteoporosis (DOP) belongs to secondary osteoporosis caused by diabetes; it has the characteristics of high morbidity and high disability. In the pr...","og:title","og:description","keywords","og:site_name","og:image","og:type","og:url","twitter:card","citation_volume","citation_journal_title","citation_publisher","citation_journal_abbrev","citation_issn","citation_doi","citation_firstpage","citation_language","citation_title","citation_keywords","citation_abstract","citation_pdf_url","citation_online_date","citation_publication_date","College of Food Science and Engineering, Northwest Agriculture and Forestry (A&F) University, China","dc.identifier","articles","editors","research-topics","https:\u002F\u002Fd2csxpduxe849s.cloudfront.net\u002Fmedia\u002FE32629C6-9347-4F84-81FEAEF7BFA342B3\u002F0B4B1380-42EB-4FD5-9D7E2DBC603E79F8\u002Fwebimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png","Man ultramarathon runner in the mountains he trains at sunset","https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fresearch-integrity","How we publish","https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fhow-we-publish","Fee policy","https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Ffee-policy","Research Topics","https:\u002F\u002Fforum.frontiersin.org\u002F","Frontiers Planet Prize","https:\u002F\u002Fwww.frontiersplanetprize.org\u002F","this link will take you to the Frontiers Planet Prize website","Career opportunities","https:\u002F\u002Fcareers.frontiersin.org\u002F","https:\u002F\u002Fwww.frontiersin.org\u002Fabout\u002Fcontact","Author guidelines","Editor guidelines","https:\u002F\u002Fwww.frontiersin.org\u002Fjournals","https:\u002F\u002Fwww.frontiersin.org\u002Farticles","Articles","https:\u002F\u002Fhelpcenter.frontiersin.org","Frontiers for Young Minds","Frontiers Facebook",9,"Transplant International","transplant-international","ti",1921,"Spanish Journal of Soil Science","spanish-journal-of-soil-science","sjss","ebm-journal.org","Public Health Reviews","public-health-reviews","phrs","Pathology and Oncology Research","pathology-and-oncology-research","pore",21,"Pastoralism: Research, Policy and Practice","pastoralism-research-policy-and-practice","past","Oncology Reviews","oncology-reviews","or","Journal of Pharmacy & Pharmaceutical Sciences","journal-of-pharmacy-pharmaceutical-sciences","jpps","Journal of Cutaneous Immunology and Allergy","journal-of-cutaneous-immunology-and-allergy","JCIA","Journal of Abdominal Wall Surgery","journal-of-abdominal-wall-surgery","jaws",1919,"International Journal of Public Health","international-journal-of-public-health","ijph","Frontiers in Pathology","pathology","fpath",13,17,6,"Experimental Biology and Medicine","experimental-biology-and-medicine","EBM","European Journal of Cultural Management and Policy","european-journal-of-cultural-management-and-policy","ejcmp","Earth Science, Systems and Society","earth-science-systems-and-society","esss","Dystonia","dystonia","dyst","British Journal of Biomedical Science","british-journal-of-biomedical-science","bjbs","Aerospace Research Communications","aerospace-research-communications","arc","Advances in Drug and Alcohol Research","advances-in-drug-and-alcohol-research","adar","Acta Virologica","acta-virologica","av","Acta Biochimica Polonica","acta-biochimica-polonica"));</script><script src="/article-pages/_nuxt/75f1046.js" defer></script><script src="/article-pages/_nuxt/a5e7651.js" defer></script><script src="/article-pages/_nuxt/f548f7f.js" defer></script><script src="/article-pages/_nuxt/e3c5a8f.js" defer></script><script src="/article-pages/_nuxt/d89174d.js" defer></script><script src="/article-pages/_nuxt/ed7fc59.js" defer></script><script src="/article-pages/_nuxt/2abb6c5.js" defer></script><script src="/article-pages/_nuxt/701e3a3.js" defer></script><script src="/article-pages/_nuxt/c9b2266.js" defer></script><script data-n-head="ssr" src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" data-body="true" async></script><script data-n-head="ssr" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML" data-body="true" async></script><script data-n-head="ssr" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js" data-body="true" async></script><script data-n-head="ssr" src="https://api.altmetric.com/v1/doi/10.3389/fendo.2021.759843?callback=_altmetric.embed_callback&amp;domain=www.frontiersin.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=14-15" data-body="true" async></script><script data-n-head="ssr" src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" data-body="true" async></script> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10